NEK4
Normalized values from positional scanning peptide array
Phospho-serine (pS) is a duplicate of phospho-tyrosine (pT) in PSPA
Position-wise Probabilities
Log-Odds: Probabilities / STY Background
Sites with acceptor types representing >8% and count ≥10 are included
S Sites Probabilities
T Sites Probabilities
Log-Odds: S Sites / S Background
Log-Odds: T Sites / T Background
Sites with acceptor types representing >8% and count ≥10 are included
Motif clusters with count ≥ 10 are shown
Download
| substrate_uniprot | site | source | substrate_genes | site_seq |
|---|---|---|---|---|
| A0A2R8Y4L2 | S95 | Sugiyama | HNRNPA1L3 HNRNPA1P48 | RPHKVDGRVVEPKRAVSREDsQRPDAHLTVKKIFVGGIKED |
| A1L429 | S7 | Sugiyama | GAGE12B; GAGE12C; GAGE12D; GAGE12E | ______________MSWRGRsTyyWPRPRRYVQPPEMIGPM |
| A5A3E0 | S1068 | Sugiyama | POTEF A26C1B | SLSTFQQMWISKQEyDEsGPsIVHRKCL_____________ |
| A5A3E0 | S939 | Sugiyama | POTEF A26C1B | VALDFEQEMATVAsSSSLEKsyELPDGQVItIGNERFRCPE |
| A5A3E0 | T949 | Sugiyama | POTEF A26C1B | TVAsSSSLEKsyELPDGQVItIGNERFRCPEALFQPCFLGM |
| A6NDE8 | S7 | Sugiyama | GAGE12H | ______________MSWRGRsTyyWPRPRRYVQPPEMIGPM |
| A6NER3 | S7 | Sugiyama | GAGE12J | ______________MSWRGRsTyyWPRPRPYVQPPEMIGPM |
| A6NMY6 | S161 | Sugiyama | ANXA2P2 ANX2L2 ANX2P2 LPC2B | QEINRVyKEMYKtDLEKDIIsDtsGDFRKLMVALAKGRRAE |
| A6NMY6 | S164 | Sugiyama | ANXA2P2 ANX2L2 ANX2P2 LPC2B | NRVyKEMYKtDLEKDIIsDtsGDFRKLMVALAKGRRAEDGS |
| B2RPK0 | S15 | Sugiyama | HMGB1P1 HMG1L1 HMGB1L1 | ______MGKGDPKKPRGKMssyAFFVQtCREEHKKKHSDAS |
| B2RPK0 | T22 | Sugiyama | HMGB1P1 HMG1L1 HMGB1L1 | GKGDPKKPRGKMssyAFFVQtCREEHKKKHSDASVNFSEFS |
| O00267 | T709 | Sugiyama | SUPT5H SPT5 SPT5H | GGSGGMSRGRGRRDNELIGQtVRISQGPYKGYIGVVKDATE |
| O00273 | T300 | Sugiyama | DFFA DFF1 DFF45 H13 | KKTETVQEACERELALRLQQtQsLHsLRsIsAsKAsPPGDL |
| O14556 | T301 | Sugiyama | GAPDHS GAPD2 GAPDH2 GAPDS HSD-35 HSD35 | ASTGAAKAVTKVIPELKGKLtGMAFRVPTPDVSVVDLTCRL |
| O14950 | T128 | Sugiyama | MYL12B MRLC2 MYLC2B | ACFDEEATGTIQEDYLRELLttMGDRFtDEEVDELyREAPI |
| O14950 | T129 | Sugiyama | MYL12B MRLC2 MYLC2B | CFDEEATGTIQEDYLRELLttMGDRFtDEEVDELyREAPID |
| O14950 | T160 | Sugiyama | MYL12B MRLC2 MYLC2B | DELyREAPIDKKGNFNyIEFtRILKHGAKDKDD________ |
| O15212 | T107 | Sugiyama | PFDN6 HKE2 PFD6 | IKRYESQLRDLERQsEQQREtLAQLQQEFQRAQAAKAGAPG |
| O15347 | S14 | Sugiyama | HMGB3 HMG2A HMG4 | _______MAKGDPKKPKGKMsAYAFFVQtCREEHKKKNPEV |
| O15347 | T22 | Sugiyama | HMGB3 HMG2A HMG4 | AKGDPKKPKGKMsAYAFFVQtCREEHKKKNPEVPVNFAEFS |
| O15371 | T46 | Sugiyama | EIF3D EIF3S7 | RDMPyQPFsKGDRLGKVADWtGAtyQDKRYTNKYSSQFGGG |
| O15371 | T49 | Sugiyama | EIF3D EIF3S7 | PyQPFsKGDRLGKVADWtGAtyQDKRYTNKYSSQFGGGSQY |
| O43242 | T69 | Sugiyama | PSMD3 | GEADGKtAAAAAEHsQRELDtVtLEDIKEHVKQLEKAVSGK |
| O43242 | T71 | Sugiyama | PSMD3 | ADGKtAAAAAEHsQRELDtVtLEDIKEHVKQLEKAVSGKEP |
| O43290 | T430 | Sugiyama | SART1 | RKKEKEVVVRADDLLPLGDQtQDGDFGsRLRGRGRRRVsEV |
| O43390 | T134 | Sugiyama | HNRNPR HNRPR | KVQESTKGPDEAKIKALLERtGytLDVttGQRKYGGPPPDS |
| O43390 | T137 | Sugiyama | HNRNPR HNRPR | ESTKGPDEAKIKALLERtGytLDVttGQRKYGGPPPDSVYS |
| O43390 | T141 | Sugiyama | HNRNPR HNRPR | GPDEAKIKALLERtGytLDVttGQRKYGGPPPDSVYSGVQP |
| O43390 | Y136 | Sugiyama | HNRNPR HNRPR | QESTKGPDEAKIKALLERtGytLDVttGQRKYGGPPPDSVY |
| O43399 | T173 | Sugiyama | TPD52L2 | RKLGDMRNsAtFKsFEDRVGtIKSKVVGDRENGsDNLPssA |
| O43423 | T101 | Sugiyama | ANP32CP PP32R1 | EKCPNLTHLYLSGNKIKDLstIEPLKQLENLKSLDLFNCEV |
| O43615 | T198 | Sugiyama | TIMM44 MIMT44 TIM44 | ALsQGVEsVKKEIDDsVLGQtGPyRRPQRLRKRTEFAGDKF |
| O43707 | T359 | Sugiyama | ACTN4 | RRVHKPPKVQEKCQLEINFNtLQtKLRLSNRPAFMPSEGKM |
| O43707 | T362 | Sugiyama | ACTN4 | HKPPKVQEKCQLEINFNtLQtKLRLSNRPAFMPSEGKMVSD |
| O43707 | T443 | Sugiyama | ACTN4 | sIHEAWtDGKEAMLKHRDyEtAtLsDIKALIRKHEAFEsDL |
| O43707 | T445 | Sugiyama | ACTN4 | HEAWtDGKEAMLKHRDyEtAtLsDIKALIRKHEAFEsDLAA |
| O43852 | T196 | Sugiyama | CALU | FtAFLHPEEyDyMKDIVVQEtMEDIDKNADGFIDLEEyIGD |
| O43852 | T89 | Sugiyama | CALU | sKERLGKIVSKIDGDKDGFVtVDELKDWIKFAQKRWIyEDV |
| O60234 | T114 | Sugiyama | GMFG | VGCKPEQQMMyAGSKNRLVQtAELtKVFEIRTTDDLTEAWL |
| O60234 | T118 | Sugiyama | GMFG | PEQQMMyAGSKNRLVQtAELtKVFEIRTTDDLTEAWLQEKL |
| O60361 | T79 | Sugiyama | NME2P1 | VAMVWEGLNVVKTGRVMLGEtNPADsKPGtIRGDFCIQVGR |
| O60361 | T88 | Sugiyama | NME2P1 | VVKTGRVMLGEtNPADsKPGtIRGDFCIQVGRNIIHGsDsV |
| O60506 | T131 | Sugiyama | SYNCRIP HNRPQ NSAP1 | KVADSSKGPDEAKIKALLERtGytLDVttGQRKYGGPPPDS |
| O60506 | T134 | Sugiyama | SYNCRIP HNRPQ NSAP1 | DSSKGPDEAKIKALLERtGytLDVttGQRKYGGPPPDSVYS |
| O60506 | T138 | Sugiyama | SYNCRIP HNRPQ NSAP1 | GPDEAKIKALLERtGytLDVttGQRKYGGPPPDSVYSGQQP |
| O60506 | Y133 | Sugiyama | SYNCRIP HNRPQ NSAP1 | ADSSKGPDEAKIKALLERtGytLDVttGQRKYGGPPPDSVY |
| O60841 | S196 | Sugiyama | EIF5B IF2 KIAA0741 | ERsRINssGEsGDEsDEFLQsRKGQKKNQKNKPGPNIEsGN |
| O60841 | T289 | Sugiyama | EIF5B IF2 KIAA0741 | QKESQRKFEEETVKSKVTVDtGVIPAsEEKAEtPtAAEDDN |
| O75347 | S60 | Sugiyama | TBCA | MRAEDGENyDIKKQAEILQEsRMMIPDCQRRLEAAyLDLQR |
| O75534 | T761 | Sugiyama | CSDE1 D1S155E KIAA0885 NRU UNR | GPKAVAAPRPDRLVNRLKNItLDDAsAPRLMVLRQPRGPDN |
| O75683 | S13 | Sugiyama | SURF6 SURF-6 | ________MASLLAKDAyLQsLAKKICSHsAPEQQARTRAG |
| O75821 | S189 | Sugiyama | EIF3G EIF3S4 | CPYKDtLGPMQKELAEQLGLstGEKEKLPGELEPVQAtQNK |
| O75821 | T190 | Sugiyama | EIF3G EIF3S4 | PYKDtLGPMQKELAEQLGLstGEKEKLPGELEPVQAtQNKt |
| O75914 | T119 | Sugiyama | PAK3 OPHN3 | QMCPGKLPEGIPEQWARLLQtsNItKLEQKKNPQAVLDVLK |
| O76087 | S7 | Sugiyama | GAGE7 GAGE12I GAGE7B | ______________MSWRGRsTyyWPRPRRYVQPPEMIGPM |
| O76094 | S524 | Sugiyama | SRP72 | KHLPSSDSMSLKVDVEALENsAGAtyIRKKGGKVTGDsQPK |
| O76094 | T528 | Sugiyama | SRP72 | SSDSMSLKVDVEALENsAGAtyIRKKGGKVTGDsQPKEQGQ |
| O94992 | T270 | Sugiyama | HEXIM1 CLP1 EDG1 HIS1 MAQ1 | GGsDGMGGDGSEFLQRDFsEtyERyHTEsLQNMsKQELIKE |
| O95071 | T119 | Sugiyama | UBR5 EDD EDD1 HYD KIAA0896 | GRTSRPGRTSDsPWFLsGSEtLGRLAGNTLGSRWSsGVGGs |
| O95218 | T50 | Sugiyama | ZRANB2 ZIS ZNF265 | SCNRCGREKTTEAKMMKAGGtEIGKtLAEKSRGLFsANDWQ |
| O95218 | T55 | Sugiyama | ZRANB2 ZIS ZNF265 | GREKTTEAKMMKAGGtEIGKtLAEKSRGLFsANDWQCKTCs |
| O95373 | T968 | Sugiyama | IPO7 RANBP7 | IIDDEDNPVDEYQIFKAIFQtIQNRNPVWyQALTHGLNEEQ |
| O95373 | T997 | Sugiyama | IPO7 RANBP7 | yQALTHGLNEEQRKQLQDIAtLADQRRAAHESKMIEKHGGY |
| O95626 | T105 | Sugiyama | ANP32D PP32R2 | EKCPNLIHLNLSGNKIKDLstIEPLKKLENLESLDLFTCEV |
| O95816 | S31 | Sugiyama | BAG2 | NEGRFCRsssMADRsSRLLEsLDQLELRVEALREAATAVEQ |
| P00338 | S161 | Sugiyama | LDHA PIG19 | DILTYVAWKISGFPKNRVIGsGCNLDsARFRyLMGERLGVH |
| P00338 | S167 | Sugiyama | LDHA PIG19 | AWKISGFPKNRVIGsGCNLDsARFRyLMGERLGVHPLSCHG |
| P00558 | S393 | Sugiyama | PGK1 PGKA MIG10 OK/SW-cl.110 | GGDtAtCCAKWNtEDKVsHVstGGGAsLELLEGKVLPGVDA |
| P00558 | S399 | Sugiyama | PGK1 PGKA MIG10 OK/SW-cl.110 | CCAKWNtEDKVsHVstGGGAsLELLEGKVLPGVDALsNI__ |
| P00558 | T168 | Sugiyama | PGK1 PGKA MIG10 OK/SW-cl.110 | EAFRAsLSKLGDVyVNDAFGtAHRAHssMVGVNLPQKAGGF |
| P00558 | T369 | Sugiyama | PGK1 PGKA MIG10 OK/SW-cl.110 | ARGTKALMDEVVKAtsRGCItIIGGGDtAtCCAKWNtEDKV |
| P00558 | T376 | Sugiyama | PGK1 PGKA MIG10 OK/SW-cl.110 | MDEVVKAtsRGCItIIGGGDtAtCCAKWNtEDKVsHVstGG |
| P00558 | T394 | Sugiyama | PGK1 PGKA MIG10 OK/SW-cl.110 | GDtAtCCAKWNtEDKVsHVstGGGAsLELLEGKVLPGVDAL |
| P00558 | Y161 | Sugiyama | PGK1 PGKA MIG10 OK/SW-cl.110 | KAEPAKIEAFRAsLSKLGDVyVNDAFGtAHRAHssMVGVNL |
| P00966 | T208 | Sugiyama | ASS1 ASS | IsyEAGILENPKNQAPPGLytKtQDPAKAPNtPDILEIEFK |
| P00966 | T210 | Sugiyama | ASS1 ASS | yEAGILENPKNQAPPGLytKtQDPAKAPNtPDILEIEFKKG |
| P02786 | T143 | Sugiyama | TFRC | yWDDLKRKLsEKLDstDFTGtIKLLNENsyVPREAGsQKDE |
| P04075 | S336 | Sugiyama | ALDOA ALDA | GKKENLKAAQEEYVKRALANsLACQGKytPsGQAGAAAsEs |
| P04075 | S356 | Sugiyama | ALDOA ALDA | sLACQGKytPsGQAGAAAsEsLFVsNHAy____________ |
| P04075 | S36 | Sugiyama | ALDOA ALDA | LsDIAHRIVAPGKGILAADEstGsIAKRLQsIGtENtEENR |
| P04075 | S360 | Sugiyama | ALDOA ALDA | QGKytPsGQAGAAAsEsLFVsNHAy________________ |
| P04075 | T119 | Sugiyama | ALDOA ALDA | KsKGGVVGIKVDKGVVPLAGtNGEtttQGLDGLsERCAQYK |
| P04075 | T123 | Sugiyama | ALDOA ALDA | GVVGIKVDKGVVPLAGtNGEtttQGLDGLsERCAQYKKDGA |
| P04075 | T125 | Sugiyama | ALDOA ALDA | VGIKVDKGVVPLAGtNGEtttQGLDGLsERCAQYKKDGADF |
| P04075 | T37 | Sugiyama | ALDOA ALDA | sDIAHRIVAPGKGILAADEstGsIAKRLQsIGtENtEENRR |
| P04075 | T49 | Sugiyama | ALDOA ALDA | GILAADEstGsIAKRLQsIGtENtEENRRFyRQLLLtADDR |
| P04075 | T65 | Sugiyama | ALDOA ALDA | QsIGtENtEENRRFyRQLLLtADDRVNPCIGGVILFHETLY |
| P04083 | S173 | Sugiyama | ANXA1 ANX1 LPC1 | NRVYREELKRDLAKDItsDtsGDFRNALLsLAKGDRsEDFG |
| P04083 | T169 | Sugiyama | ANXA1 ANX1 LPC1 | IRDINRVYREELKRDLAKDItsDtsGDFRNALLsLAKGDRs |
| P04083 | T172 | Sugiyama | ANXA1 ANX1 LPC1 | INRVYREELKRDLAKDItsDtsGDFRNALLsLAKGDRsEDF |
| P04083 | T223 | Sugiyama | ANXA1 ANX1 LPC1 | ARALyEAGERRKGtDVNVFNtILttRSyPQLRRVFQKYTKY |
| P04083 | T226 | Sugiyama | ANXA1 ANX1 LPC1 | LyEAGERRKGtDVNVFNtILttRSyPQLRRVFQKYTKYSKH |
| P04406 | S151 | Sugiyama | GAPDH GAPD CDABP0047 OK/SW-cl.12 | FVMGVNHEKYDNSLKIIsNAsCttNCLAPLAKVIHDNFGIV |
| P04406 | S210 | Sugiyama | GAPDH GAPD CDABP0047 OK/SW-cl.12 | GPsGKLWRDGRGALQNIIPAstGAAKAVGKVIPELNGKLtG |
| P04406 | T104 | Sugiyama | GAPDH GAPD CDABP0047 OK/SW-cl.12 | KIKWGDAGAEyVVEstGVFttMEKAGAHLQGGAKRVIIsAP |
| P04406 | T154 | Sugiyama | GAPDH GAPD CDABP0047 OK/SW-cl.12 | GVNHEKYDNSLKIIsNAsCttNCLAPLAKVIHDNFGIVEGL |
| P04406 | T211 | Sugiyama | GAPDH GAPD CDABP0047 OK/SW-cl.12 | PsGKLWRDGRGALQNIIPAstGAAKAVGKVIPELNGKLtGM |
| P04406 | T229 | Sugiyama | GAPDH GAPD CDABP0047 OK/SW-cl.12 | AstGAAKAVGKVIPELNGKLtGMAFRVPtANVsVVDLtCRL |
| P04406 | T246 | Sugiyama | GAPDH GAPD CDABP0047 OK/SW-cl.12 | GKLtGMAFRVPtANVsVVDLtCRLEKPAKyDDIKKVVKQAS |
| P04406 | T99 | Sugiyama | GAPDH GAPD CDABP0047 OK/SW-cl.12 | ERDPsKIKWGDAGAEyVVEstGVFttMEKAGAHLQGGAKRV |
| P04406 | Y320 | Sugiyama | GAPDH GAPD CDABP0047 OK/SW-cl.12 | GIALNDHFVKLIsWyDNEFGysNRVVDLMAHMAsKE_____ |
| P04792 | S82 | Sugiyama | HSPB1 HSP27 HSP28 | AIEsPAVAAPAYsRALsRQLssGVsEIRHtADRWRVsLDVN |
| P05787 | S291 | Sugiyama | KRT8 CYK8 | ANRsRAEAEsMyQIKyEELQsLAGKHGDDLRRTKTEISEMN |
| P06733 | S268 | Sugiyama | ENO1 ENO1L1 MBPB1 MPB1 | ASEFFRsGKyDLDFKsPDDPsRyIsPDQLADLyKsFIKDyP |
| P06733 | S27 | Sugiyama | ENO1 ENO1L1 MBPB1 MPB1 | HAREIFDsRGNPtVEVDLFtsKGLFRAAVPsGAstGIyEAL |
| P06733 | T100 | Sugiyama | ENO1 ENO1L1 MBPB1 MPB1 | KKLNVtEQEKIDKLMIEMDGtENKsKFGANAILGVsLAVCK |
| P06733 | T19 | Sugiyama | ENO1 ENO1L1 MBPB1 MPB1 | __MSILKIHAREIFDsRGNPtVEVDLFtsKGLFRAAVPsGA |
| P06733 | T205 | Sugiyama | ENO1 ENO1L1 MBPB1 MPB1 | GAEVyHNLKNVIKEKyGKDAtNVGDEGGFAPNILENKEGLE |
| P06733 | T26 | Sugiyama | ENO1 ENO1L1 MBPB1 MPB1 | IHAREIFDsRGNPtVEVDLFtsKGLFRAAVPsGAstGIyEA |
| P06733 | T41 | Sugiyama | ENO1 ENO1L1 MBPB1 MPB1 | EVDLFtsKGLFRAAVPsGAstGIyEALELRDNDKtRYMGKG |
| P06733 | T55 | Sugiyama | ENO1 ENO1L1 MBPB1 MPB1 | VPsGAstGIyEALELRDNDKtRYMGKGVSKAVEHINKtIAP |
| P06733 | Y270 | Sugiyama | ENO1 ENO1L1 MBPB1 MPB1 | EFFRsGKyDLDFKsPDDPsRyIsPDQLADLyKsFIKDyPVV |
| P07195 | S162 | Sugiyama | LDHB | DILTYVTWKLSGLPKHRVIGsGCNLDsARFRyLMAEKLGIH |
| P07195 | S168 | Sugiyama | LDHB | TWKLSGLPKHRVIGsGCNLDsARFRyLMAEKLGIHPSSCHG |
| P07195 | S303 | Sugiyama | LDHB | GIENEVFLSLPCILNARGLtsVINQKLKDDEVAQLKKsADt |
| P07195 | S320 | Sugiyama | LDHB | GLtsVINQKLKDDEVAQLKKsADtLWDIQKDLKDL______ |
| P07195 | T302 | Sugiyama | LDHB | YGIENEVFLSLPCILNARGLtsVINQKLKDDEVAQLKKsAD |
| P07195 | T323 | Sugiyama | LDHB | sVINQKLKDDEVAQLKKsADtLWDIQKDLKDL_________ |
| P07205 | S393 | Sugiyama | PGK2 PGKB | GGDTATCCAKWNtEDKVsHVstGGGAsLELLEGKILPGVEA |
| P07205 | S399 | Sugiyama | PGK2 PGKB | CCAKWNtEDKVsHVstGGGAsLELLEGKILPGVEALSNM__ |
| P07205 | T168 | Sugiyama | PGK2 PGKB | EAFRAsLSKLGDVyVNDAFGtAHRAHSSMVGVNLPHKASGF |
| P07205 | T394 | Sugiyama | PGK2 PGKB | GDTATCCAKWNtEDKVsHVstGGGAsLELLEGKILPGVEAL |
| P07205 | Y161 | Sugiyama | PGK2 PGKB | KAEPDKIEAFRAsLSKLGDVyVNDAFGtAHRAHSSMVGVNL |
| P07237 | T428 | Sugiyama | P4HB ERBA2L PDI PDIA1 PO4DB | DKLGEtyKDHENIVIAKMDstANEVEAVKVHsFPtLKFFPA |
| P07355 | S161 | Sugiyama | ANXA2 ANX2 ANX2L4 CAL1H LPC2D | QEINRVyKEMYKtDLEKDIIsDtsGDFRKLMVALAKGRRAE |
| P07355 | S164 | Sugiyama | ANXA2 ANX2 ANX2L4 CAL1H LPC2D | NRVyKEMYKtDLEKDIIsDtsGDFRKLMVALAKGRRAEDGs |
| P07437 | S115 | Sugiyama | TUBB TUBB5 OK/SW-cl.56 | sGAGNNWAKGHytEGAELVDsVLDVVRKEAESCDCLQGFQL |
| P07437 | T107 | Sugiyama | TUBB TUBB5 OK/SW-cl.56 | PDNFVFGQsGAGNNWAKGHytEGAELVDsVLDVVRKEAESC |
| P07814 | S335 | Sugiyama | EPRS1 EPRS GLNS PARS QARS QPRS PIG32 | PIEKNLQMWEEMKKGsQFGQsCCLRAKIDMSSNNGCMRDPt |
| P07858 | T95 | Sugiyama | CTSB CPSB | TEDLKLPAsFDAREQWPQCPtIKEIRDQGSCGSCWAFGAVE |
| P07864 | S161 | Sugiyama | LDHC LDH3 LDHX | DILTYIVWKISGLPVTRVIGsGCNLDsARFRYLIGEKLGVH |
| P07864 | S167 | Sugiyama | LDHC LDH3 LDHX | VWKISGLPVTRVIGsGCNLDsARFRYLIGEKLGVHPTSCHG |
| P07900 | S399 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | PEYLNFIRGVVDsEDLPLNIsREMLQQsKILKVIRKNLVKK |
| P07900 | S406 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | RGVVDsEDLPLNIsREMLQQsKILKVIRKNLVKKCLELFtE |
| P07900 | S476 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | RKKLsELLRyytsAsGDEMVsLKDYCTRMKENQKHIyyItG |
| P07900 | S543 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | EPIDEyCVQQLKEFEGKtLVsVTKEGLELPEDEEEKKKQEE |
| P07900 | S641 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | DNstMGyMAAKKHLEINPDHsIIEtLRQKAEADKNDKSVKD |
| P07900 | T195 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | DTGEPMGRGTKVILHLKEDQtEyLEERRIKEIVKKHSQFIG |
| P07900 | T317 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | WtRNPDDItNEEyGEFyKsLtNDWEDHLAVKHFSVEGQLEF |
| P07900 | T540 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | yMIEPIDEyCVQQLKEFEGKtLVsVTKEGLELPEDEEEKKK |
| P07900 | T645 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | MGyMAAKKHLEINPDHsIIEtLRQKAEADKNDKSVKDLVIL |
| P08195 | S598 | Sugiyama | SLC3A2 MDU1 | LQASDLPASASLPAKADLLLstQPGREEGsPLELERLKLEP |
| P08195 | T401 | Sugiyama | SLC3A2 MDU1 | NSSDLQQILSLLESNKDLLLtssyLsDsGstGEHtKSLVTQ |
| P08195 | T415 | Sugiyama | SLC3A2 MDU1 | NKDLLLtssyLsDsGstGEHtKSLVTQYLNATGNRWCSWSL |
| P08195 | T599 | Sugiyama | SLC3A2 MDU1 | QASDLPASASLPAKADLLLstQPGREEGsPLELERLKLEPH |
| P08238 | S391 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | PEYLNFIRGVVDsEDLPLNIsREMLQQsKILKVIRKNIVKK |
| P08238 | S398 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | RGVVDsEDLPLNIsREMLQQsKILKVIRKNIVKKCLELFsE |
| P08238 | S45 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | MSLIINTFYSNKEIFLRELIsNAsDALDKIRyEsLtDPsKL |
| P08238 | S462 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | HEDstNRRRLsELLRyHtsQsGDEMtsLsEyVsRMKEtQKs |
| P08238 | S468 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | RRRLsELLRyHtsQsGDEMtsLsEyVsRMKEtQKsIyyItG |
| P08238 | S48 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | IINTFYSNKEIFLRELIsNAsDALDKIRyEsLtDPsKLDsG |
| P08238 | T190 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | DHGEPIGRGTKVILHLKEDQtEyLEERRVKEVVKKHsQFIG |
| P08238 | T309 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | WtRNPDDItQEEyGEFyKsLtNDWEDHLAVKHFSVEGQLEF |
| P08238 | T637 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | MGyMMAKKHLEINPDHPIVEtLRQKAEADKNDKAVKDLVVL |
| P08238 | Y457 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | LKLGIHEDstNRRRLsELLRyHtsQsGDEMtsLsEyVsRMK |
| P08758 | S44 | Sugiyama | ANXA5 ANX5 ENX2 PP4 | LRKAMKGLGtDEEsILtLLtsRsNAQRQEISAAFKTLFGRD |
| P08758 | T40 | Sugiyama | ANXA5 ANX5 ENX2 PP4 | DAEtLRKAMKGLGtDEEsILtLLtsRsNAQRQEISAAFKTL |
| P08758 | T8 | Sugiyama | ANXA5 ANX5 ENX2 PP4 | _____________MAQVLRGtVtDFPGFDERADAEtLRKAM |
| P09382 | S63 | Sugiyama | LGALS1 | CLHFNPRFNAHGDANtIVCNsKDGGAWGTEQREAVFPFQPG |
| P09382 | T58 | Sugiyama | LGALS1 | DsNNLCLHFNPRFNAHGDANtIVCNsKDGGAWGTEQREAVF |
| P09429 | S15 | Sugiyama | HMGB1 HMG1 | ______MGKGDPKKPRGKMssyAFFVQtCREEHKKKHPDAs |
| P09429 | T22 | Sugiyama | HMGB1 HMG1 | GKGDPKKPRGKMssyAFFVQtCREEHKKKHPDAsVNFsEFs |
| P09651 | S95 | Sugiyama | HNRNPA1 HNRPA1 | RPHKVDGRVVEPKRAVsREDsQRPGAHLtVKKIFVGGIKED |
| P09661 | S226 | Sugiyama | SNRPA1 | NAIANAstLAEVERLKGLLQsGQIPGRERRsGPtDDGEEEM |
| P0CG38 | S1068 | Sugiyama | POTEI | SLSTFQQMWISKQEyDEsGPsIVHRKCF_____________ |
| P0CG39 | S1031 | Sugiyama | POTEJ | SLSTFQQMWISKQEyDEsGPsIVHRKCF_____________ |
| P0CL80 | S7 | Sugiyama | GAGE12F | ______________MSWRGRsTyyWPRPRRYVQPPEMIGPM |
| P0DPH7 | T334 | Sugiyama | TUBA3C TUBA2 | ACCMLYRGDVVPKDVNAAIAtIKtKRTIQFVDWCPTGFKVG |
| P0DPH7 | T337 | Sugiyama | TUBA3C TUBA2 | MLYRGDVVPKDVNAAIAtIKtKRTIQFVDWCPTGFKVGINy |
| P0DPH7 | T51 | Sugiyama | TUBA3C TUBA2 | QPDGQMPSDKtIGGGDDsFNtFFsEtGAGKHVPRAVFVDLE |
| P0DPH7 | T56 | Sugiyama | TUBA3C TUBA2 | MPSDKtIGGGDDsFNtFFsEtGAGKHVPRAVFVDLEPtVVD |
| P0DPH7 | T73 | Sugiyama | TUBA3C TUBA2 | FsEtGAGKHVPRAVFVDLEPtVVDEVRtGtyRQLFHPEQLI |
| P0DPH7 | T80 | Sugiyama | TUBA3C TUBA2 | KHVPRAVFVDLEPtVVDEVRtGtyRQLFHPEQLItGKEDAA |
| P0DPH7 | T82 | Sugiyama | TUBA3C TUBA2 | VPRAVFVDLEPtVVDEVRtGtyRQLFHPEQLItGKEDAANN |
| P0DPH7 | Y83 | Sugiyama | TUBA3C TUBA2 | PRAVFVDLEPtVVDEVRtGtyRQLFHPEQLItGKEDAANNy |
| P0DSO3 | S7 | Sugiyama | GAGE4 | ______________MSWRGRsTyyWPRPRRYVQPPEMIGPM |
| P10412 | S55 | Sugiyama | H1-4 H1F4 HIST1H1E | AsGPPVsELItKAVAASKERsGVsLAALKKALAAAGyDVEK |
| P10412 | T45 | Sugiyama | H1-4 H1F4 HIST1H1E | RKsAGAAKRKAsGPPVsELItKAVAASKERsGVsLAALKKA |
| P10412 | T92 | Sugiyama | H1-4 H1F4 HIST1H1E | DVEKNNSRIKLGLKsLVsKGtLVQtKGtGAsGsFKLNKKAA |
| P10412 | T96 | Sugiyama | H1-4 H1F4 HIST1H1E | NNSRIKLGLKsLVsKGtLVQtKGtGAsGsFKLNKKAAsGEA |
| P10412 | T99 | Sugiyama | H1-4 H1F4 HIST1H1E | RIKLGLKsLVsKGtLVQtKGtGAsGsFKLNKKAAsGEAKPK |
| P10412 | Y71 | Sugiyama | H1-4 H1F4 HIST1H1E | SKERsGVsLAALKKALAAAGyDVEKNNSRIKLGLKsLVsKG |
| P10809 | S488 | Sugiyama | HSPD1 HSP60 | IKRTLKIPAMtIAKNAGVEGsLIVEKIMQSSsEVGYDAMAG |
| P10809 | T231 | Sugiyama | HSPD1 HSP60 | LEIIEGMKFDRGyIsPyFINtsKGQKCEFQDAyVLLsEKKI |
| P10809 | Y223 | Sugiyama | HSPD1 HSP60 | DGKtLNDELEIIEGMKFDRGyIsPyFINtsKGQKCEFQDAy |
| P11142 | T163 | Sugiyama | HSPA8 HSC70 HSP73 HSPA10 | VVtVPAyFNDsQRQAtKDAGtIAGLNVLRIINEPtAAAIAy |
| P11142 | T226 | Sugiyama | HSPA8 HSC70 HSP73 HSPA10 | DVSILTIEDGIFEVKstAGDtHLGGEDFDNRMVNHFIAEFK |
| P11142 | T37 | Sugiyama | HSPA8 HSC70 HSP73 HSPA10 | CVGVFQHGKVEIIANDQGNRttPsyVAFtDtERLIGDAAKN |
| P11142 | T47 | Sugiyama | HSPA8 HSC70 HSP73 HSPA10 | EIIANDQGNRttPsyVAFtDtERLIGDAAKNQVAMNPtNtV |
| P11142 | T64 | Sugiyama | HSPA8 HSC70 HSP73 HSPA10 | FtDtERLIGDAAKNQVAMNPtNtVFDAKRLIGRRFDDAVVQ |
| P11142 | T66 | Sugiyama | HSPA8 HSC70 HSP73 HSPA10 | DtERLIGDAAKNQVAMNPtNtVFDAKRLIGRRFDDAVVQsD |
| P11586 | T128 | Sugiyama | MTHFD1 MTHFC MTHFD | SINTEEVINAIAPEKDVDGLtsINAGKLARGDLNDCFIPCt |
| P11940 | T191 | Sugiyama | PABPC1 PAB1 PABP PABP1 PABPC2 | GRFKSRKEREAELGARAKEFtNVyIKNFGEDMDDERLKDLF |
| P11940 | Y194 | Sugiyama | PABPC1 PAB1 PABP PABP1 PABPC2 | KSRKEREAELGARAKEFtNVyIKNFGEDMDDERLKDLFGKF |
| P12004 | S172 | Sugiyama | PCNA | sHIGDAVVIsCAKDGVKFSAsGELGNGNIKLSQTSNVDKEE |
| P12814 | T340 | Sugiyama | ACTN1 | RRLHKPPKVQEKCQLEINFNtLQtKLRLsNRPAFMPsEGRM |
| P12814 | T343 | Sugiyama | ACTN1 | HKPPKVQEKCQLEINFNtLQtKLRLsNRPAFMPsEGRMVSD |
| P13639 | S593 | Sugiyama | EEF2 EF2 | SDPVVsyREtVsEEsNVLCLsKsPNKHNRLyMKARPFPDGL |
| P13639 | S732 | Sugiyama | EEF2 EF2 | DAIHRGGGQIIPtARRCLyAsVLtAQPRLMEPIyLVEIQCP |
| P13639 | T735 | Sugiyama | EEF2 EF2 | HRGGGQIIPtARRCLyAsVLtAQPRLMEPIyLVEIQCPEQV |
| P13639 | Y730 | Sugiyama | EEF2 EF2 | HADAIHRGGGQIIPtARRCLyAsVLtAQPRLMEPIyLVEIQ |
| P13667 | S379 | Sugiyama | PDIA4 ERP70 ERP72 | QPEKFQSKYEPRSHMMDVQGstQDsAIKDFVLKyALPLVGH |
| P13861 | S99 | Sugiyama | PRKAR2A PKR2 PRKAR2 | EsEEDEDLEVPVPsRFNRRVsVCAEtyNPDEEEEDTDPRVI |
| P14314 | T115 | Sugiyama | PRKCSH G19P1 | GVCDCCDGtDEyNsGVICENtCKEKGRKEREsLQQMAEVtR |
| P14314 | T134 | Sugiyama | PRKCSH G19P1 | NtCKEKGRKEREsLQQMAEVtREGFRLKKILIEDWKKAREE |
| P14314 | T469 | Sugiyama | PRKCSH G19P1 | WGsWIGPDHDKFSAMKyEQGtGCWQGPNRstTVRLLCGKEt |
| P14618 | S202 | Sugiyama | PKM OIP3 PK2 PK3 PKM2 | SLQVKQKGADFLVtEVENGGsLGsKKGVNLPGAAVDLPAVs |
| P14618 | T195 | Sugiyama | PKM OIP3 PK2 PK3 PKM2 | yVDDGLISLQVKQKGADFLVtEVENGGsLGsKKGVNLPGAA |
| P14618 | T45 | Sugiyama | PKM OIP3 PK2 PK3 PKM2 | TFLEHMCRLDIDsPPItARNtGIICtIGPAsRsVEtLKEMI |
| P14618 | T50 | Sugiyama | PKM OIP3 PK2 PK3 PKM2 | MCRLDIDsPPItARNtGIICtIGPAsRsVEtLKEMIKsGMN |
| P14625 | S106 | Sugiyama | HSP90B1 GRP94 HSPC4 TRA1 | MKLIINSLYKNKEIFLRELIsNAsDALDKIRLISLTDENAL |
| P14625 | S109 | Sugiyama | HSP90B1 GRP94 HSPC4 TRA1 | IINSLYKNKEIFLRELIsNAsDALDKIRLISLTDENALSGN |
| P14625 | S64 | Sugiyama | HSP90B1 GRP94 HSPC4 TRA1 | tDDEVVQREEEAIQLDGLNAsQIRELREKSEKFAFQAEVNR |
| P14625 | T171 | Sugiyama | HSP90B1 GRP94 HSPC4 TRA1 | GVGMtREELVKNLGTIAKsGtsEFLNKMTEAQEDGQSTSEL |
| P15311 | S535 | Sugiyama | EZR VIL2 | EKRITEAEKNERVQRQLLtLssELsQARDENKRTHNDIIHN |
| P15311 | T533 | Sugiyama | EZR VIL2 | NEEKRITEAEKNERVQRQLLtLssELsQARDENKRTHNDII |
| P15531 | T103 | Sugiyama | NME1 NDPKA NM23 | VVKTGRVMLGEtNPADsKPGtIRGDFCIQVGRNIIHGsDsV |
| P15531 | T94 | Sugiyama | NME1 NDPKA NM23 | VAMVWEGLNVVKTGRVMLGEtNPADsKPGtIRGDFCIQVGR |
| P16070 | T76 | Sugiyama | CD44 LHR MDU2 MDU3 MIC4 | FNSTLPTMAQMEKALsIGFEtCRyGFIEGHVVIPRIHPNSI |
| P16401 | T102 | Sugiyama | H1-5 H1F5 HIST1H1B | RIKLGLKsLVsKGtLVQtKGtGAsGsFKLNKKAAsGEAKPK |
| P16401 | T95 | Sugiyama | H1-5 H1F5 HIST1H1B | DVEKNNSRIKLGLKsLVsKGtLVQtKGtGAsGsFKLNKKAA |
| P16401 | T99 | Sugiyama | H1-5 H1F5 HIST1H1B | NNSRIKLGLKsLVsKGtLVQtKGtGAsGsFKLNKKAAsGEA |
| P16402 | S56 | Sugiyama | H1-3 H1F3 HIST1H1D | AsGPPVsELItKAVAASKERsGVsLAALKKALAAAGyDVEK |
| P16402 | T100 | Sugiyama | H1-3 H1F3 HIST1H1D | RIKLGLKsLVsKGtLVQtKGtGAsGsFKLNKKAASGEGKPK |
| P16402 | T46 | Sugiyama | H1-3 H1F3 HIST1H1D | KAGATAGKRKAsGPPVsELItKAVAASKERsGVsLAALKKA |
| P16402 | T93 | Sugiyama | H1-3 H1F3 HIST1H1D | DVEKNNSRIKLGLKsLVsKGtLVQtKGtGAsGsFKLNKKAA |
| P16402 | T97 | Sugiyama | H1-3 H1F3 HIST1H1D | NNSRIKLGLKsLVsKGtLVQtKGtGAsGsFKLNKKAASGEG |
| P16402 | Y72 | Sugiyama | H1-3 H1F3 HIST1H1D | SKERsGVsLAALKKALAAAGyDVEKNNSRIKLGLKsLVsKG |
| P16403 | S55 | Sugiyama | H1-2 H1F2 HIST1H1C | AsGPPVsELItKAVAASKERsGVsLAALKKALAAAGyDVEK |
| P16403 | T45 | Sugiyama | H1-2 H1F2 HIST1H1C | AKKAGGtPRKAsGPPVsELItKAVAASKERsGVsLAALKKA |
| P16403 | T92 | Sugiyama | H1-2 H1F2 HIST1H1C | DVEKNNSRIKLGLKsLVsKGtLVQtKGtGAsGsFKLNKKAA |
| P16403 | T96 | Sugiyama | H1-2 H1F2 HIST1H1C | NNSRIKLGLKsLVsKGtLVQtKGtGAsGsFKLNKKAAsGEA |
| P16403 | T99 | Sugiyama | H1-2 H1F2 HIST1H1C | RIKLGLKsLVsKGtLVQtKGtGAsGsFKLNKKAAsGEAKPK |
| P16403 | Y71 | Sugiyama | H1-2 H1F2 HIST1H1C | SKERsGVsLAALKKALAAAGyDVEKNNSRIKLGLKsLVsKG |
| P17066 | T228 | Sugiyama | HSPA6 HSP70B' | DVSVLSIDAGVFEVKAtAGDtHLGGEDFDNRLVNHFMEEFR |
| P17066 | T49 | Sugiyama | HSPA6 HSP70B' | EILANDQGNRTtPsyVAFtDtERLVGDAAKsQAALNPHNtV |
| P18124 | T17 | Sugiyama | RPL7 | ____MEGVEEKKKEVPAVPEtLKKKRRNFAELKIKRLRKKF |
| P18206 | S820 | Sugiyama | VCL | DAKAVAGNIsDPGLQKsFLDsGyRILGAVAKVREAFQPQEP |
| P18615 | S135 | Sugiyama | NELFE RD RDBP | sADDDLQEsSRRPQRKsLyEsFVsssDRLRELGPDGEEAEG |
| P18621 | S111 | Sugiyama | RPL17 | LLHMLKNAESNAELKGLDVDsLVIEHIQVNKAPKMRRRTYR |
| P18621 | T79 | Sugiyama | RPL17 | PFRRYNGGVGRCAQAKQWGWtQGRWPKKSAEFLLHMLKNAE |
| P18669 | S155 | Sugiyama | PGAM1 PGAMA CDABP0006 | NIsKDRRyADLtEDQLPsCEsLKDtIARALPFWNEEIVPQI |
| P18669 | T146 | Sugiyama | PGAM1 PGAMA CDABP0006 | MEPDHPFysNIsKDRRyADLtEDQLPsCEsLKDtIARALPF |
| P18669 | T159 | Sugiyama | PGAM1 PGAMA CDABP0006 | DRRyADLtEDQLPsCEsLKDtIARALPFWNEEIVPQIKEGK |
| P19105 | T127 | Sugiyama | MYL12A MLCB MRLC3 RLC | ACFDEEATGTIQEDYLRELLttMGDRFtDEEVDELyREAPI |
| P19105 | T128 | Sugiyama | MYL12A MLCB MRLC3 RLC | CFDEEATGTIQEDYLRELLttMGDRFtDEEVDELyREAPID |
| P19105 | T159 | Sugiyama | MYL12A MLCB MRLC3 RLC | DELyREAPIDKKGNFNyIEFtRILKHGAKDKDD________ |
| P19338 | S460 | Sugiyama | NCL | ADAEKTFEEKQGtEIDGRsIsLyytGEKGQNQDYRGGKNST |
| P19338 | T464 | Sugiyama | NCL | KTFEEKQGtEIDGRsIsLyytGEKGQNQDYRGGKNSTWsGE |
| P20290 | T131 | Sugiyama | BTF3 NACB OK/SW-cl.8 | NQGTVIHFNNPKVQAsLAANtFtItGHAEtKQLTEMLPsIL |
| P20290 | T133 | Sugiyama | BTF3 NACB OK/SW-cl.8 | GTVIHFNNPKVQAsLAANtFtItGHAEtKQLTEMLPsILNQ |
| P20290 | T135 | Sugiyama | BTF3 NACB OK/SW-cl.8 | VIHFNNPKVQAsLAANtFtItGHAEtKQLTEMLPsILNQLG |
| P20290 | T140 | Sugiyama | BTF3 NACB OK/SW-cl.8 | NPKVQAsLAANtFtItGHAEtKQLTEMLPsILNQLGADsLt |
| P20618 | S157 | Sugiyama | PSMB1 PSC5 | IIGGLDEEGKGAVysFDPVGsyQRDsFKAGGSASAMLQPLL |
| P20674 | T105 | Sugiyama | COX5A | EPKIIDAALRACRRLNDFAstVRILEVVKDKAGPHKEIYPY |
| P22061 | S133 | Sugiyama | PCMT1 | KELVDDsVNNVRKDDPTLLssGRVQLVVGDGRMGYAEEAPY |
| P22392 | T103 | Sugiyama | NME2 NM23B | VVKTGRVMLGEtNPADsKPGtIRGDFCIQVGRNIIHGsDsV |
| P22392 | T94 | Sugiyama | NME2 NM23B | VAMVWEGLNVVKTGRVMLGEtNPADsKPGtIRGDFCIQVGR |
| P22492 | Y75 | Sugiyama | H1-6 H1FT H1T HIST1H1T | SQERVGMSLVALKKALAAAGyDVEKNNSRIKLSLKSLVNKG |
| P22626 | S212 | Sugiyama | HNRNPA2B1 HNRPA2B1 | EMQEVQssRsGRGGNFGFGDsRGGGGNFGPGPGsNFRGGsD |
| P23381 | S358 | Sugiyama | WARS1 IFI53 WARS WRS | TFFPALQGAQTKMsAsDPNssIFLtDtAKQIKTKVNKHAFs |
| P23381 | T364 | Sugiyama | WARS1 IFI53 WARS WRS | QGAQTKMsAsDPNssIFLtDtAKQIKTKVNKHAFsGGRDtI |
| P23396 | S104 | Sugiyama | RPS3 OK/SW-cl.26 | VELyAEKVAtRGLCAIAQAEsLRyKLLGGLAVRRACyGVLR |
| P23396 | T242 | Sugiyama | RPS3 OK/SW-cl.26 | PIsEQKGGKPEPPAMPQPVPtA___________________ |
| P23396 | T93 | Sugiyama | RPS3 OK/SW-cl.26 | VQKRFGFPEGsVELyAEKVAtRGLCAIAQAEsLRyKLLGGL |
| P23528 | T63 | Sugiyama | CFL1 CFL | DKKNIILEEGKEILVGDVGQtVDDPyAtFVKMLPDKDCRyA |
| P23528 | T70 | Sugiyama | CFL1 CFL | EEGKEILVGDVGQtVDDPyAtFVKMLPDKDCRyALyDAtyE |
| P23588 | S122 | Sugiyama | EIF4B | NLPyDVTEESIKEFFRGLNIsAVRLPREPsNPERLKGFGyA |
| P23588 | S207 | Sugiyama | EIF4B | DRNRDsDKtDTDWRARPAtDsFDDyPPRRGDDsFGDKYRDR |
| P23588 | T205 | Sugiyama | EIF4B | GRDRNRDsDKtDTDWRARPAtDsFDDyPPRRGDDsFGDKYR |
| P24534 | S174 | Sugiyama | EEF1B2 EEF1B EF1B | DMAKLEECVRsIQADGLVWGssKLVPVGyGIKKLQIQCVVE |
| P25788 | S243 | Sugiyama | PSMA3 HC8 PSC8 | GRHEIVPKDIREEAEKyAKEsLKEEDEsDDDNM________ |
| P26038 | S576 | Sugiyama | MSN | YKtLRQIRQGNTKQRIDEFEsM___________________ |
| P26373 | S109 | Sugiyama | RPL13 BBC1 OK/SW-cl.46 | KVARTIGIsVDPRRRNKstEsLQANVQRLKEYRSKLILFPR |
| P26373 | S181 | Sugiyama | RPL13 BBC1 OK/SW-cl.46 | YKKEKARVItEEEKNFKAFAsLRMARANARLFGIRAKRAKE |
| P26373 | S77 | Sugiyama | RPL13 BBC1 OK/SW-cl.46 | PIVRCPTVRYHTKVRAGRGFsLEELRVAGIHKKVARTIGIs |
| P26373 | T148 | Sugiyama | RPL13 BBC1 OK/SW-cl.46 | PRKPSAPKKGDssAEELKLAtQLtGPVMPVRNVYKKEKARV |
| P26373 | T151 | Sugiyama | RPL13 BBC1 OK/SW-cl.46 | PSAPKKGDssAEELKLAtQLtGPVMPVRNVYKKEKARVItE |
| P26447 | T15 | Sugiyama | S100A4 CAPL MTS1 | ______MACPLEKALDVMVstFHKYSGKEGDKFKLNKSELK |
| P26583 | S15 | Sugiyama | HMGB2 HMG2 | ______MGKGDPNKPRGKMssyAFFVQtCREEHKKKHPDss |
| P26583 | T22 | Sugiyama | HMGB2 HMG2 | GKGDPNKPRGKMssyAFFVQtCREEHKKKHPDssVNFAEFS |
| P26639 | S522 | Sugiyama | TARS1 TARS | PEKFLGDIEVWDQAEKQLENsLNEFGEKWELNsGDGAFyGP |
| P26641 | T287 | Sugiyama | EEF1G EF1G PRO1608 | EQALAAEPKAKDPFAHLPKstFVLDEFKRKysNEDtLsVAL |
| P27797 | S52 | Sugiyama | CALR CRTC | GWtsRWIEsKHKSDFGKFVLssGKFyGDEEKDKGLQTSQDA |
| P27797 | T34 | Sugiyama | CALR CRTC | LAVAEPAVYFKEQFLDGDGWtsRWIEsKHKSDFGKFVLssG |
| P29401 | T444 | Sugiyama | TKT | DGPSQMALEDLAMFRsVPtstVFyPsDGVAtEKAVELAANT |
| P29692 | S64 | Sugiyama | EEF1D EF1D | sVILRDIARARENIQKsLAGssGPGAssGtsGDHGELVVRI |
| P30041 | T48 | Sugiyama | PRDX6 AOP2 KIAA0106 | FLGDSWGILFSHPRDFtPVCttELGRAAKLAPEFAKRNVKL |
| P30050 | T135 | Sugiyama | RPL12 | QMRHRSLARELsGtIKEILGtAQsVGCNVDGRHPHDIIDDI |
| P30050 | T18 | Sugiyama | RPL12 | ___MPPKFDPNEIKVVYLRCtGGEVGAtsALAPKIGPLGLs |
| P30050 | T25 | Sugiyama | RPL12 | FDPNEIKVVYLRCtGGEVGAtsALAPKIGPLGLsPKKVGDD |
| P30086 | S60 | Sugiyama | PEBP1 PBP PEBP | VLtPtQVKNRPtsIsWDGLDsGKLytLVLtDPDAPsRKDPK |
| P30086 | T167 | Sugiyama | PEBP1 PBP PEBP | GKFKVAsFRKKyELRAPVAGtCyQAEWDDyVPKLyEQLsGK |
| P30086 | T65 | Sugiyama | PEBP1 PBP PEBP | QVKNRPtsIsWDGLDsGKLytLVLtDPDAPsRKDPKYREWH |
| P30086 | Y64 | Sugiyama | PEBP1 PBP PEBP | tQVKNRPtsIsWDGLDsGKLytLVLtDPDAPsRKDPKYREW |
| P30101 | T485 | Sugiyama | PDIA3 ERP57 ERP60 GRP58 | KKyEGGRELsDFIsyLQREAtNPPVIQEEKPKKKKKAQEDL |
| P30622 | Y262 | Sugiyama | CLIP1 CYLN1 RSN | CGVELDEPLGKNDGAVAGtRyFQCQPKyGLFAPVHKVTKIG |
| P31327 | T326 | Sugiyama | CPS1 | AKTYKMSMANRGQNQPVLNItNKQAFITAQNHGYALDNTLP |
| P31327 | T45 | Sugiyama | CPS1 | AHQKWKFSRPGIRLLSVKAQtAHIVLEDGtKMKGYSFGHPS |
| P31946 | T231 | Sugiyama | YWHAB | EsyKDstLIMQLLRDNLtLWtSENQGDEGDAGEGEN_____ |
| P31947 | T228 | Sugiyama | SFN HME1 | LsEDsyKDstLIMQLLRDNLtLWTADNAGEEGGEAPQEPQs |
| P31948 | S460 | Sugiyama | STIP1 | AMKDytKAMDVYQKALDLDssCKEAADGYQRCMMAQyNRHD |
| P31949 | T33 | Sugiyama | S100A11 MLN70 S100C | CIESLIAVFQKYAGKDGyNytLsKtEFLsFMNTELAAFTKN |
| P33240 | T333 | Sugiyama | CSTF2 | ANVPtPRGLLGDAPNDPRGGtLLsVtGEVEPRGYLGPPHQG |
| P33240 | T338 | Sugiyama | CSTF2 | PRGLLGDAPNDPRGGtLLsVtGEVEPRGYLGPPHQGPPMHH |
| P34931 | T228 | Sugiyama | HSPA1L | DVSILTIDDGIFEVKAtAGDtHLGGEDFDNRLVsHFVEEFK |
| P34931 | T39 | Sugiyama | HSPA1L | CVGVFQHGKVEIIANDQGNRttPsyVAFtDtERLIGDAAKN |
| P34931 | T49 | Sugiyama | HSPA1L | EIIANDQGNRttPsyVAFtDtERLIGDAAKNQVAMNPQNTV |
| P35269 | T154 | Sugiyama | GTF2F1 RAP74 | AFEAFPVHNWYNFTPLARHRtLtAEEAEEEWERRNKVLNHF |
| P35579 | S1195 | Sugiyama | MYH9 | TLEEEAKTHEAQIQEMRQKHsQAVEELAEQLEQtKRVKANL |
| P35579 | S1308 | Sugiyama | MYH9 | LLsQsDSKSSKLTKDFsALEsQLQDtQELLQEENRQKLsLs |
| P35579 | S1376 | Sugiyama | MYH9 | EKQIATLHAQVADMKKKMEDsVGCLEtAEEVKRKLQKDLEG |
| P35579 | S1714 | Sugiyama | MYH9 | RAKRQAQQERDELADEIANssGKGALALEEKRRLEARIAQL |
| P35579 | S1916 | Sugiyama | MYH9 | LQRELEDAtEtADAMNREVssLKNKLRRGDLPFVVPRRMAR |
| P35579 | S876 | Sugiyama | MYH9 | KVREKQLAAENRLTEMEtLQsQLMAEKLQLQEQLQAETELC |
| P35579 | T1005 | Sugiyama | MYH9 | DQNCKLAKEKKLLEDRIAEFtTNLtEEEEKSKsLAKLKNKH |
| P35579 | T1009 | Sugiyama | MYH9 | KLAKEKKLLEDRIAEFtTNLtEEEEKSKsLAKLKNKHEAMI |
| P35579 | T1151 | Sugiyama | MYH9 | EKQKRDLGEELEALKtELEDtLDstAAQQELRSKREQEVNI |
| P35579 | T1155 | Sugiyama | MYH9 | RDLGEELEALKtELEDtLDstAAQQELRSKREQEVNILKKT |
| P35579 | T1208 | Sugiyama | MYH9 | QEMRQKHsQAVEELAEQLEQtKRVKANLEKAKQtLENERGE |
| P35579 | T1313 | Sugiyama | MYH9 | DSKSSKLTKDFsALEsQLQDtQELLQEENRQKLsLstKLKQ |
| P35579 | T1382 | Sugiyama | MYH9 | LHAQVADMKKKMEDsVGCLEtAEEVKRKLQKDLEGLSQRHE |
| P35579 | T1745 | Sugiyama | MYH9 | RRLEARIAQLEEELEEEQGNtELINDRLKKANLQIDQINtD |
| P35579 | T1904 | Sugiyama | MYH9 | EEAQRANAsRRKLQRELEDAtEtADAMNREVssLKNKLRRG |
| P35579 | T1906 | Sugiyama | MYH9 | AQRANAsRRKLQRELEDAtEtADAMNREVssLKNKLRRGDL |
| P35579 | T873 | Sugiyama | MYH9 | ELVKVREKQLAAENRLTEMEtLQsQLMAEKLQLQEQLQAET |
| P35580 | S1371 | Sugiyama | MYH10 | QQEEEEEARKNLEKQVLALQsQLADtKKKVDDDLGTIESLE |
| P35580 | T1320 | Sugiyama | MYH10 | EKKGIKFAKDAAsLEsQLQDtQELLQEETRQKLNLSSRIRQ |
| P35580 | T1376 | Sugiyama | MYH10 | EEARKNLEKQVLALQsQLADtKKKVDDDLGTIESLEEAKKK |
| P35609 | T347 | Sugiyama | ACTN2 | RRKHKPPKVQEKCQLEINFNtLQtKLRISNRPAFMPSEGKM |
| P35609 | T350 | Sugiyama | ACTN2 | HKPPKVQEKCQLEINFNtLQtKLRISNRPAFMPSEGKMVSD |
| P36578 | S87 | Sugiyama | RPL4 RPL1 | WGtGRAVARIPRVRGGGtHRsGQGAFGNMCRGGRMFAPTKT |
| P36578 | T62 | Sugiyama | RPL4 RPL1 | TNLRKNNRQPyAVsELAGHQtsAEsWGtGRAVARIPRVRGG |
| P36578 | T69 | Sugiyama | RPL4 RPL1 | RQPyAVsELAGHQtsAEsWGtGRAVARIPRVRGGGtHRsGQ |
| P36578 | T84 | Sugiyama | RPL4 RPL1 | AEsWGtGRAVARIPRVRGGGtHRsGQGAFGNMCRGGRMFAP |
| P37108 | T45 | Sugiyama | SRP14 | sVyItLKKYDGRTKPIPKKGtVEGFEPADNKCLLRATDGKK |
| P37802 | S83 | Sugiyama | TAGLN2 KIAA0120 CDABP0035 | CELINALYPEGQAPVKKIQAstMAFKQMEQIsQFLQAAERY |
| P37802 | T180 | Sugiyama | TAGLN2 KIAA0120 CDABP0035 | RNFsDNQLQEGKNVIGLQMGtNRGAsQAGMtGyGMPRQIL_ |
| P37802 | T190 | Sugiyama | TAGLN2 KIAA0120 CDABP0035 | GKNVIGLQMGtNRGAsQAGMtGyGMPRQIL___________ |
| P38646 | T116 | Sugiyama | HSPA9 GRP75 HSPA9B mt-HSP70 | DGERLVGMPAKRQAVtNPNNtFyAtKRLIGRRYDDPEVQKD |
| P38646 | T120 | Sugiyama | HSPA9 GRP75 HSPA9B mt-HSP70 | LVGMPAKRQAVtNPNNtFyAtKRLIGRRYDDPEVQKDIKNV |
| P38646 | T398 | Sugiyama | HSPA9 GRP75 HSPA9B mt-HSP70 | SDIGEVILVGGMTRMPKVQQtVQDLFGRAPsKAVNPDEAVA |
| P38646 | T86 | Sugiyama | HSPA9 GRP75 HSPA9B mt-HSP70 | CVAVMEGKQAKVLENAEGARttPsVVAFtADGERLVGMPAK |
| P38646 | Y118 | Sugiyama | HSPA9 GRP75 HSPA9B mt-HSP70 | ERLVGMPAKRQAVtNPNNtFyAtKRLIGRRYDDPEVQKDIK |
| P39019 | T36 | Sugiyama | RPS19 | RALAAFLKKSGKLKVPEWVDtVKLAKHKELAPyDENWFytR |
| P39019 | Y54 | Sugiyama | RPS19 | VDtVKLAKHKELAPyDENWFytRAAstARHLYLRGGAGVGs |
| P39023 | S13 | Sugiyama | RPL3 OK/SW-cl.32 | ________MSHRKFSAPRHGsLGFLPRKRSSRHRGKVKSFP |
| P39687 | T105 | Sugiyama | ANP32A C15orf1 LANP MAPM PHAP1 | EKCPNLTHLNLsGNKIKDLstIEPLKKLENLKsLDLFNCEV |
| P40429 | T155 | Sugiyama | RPL13A | FAYLGRLAHEVGWKyQAVtAtLEEKRKEKAKIHYRKKKQLM |
| P40855 | S147 | Sugiyama | PEX19 HK33 PXF OK/SW-cl.22 | SCLKETLSGLAKNATDLQNssMsEEELTKAMEGLGMDEGDG |
| P42766 | T59 | Sugiyama | RPL35 | GAASKLsKIRVVRKSIARVLtVINQtQKENLRKFYKGKKyK |
| P42766 | T64 | Sugiyama | RPL35 | LsKIRVVRKSIARVLtVINQtQKENLRKFYKGKKyKPLDLR |
| P46776 | S68 | Sugiyama | RPL27A | yHPGyFGKVGMKHYHLKRNQsFCPtVNLDKLWtLVsEQtRV |
| P46776 | T72 | Sugiyama | RPL27A | yFGKVGMKHYHLKRNQsFCPtVNLDKLWtLVsEQtRVNAAK |
| P46776 | T80 | Sugiyama | RPL27A | HYHLKRNQsFCPtVNLDKLWtLVsEQtRVNAAKNKtGAAPI |
| P46776 | T86 | Sugiyama | RPL27A | NQsFCPtVNLDKLWtLVsEQtRVNAAKNKtGAAPIIDVVRs |
| P46776 | T95 | Sugiyama | RPL27A | LDKLWtLVsEQtRVNAAKNKtGAAPIIDVVRsGyyKVLGKG |
| P46777 | S224 | Sugiyama | RPL5 MSTP030 | VADyMRyLMEEDEDAyKKQFsQyIKNsVtPDMMEEMyKKAH |
| P46777 | T177 | Sugiyama | RPL5 MSTP030 | NKVFGALKGAVDGGLsIPHstKRFPGyDsEsKEFNAEVHRK |
| P46778 | T29 | Sugiyama | RPL21 | RGTRYMFSRPFRKHGVVPLAtyMRIYKKGDIVDIKGMGTVQ |
| P46783 | T148 | Sugiyama | RPS10 | RRSAVPPGADKKAEAGAGsAtEFQFRGGFGRGRGQPPQ___ |
| P48741 | T228 | Sugiyama | HSPA7 HSP70B | DVSVLSIDAGVFEVKAtAGDtHLGGEDFDNRLVNHFMEEFR |
| P48741 | T49 | Sugiyama | HSPA7 HSP70B | EILANDQGNRTtPsyVAFtDtERLVGDAAKsQAALNPHNtV |
| P49327 | T1999 | Sugiyama | FASN FAS | LLENQTPEFFQDVCKPKYsGtLNLDRVTREACPELDYFVVF |
| P49327 | T2215 | Sugiyama | FASN FAS | DEAsELACPtPKEDGLAQQQtQLNLRSLLVNPEGPtLMRLN |
| P49411 | T433 | Sugiyama | TUFM | LRQPMILEKGQRFTLRDGNRtIGTGLVTNTLAMTEEEKNIK |
| P50991 | S51 | Sugiyama | CCT4 CCTD SRB | AQIRFsNISAAKAVADAIRtsLGPKGMDKMIQDGKGDVtIt |
| P50991 | T50 | Sugiyama | CCT4 CCTD SRB | PAQIRFsNISAAKAVADAIRtsLGPKGMDKMIQDGKGDVtI |
| P50991 | T69 | Sugiyama | CCT4 CCTD SRB | RtsLGPKGMDKMIQDGKGDVtItNDGAtILKQMQVLHPAAR |
| P50991 | T76 | Sugiyama | CCT4 CCTD SRB | GMDKMIQDGKGDVtItNDGAtILKQMQVLHPAARMLVELSK |
| P51149 | T168 | Sugiyama | RAB7A RAB7 | NIPyFEtSAKEAINVEQAFQtIARNALKQETEVELyNEFPE |
| P51957 | S16 | Sugiyama | NEK4 STK2 | _____MPLAAYCYLRVVGKGsyGEVtLVKHRRDGKQYVIKK |
| P51957 | S213 | Sugiyama | NEK4 STK2 | GCCVYEMATLKHAFNAKDMNsLVYRIIEGKLPPMPRDYSPE |
| P51957 | S377 | Sugiyama | NEK4 STK2 | TELATISSVNIDILPAKGRDsVsDGFVQENQPRYLDASNEL |
| P51957 | S379 | Sugiyama | NEK4 STK2 | LATISSVNIDILPAKGRDsVsDGFVQENQPRYLDASNELGG |
| P51957 | S402 | Sugiyama | NEK4 STK2 | FVQENQPRYLDASNELGGICsIsQVEEEMLQDNTKSSAQPE |
| P51957 | S404 | Sugiyama | NEK4 STK2 | QENQPRYLDASNELGGICsIsQVEEEMLQDNTKSSAQPENL |
| P51957 | S457 | Sugiyama | NEK4 STK2 | KNEPVKPLQPLIKEQKPKDQsLALsPKLECsGtILAHsNLR |
| P51957 | S461 | Sugiyama | NEK4 STK2 | VKPLQPLIKEQKPKDQsLALsPKLECsGtILAHsNLRLLGs |
| P51957 | S467 | Sugiyama | NEK4 STK2 | LIKEQKPKDQsLALsPKLECsGtILAHsNLRLLGsSDsPAS |
| P51957 | S474 | Sugiyama | NEK4 STK2 | KDQsLALsPKLECsGtILAHsNLRLLGsSDsPASASRVAGI |
| P51957 | S481 | Sugiyama | NEK4 STK2 | sPKLECsGtILAHsNLRLLGsSDsPASASRVAGITGVCHHA |
| P51957 | S484 | Sugiyama | NEK4 STK2 | LECsGtILAHsNLRLLGsSDsPASASRVAGITGVCHHAQDQ |
| P51957 | S526 | Sugiyama | NEK4 STK2 | AGECIIEKQGRIHPDLQPHNsGSEPsLsRQRRQKRREQTEH |
| P51957 | S531 | Sugiyama | NEK4 STK2 | IEKQGRIHPDLQPHNsGSEPsLsRQRRQKRREQTEHRGEKR |
| P51957 | S533 | Sugiyama | NEK4 STK2 | KQGRIHPDLQPHNsGSEPsLsRQRRQKRREQTEHRGEKRQV |
| P51957 | S563 | Sugiyama | NEK4 STK2 | QTEHRGEKRQVRRDLFAFQEsPPRFLPSHPIVGKVDVTSTQ |
| P51957 | S58 | Sugiyama | NEK4 STK2 | NLRNASSRERRAAEQEAQLLsQLKHPNIVTYKESWEGGDGL |
| P51957 | S624 | Sugiyama | NEK4 STK2 | EMSSSKDRPLSARERRRLKQsQEEMSSsGPSVRKAsLsVAG |
| P51957 | S631 | Sugiyama | NEK4 STK2 | RPLSARERRRLKQsQEEMSSsGPSVRKAsLsVAGPGKPQEE |
| P51957 | S639 | Sugiyama | NEK4 STK2 | RRLKQsQEEMSSsGPSVRKAsLsVAGPGKPQEEDQPLPARR |
| P51957 | S641 | Sugiyama | NEK4 STK2 | LKQsQEEMSSsGPSVRKAsLsVAGPGKPQEEDQPLPARRLs |
| P51957 | S661 | Sugiyama | NEK4 STK2 | sVAGPGKPQEEDQPLPARRLssDCsVtQERKQIHCLsEDEL |
| P51957 | S662 | Sugiyama | NEK4 STK2 | VAGPGKPQEEDQPLPARRLssDCsVtQERKQIHCLsEDELS |
| P51957 | S720 | Sugiyama | NEK4 STK2 | GQTNEINALVQLMTQTLKLDsKEsCEDVPVANPVSEFKLHR |
| P51957 | S723 | Sugiyama | NEK4 STK2 | NEINALVQLMTQTLKLDsKEsCEDVPVANPVSEFKLHRKyR |
| P51957 | S766 | Sugiyama | NEK4 STK2 | LILHGKVAEEAEEIHFKELPsAIMPGsEKIRRLVEVLRtDV |
| P51957 | S772 | Sugiyama | NEK4 STK2 | VAEEAEEIHFKELPsAIMPGsEKIRRLVEVLRtDVIRGLGV |
| P51957 | T21 | Sugiyama | NEK4 STK2 | MPLAAYCYLRVVGKGsyGEVtLVKHRRDGKQYVIKKLNLRN |
| P51957 | T469 | Sugiyama | NEK4 STK2 | KEQKPKDQsLALsPKLECsGtILAHsNLRLLGsSDsPASAS |
| P51957 | T745 | Sugiyama | NEK4 STK2 | EDVPVANPVSEFKLHRKyRDtLILHGKVAEEAEEIHFKELP |
| P51957 | T784 | Sugiyama | NEK4 STK2 | LPsAIMPGsEKIRRLVEVLRtDVIRGLGVQLLEQVYDLLEE |
| P51957 | Y17 | Sugiyama | NEK4 STK2 | ____MPLAAYCYLRVVGKGsyGEVtLVKHRRDGKQYVIKKL |
| P51957 | Y742 | Sugiyama | NEK4 STK2 | EsCEDVPVANPVSEFKLHRKyRDtLILHGKVAEEAEEIHFK |
| P52565 | S148 | Sugiyama | ARHGDIA GDIA1 | YIQHTyRKGVKIDKtDyMVGsYGPRAEEyEFLtPVEEAPKG |
| P52565 | T142 | Sugiyama | ARHGDIA GDIA1 | IVSGMKYIQHTyRKGVKIDKtDyMVGsYGPRAEEyEFLtPV |
| P53634 | T431 | Sugiyama | CTSC CPPI | GYGTDSASGMDYWIVKNsWGtGWGENGyFRIRRGtDECAIE |
| P53999 | S118 | Sugiyama | SUB1 PC4 RPO2TC1 | PGRKGIsLNPEQWsQLKEQIsDIDDAVRKL___________ |
| P54105 | T34 | Sugiyama | CLNS1A CLCI ICLN | EGLLRQQPDTEAVLNGKGLGtGtLyIAEsRLSWLDGsGLGF |
| P54105 | T36 | Sugiyama | CLNS1A CLCI ICLN | LLRQQPDTEAVLNGKGLGtGtLyIAEsRLSWLDGsGLGFSL |
| P54652 | T229 | Sugiyama | HSPA2 | DVSILTIEDGIFEVKstAGDtHLGGEDFDNRMVSHLAEEFK |
| P54652 | T38 | Sugiyama | HSPA2 | CVGVFQHGKVEIIANDQGNRttPsyVAFtDtERLIGDAAKN |
| P54652 | T48 | Sugiyama | HSPA2 | EIIANDQGNRttPsyVAFtDtERLIGDAAKNQVAMNPTNTI |
| P55010 | T227 | Sugiyama | EIF5 | ttEEAQRRRMDEISDHAKVLtLsDDLERtIEERVNILFDFV |
| P55010 | T235 | Sugiyama | EIF5 | RMDEISDHAKVLtLsDDLERtIEERVNILFDFVKKKKEEGV |
| P55209 | T269 | Sugiyama | NAP1L1 NRP | GPEIMGCTGCQIDWKKGKNVtLKtIKKKQKHKGRGTVRTVT |
| P55209 | T272 | Sugiyama | NAP1L1 NRP | IMGCTGCQIDWKKGKNVtLKtIKKKQKHKGRGTVRTVTKTV |
| P60174 | S204 | Sugiyama | TPI1 TPI | EVHEKLRGWLKsNVsDAVAQstRIIyGGsVtGAtCKELASQ |
| P60174 | T214 | Sugiyama | TPI1 TPI | KsNVsDAVAQstRIIyGGsVtGAtCKELASQPDVDGFLVGG |
| P60174 | T217 | Sugiyama | TPI1 TPI | VsDAVAQstRIIyGGsVtGAtCKELASQPDVDGFLVGGAsL |
| P60174 | T28 | Sugiyama | TPI1 TPI | FVGGNWKMNGRKQsLGELIGtLNAAKVPADtEVVCAPPtAy |
| P60174 | T38 | Sugiyama | TPI1 TPI | RKQsLGELIGtLNAAKVPADtEVVCAPPtAyIDFARQKLDP |
| P60174 | T46 | Sugiyama | TPI1 TPI | IGtLNAAKVPADtEVVCAPPtAyIDFARQKLDPKIAVAAQN |
| P60174 | T90 | Sugiyama | TPI1 TPI | VTNGAFtGEIsPGMIKDCGAtWVVLGHsERRHVFGEsDELI |
| P60174 | Y209 | Sugiyama | TPI1 TPI | LRGWLKsNVsDAVAQstRIIyGGsVtGAtCKELASQPDVDG |
| P60660 | T103 | Sugiyama | MYL6 | QGtyEDyVEGLRVFDKEGNGtVMGAEIRHVLVtLGEKMTEE |
| P60660 | T22 | Sugiyama | MYL6 | CDFTEDQTAEFKEAFQLFDRtGDGKILysQCGDVMRALGQN |
| P60709 | S239 | Sugiyama | ACTB | VALDFEQEMAtAAssssLEKsyELPDGQVItIGNERFRCPE |
| P60709 | S300 | Sugiyama | ACTB | NSIMKCDVDIRKDLyANtVLsGGttMyPGIADRMQKEItAL |
| P60709 | S323 | Sugiyama | ACTB | ttMyPGIADRMQKEItALAPstMKIKIIAPPERKYsVWIGG |
| P60709 | S368 | Sugiyama | ACTB | sLstFQQMWISKQEyDEsGPsIVHRKCF_____________ |
| P60709 | T106 | Sugiyama | ACTB | WHHtFyNELRVAPEEHPVLLtEAPLNPKANREKMTQIMFET |
| P60709 | T201 | Sugiyama | ACTB | AGRDLTDyLMKILtERGysFtttAEREIVRDIKEKLCyVAL |
| P60709 | T203 | Sugiyama | ACTB | RDLTDyLMKILtERGysFtttAEREIVRDIKEKLCyVALDF |
| P60709 | T229 | Sugiyama | ACTB | VRDIKEKLCyVALDFEQEMAtAAssssLEKsyELPDGQVIt |
| P60709 | T249 | Sugiyama | ACTB | tAAssssLEKsyELPDGQVItIGNERFRCPEALFQPsFLGM |
| P60709 | T303 | Sugiyama | ACTB | MKCDVDIRKDLyANtVLsGGttMyPGIADRMQKEItALAPs |
| P60709 | T304 | Sugiyama | ACTB | KCDVDIRKDLyANtVLsGGttMyPGIADRMQKEItALAPst |
| P60709 | T318 | Sugiyama | ACTB | VLsGGttMyPGIADRMQKEItALAPstMKIKIIAPPERKYs |
| P60709 | T324 | Sugiyama | ACTB | tMyPGIADRMQKEItALAPstMKIKIIAPPERKYsVWIGGs |
| P60709 | Y294 | Sugiyama | ACTB | IHETTFNSIMKCDVDIRKDLyANtVLsGGttMyPGIADRMQ |
| P60983 | T114 | Sugiyama | GMFB | VGCKPEQQMMYAGSKNKLVQtAELtKVFEIRNTEDLTEEWL |
| P60983 | T118 | Sugiyama | GMFB | PEQQMMYAGSKNKLVQtAELtKVFEIRNTEDLTEEWLREKL |
| P61247 | S238 | Sugiyama | RPS3A FTE1 MFTL | LKKPKFELGKLMELHGEGsssGKAtGDEtGAKVERADGyEP |
| P61254 | T8 | Sugiyama | RPL26 | _____________MKFNPFVtsDRsKNRKRHFNAPsHIRRK |
| P61313 | S97 | Sugiyama | RPL15 EC45 TCBAP0781 | KGAtyGKPVHHGVNQLKFARsLQsVAEERAGRHCGALRVLN |
| P61604 | T45 | Sugiyama | HSPE1 | TVTKGGIMLPEKSQGKVLQAtVVAVGsGsKGKGGEIQPVsV |
| P61769 | T106 | Sugiyama | B2M CDABP0092 HDCMA22P | YYTEFTPTEKDEYACRVNHVtLsQPKIVKWDRDM_______ |
| P61978 | S401 | Sugiyama | HNRNPK HNRPK | GDLGGPIIttQVtIPKDLAGsIIGKGGQRIKQIRHEsGAsI |
| P61978 | S75 | Sugiyama | HNRNPK HNRPK | GAVIGKGGKNIKALRtDyNAsVsVPDssGPERILsISADIE |
| P61978 | Y72 | Sugiyama | HNRNPK HNRPK | KNAGAVIGKGGKNIKALRtDyNAsVsVPDssGPERILsISA |
| P61981 | T31 | Sugiyama | YWHAG | ARLAEQAERyDDMAAAMKNVtELNEPLsNEERNLLsVAyKN |
| P62241 | S160 | Sugiyama | RPS8 OK/SW-cl.83 | KRSKKIQKKYDERKKNAKIssLLEEQFQQGKLLACIASRPG |
| P62249 | S9 | Sugiyama | RPS16 | ____________MPsKGPLQsVQVFGRKKTATAVAHCKRGN |
| P62258 | S148 | Sugiyama | YWHAE | YHRyLAEFAtGNDRKEAAENsLVAyKAAsDIAMtELPPTHP |
| P62258 | T229 | Sugiyama | YWHAE | LsEEsyKDstLIMQLLRDNLtLWtsDMQGDGEEQNKEALQD |
| P62266 | T34 | Sugiyama | RPS23 | RSHRRDQKWHDKQYKKAHLGtALKANPFGGAsHAKGIVLEK |
| P62273 | S9 | Sugiyama | RPS29 | ____________MGHQQLyWsHPRKFGQGSRSCRVCSNRHG |
| P62277 | S14 | Sugiyama | RPS13 | _______MGRMHAPGKGLsQsALPyRRsVPtWLKLTsDDVK |
| P62280 | T15 | Sugiyama | RPS11 | ______MADIQTERAyQKQPtIFQNKKRVLLGEtGKEKLPR |
| P62280 | T28 | Sugiyama | RPS11 | RAyQKQPtIFQNKKRVLLGEtGKEKLPRYYKNIGLGFKtPK |
| P62280 | T54 | Sugiyama | RPS11 | PRYYKNIGLGFKtPKEAIEGtyIDKKCPFTGNVsIRGRILs |
| P62312 | T75 | Sugiyama | LSM6 | QLKNKyGDAFIRGNNVLyIstQKRRM_______________ |
| P62314 | S59 | Sugiyama | SNRPD1 | HLKAVKMTLKNREPVQLEtLsIRGNNIRYFILPDsLPLDTL |
| P62314 | T57 | Sugiyama | SNRPD1 | NTHLKAVKMTLKNREPVQLEtLsIRGNNIRYFILPDsLPLD |
| P62424 | T84 | Sugiyama | RPL7A SURF-3 SURF3 | QRQRAILyKRLKVPPAINQFtQALDRQTAtQLLKLAHKYRP |
| P62736 | S241 | Sugiyama | ACTA2 ACTSA ACTVS GIG46 | VALDFENEMAtAAssssLEKsyELPDGQVItIGNERFRCPE |
| P62736 | S325 | Sugiyama | ACTA2 ACTSA ACTVS GIG46 | tTMYPGIADRMQKEItALAPstMKIKIIAPPERKYSVWIGG |
| P62736 | T251 | Sugiyama | ACTA2 ACTSA ACTVS GIG46 | tAAssssLEKsyELPDGQVItIGNERFRCPETLFQPSFIGM |
| P62736 | T320 | Sugiyama | ACTA2 ACTSA ACTVS GIG46 | VLSGGtTMYPGIADRMQKEItALAPstMKIKIIAPPERKYS |
| P62736 | T326 | Sugiyama | ACTA2 ACTSA ACTVS GIG46 | TMYPGIADRMQKEItALAPstMKIKIIAPPERKYSVWIGGS |
| P62753 | S148 | Sugiyama | RPS6 OK/SW-cl.2 | tVPRRLGPKRASRIRKLFNLsKEDDVRQyVVRKPLNKEGKK |
| P62826 | T21 | Sugiyama | RAN ARA24 OK/SW-cl.81 | MAAQGEPQVQFKLVLVGDGGtGKttFVKRHLtGEFEKKyVA |
| P62826 | T32 | Sugiyama | RAN ARA24 OK/SW-cl.81 | KLVLVGDGGtGKttFVKRHLtGEFEKKyVATLGVEVHPLVF |
| P62826 | T66 | Sugiyama | RAN ARA24 OK/SW-cl.81 | EVHPLVFHTNRGPIKFNVWDtAGQEKFGGLRDGYYIQAQCA |
| P62857 | T21 | Sugiyama | RPS28 | MDTSRVQPIKLARVTKVLGRtGsQGQCtQVRVEFMDDtsRs |
| P62857 | T38 | Sugiyama | RPS28 | LGRtGsQGQCtQVRVEFMDDtsRsIIRNVKGPVREGDVLtL |
| P62899 | T22 | Sugiyama | RPL31 | APAKKGGEKKKGRsAINEVVtREytINIHKRIHGVGFKKRA |
| P62899 | T26 | Sugiyama | RPL31 | KGGEKKKGRsAINEVVtREytINIHKRIHGVGFKKRAPRAL |
| P62906 | S113 | Sugiyama | RPL10A NEDD6 | LNKNKKLVKKLAKKyDAFLAsEsLIKQIPRILGPGLNKAGK |
| P62906 | S115 | Sugiyama | RPL10A NEDD6 | KNKKLVKKLAKKyDAFLAsEsLIKQIPRILGPGLNKAGKFP |
| P62906 | T9 | Sugiyama | RPL10A NEDD6 | ____________MSSKVsRDtLyEAVREVLHGNQRKRRKFL |
| P62917 | S130 | Sugiyama | RPL8 | GTIVCCLEEKPGDRGKLARAsGNyAtVIsHNPEtKKtRVKL |
| P62917 | T135 | Sugiyama | RPL8 | CLEEKPGDRGKLARAsGNyAtVIsHNPEtKKtRVKLPSGSK |
| P62917 | T143 | Sugiyama | RPL8 | RGKLARAsGNyAtVIsHNPEtKKtRVKLPSGSKKVISSANR |
| P62917 | T146 | Sugiyama | RPL8 | LARAsGNyAtVIsHNPEtKKtRVKLPSGSKKVISSANRAVV |
| P62917 | Y133 | Sugiyama | RPL8 | VCCLEEKPGDRGKLARAsGNyAtVIsHNPEtKKtRVKLPSG |
| P62942 | T22 | Sugiyama | FKBP1A FKBP1 FKBP12 | GVQVEtIsPGDGRtFPKRGQtCVVHytGMLEDGKKFDSSRD |
| P62942 | T28 | Sugiyama | FKBP1A FKBP1 FKBP12 | IsPGDGRtFPKRGQtCVVHytGMLEDGKKFDSSRDRNKPFK |
| P62942 | T7 | Sugiyama | FKBP1A FKBP1 FKBP12 | ______________MGVQVEtIsPGDGRtFPKRGQtCVVHy |
| P62979 | S134 | Sugiyama | RPS27A UBA80 UBCEP1 | IsRLRRECPsDECGAGVFMAsHFDRHyCGKCCLtyCFNKPE |
| P63104 | S145 | Sugiyama | YWHAZ | YYRyLAEVAAGDDKKGIVDQsQQAyQEAFEIsKKEMQPTHP |
| P63104 | S156 | Sugiyama | YWHAZ | DDKKGIVDQsQQAyQEAFEIsKKEMQPTHPIRLGLALNFSV |
| P63104 | S28 | Sugiyama | YWHAZ | QKAKLAEQAERyDDMAACMKsVtEQGAELsNEERNLLsVAy |
| P63104 | T226 | Sugiyama | YWHAZ | LsEEsyKDstLIMQLLRDNLtLWtsDtQGDEAEAGEGGEN_ |
| P63165 | S61 | Sugiyama | SUMO1 SMT3C SMT3H3 UBL1 OK/SW-cl.43 | TTHLKKLKESYCQRQGVPMNsLRFLFEGQRIADNHtPKELG |
| P63167 | T26 | Sugiyama | DYNLL1 DLC1 DNCL1 DNCLC1 HDLC1 | AVIKNADMsEEMQQDsVECAtQALEKYNIEKDIAAHIKKEF |
| P63173 | T14 | Sugiyama | RPL38 | _______MPRKIEEIKDFLLtARRKDAKSVKIKKNKDNVKF |
| P63261 | S239 | Sugiyama | ACTG1 ACTG | VALDFEQEMAtAAssssLEKsyELPDGQVItIGNERFRCPE |
| P63261 | S300 | Sugiyama | ACTG1 ACTG | NSIMKCDVDIRKDLyANtVLsGGttMyPGIADRMQKEItAL |
| P63261 | S323 | Sugiyama | ACTG1 ACTG | ttMyPGIADRMQKEItALAPstMKIKIIAPPERKYsVWIGG |
| P63261 | S368 | Sugiyama | ACTG1 ACTG | sLstFQQMWISKQEyDEsGPsIVHRKCF_____________ |
| P63261 | T106 | Sugiyama | ACTG1 ACTG | WHHtFyNELRVAPEEHPVLLtEAPLNPKANREKMTQIMFET |
| P63261 | T201 | Sugiyama | ACTG1 ACTG | AGRDLTDyLMKILtERGysFtttAEREIVRDIKEKLCyVAL |
| P63261 | T203 | Sugiyama | ACTG1 ACTG | RDLTDyLMKILtERGysFtttAEREIVRDIKEKLCyVALDF |
| P63261 | T229 | Sugiyama | ACTG1 ACTG | VRDIKEKLCyVALDFEQEMAtAAssssLEKsyELPDGQVIt |
| P63261 | T249 | Sugiyama | ACTG1 ACTG | tAAssssLEKsyELPDGQVItIGNERFRCPEALFQPsFLGM |
| P63261 | T303 | Sugiyama | ACTG1 ACTG | MKCDVDIRKDLyANtVLsGGttMyPGIADRMQKEItALAPs |
| P63261 | T304 | Sugiyama | ACTG1 ACTG | KCDVDIRKDLyANtVLsGGttMyPGIADRMQKEItALAPst |
| P63261 | T318 | Sugiyama | ACTG1 ACTG | VLsGGttMyPGIADRMQKEItALAPstMKIKIIAPPERKYs |
| P63261 | T324 | Sugiyama | ACTG1 ACTG | tMyPGIADRMQKEItALAPstMKIKIIAPPERKYsVWIGGs |
| P63261 | Y294 | Sugiyama | ACTG1 ACTG | IHETTFNSIMKCDVDIRKDLyANtVLsGGttMyPGIADRMQ |
| P63267 | S240 | Sugiyama | ACTG2 ACTA3 ACTL3 ACTSG | VALDFENEMAtAAssssLEKsyELPDGQVItIGNERFRCPE |
| P63267 | S324 | Sugiyama | ACTG2 ACTA3 ACTL3 ACTSG | tTMYPGIADRMQKEItALAPstMKIKIIAPPERKYSVWIGG |
| P63267 | T250 | Sugiyama | ACTG2 ACTA3 ACTL3 ACTSG | tAAssssLEKsyELPDGQVItIGNERFRCPETLFQPSFIGM |
| P63267 | T319 | Sugiyama | ACTG2 ACTA3 ACTL3 ACTSG | VLSGGtTMYPGIADRMQKEItALAPstMKIKIIAPPERKYS |
| P63267 | T325 | Sugiyama | ACTG2 ACTA3 ACTL3 ACTSG | TMYPGIADRMQKEItALAPstMKIKIIAPPERKYSVWIGGS |
| P67809 | S102 | Sugiyama | YBX1 NSEP1 YB1 | EDVFVHQtAIKKNNPRKyLRsVGDGEtVEFDVVEGEKGAEA |
| P67809 | S136 | Sugiyama | YBX1 NSEP1 YB1 | GEKGAEAANVtGPGGVPVQGsKYAADRNHYRRYPRRRGPPR |
| P67809 | T108 | Sugiyama | YBX1 NSEP1 YB1 | QtAIKKNNPRKyLRsVGDGEtVEFDVVEGEKGAEAANVtGP |
| P67809 | T126 | Sugiyama | YBX1 NSEP1 YB1 | GEtVEFDVVEGEKGAEAANVtGPGGVPVQGsKYAADRNHYR |
| P67809 | Y99 | Sugiyama | YBX1 NSEP1 YB1 | DtKEDVFVHQtAIKKNNPRKyLRsVGDGEtVEFDVVEGEKG |
| P67936 | T237 | Sugiyama | TPM4 | IDDLEEKLAQAKEENVGLHQtLDQtLNELNCI_________ |
| P67936 | T241 | Sugiyama | TPM4 | EEKLAQAKEENVGLHQtLDQtLNELNCI_____________ |
| P68032 | S241 | Sugiyama | ACTC1 ACTC | VALDFENEMAtAAssssLEKsyELPDGQVItIGNERFRCPE |
| P68032 | S325 | Sugiyama | ACTC1 ACTC | tTMYPGIADRMQKEItALAPstMKIKIIAPPERKYSVWIGG |
| P68032 | T251 | Sugiyama | ACTC1 ACTC | tAAssssLEKsyELPDGQVItIGNERFRCPETLFQPSFIGM |
| P68032 | T320 | Sugiyama | ACTC1 ACTC | VLSGGtTMYPGIADRMQKEItALAPstMKIKIIAPPERKYS |
| P68032 | T326 | Sugiyama | ACTC1 ACTC | TMYPGIADRMQKEItALAPstMKIKIIAPPERKYSVWIGGS |
| P68104 | T432 | Sugiyama | EEF1A1 EEF1A EF1A LENG7 | VEsFSDyPPLGRFAVRDMRQtVAVGVIKAVDKKAAGAGKVT |
| P68133 | S241 | Sugiyama | ACTA1 ACTA | VALDFENEMAtAAssssLEKsyELPDGQVItIGNERFRCPE |
| P68133 | S325 | Sugiyama | ACTA1 ACTA | TTMYPGIADRMQKEItALAPstMKIKIIAPPERKYSVWIGG |
| P68133 | T251 | Sugiyama | ACTA1 ACTA | tAAssssLEKsyELPDGQVItIGNERFRCPETLFQPSFIGM |
| P68133 | T320 | Sugiyama | ACTA1 ACTA | VMSGGTTMYPGIADRMQKEItALAPstMKIKIIAPPERKYS |
| P68133 | T326 | Sugiyama | ACTA1 ACTA | TMYPGIADRMQKEItALAPstMKIKIIAPPERKYSVWIGGS |
| P68363 | T334 | Sugiyama | TUBA1B | ACCLLyRGDVVPKDVNAAIAtIKtKRsIQFVDWCPTGFKVG |
| P68363 | T337 | Sugiyama | TUBA1B | LLyRGDVVPKDVNAAIAtIKtKRsIQFVDWCPTGFKVGINy |
| P68363 | T51 | Sugiyama | TUBA1B | QPDGQMPSDKtIGGGDDsFNtFFsEtGAGKHVPRAVFVDLE |
| P68363 | T56 | Sugiyama | TUBA1B | MPSDKtIGGGDDsFNtFFsEtGAGKHVPRAVFVDLEPtVID |
| P68363 | T73 | Sugiyama | TUBA1B | FsEtGAGKHVPRAVFVDLEPtVIDEVRtGtyRQLFHPEQLI |
| P68363 | T80 | Sugiyama | TUBA1B | KHVPRAVFVDLEPtVIDEVRtGtyRQLFHPEQLItGKEDAA |
| P68363 | T82 | Sugiyama | TUBA1B | VPRAVFVDLEPtVIDEVRtGtyRQLFHPEQLItGKEDAANN |
| P68363 | Y432 | Sugiyama | TUBA1B | GMEEGEFSEAREDMAALEKDyEEVGVDsVEGEGEEEGEEy_ |
| P68363 | Y83 | Sugiyama | TUBA1B | PRAVFVDLEPtVIDEVRtGtyRQLFHPEQLItGKEDAANNy |
| P78371 | S144 | Sugiyama | CCT2 99D8.1 CCTB | QTIIAGWREATKAAREALLssAVDHGsDEVKFRQDLMNIAG |
| P78371 | T475 | Sugiyama | CCT2 99D8.1 CCTB | GYDSADLVAQLRAAHsEGNttAGLDMREGTIGDMAILGITE |
| P83731 | S38 | Sugiyama | RPL24 | GRRYARTDGKVFQFLNAKCEsAFLSKRNPRQINWtVLyRRK |
| P83731 | S7 | Sugiyama | RPL24 | ______________MKVELCsFsGyKIYPGHGRRYARTDGK |
| P83731 | S86 | Sugiyama | RPL24 | EIQKKRTRRAVKFQRAItGAsLADIMAKRNQKPEVRKAQRE |
| P83731 | T52 | Sugiyama | RPL24 | LNAKCEsAFLSKRNPRQINWtVLyRRKHKKGQsEEIQKKRT |
| P83731 | T83 | Sugiyama | RPL24 | QsEEIQKKRTRRAVKFQRAItGAsLADIMAKRNQKPEVRKA |
| P84098 | S37 | Sugiyama | RPL19 | CGKKKVWLDPNEtNEIANANsRQQIRKLIKDGLIIRKPVtV |
| P84098 | T29 | Sugiyama | RPL19 | RLAssVLRCGKKKVWLDPNEtNEIANANsRQQIRKLIKDGL |
| Q00839 | T530 | Sugiyama | HNRNPU C1orf199 HNRPU SAFA U21.1 | KTTWVTKHAAENPGKyNILGtNtIMDKMMVAGFKKQMADtG |
| Q00839 | T532 | Sugiyama | HNRNPU C1orf199 HNRPU SAFA U21.1 | TWVTKHAAENPGKyNILGtNtIMDKMMVAGFKKQMADtGKL |
| Q00839 | T582 | Sugiyama | HNRNPU C1orf199 HNRPU SAFA U21.1 | CLGKFIEIAARKKRNFILDQtNVsAAAQRRKMCLFAGFQRK |
| Q01105 | S161 | Sugiyama | SET | FDENPyFENKVLSKEFHLNEsGDPssKstEIKWKSGKDLTK |
| Q01105 | T169 | Sugiyama | SET | NKVLSKEFHLNEsGDPssKstEIKWKSGKDLTKRssQTQNK |
| Q02539 | T102 | Sugiyama | H1-1 H1F1 HIST1H1A | RIKLGIKsLVsKGtLVQtKGtGAsGsFKLNKKASSVETKPG |
| Q02539 | T95 | Sugiyama | H1-1 H1F1 HIST1H1A | DVEKNNSRIKLGIKsLVsKGtLVQtKGtGAsGsFKLNKKAS |
| Q02539 | T99 | Sugiyama | H1-1 H1F1 HIST1H1A | NNSRIKLGIKsLVsKGtLVQtKGtGAsGsFKLNKKASSVET |
| Q02539 | Y74 | Sugiyama | H1-1 H1F1 HIST1H1A | SKERGGVSLAALKKALAAAGyDVEKNNSRIKLGIKsLVsKG |
| Q02878 | S255 | Sugiyama | RPL6 TXREB1 | tEKEKYEITEQRKIDQKAVDsQILPKIKAIPQLQGYLRSVF |
| Q02878 | T91 | Sugiyama | RPL6 TXREB1 | RKYSAAKSKVEKKKKEKVLAtVtKPVGGDKNGGTRVVKLRK |
| Q02878 | T93 | Sugiyama | RPL6 TXREB1 | YSAAKSKVEKKKKEKVLAtVtKPVGGDKNGGTRVVKLRKMP |
| Q05639 | T432 | Sugiyama | EEF1A2 EEF1AL STN | VESFSQYPPLGRFAVRDMRQtVAVGVIKNVEKKSGGAGKVT |
| Q06323 | S55 | Sugiyama | PSME1 IFI5111 | KKIsELDAFLKEPALNEANLsNLKAPLDIPVPDPVKEKEKE |
| Q06830 | T166 | Sugiyama | PRDX1 PAGA PAGB TDPX2 | DLPVGRsVDEtLRLVQAFQFtDKHGEVCPAGWKPGsDtIKP |
| Q06830 | T18 | Sugiyama | PRDX1 PAGA PAGB TDPX2 | ___MSSGNAKIGHPAPNFKAtAVMPDGQFKDIsLsDyKGKY |
| Q07020 | S140 | Sugiyama | RPL18 | ILtFDQLALDsPKGCGtVLLsGPRKGREVYRHFGKAPGtPH |
| Q07020 | T136 | Sugiyama | RPL18 | AGGKILtFDQLALDsPKGCGtVLLsGPRKGREVYRHFGKAP |
| Q07021 | T214 | Sugiyama | C1QBP GC1QBP HABP1 SF2P32 | GQEDEAEsDIFsIREVsFQstGESEWKDTNYTLNTDSLDWA |
| Q08043 | T354 | Sugiyama | ACTN3 | RRLHKPPRIQEKCQLEINFNtLQtKLRLSHRPAFMPSEGKL |
| Q08043 | T357 | Sugiyama | ACTN3 | HKPPRIQEKCQLEINFNtLQtKLRLSHRPAFMPSEGKLVSD |
| Q12906 | T300 | Sugiyama | ILF3 DRBF MPHOSPH4 NF90 | ASGIVMPDGSGIYDPCEKEAtDAIGHLDRQQREDItQsAQH |
| Q13069 | S7 | Sugiyama | GAGE5 | ______________MSWRGRsTyyWPRPRRYVQPPEVIGPM |
| Q13070 | S7 | Sugiyama | GAGE6 | ______________MSWRGRsTyyWPRPRRYVQPPEVIGPM |
| Q13153 | T109 | Sugiyama | PAK1 | FDAVTGEFTGMPEQWARLLQtsNITKsEQKKNPQAVLDVLE |
| Q13177 | T108 | Sugiyama | PAK2 | FDAVTGEFTGMPEQWARLLQtsNItKLEQKKNPQAVLDVLK |
| Q13310 | T191 | Sugiyama | PABPC4 APP1 PABP4 | GRFKSRKEREAELGAKAKEFtNVyIKNFGEEVDDEsLKELF |
| Q13310 | Y194 | Sugiyama | PABPC4 APP1 PABP4 | KSRKEREAELGAKAKEFtNVyIKNFGEEVDDEsLKELFsQF |
| Q13509 | S115 | Sugiyama | TUBB3 TUBB4 | SGAGNNWAKGHytEGAELVDsVLDVVRKECENCDCLQGFQL |
| Q13509 | T107 | Sugiyama | TUBB3 TUBB4 | PDNFIFGQSGAGNNWAKGHytEGAELVDsVLDVVRKECENC |
| Q13561 | T315 | Sugiyama | DCTN2 DCTN50 | KHKASVEDADTQSKVHQLyEtIQRWsPIASTLPELVQRLVT |
| Q13601 | S284 | Sugiyama | KRR1 HRB2 | KEYtPFPPPQPESQIDKELAsGEyFLKANQKKRQKMEAIKA |
| Q13765 | S186 | Sugiyama | NACA HSD48 | sEEEEVDEtGVEVKDIELVMsQANVsRAKAVRALKNNSNDI |
| Q13765 | S191 | Sugiyama | NACA HSD48 | VDEtGVEVKDIELVMsQANVsRAKAVRALKNNSNDIVNAIM |
| Q13885 | S115 | Sugiyama | TUBB2A TUBB2 | sGAGNNWAKGHytEGAELVDsVLDVVRKESESCDCLQGFQL |
| Q13885 | T107 | Sugiyama | TUBB2A TUBB2 | PDNFVFGQsGAGNNWAKGHytEGAELVDsVLDVVRKESESC |
| Q14152 | S1028 | Sugiyama | EIF3A EIF3S10 KIAA0139 | NWRHADDDRPPRRGLDEDRGsWRtADEDRGPRRGMDDDRGP |
| Q14152 | S1256 | Sugiyama | EIF3A EIF3S10 KIAA0139 | EDRFRRPRDEGGWRRGPAEEsssWRDssRRDDRDRDDRRRE |
| Q14152 | S584 | Sugiyama | EIF3A EIF3S10 KIAA0139 | EHQRILARRQtIEERKERLEsLNIQREKEELEQREAELQKV |
| Q14157 | T239 | Sugiyama | UBAP2L KIAA0144 NICE4 | GNTWNNTGHFEPDDGTSAWRtAtEEWGtEDWNEDLsEtKIF |
| Q14157 | T241 | Sugiyama | UBAP2L KIAA0144 NICE4 | TWNNTGHFEPDDGTSAWRtAtEEWGtEDWNEDLsEtKIFtA |
| Q14157 | T246 | Sugiyama | UBAP2L KIAA0144 NICE4 | GHFEPDDGTSAWRtAtEEWGtEDWNEDLsEtKIFtAsNVss |
| Q14157 | T256 | Sugiyama | UBAP2L KIAA0144 NICE4 | AWRtAtEEWGtEDWNEDLsEtKIFtAsNVssVPLPAENVtI |
| Q14192 | T234 | Sugiyama | FHL2 DRAL SLIM3 | CDLyAKKCAGCTNPISGLGGtKyIsFEERQWHNDCFNCKKC |
| Q14247 | T68 | Sugiyama | CTTN EMS1 | GHQEHINIHKLRENVFQEHQtLKEKELETGPKASHGyGGKF |
| Q14320 | S63 | Sugiyama | FAM50A DXS9928E HXC26 XAP5 | SNIDKKFsAHyDAVEAELKsstVGLVtLNDMKAKQEALVKE |
| Q14320 | T69 | Sugiyama | FAM50A DXS9928E HXC26 XAP5 | FsAHyDAVEAELKsstVGLVtLNDMKAKQEALVKEREKQLA |
| Q14444 | T303 | Sugiyama | CAPRIN1 GPIAP1 GPIP137 M11S1 RNG105 | YTEQSEVESTEYVNRQFMAEtQFtsGEKEQVDEWTVETVEV |
| Q14444 | T306 | Sugiyama | CAPRIN1 GPIAP1 GPIP137 M11S1 RNG105 | QSEVESTEYVNRQFMAEtQFtsGEKEQVDEWTVETVEVVNS |
| Q14677 | T271 | Sugiyama | CLINT1 ENTH EPN4 EPNR KIAA0171 | KDEEETVTTKHIHItQATEttttRHKRTANPsKtIDLGAAA |
| Q15056 | S110 | Sugiyama | EIF4H KIAA0038 WBSCR1 WSCR1 | DEVDsLKEALtyDGALLGDRsLRVDIAEGRKQDKGGFGFRK |
| Q15056 | S69 | Sugiyama | EIF4H KIAA0038 WBSCR1 WSCR1 | LPFNTVQGDIDAIFKDLsIRsVRLVRDKDTDKFKGFCyVEF |
| Q15056 | T100 | Sugiyama | EIF4H KIAA0038 WBSCR1 WSCR1 | KFKGFCyVEFDEVDsLKEALtyDGALLGDRsLRVDIAEGRK |
| Q15084 | T166 | Sugiyama | PDIA6 ERP5 P5 TXNDC7 | YSSGKQGRSDsSSKKDVIELtDDsFDKNVLDSEDVWMVEFY |
| Q15293 | T100 | Sugiyama | RCN1 RCN | sKERLGKIVDRIDNDGDGFVttEELKtWIKRVQKRyIFDNV |
| Q15293 | T101 | Sugiyama | RCN1 RCN | KERLGKIVDRIDNDGDGFVttEELKtWIKRVQKRyIFDNVA |
| Q15293 | T211 | Sugiyama | RCN1 RCN | FTAFLHPEEFEHMKEIVVLEtLEDIDKNGDGFVDQDEyIAD |
| Q15427 | T14 | Sugiyama | SF3B4 SAP49 | _______MAAGPISERNQDAtVyVGGLDEKVSEPLLWELFL |
| Q16204 | T205 | Sugiyama | CCDC6 D10S170 TST1 | TISKQLTLEQLRREKIDLENtLEQEQEALVNRLWKRMDKLE |
| Q16576 | T10 | Sugiyama | RBBP7 RBAP46 | ___________MAsKEMFEDtVEERVINEEYKIWKKNTPFL |
| Q16630 | T404 | Sugiyama | CPSF6 CFIM68 | yGRPPPYDRGDyGPPGREMDtARtPLsEAEFEEIMNRNRAI |
| Q16637 | T25 | Sugiyama | SMN1 SMN SMNT; SMN2 SMNC | sGGsGGGVPEQEDsVLFRRGtGQsDDsDIWDDtALIKAYDK |
| Q16637 | T37 | Sugiyama | SMN1 SMN SMNT; SMN2 SMNC | DsVLFRRGtGQsDDsDIWDDtALIKAYDKAVAsFKHALKNG |
| Q16658 | T239 | Sugiyama | FSCN1 FAN1 HSN SNL | GKVAFRDCEGRyLAPsGPsGtLKAGKATKVGKDELFALEQs |
| Q32P51 | S95 | Sugiyama | HNRNPA1L2 HNRNPA1L | TPHKVDGRVVEPKRAVsREDsQRPGAHLtVKKIFVGGIKED |
| Q3ZCM7 | T72 | Sugiyama | TUBB8 | NEASGGRYVPRAVLVDLEPGtMDsVRSGPFGQVFRPDNFIF |
| Q562R1 | S240 | Sugiyama | ACTBL2 | VALDFEQEMVRAAAssSPERsyELPDGQVItIGNERFRCPE |
| Q562R1 | T250 | Sugiyama | ACTBL2 | RAAAssSPERsyELPDGQVItIGNERFRCPEAIFQPSFLGI |
| Q58FF6 | T165 | Sugiyama | HSP90AB4P | DHGEPIDRDTKVILHLKEDQtEyLEERWVKEVVKKHPQFIG |
| Q58FF7 | T169 | Sugiyama | HSP90AB3P HSP90BC | DHGEPIGRGTKVILHLKEDQtEyLEERRVKEVVKKHsQFIG |
| Q58FG1 | S251 | Sugiyama | HSP90AA4P HSP90AD HSPCAL2 | EPIDEYCVQQLKEFEGKtLVsVTKEDLELPEDEEEKKKQEE |
| Q58FG1 | T248 | Sugiyama | HSP90AA4P HSP90AD HSPCAL2 | YTIEPIDEYCVQQLKEFEGKtLVsVTKEDLELPEDEEEKKK |
| Q5VTE0 | T432 | Sugiyama | EEF1A1P5 EEF1AL3 | VEsFSDyPPLGRFAVRDMRQtVAVGVIKAVDKKAAGAGKVT |
| Q6NUQ4 | T55 | Sugiyama | TMEM214 PP446 | RRALGEANGVWKYDLTPAIQtTSTLYERGFENIMKRQNKEQ |
| Q6PEY2 | T334 | Sugiyama | TUBA3E | ACCMLYRGDVVPKDVNAAIAtIKtKRTIQFVDWCPTGFKVG |
| Q6PEY2 | T337 | Sugiyama | TUBA3E | MLYRGDVVPKDVNAAIAtIKtKRTIQFVDWCPTGFKVGINy |
| Q6PEY2 | T51 | Sugiyama | TUBA3E | QPDGQMPSDKtIGGGDDsFNtFFsEtGAGKHVPRAVFVDLE |
| Q6PEY2 | T56 | Sugiyama | TUBA3E | MPSDKtIGGGDDsFNtFFsEtGAGKHVPRAVFVDLEPtVVD |
| Q6PEY2 | T73 | Sugiyama | TUBA3E | FsEtGAGKHVPRAVFVDLEPtVVDEVRtGtyRQLFHPEQLI |
| Q6PEY2 | T80 | Sugiyama | TUBA3E | KHVPRAVFVDLEPtVVDEVRtGtyRQLFHPEQLITGKEDAA |
| Q6PEY2 | T82 | Sugiyama | TUBA3E | VPRAVFVDLEPtVVDEVRtGtyRQLFHPEQLITGKEDAASN |
| Q6PEY2 | Y83 | Sugiyama | TUBA3E | PRAVFVDLEPtVVDEVRtGtyRQLFHPEQLITGKEDAASNY |
| Q6S8J3 | S1068 | Sugiyama | POTEE A26C1A POTE2 | SLSTFQQMWISKQEyDEsGPsIVHRKCF_____________ |
| Q6S8J3 | S939 | Sugiyama | POTEE A26C1A POTE2 | VALDFEQEMAtAAssssLEKsyELPDGQVItIGNERFRCPE |
| Q6S8J3 | T929 | Sugiyama | POTEE A26C1A POTE2 | VRDIKEKLCyVALDFEQEMAtAAssssLEKsyELPDGQVIt |
| Q6S8J3 | T949 | Sugiyama | POTEE A26C1A POTE2 | tAAssssLEKsyELPDGQVItIGNERFRCPEALFQPCFLGM |
| Q6UXH1 | T300 | Sugiyama | CRELD2 UNQ185/PRO211 | GYAREHGQCADVDECsLAEKtCVRKNENCYNTPGSYVCVCP |
| Q6ZMR3 | S161 | Sugiyama | LDHAL6A LDHL2 | DILTYVAWKLSGFPKNRVIGsGCNLDsARFRYFIGQRLGIH |
| Q6ZMR3 | S167 | Sugiyama | LDHAL6A LDHL2 | AWKLSGFPKNRVIGsGCNLDsARFRYFIGQRLGIHSESCHG |
| Q71U36 | T334 | Sugiyama | TUBA1A TUBA3 | ACCLLyRGDVVPKDVNAAIAtIKtKRTIQFVDWCPTGFKVG |
| Q71U36 | T337 | Sugiyama | TUBA1A TUBA3 | LLyRGDVVPKDVNAAIAtIKtKRTIQFVDWCPTGFKVGINy |
| Q71U36 | T51 | Sugiyama | TUBA1A TUBA3 | QPDGQMPSDKtIGGGDDsFNtFFsEtGAGKHVPRAVFVDLE |
| Q71U36 | T56 | Sugiyama | TUBA1A TUBA3 | MPSDKtIGGGDDsFNtFFsEtGAGKHVPRAVFVDLEPtVID |
| Q71U36 | T73 | Sugiyama | TUBA1A TUBA3 | FsEtGAGKHVPRAVFVDLEPtVIDEVRtGtyRQLFHPEQLI |
| Q71U36 | T80 | Sugiyama | TUBA1A TUBA3 | KHVPRAVFVDLEPtVIDEVRtGtyRQLFHPEQLItGKEDAA |
| Q71U36 | T82 | Sugiyama | TUBA1A TUBA3 | VPRAVFVDLEPtVIDEVRtGtyRQLFHPEQLItGKEDAANN |
| Q71U36 | Y432 | Sugiyama | TUBA1A TUBA3 | GMEEGEFSEAREDMAALEKDyEEVGVDsVEGEGEEEGEEy_ |
| Q71U36 | Y83 | Sugiyama | TUBA1A TUBA3 | PRAVFVDLEPtVIDEVRtGtyRQLFHPEQLItGKEDAANNy |
| Q7Z417 | S652 | Sugiyama | NUFIP2 KIAA1321 PIG1 | NtLLGsAKEQRYQRGLERNDsWGsFDLRAAIVYHTKEMEsI |
| Q7Z739 | T177 | Sugiyama | YTHDF3 | YPPSSLGRAITDGQAGFGNDtLSKVPGISsIEQGMTGLKIG |
| Q86U42 | S225 | Sugiyama | PABPN1 PAB2 PABP2 | CDKFSGHPKGFAyIEFSDKEsVRTSLALDEsLFRGRQIKVI |
| Q86U42 | S235 | Sugiyama | PABPN1 PAB2 PABP2 | FAyIEFSDKEsVRTSLALDEsLFRGRQIKVIPKRTNRPGIS |
| Q86V81 | S8 | Sugiyama | ALYREF ALY BEF THOC4 | _____________MADKMDMsLDDIIKLNRSQRGGRGGGRG |
| Q86V81 | S94 | Sugiyama | ALYREF ALY BEF THOC4 | PAPYSRPKQLPDKWQHDLFDsGFGGGAGVEtGGKLLVSNLD |
| Q86V81 | T104 | Sugiyama | ALYREF ALY BEF THOC4 | PDKWQHDLFDsGFGGGAGVEtGGKLLVSNLDFGVSDADIQE |
| Q8TAM6 | S280 | Sugiyama | ERMN KIAA1189 | TISYRKIRKGNTKQRIDEFEsMMHL________________ |
| Q8WXX5 | S215 | Sugiyama | DNAJC9 | EEAKEAEMSRKELGLDEGVDsLKAAIQSRQKDRQKEMDNFL |
| Q92522 | T55 | Sugiyama | H1-10 H1FX | KRKNSKKKNQPGKySQLVVEtIRRLGERNGSSLAKIYTEAK |
| Q96B36 | T233 | Sugiyama | AKT1S1 PRAS40 | PDLDRIAAsMRALVLREAEDtQVFGDLPRPRLNtsDFQKLK |
| Q96HC4 | T80 | Sugiyama | PDLIM5 ENH L9 | GMTHLEAQNKIKGCTGsLNMtLQRAsAAPKPEPVPVQKGEP |
| Q96HE7 | S143 | Sugiyama | ERO1A ERO1L UNQ434/PRO865 | EANNLIEECEQAERLGAVDEsLsEEtQKAVLQWTKHDDSSD |
| Q96HE7 | T148 | Sugiyama | ERO1A ERO1L UNQ434/PRO865 | IEECEQAERLGAVDEsLsEEtQKAVLQWTKHDDSSDNFCEA |
| Q96MH2 | T196 | Sugiyama | HEXIM2 L3 | GDSDGRGRAHGEFQRKDFsEtYERFHTESLQGRSKQELVRD |
| Q99497 | T154 | Sugiyama | PARK7 | MNGGHytysENRVEKDGLILtSRGPGTSFEFALAIVEALNG |
| Q99613 | S865 | Sugiyama | EIF3C EIF3S8 | HRTEPTAQQNLALQLAEKLGsLVENNERVFDHKQGtyGGyF |
| Q99832 | T57 | Sugiyama | CCT7 CCTH NIP7-1 | RTTLGPRGMDKLIVDGRGKAtIsNDGAtILKLLDVVHPAAK |
| Q99832 | T64 | Sugiyama | CCT7 CCTH NIP7-1 | GMDKLIVDGRGKAtIsNDGAtILKLLDVVHPAAKTLVDIAK |
| Q9BQE3 | T334 | Sugiyama | TUBA1C TUBA6 | ACCLLyRGDVVPKDVNAAIAtIKtKRTIQFVDWCPTGFKVG |
| Q9BQE3 | T337 | Sugiyama | TUBA1C TUBA6 | LLyRGDVVPKDVNAAIAtIKtKRTIQFVDWCPTGFKVGINy |
| Q9BQE3 | T51 | Sugiyama | TUBA1C TUBA6 | QPDGQMPSDKtIGGGDDsFNtFFsEtGAGKHVPRAVFVDLE |
| Q9BQE3 | T56 | Sugiyama | TUBA1C TUBA6 | MPSDKtIGGGDDsFNtFFsEtGAGKHVPRAVFVDLEPtVID |
| Q9BQE3 | T73 | Sugiyama | TUBA1C TUBA6 | FsEtGAGKHVPRAVFVDLEPtVIDEVRtGtyRQLFHPEQLI |
| Q9BQE3 | T80 | Sugiyama | TUBA1C TUBA6 | KHVPRAVFVDLEPtVIDEVRtGtyRQLFHPEQLItGKEDAA |
| Q9BQE3 | T82 | Sugiyama | TUBA1C TUBA6 | VPRAVFVDLEPtVIDEVRtGtyRQLFHPEQLItGKEDAANN |
| Q9BQE3 | Y83 | Sugiyama | TUBA1C TUBA6 | PRAVFVDLEPtVIDEVRtGtyRQLFHPEQLItGKEDAANNy |
| Q9BVA1 | S115 | Sugiyama | TUBB2B | sGAGNNWAKGHytEGAELVDsVLDVVRKESESCDCLQGFQL |
| Q9BVA1 | T107 | Sugiyama | TUBB2B | PDNFVFGQsGAGNNWAKGHytEGAELVDsVLDVVRKESESC |
| Q9BYX7 | S239 | Sugiyama | POTEKP ACTBL3 FKSG30 | VALDSEQEMAMAASSSSVEKsyELPDGQVItIGNERFRCPE |
| Q9BYX7 | S368 | Sugiyama | POTEKP ACTBL3 FKSG30 | SLSTFQQMWISKQEyDEsGPsIVHRKCF_____________ |
| Q9BYX7 | T249 | Sugiyama | POTEKP ACTBL3 FKSG30 | MAASSSSVEKsyELPDGQVItIGNERFRCPEALFQPCFLGM |
| Q9C0C2 | T1323 | Sugiyama | TNKS1BP1 KIAA1741 TAB182 | ELGVGQMDWGNNLGLRDLEVtCDPDsGGsQGLRGCGVGQMD |
| Q9H0C5 | S273 | Sugiyama | BTBD1 C15orf1 NS5ATP8 | QRQQLPVTFGNKQKVLGKALsLIRFPLMTIEEFAAGPAQSG |
| Q9H0L4 | T341 | Sugiyama | CSTF2T KIAA0689 | PGGLPPRGLLGDAPNDPRGGtLLsVtGEVEPRGYLGPPHQG |
| Q9H0L4 | T346 | Sugiyama | CSTF2T KIAA0689 | PRGLLGDAPNDPRGGtLLsVtGEVEPRGYLGPPHQGPPMHH |
| Q9NQ39 | T159 | Sugiyama | RPS10P5 RPS10L | RRCSVPPGADKKAEAGAGsAtEFQFRGRCGRGRGQPPQ___ |
| Q9NZL9 | T34 | Sugiyama | MAT2B TGR MSTP045 Nbla02999 UNQ2435/PRO4995 | PGsCRLVEEEVNIPNRRVLVtGAtGLLGRAVHKEFQQNNWH |
| Q9NZL9 | T37 | Sugiyama | MAT2B TGR MSTP045 Nbla02999 UNQ2435/PRO4995 | CRLVEEEVNIPNRRVLVtGAtGLLGRAVHKEFQQNNWHAVG |
| Q9UBR2 | T172 | Sugiyama | CTSZ | ETCNNYQAKDQECDKFNQCGtCNEFKECHAIRNYTLWRVGD |
| Q9UHV9 | T103 | Sugiyama | PFDN2 PFD2 HSPC231 | VKEVLPALENNKEQIQKIIEtLtQQLQAKGKELNEFREKHN |
| Q9UHV9 | T105 | Sugiyama | PFDN2 PFD2 HSPC231 | EVLPALENNKEQIQKIIEtLtQQLQAKGKELNEFREKHNIR |
| Q9UI15 | T190 | Sugiyama | TAGLN3 NP25 | GQNVIGLQMGSNKGAsQAGMtGyGMPRQIM___________ |
| Q9ULW6 | T342 | Sugiyama | NAP1L2 BPX | GTAIEYSTGCEIDWNEGKNVtLKtIKKKQKHRIWGTIRTVT |
| Q9ULW6 | T345 | Sugiyama | NAP1L2 BPX | IEYSTGCEIDWNEGKNVtLKtIKKKQKHRIWGTIRTVTEDF |
| Q9UNF1 | T117 | Sugiyama | MAGED2 BCG1 | AENKSLAADTKKQNADPQAVtMPATEtKKVSHVADTKVNTK |
| Q9UNF1 | T123 | Sugiyama | MAGED2 BCG1 | AADTKKQNADPQAVtMPATEtKKVSHVADTKVNTKAQETEA |
| Q9UNF1 | T87 | Sugiyama | MAGED2 BCG1 | tEVsKtPEAREAPAtQAssttQLtDtQVLAAENKSLAADTK |
| Q9UNF1 | T90 | Sugiyama | MAGED2 BCG1 | sKtPEAREAPAtQAssttQLtDtQVLAAENKSLAADTKKQN |
| Q9UNF1 | T92 | Sugiyama | MAGED2 BCG1 | tPEAREAPAtQAssttQLtDtQVLAAENKSLAADTKKQNAD |
| Q9UNX3 | T8 | Sugiyama | RPL26L1 RPL26P1 | _____________MKFNPFVtsDRsKNRKRHFNAPSHVRRK |
| Q9UQ80 | T200 | Sugiyama | PA2G4 EBP1 | TPIEGMLSHQLKQHVIDGEKtIIQNPTDQQKKDHEKAEFEV |
| Q9UQ80 | T386 | Sugiyama | PA2G4 EBP1 | tQKKKKKKAsKtAENAtsGEtLEENEAGD____________ |
| Q9Y247 | S63 | Sugiyama | FAM50B X5L | SQVDKRFSAHyDAVEAELKsstVGLVtLNDMKARQEALVRE |
| Q9Y247 | T69 | Sugiyama | FAM50B X5L | FSAHyDAVEAELKsstVGLVtLNDMKARQEALVRERERQLA |
| Q9Y2B0 | S115 | Sugiyama | CNPY2 MSAP TMEM4 ZSIG9 UNQ1943/PRO4426 | QIDPstHRKNYVRVVGRNGEssELDLQGIRIDsDISGtLKF |
| Q9Y2B0 | S63 | Sugiyama | CNPY2 MSAP TMEM4 ZSIG9 UNQ1943/PRO4426 | AQVDPKKTIQMGsFRINPDGsQsVVEVPyARsEAHLtELLE |
| Q9Y2B0 | T132 | Sugiyama | CNPY2 MSAP TMEM4 ZSIG9 UNQ1943/PRO4426 | NGEssELDLQGIRIDsDISGtLKFACEsIVEEyEDELIEFF |
| Q9Y2W1 | T227 | Sugiyama | THRAP3 BCLAF2 TRAP150 | sGGtsQDTKAsEssKPWPDAtyGtGsAsRAsAVsELsPRER |
| Q9Y2W1 | T230 | Sugiyama | THRAP3 BCLAF2 TRAP150 | tsQDTKAsEssKPWPDAtyGtGsAsRAsAVsELsPRERsPA |
| Q9Y2W1 | Y228 | Sugiyama | THRAP3 BCLAF2 TRAP150 | GGtsQDTKAsEssKPWPDAtyGtGsAsRAsAVsELsPRERs |
| Q9Y2X3 | S434 | Sugiyama | NOP58 NOL5 NOP5 HSPC120 | AKTEKYEHKSEVKtyDPSGDstLPtCsKKRKIEQVDKEDEI |
| Q9Y3F4 | S228 | Sugiyama | STRAP MAWD UNRIP | FHSAVSLDPIKsFEAPAtINsAsLHPEKEFLVAGGEDFKLy |
| Q9Y3F4 | S230 | Sugiyama | STRAP MAWD UNRIP | SAVSLDPIKsFEAPAtINsAsLHPEKEFLVAGGEDFKLyKy |
| Q9Y3F4 | T225 | Sugiyama | STRAP MAWD UNRIP | SIAFHSAVSLDPIKsFEAPAtINsAsLHPEKEFLVAGGEDF |
| Q9Y3F4 | T48 | Sugiyama | STRAP MAWD UNRIP | YGYFLISACKDGKPMLRQGDtGDWIGtFLGHKGAVWGAtLN |
| Q9Y3F4 | T54 | Sugiyama | STRAP MAWD UNRIP | SACKDGKPMLRQGDtGDWIGtFLGHKGAVWGAtLNKDATKA |
| Q9Y3S2 | S25 | Sugiyama | ZNF330 NOA36 | KTGARKKAENRREREKQLRAsRstIDLAKHPCNASMECDKC |
| Q9Y3S2 | S27 | Sugiyama | ZNF330 NOA36 | GARKKAENRREREKQLRAsRstIDLAKHPCNASMECDKCQR |
| Q9Y3S2 | T28 | Sugiyama | ZNF330 NOA36 | ARKKAENRREREKQLRAsRstIDLAKHPCNASMECDKCQRR |
| Q9Y5J9 | T71 | Sugiyama | TIMM8B DDP2 DDPL TIM8B | RTENCLsSCVDRFIDTTLAItSRFAQIVQKGGQ________ |
| Q9Y5L4 | S57 | Sugiyama | TIMM13 TIM13B TIMM13A TIMM13B | ELLQRMTDKCFRKCIGKPGGsLDNSEQKCIAMCMDRyMDAW |
Site Promiscuity
Motif of predicted substrate sequence
Reactome pathways of predicted substrates
Download
| name | reactome_id | p | -log10p | ref_path | ref_path_lowest |
|---|---|---|---|---|---|
| Signal Transduction | R-HSA-162582 | 6.100736e-08 | 7.215 | 0 | 0 |
| L1CAM interactions | R-HSA-373760 | 7.630482e-07 | 6.117 | 0 | 0 |
| EML4 and NUDC in mitotic spindle formation | R-HSA-9648025 | 3.775608e-06 | 5.423 | 0 | 0 |
| Recycling pathway of L1 | R-HSA-437239 | 1.012195e-05 | 4.995 | 0 | 0 |
| Formation of tubulin folding intermediates by CCT/TriC | R-HSA-389960 | 1.125906e-05 | 4.948 | 0 | 0 |
| PKR-mediated signaling | R-HSA-9833482 | 1.525813e-05 | 4.816 | 0 | 0 |
| Resolution of Sister Chromatid Cohesion | R-HSA-2500257 | 1.703839e-05 | 4.769 | 0 | 0 |
| Assembly and cell surface presentation of NMDA receptors | R-HSA-9609736 | 1.814620e-05 | 4.741 | 0 | 0 |
| Cell Cycle | R-HSA-1640170 | 2.335288e-05 | 4.632 | 0 | 0 |
| Oncogene Induced Senescence | R-HSA-2559585 | 2.650351e-05 | 4.577 | 0 | 0 |
| Axon guidance | R-HSA-422475 | 2.603900e-05 | 4.584 | 0 | 0 |
| COPI-dependent Golgi-to-ER retrograde traffic | R-HSA-6811434 | 3.824918e-05 | 4.417 | 0 | 0 |
| Signaling by ALK fusions and activated point mutants | R-HSA-9725370 | 3.880019e-05 | 4.411 | 0 | 0 |
| Signaling by ALK in cancer | R-HSA-9700206 | 3.880019e-05 | 4.411 | 0 | 0 |
| Selective autophagy | R-HSA-9663891 | 4.566026e-05 | 4.340 | 0 | 0 |
| Mitotic Prometaphase | R-HSA-68877 | 4.694484e-05 | 4.328 | 0 | 0 |
| Cooperation of Prefoldin and TriC/CCT in actin and tubulin folding | R-HSA-389958 | 5.649365e-05 | 4.248 | 0 | 0 |
| Golgi-to-ER retrograde transport | R-HSA-8856688 | 5.744492e-05 | 4.241 | 0 | 0 |
| Diseases of signal transduction by growth factor receptors and second messengers | R-HSA-5663202 | 5.843614e-05 | 4.233 | 0 | 0 |
| Aggrephagy | R-HSA-9646399 | 6.699010e-05 | 4.174 | 0 | 0 |
| Microtubule-dependent trafficking of connexons from Golgi to the plasma membrane | R-HSA-190840 | 7.362878e-05 | 4.133 | 0 | 0 |
| Kinesins | R-HSA-983189 | 7.675550e-05 | 4.115 | 0 | 0 |
| Transport of connexons to the plasma membrane | R-HSA-190872 | 9.673620e-05 | 4.014 | 0 | 0 |
| Nervous system development | R-HSA-9675108 | 1.169411e-04 | 3.932 | 0 | 0 |
| Post-chaperonin tubulin folding pathway | R-HSA-389977 | 1.606640e-04 | 3.794 | 0 | 0 |
| Autophagy | R-HSA-9612973 | 1.605581e-04 | 3.794 | 0 | 0 |
| Nuclear Receptor transcription pathway | R-HSA-383280 | 1.785973e-04 | 3.748 | 0 | 0 |
| Activation of AMPK downstream of NMDARs | R-HSA-9619483 | 1.807609e-04 | 3.743 | 0 | 0 |
| Intra-Golgi and retrograde Golgi-to-ER traffic | R-HSA-6811442 | 1.965111e-04 | 3.707 | 0 | 0 |
| MHC class II antigen presentation | R-HSA-2132295 | 2.046995e-04 | 3.689 | 0 | 0 |
| Cell Cycle, Mitotic | R-HSA-69278 | 2.273864e-04 | 3.643 | 0 | 0 |
| Separation of Sister Chromatids | R-HSA-2467813 | 2.845927e-04 | 3.546 | 0 | 0 |
| Prefoldin mediated transfer of substrate to CCT/TriC | R-HSA-389957 | 3.898975e-04 | 3.409 | 0 | 0 |
| Chaperonin-mediated protein folding | R-HSA-390466 | 5.003067e-04 | 3.301 | 0 | 0 |
| Recruitment of NuMA to mitotic centrosomes | R-HSA-380320 | 5.500497e-04 | 3.260 | 0 | 0 |
| Sema4D in semaphorin signaling | R-HSA-400685 | 5.763408e-04 | 3.239 | 0 | 0 |
| Mitotic G2-G2/M phases | R-HSA-453274 | 5.675179e-04 | 3.246 | 0 | 0 |
| Mitotic Anaphase | R-HSA-68882 | 5.464717e-04 | 3.262 | 0 | 0 |
| Mitotic Metaphase and Anaphase | R-HSA-2555396 | 5.781267e-04 | 3.238 | 0 | 0 |
| COPI-independent Golgi-to-ER retrograde traffic | R-HSA-6811436 | 6.685030e-04 | 3.175 | 0 | 0 |
| Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors | R-HSA-8864260 | 6.730302e-04 | 3.172 | 0 | 0 |
| FOXO-mediated transcription of cell death genes | R-HSA-9614657 | 6.765698e-04 | 3.170 | 0 | 0 |
| RUNX3 regulates p14-ARF | R-HSA-8951936 | 8.561445e-04 | 3.067 | 0 | 0 |
| Protein folding | R-HSA-391251 | 8.660541e-04 | 3.062 | 0 | 0 |
| Macroautophagy | R-HSA-1632852 | 9.879648e-04 | 3.005 | 0 | 0 |
| Developmental Lineage of Mammary Gland Myoepithelial Cells | R-HSA-9927432 | 1.158066e-03 | 2.936 | 0 | 0 |
| Amplification of signal from the kinetochores | R-HSA-141424 | 1.328657e-03 | 2.877 | 0 | 0 |
| Amplification of signal from unattached kinetochores via a MAD2 inhibitory signal | R-HSA-141444 | 1.328657e-03 | 2.877 | 0 | 0 |
| Signaling by NOTCH1 | R-HSA-1980143 | 1.705852e-03 | 2.768 | 0 | 0 |
| Membrane Trafficking | R-HSA-199991 | 1.867956e-03 | 2.729 | 0 | 0 |
| RAF/MAP kinase cascade | R-HSA-5673001 | 1.977303e-03 | 2.704 | 0 | 0 |
| Activation of NMDA receptors and postsynaptic events | R-HSA-442755 | 2.116697e-03 | 2.674 | 0 | 0 |
| Sealing of the nuclear envelope (NE) by ESCRT-III | R-HSA-9668328 | 2.123318e-03 | 2.673 | 0 | 0 |
| Muscle contraction | R-HSA-397014 | 2.246562e-03 | 2.648 | 0 | 0 |
| Death Receptor Signaling | R-HSA-73887 | 2.378150e-03 | 2.624 | 0 | 0 |
| Loss of Function of FBXW7 in Cancer and NOTCH1 Signaling | R-HSA-2644607 | 2.626196e-03 | 2.581 | 0 | 0 |
| FBXW7 Mutants and NOTCH1 in Cancer | R-HSA-2644605 | 2.626196e-03 | 2.581 | 0 | 0 |
| NRAGE signals death through JNK | R-HSA-193648 | 2.739498e-03 | 2.562 | 0 | 0 |
| MAPK1/MAPK3 signaling | R-HSA-5684996 | 2.657647e-03 | 2.576 | 0 | 0 |
| G2/M Transition | R-HSA-69275 | 2.759869e-03 | 2.559 | 0 | 0 |
| Sensory processing of sound by inner hair cells of the cochlea | R-HSA-9662360 | 2.625155e-03 | 2.581 | 0 | 0 |
| Sensory processing of sound by outer hair cells of the cochlea | R-HSA-9662361 | 2.739498e-03 | 2.562 | 0 | 0 |
| MAPK family signaling cascades | R-HSA-5683057 | 2.772397e-03 | 2.557 | 0 | 0 |
| Gap junction assembly | R-HSA-190861 | 2.794333e-03 | 2.554 | 0 | 0 |
| Signal attenuation | R-HSA-74749 | 2.983641e-03 | 2.525 | 0 | 0 |
| Cytosolic sensors of pathogen-associated DNA | R-HSA-1834949 | 3.148723e-03 | 2.502 | 0 | 0 |
| COPI-mediated anterograde transport | R-HSA-6807878 | 3.762142e-03 | 2.425 | 0 | 0 |
| ER to Golgi Anterograde Transport | R-HSA-199977 | 3.764424e-03 | 2.424 | 0 | 0 |
| Regulation of beta-cell development | R-HSA-186712 | 3.685049e-03 | 2.434 | 0 | 0 |
| Interleukin-2 signaling | R-HSA-9020558 | 3.875717e-03 | 2.412 | 0 | 0 |
| IRS activation | R-HSA-74713 | 4.035291e-03 | 2.394 | 0 | 0 |
| LRR FLII-interacting protein 1 (LRRFIP1) activates type I IFN production | R-HSA-3134973 | 4.035291e-03 | 2.394 | 0 | 0 |
| Cell death signalling via NRAGE, NRIF and NADE | R-HSA-204998 | 4.086536e-03 | 2.389 | 0 | 0 |
| Nuclear events stimulated by ALK signaling in cancer | R-HSA-9725371 | 4.207431e-03 | 2.376 | 0 | 0 |
| Signaling by Interleukins | R-HSA-449147 | 4.447546e-03 | 2.352 | 0 | 0 |
| Post NMDA receptor activation events | R-HSA-438064 | 4.628281e-03 | 2.335 | 0 | 0 |
| NOTCH1 Intracellular Domain Regulates Transcription | R-HSA-2122947 | 4.666198e-03 | 2.331 | 0 | 0 |
| Mitotic Spindle Checkpoint | R-HSA-69618 | 4.992274e-03 | 2.302 | 0 | 0 |
| NFE2L2 regulates pentose phosphate pathway genes | R-HSA-9818028 | 4.932834e-03 | 2.307 | 0 | 0 |
| Signaling by Non-Receptor Tyrosine Kinases | R-HSA-9006927 | 5.323391e-03 | 2.274 | 0 | 0 |
| Signaling by PTK6 | R-HSA-8848021 | 5.323391e-03 | 2.274 | 0 | 0 |
| Hedgehog 'off' state | R-HSA-5610787 | 4.992274e-03 | 2.302 | 0 | 0 |
| Signaling by Hedgehog | R-HSA-5358351 | 5.017272e-03 | 2.300 | 0 | 0 |
| Signaling by ALK | R-HSA-201556 | 5.180755e-03 | 2.286 | 0 | 0 |
| Interleukin-12 signaling | R-HSA-9020591 | 5.232283e-03 | 2.281 | 0 | 0 |
| Regulation of gene expression in beta cells | R-HSA-210745 | 5.383298e-03 | 2.269 | 0 | 0 |
| M Phase | R-HSA-68886 | 5.435099e-03 | 2.265 | 0 | 0 |
| Antiviral mechanism by IFN-stimulated genes | R-HSA-1169410 | 5.529203e-03 | 2.257 | 0 | 0 |
| Regulation of cytoskeletal remodeling and cell spreading by IPP complex components | R-HSA-446388 | 5.828965e-03 | 2.234 | 0 | 0 |
| IRAK1 recruits IKK complex | R-HSA-937039 | 6.167765e-03 | 2.210 | 0 | 0 |
| IRAK1 recruits IKK complex upon TLR7/8 or 9 stimulation | R-HSA-975144 | 6.167765e-03 | 2.210 | 0 | 0 |
| Sema4D induced cell migration and growth-cone collapse | R-HSA-416572 | 5.757848e-03 | 2.240 | 0 | 0 |
| Signaling by LTK | R-HSA-9842663 | 6.167765e-03 | 2.210 | 0 | 0 |
| Interleukin-37 signaling | R-HSA-9008059 | 6.143944e-03 | 2.212 | 0 | 0 |
| Sensory processing of sound | R-HSA-9659379 | 6.615491e-03 | 2.179 | 0 | 0 |
| NOTCH4 Intracellular Domain Regulates Transcription | R-HSA-9013695 | 6.757927e-03 | 2.170 | 0 | 0 |
| Nuclear Envelope (NE) Reassembly | R-HSA-2995410 | 7.134621e-03 | 2.147 | 0 | 0 |
| IKBKB deficiency causes SCID | R-HSA-5602636 | 8.221407e-03 | 2.085 | 0 | 0 |
| IKBKG deficiency causes anhidrotic ectodermal dysplasia with immunodeficiency (EDA-ID) (via TLR) | R-HSA-5603027 | 8.221407e-03 | 2.085 | 0 | 0 |
| TFAP2A acts as a transcriptional repressor during retinoic acid induced cell differentiation | R-HSA-8869496 | 8.031993e-03 | 2.095 | 0 | 0 |
| PTK6 promotes HIF1A stabilization | R-HSA-8857538 | 8.031993e-03 | 2.095 | 0 | 0 |
| NFE2L2 regulating tumorigenic genes | R-HSA-9818030 | 7.592505e-03 | 2.120 | 0 | 0 |
| Apoptotic cleavage of cellular proteins | R-HSA-111465 | 7.895256e-03 | 2.103 | 0 | 0 |
| Regulation of NFE2L2 gene expression | R-HSA-9818749 | 8.031993e-03 | 2.095 | 0 | 0 |
| Interleukin-3, Interleukin-5 and GM-CSF signaling | R-HSA-512988 | 7.993826e-03 | 2.097 | 0 | 0 |
| Factors involved in megakaryocyte development and platelet production | R-HSA-983231 | 7.603225e-03 | 2.119 | 0 | 0 |
| HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand | R-HSA-3371497 | 8.105408e-03 | 2.091 | 0 | 0 |
| Neurotransmitter receptors and postsynaptic signal transmission | R-HSA-112314 | 9.742504e-03 | 2.011 | 0 | 0 |
| Gap junction trafficking | R-HSA-190828 | 9.761310e-03 | 2.010 | 0 | 0 |
| Potassium Channels | R-HSA-1296071 | 9.936248e-03 | 2.003 | 0 | 0 |
| Striated Muscle Contraction | R-HSA-390522 | 9.979810e-03 | 2.001 | 0 | 0 |
| Interleukin receptor SHC signaling | R-HSA-912526 | 1.047649e-02 | 1.980 | 0 | 0 |
| RAF activation | R-HSA-5673000 | 1.115678e-02 | 1.952 | 0 | 0 |
| Cell-extracellular matrix interactions | R-HSA-446353 | 1.105511e-02 | 1.956 | 0 | 0 |
| NOD1/2 Signaling Pathway | R-HSA-168638 | 1.115678e-02 | 1.952 | 0 | 0 |
| Cargo trafficking to the periciliary membrane | R-HSA-5620920 | 1.023699e-02 | 1.990 | 0 | 0 |
| Cellular responses to stimuli | R-HSA-8953897 | 1.153522e-02 | 1.938 | 0 | 0 |
| Apoptotic execution phase | R-HSA-75153 | 1.179822e-02 | 1.928 | 0 | 0 |
| Translocation of SLC2A4 (GLUT4) to the plasma membrane | R-HSA-1445148 | 1.187580e-02 | 1.925 | 0 | 0 |
| p75 NTR receptor-mediated signalling | R-HSA-193704 | 1.198515e-02 | 1.921 | 0 | 0 |
| Drug resistance in ERBB2 KD mutants | R-HSA-9665230 | 1.419324e-02 | 1.848 | 0 | 0 |
| Drug-mediated inhibition of ERBB2 signaling | R-HSA-9652282 | 1.419324e-02 | 1.848 | 0 | 0 |
| Diseases of cellular response to stress | R-HSA-9675132 | 1.419324e-02 | 1.848 | 0 | 0 |
| Diseases of Cellular Senescence | R-HSA-9630747 | 1.419324e-02 | 1.848 | 0 | 0 |
| Localization of the PINCH-ILK-PARVIN complex to focal adhesions | R-HSA-446343 | 1.419324e-02 | 1.848 | 0 | 0 |
| Resistance of ERBB2 KD mutants to sapitinib | R-HSA-9665244 | 1.419324e-02 | 1.848 | 0 | 0 |
| Resistance of ERBB2 KD mutants to tesevatinib | R-HSA-9665245 | 1.419324e-02 | 1.848 | 0 | 0 |
| Resistance of ERBB2 KD mutants to afatinib | R-HSA-9665249 | 1.419324e-02 | 1.848 | 0 | 0 |
| Resistance of ERBB2 KD mutants to lapatinib | R-HSA-9665251 | 1.419324e-02 | 1.848 | 0 | 0 |
| Resistance of ERBB2 KD mutants to osimertinib | R-HSA-9665247 | 1.419324e-02 | 1.848 | 0 | 0 |
| Drug resistance in ERBB2 TMD/JMD mutants | R-HSA-9665737 | 1.419324e-02 | 1.848 | 0 | 0 |
| Resistance of ERBB2 KD mutants to trastuzumab | R-HSA-9665233 | 1.419324e-02 | 1.848 | 0 | 0 |
| Resistance of ERBB2 KD mutants to AEE788 | R-HSA-9665250 | 1.419324e-02 | 1.848 | 0 | 0 |
| Resistance of ERBB2 KD mutants to neratinib | R-HSA-9665246 | 1.419324e-02 | 1.848 | 0 | 0 |
| Apoptotic cleavage of cell adhesion proteins | R-HSA-351906 | 1.373802e-02 | 1.862 | 0 | 0 |
| Carboxyterminal post-translational modifications of tubulin | R-HSA-8955332 | 1.292433e-02 | 1.889 | 0 | 0 |
| Signaling by NOTCH1 in Cancer | R-HSA-2644603 | 1.261144e-02 | 1.899 | 0 | 0 |
| Signaling by NOTCH1 PEST Domain Mutants in Cancer | R-HSA-2644602 | 1.261144e-02 | 1.899 | 0 | 0 |
| Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants | R-HSA-2894862 | 1.261144e-02 | 1.899 | 0 | 0 |
| Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer | R-HSA-2894858 | 1.261144e-02 | 1.899 | 0 | 0 |
| Constitutive Signaling by NOTCH1 PEST Domain Mutants | R-HSA-2644606 | 1.261144e-02 | 1.899 | 0 | 0 |
| The role of GTSE1 in G2/M progression after G2 checkpoint | R-HSA-8852276 | 1.474602e-02 | 1.831 | 0 | 0 |
| Oxidative Stress Induced Senescence | R-HSA-2559580 | 1.434120e-02 | 1.843 | 0 | 0 |
| Intraflagellar transport | R-HSA-5620924 | 1.412566e-02 | 1.850 | 0 | 0 |
| Interleukin-12 family signaling | R-HSA-447115 | 1.250201e-02 | 1.903 | 0 | 0 |
| Neuronal System | R-HSA-112316 | 1.427809e-02 | 1.845 | 0 | 0 |
| Signaling by NOTCH4 | R-HSA-9013694 | 1.276506e-02 | 1.894 | 0 | 0 |
| TFAP2 (AP-2) family regulates transcription of growth factors and their receptors | R-HSA-8866910 | 1.539882e-02 | 1.813 | 0 | 0 |
| Gap junction trafficking and regulation | R-HSA-157858 | 1.540472e-02 | 1.812 | 0 | 0 |
| Cell Cycle Checkpoints | R-HSA-69620 | 1.556973e-02 | 1.808 | 0 | 0 |
| Semaphorin interactions | R-HSA-373755 | 1.590648e-02 | 1.798 | 0 | 0 |
| TNFR1-induced NF-kappa-B signaling pathway | R-HSA-5357956 | 1.732949e-02 | 1.761 | 0 | 0 |
| EPH-Ephrin signaling | R-HSA-2682334 | 1.819514e-02 | 1.740 | 0 | 0 |
| Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation | R-HSA-8950505 | 1.842305e-02 | 1.735 | 0 | 0 |
| Cellular Senescence | R-HSA-2559583 | 1.943316e-02 | 1.711 | 0 | 0 |
| Cellular responses to stress | R-HSA-2262752 | 1.958529e-02 | 1.708 | 0 | 0 |
| Interleukin-2 family signaling | R-HSA-451927 | 2.033383e-02 | 1.692 | 0 | 0 |
| Signaling by ERBB2 ECD mutants | R-HSA-9665348 | 2.068653e-02 | 1.684 | 0 | 0 |
| Platelet sensitization by LDL | R-HSA-432142 | 2.068653e-02 | 1.684 | 0 | 0 |
| Smooth Muscle Contraction | R-HSA-445355 | 2.134684e-02 | 1.671 | 0 | 0 |
| Other interleukin signaling | R-HSA-449836 | 2.369976e-02 | 1.625 | 0 | 0 |
| SHC1 events in ERBB2 signaling | R-HSA-1250196 | 2.406798e-02 | 1.619 | 0 | 0 |
| Signaling by NOTCH | R-HSA-157118 | 2.762841e-02 | 1.559 | 0 | 0 |
| Cytokine Signaling in Immune system | R-HSA-1280215 | 2.571336e-02 | 1.590 | 0 | 0 |
| TNF signaling | R-HSA-75893 | 2.673383e-02 | 1.573 | 0 | 0 |
| Regulation of CDH1 Function | R-HSA-9764561 | 2.871776e-02 | 1.542 | 0 | 0 |
| NADE modulates death signalling | R-HSA-205025 | 3.012494e-02 | 1.521 | 0 | 0 |
| NFE2L2 regulating ER-stress associated genes | R-HSA-9818035 | 3.012494e-02 | 1.521 | 0 | 0 |
| PLCG1 events in ERBB2 signaling | R-HSA-1251932 | 3.012494e-02 | 1.521 | 0 | 0 |
| Regulation of gene expression by Hypoxia-inducible Factor | R-HSA-1234158 | 3.060088e-02 | 1.514 | 0 | 0 |
| Sema4D mediated inhibition of cell attachment and migration | R-HSA-416550 | 3.060088e-02 | 1.514 | 0 | 0 |
| Signaling by GSK3beta mutants | R-HSA-5339716 | 3.060088e-02 | 1.514 | 0 | 0 |
| Recruitment of mitotic centrosome proteins and complexes | R-HSA-380270 | 3.135138e-02 | 1.504 | 0 | 0 |
| VEGFA-VEGFR2 Pathway | R-HSA-4420097 | 3.316426e-02 | 1.479 | 0 | 0 |
| NFE2L2 regulating inflammation associated genes | R-HSA-9818026 | 3.983127e-02 | 1.400 | 0 | 0 |
| G2 Phase | R-HSA-68911 | 3.983127e-02 | 1.400 | 0 | 0 |
| Constitutive Signaling by Overexpressed ERBB2 | R-HSA-9634285 | 3.596136e-02 | 1.444 | 0 | 0 |
| SHC-related events triggered by IGF1R | R-HSA-2428933 | 3.596136e-02 | 1.444 | 0 | 0 |
| Signaling by CTNNB1 phospho-site mutants | R-HSA-4839743 | 3.596136e-02 | 1.444 | 0 | 0 |
| CTNNB1 S37 mutants aren't phosphorylated | R-HSA-5358749 | 3.596136e-02 | 1.444 | 0 | 0 |
| CTNNB1 S33 mutants aren't phosphorylated | R-HSA-5358747 | 3.596136e-02 | 1.444 | 0 | 0 |
| CTNNB1 T41 mutants aren't phosphorylated | R-HSA-5358752 | 3.596136e-02 | 1.444 | 0 | 0 |
| CTNNB1 S45 mutants aren't phosphorylated | R-HSA-5358751 | 3.596136e-02 | 1.444 | 0 | 0 |
| Notch-HLH transcription pathway | R-HSA-350054 | 3.830805e-02 | 1.417 | 0 | 0 |
| Centrosome maturation | R-HSA-380287 | 3.536164e-02 | 1.451 | 0 | 0 |
| Negative regulation of NMDA receptor-mediated neuronal transmission | R-HSA-9617324 | 3.426751e-02 | 1.465 | 0 | 0 |
| Mitophagy | R-HSA-5205647 | 3.864804e-02 | 1.413 | 0 | 0 |
| RUNX3 regulates NOTCH signaling | R-HSA-8941856 | 3.596136e-02 | 1.444 | 0 | 0 |
| PTK6 Regulates Proteins Involved in RNA Processing | R-HSA-8849468 | 3.983127e-02 | 1.400 | 0 | 0 |
| Cellular response to chemical stress | R-HSA-9711123 | 3.801754e-02 | 1.420 | 0 | 0 |
| NrCAM interactions | R-HSA-447038 | 3.983127e-02 | 1.400 | 0 | 0 |
| Non-integrin membrane-ECM interactions | R-HSA-3000171 | 3.536164e-02 | 1.451 | 0 | 0 |
| Regulation of TNFR1 signaling | R-HSA-5357905 | 3.628428e-02 | 1.440 | 0 | 0 |
| G alpha (12/13) signalling events | R-HSA-416482 | 4.200431e-02 | 1.377 | 0 | 0 |
| The role of Nef in HIV-1 replication and disease pathogenesis | R-HSA-164952 | 4.260963e-02 | 1.370 | 0 | 0 |
| Growth hormone receptor signaling | R-HSA-982772 | 4.260963e-02 | 1.370 | 0 | 0 |
| Transport to the Golgi and subsequent modification | R-HSA-948021 | 4.359277e-02 | 1.361 | 0 | 0 |
| Evasion of Oncogene Induced Senescence Due to p14ARF Defects | R-HSA-9646303 | 4.372864e-02 | 1.359 | 0 | 0 |
| Evasion of Oxidative Stress Induced Senescence Due to p14ARF Defects | R-HSA-9646304 | 4.372864e-02 | 1.359 | 0 | 0 |
| KEAP1-NFE2L2 pathway | R-HSA-9755511 | 4.387834e-02 | 1.358 | 0 | 0 |
| Developmental Cell Lineages of the Integumentary System | R-HSA-9734779 | 4.645148e-02 | 1.333 | 0 | 0 |
| Signaling by ERBB2 TMD/JMD mutants | R-HSA-9665686 | 4.717221e-02 | 1.326 | 0 | 0 |
| Voltage gated Potassium channels | R-HSA-1296072 | 4.951133e-02 | 1.305 | 0 | 0 |
| Programmed Cell Death | R-HSA-5357801 | 4.962489e-02 | 1.304 | 0 | 0 |
| Signaling by NOTCH1 t(7;9)(NOTCH1:M1580_K2555) Translocation Mutant | R-HSA-2660825 | 5.054310e-02 | 1.296 | 0 | 0 |
| Constitutive Signaling by NOTCH1 t(7;9)(NOTCH1:M1580_K2555) Translocation Mutant | R-HSA-2660826 | 5.054310e-02 | 1.296 | 0 | 0 |
| GLI proteins bind promoters of Hh responsive genes to promote transcription | R-HSA-5635851 | 5.054310e-02 | 1.296 | 0 | 0 |
| CDH11 homotypic and heterotypic interactions | R-HSA-9833576 | 5.054310e-02 | 1.296 | 0 | 0 |
| Negative feedback regulation of MAPK pathway | R-HSA-5674499 | 5.054310e-02 | 1.296 | 0 | 0 |
| IkBA variant leads to EDA-ID | R-HSA-5603029 | 5.054310e-02 | 1.296 | 0 | 0 |
| Regulation of CDH19 Expression and Function | R-HSA-9764302 | 5.054310e-02 | 1.296 | 0 | 0 |
| SLC15A4:TASL-dependent IRF5 activation | R-HSA-9860276 | 5.054310e-02 | 1.296 | 0 | 0 |
| Beta-catenin phosphorylation cascade | R-HSA-196299 | 5.470153e-02 | 1.262 | 0 | 0 |
| Transcription of E2F targets under negative control by p107 (RBL1) and p130 (RBL2) in complex with HDAC1 | R-HSA-1362300 | 6.179998e-02 | 1.209 | 0 | 0 |
| Phase 4 - resting membrane potential | R-HSA-5576886 | 6.179998e-02 | 1.209 | 0 | 0 |
| Activated NOTCH1 Transmits Signal to the Nucleus | R-HSA-2122948 | 5.707630e-02 | 1.244 | 0 | 0 |
| RIP-mediated NFkB activation via ZBP1 | R-HSA-1810476 | 5.470153e-02 | 1.262 | 0 | 0 |
| TICAM1, RIP1-mediated IKK complex recruitment | R-HSA-168927 | 5.470153e-02 | 1.262 | 0 | 0 |
| TRP channels | R-HSA-3295583 | 5.707630e-02 | 1.244 | 0 | 0 |
| Transcriptional regulation by RUNX3 | R-HSA-8878159 | 5.687097e-02 | 1.245 | 0 | 0 |
| Vesicle-mediated transport | R-HSA-5653656 | 5.968949e-02 | 1.224 | 0 | 0 |
| STAT3 nuclear events downstream of ALK signaling | R-HSA-9701898 | 5.470153e-02 | 1.262 | 0 | 0 |
| Transmission across Chemical Synapses | R-HSA-112315 | 6.177341e-02 | 1.209 | 0 | 0 |
| Regulation of gene expression in late stage (branching morphogenesis) pancreatic bud precursor cells | R-HSA-210744 | 6.179998e-02 | 1.209 | 0 | 0 |
| IRF3-mediated induction of type I IFN | R-HSA-3270619 | 5.470153e-02 | 1.262 | 0 | 0 |
| Signaling by VEGF | R-HSA-194138 | 5.350139e-02 | 1.272 | 0 | 0 |
| FOXO-mediated transcription | R-HSA-9614085 | 6.223790e-02 | 1.206 | 0 | 0 |
| Disassembly of the destruction complex and recruitment of AXIN to the membrane | R-HSA-4641262 | 6.241389e-02 | 1.205 | 0 | 0 |
| Interaction between L1 and Ankyrins | R-HSA-445095 | 6.241389e-02 | 1.205 | 0 | 0 |
| Signaling by NOTCH3 | R-HSA-9012852 | 6.621288e-02 | 1.179 | 0 | 0 |
| Transcriptional Regulation by VENTX | R-HSA-8853884 | 6.651849e-02 | 1.177 | 0 | 0 |
| PINK1-PRKN Mediated Mitophagy | R-HSA-5205685 | 6.800475e-02 | 1.167 | 0 | 0 |
| Detoxification of Reactive Oxygen Species | R-HSA-3299685 | 7.022126e-02 | 1.154 | 0 | 0 |
| Developmental Lineages of the Mammary Gland | R-HSA-9924644 | 7.089501e-02 | 1.149 | 0 | 0 |
| Deubiquitination | R-HSA-5688426 | 7.326798e-02 | 1.135 | 0 | 0 |
| Signaling by ERBB2 KD Mutants | R-HSA-9664565 | 7.384522e-02 | 1.132 | 0 | 0 |
| Diseases of Telomere Maintenance | R-HSA-9673013 | 8.554762e-02 | 1.068 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere | R-HSA-9670621 | 8.554762e-02 | 1.068 | 0 | 0 |
| Alternative Lengthening of Telomeres (ALT) | R-HSA-9006821 | 8.554762e-02 | 1.068 | 0 | 0 |
| Evasion of Oncogene Induced Senescence Due to Defective p16INK4A binding to CDK4 | R-HSA-9630791 | 8.554762e-02 | 1.068 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere Due to DAXX Mutations | R-HSA-9670613 | 8.554762e-02 | 1.068 | 0 | 0 |
| Defective Intrinsic Pathway for Apoptosis Due to p14ARF Loss of Function | R-HSA-9645722 | 8.554762e-02 | 1.068 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere Due to ATRX Mutations | R-HSA-9670615 | 8.554762e-02 | 1.068 | 0 | 0 |
| Evasion of Oxidative Stress Induced Senescence Due to Defective p16INK4A binding to CDK4 | R-HSA-9632697 | 8.554762e-02 | 1.068 | 0 | 0 |
| Defective Mismatch Repair Associated With MSH6 | R-HSA-5632968 | 8.554762e-02 | 1.068 | 0 | 0 |
| IFNG signaling activates MAPKs | R-HSA-9732724 | 7.456562e-02 | 1.127 | 0 | 0 |
| PTK6 Expression | R-HSA-8849473 | 7.456562e-02 | 1.127 | 0 | 0 |
| SOS-mediated signalling | R-HSA-112412 | 7.456562e-02 | 1.127 | 0 | 0 |
| SHOC2 M1731 mutant abolishes MRAS complex function | R-HSA-9726840 | 7.456562e-02 | 1.127 | 0 | 0 |
| Type I hemidesmosome assembly | R-HSA-446107 | 8.768544e-02 | 1.057 | 0 | 0 |
| Signaling by MRAS-complex mutants | R-HSA-9660537 | 8.768544e-02 | 1.057 | 0 | 0 |
| Activation of RAS in B cells | R-HSA-1169092 | 8.768544e-02 | 1.057 | 0 | 0 |
| Gain-of-function MRAS complexes activate RAF signaling | R-HSA-9726842 | 8.768544e-02 | 1.057 | 0 | 0 |
| Signaling by ERBB2 in Cancer | R-HSA-1227990 | 7.993109e-02 | 1.097 | 0 | 0 |
| GABA B receptor activation | R-HSA-977444 | 7.609790e-02 | 1.119 | 0 | 0 |
| Activation of GABAB receptors | R-HSA-991365 | 7.609790e-02 | 1.119 | 0 | 0 |
| Signaling by ERBB2 | R-HSA-1227986 | 8.761909e-02 | 1.057 | 0 | 0 |
| Diseases of mitotic cell cycle | R-HSA-9675126 | 9.281934e-02 | 1.032 | 0 | 0 |
| Cation-coupled Chloride cotransporters | R-HSA-426117 | 7.456562e-02 | 1.127 | 0 | 0 |
| Nef mediated downregulation of MHC class I complex cell surface expression | R-HSA-164940 | 8.768544e-02 | 1.057 | 0 | 0 |
| Inwardly rectifying K+ channels | R-HSA-1296065 | 9.281934e-02 | 1.032 | 0 | 0 |
| G alpha (q) signalling events | R-HSA-416476 | 9.181095e-02 | 1.037 | 0 | 0 |
| Signaling by WNT in cancer | R-HSA-4791275 | 9.281934e-02 | 1.032 | 0 | 0 |
| Formation of editosomes by ADAR proteins | R-HSA-77042 | 8.554762e-02 | 1.068 | 0 | 0 |
| Inhibition of PKR | R-HSA-169131 | 8.554762e-02 | 1.068 | 0 | 0 |
| Cilium Assembly | R-HSA-5617833 | 9.117502e-02 | 1.040 | 0 | 0 |
| G1 Phase | R-HSA-69236 | 8.638141e-02 | 1.064 | 0 | 0 |
| Cyclin D associated events in G1 | R-HSA-69231 | 8.638141e-02 | 1.064 | 0 | 0 |
| PLC beta mediated events | R-HSA-112043 | 9.230584e-02 | 1.035 | 0 | 0 |
| Formation of the dystrophin-glycoprotein complex (DGC) | R-HSA-9913351 | 8.625756e-02 | 1.064 | 0 | 0 |
| Evasion by RSV of host interferon responses | R-HSA-9833109 | 8.625756e-02 | 1.064 | 0 | 0 |
| ZBP1(DAI) mediated induction of type I IFNs | R-HSA-1606322 | 8.546356e-02 | 1.068 | 0 | 0 |
| Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters | R-HSA-164938 | 7.719614e-02 | 1.112 | 0 | 0 |
| MECP2 regulates transcription factors | R-HSA-9022707 | 7.456562e-02 | 1.127 | 0 | 0 |
| Apoptotic factor-mediated response | R-HSA-111471 | 8.546356e-02 | 1.068 | 0 | 0 |
| Interleukin-1 family signaling | R-HSA-446652 | 8.419043e-02 | 1.075 | 0 | 0 |
| TP53 Regulates Transcription of Cell Cycle Genes | R-HSA-6791312 | 7.436664e-02 | 1.129 | 0 | 0 |
| IKK complex recruitment mediated by RIP1 | R-HSA-937041 | 9.408890e-02 | 1.026 | 0 | 0 |
| STING mediated induction of host immune responses | R-HSA-1834941 | 9.408890e-02 | 1.026 | 0 | 0 |
| Synthesis of PIPs at the plasma membrane | R-HSA-1660499 | 9.712535e-02 | 1.013 | 0 | 0 |
| Paradoxical activation of RAF signaling by kinase inactive BRAF | R-HSA-6802955 | 9.735292e-02 | 1.012 | 0 | 0 |
| Signaling downstream of RAS mutants | R-HSA-9649948 | 9.735292e-02 | 1.012 | 0 | 0 |
| Signaling by moderate kinase activity BRAF mutants | R-HSA-6802946 | 9.735292e-02 | 1.012 | 0 | 0 |
| Signaling by RAS mutants | R-HSA-6802949 | 9.735292e-02 | 1.012 | 0 | 0 |
| NFG and proNGF binds to p75NTR | R-HSA-205017 | 1.255402e-01 | 0.901 | 0 | 0 |
| Abasic sugar-phosphate removal via the single-nucleotide replacement pathway | R-HSA-73930 | 1.255402e-01 | 0.901 | 0 | 0 |
| Evasion of Oncogene Induced Senescence Due to p16INK4A Defects | R-HSA-9630750 | 1.255402e-01 | 0.901 | 0 | 0 |
| Evasion of Oxidative Stress Induced Senescence Due to p16INK4A Defects | R-HSA-9632693 | 1.255402e-01 | 0.901 | 0 | 0 |
| Defective SLC6A3 causes Parkinsonism-dystonia infantile (PKDYS) | R-HSA-5660724 | 1.255402e-01 | 0.901 | 0 | 0 |
| Evasion of Oxidative Stress Induced Senescence Due to Defective p16INK4A binding to CDK4 and CDK6 | R-HSA-9632700 | 1.255402e-01 | 0.901 | 0 | 0 |
| Defective PGM1 causes PGM1-CDG | R-HSA-5609974 | 1.255402e-01 | 0.901 | 0 | 0 |
| Evasion of Oncogene Induced Senescence Due to Defective p16INK4A binding to CDK4 and CDK6 | R-HSA-9630794 | 1.255402e-01 | 0.901 | 0 | 0 |
| TWIK-releated acid-sensitive K+ channel (TASK) | R-HSA-1299316 | 1.255402e-01 | 0.901 | 0 | 0 |
| Defective SLC6A3 causes Parkinsonism-dystonia infantile (PKDYS) | R-HSA-5619081 | 1.255402e-01 | 0.901 | 0 | 0 |
| Defective SLC12A3 causes Gitelman syndrome (GS) | R-HSA-5619087 | 1.255402e-01 | 0.901 | 0 | 0 |
| NFE2L2 regulating MDR associated enzymes | R-HSA-9818032 | 1.014281e-01 | 0.994 | 0 | 0 |
| Folding of actin by CCT/TriC | R-HSA-390450 | 1.157143e-01 | 0.937 | 0 | 0 |
| Activation of Ca-permeable Kainate Receptor | R-HSA-451308 | 1.157143e-01 | 0.937 | 0 | 0 |
| InlA-mediated entry of Listeria monocytogenes into host cells | R-HSA-8876493 | 1.304704e-01 | 0.884 | 0 | 0 |
| Activated NTRK3 signals through RAS | R-HSA-9034864 | 1.304704e-01 | 0.884 | 0 | 0 |
| Truncations of AMER1 destabilize the destruction complex | R-HSA-5467348 | 1.304704e-01 | 0.884 | 0 | 0 |
| APC truncation mutants have impaired AXIN binding | R-HSA-5467337 | 1.304704e-01 | 0.884 | 0 | 0 |
| AXIN missense mutants destabilize the destruction complex | R-HSA-5467340 | 1.304704e-01 | 0.884 | 0 | 0 |
| Transcription of E2F targets under negative control by DREAM complex | R-HSA-1362277 | 1.030551e-01 | 0.987 | 0 | 0 |
| Unblocking of NMDA receptors, glutamate binding and activation | R-HSA-438066 | 1.219392e-01 | 0.914 | 0 | 0 |
| Ras activation upon Ca2+ influx through NMDA receptor | R-HSA-442982 | 1.219392e-01 | 0.914 | 0 | 0 |
| Association of TriC/CCT with target proteins during biosynthesis | R-HSA-390471 | 1.066253e-01 | 0.972 | 0 | 0 |
| Nonhomologous End-Joining (NHEJ) | R-HSA-5693571 | 1.089918e-01 | 0.963 | 0 | 0 |
| Loss of proteins required for interphase microtubule organization from the centrosome | R-HSA-380284 | 1.020762e-01 | 0.991 | 0 | 0 |
| Loss of Nlp from mitotic centrosomes | R-HSA-380259 | 1.020762e-01 | 0.991 | 0 | 0 |
| AURKA Activation by TPX2 | R-HSA-8854518 | 1.177009e-01 | 0.929 | 0 | 0 |
| Oncogenic MAPK signaling | R-HSA-6802957 | 1.272044e-01 | 0.895 | 0 | 0 |
| Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding | R-HSA-6814122 | 1.138566e-01 | 0.944 | 0 | 0 |
| Alpha-protein kinase 1 signaling pathway | R-HSA-9645460 | 1.304704e-01 | 0.884 | 0 | 0 |
| Transcriptional regulation of white adipocyte differentiation | R-HSA-381340 | 1.111213e-01 | 0.954 | 0 | 0 |
| Regulation of CDH11 function | R-HSA-9762292 | 1.157143e-01 | 0.937 | 0 | 0 |
| PI3K/AKT activation | R-HSA-198203 | 1.157143e-01 | 0.937 | 0 | 0 |
| IGF1R signaling cascade | R-HSA-2428924 | 1.071570e-01 | 0.970 | 0 | 0 |
| Caspase-mediated cleavage of cytoskeletal proteins | R-HSA-264870 | 1.014281e-01 | 0.994 | 0 | 0 |
| Regulated Necrosis | R-HSA-5218859 | 1.287418e-01 | 0.890 | 0 | 0 |
| Adipogenesis | R-HSA-9843745 | 1.279573e-01 | 0.893 | 0 | 0 |
| Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R) | R-HSA-2404192 | 1.123658e-01 | 0.949 | 0 | 0 |
| Caspase activation via Dependence Receptors in the absence of ligand | R-HSA-418889 | 1.014281e-01 | 0.994 | 0 | 0 |
| HSF1-dependent transactivation | R-HSA-3371571 | 1.276466e-01 | 0.894 | 0 | 0 |
| NFE2L2 regulating anti-oxidant/detoxification enzymes | R-HSA-9818027 | 1.066253e-01 | 0.972 | 0 | 0 |
| G-protein mediated events | R-HSA-112040 | 1.231603e-01 | 0.910 | 0 | 0 |
| TGFBR3 regulates FGF2 signaling | R-HSA-9839397 | 1.255402e-01 | 0.901 | 0 | 0 |
| Defective Mismatch Repair Associated With MSH2 | R-HSA-5632928 | 1.255402e-01 | 0.901 | 0 | 0 |
| Regulation of gene expression in early pancreatic precursor cells | R-HSA-210747 | 1.304704e-01 | 0.884 | 0 | 0 |
| Ionotropic activity of kainate receptors | R-HSA-451306 | 1.304704e-01 | 0.884 | 0 | 0 |
| Signaling by APC mutants | R-HSA-4839744 | 1.304704e-01 | 0.884 | 0 | 0 |
| Regulation of PLK1 Activity at G2/M Transition | R-HSA-2565942 | 1.222392e-01 | 0.913 | 0 | 0 |
| GPER1 signaling | R-HSA-9634597 | 1.089918e-01 | 0.963 | 0 | 0 |
| Apoptosis | R-HSA-109581 | 1.142138e-01 | 0.942 | 0 | 0 |
| Breakdown of the nuclear lamina | R-HSA-352238 | 1.255402e-01 | 0.901 | 0 | 0 |
| Cross-presentation of particulate exogenous antigens (phagosomes) | R-HSA-1236973 | 1.157143e-01 | 0.937 | 0 | 0 |
| MyD88 cascade initiated on plasma membrane | R-HSA-975871 | 1.197940e-01 | 0.922 | 0 | 0 |
| Toll Like Receptor 10 (TLR10) Cascade | R-HSA-168142 | 1.197940e-01 | 0.922 | 0 | 0 |
| Toll Like Receptor 5 (TLR5) Cascade | R-HSA-168176 | 1.197940e-01 | 0.922 | 0 | 0 |
| Signaling by NTRK3 (TRKC) | R-HSA-9034015 | 1.219392e-01 | 0.914 | 0 | 0 |
| Regulation of TP53 Activity | R-HSA-5633007 | 1.077682e-01 | 0.968 | 0 | 0 |
| Cell junction organization | R-HSA-446728 | 1.261670e-01 | 0.899 | 0 | 0 |
| Initiation of Nuclear Envelope (NE) Reformation | R-HSA-2995383 | 1.219392e-01 | 0.914 | 0 | 0 |
| Signaling by Receptor Tyrosine Kinases | R-HSA-9006934 | 1.210192e-01 | 0.917 | 0 | 0 |
| Cell-Cell communication | R-HSA-1500931 | 1.237287e-01 | 0.908 | 0 | 0 |
| Activation of the TFAP2 (AP-2) family of transcription factors | R-HSA-8866907 | 1.014281e-01 | 0.994 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in cell cycle and proliferation | R-HSA-9825892 | 1.219392e-01 | 0.914 | 0 | 0 |
| Regulation of TP53 Degradation | R-HSA-6804757 | 1.289414e-01 | 0.890 | 0 | 0 |
| NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10 | R-HSA-933543 | 1.304704e-01 | 0.884 | 0 | 0 |
| FOXO-mediated transcription of cell cycle genes | R-HSA-9617828 | 1.219392e-01 | 0.914 | 0 | 0 |
| ChREBP activates metabolic gene expression | R-HSA-163765 | 1.304704e-01 | 0.884 | 0 | 0 |
| Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways | R-HSA-168643 | 1.071570e-01 | 0.970 | 0 | 0 |
| Signaling by Leptin | R-HSA-2586552 | 1.157143e-01 | 0.937 | 0 | 0 |
| Mitochondrial calcium ion transport | R-HSA-8949215 | 1.219392e-01 | 0.914 | 0 | 0 |
| NOTCH3 Activation and Transmission of Signal to the Nucleus | R-HSA-9013507 | 1.318210e-01 | 0.880 | 0 | 0 |
| Potassium transport channels | R-HSA-1296067 | 1.637861e-01 | 0.786 | 0 | 0 |
| Axonal growth stimulation | R-HSA-209563 | 2.003615e-01 | 0.698 | 0 | 0 |
| Defective GCLC causes HAGGSD | R-HSA-5578999 | 2.003615e-01 | 0.698 | 0 | 0 |
| Classical Kir channels | R-HSA-1296053 | 2.003615e-01 | 0.698 | 0 | 0 |
| HCN channels | R-HSA-1296061 | 2.353392e-01 | 0.628 | 0 | 0 |
| Nucleotide catabolism defects | R-HSA-9735786 | 2.353392e-01 | 0.628 | 0 | 0 |
| Defective PNP disrupts phosphorolysis of (deoxy)guanosine and (deoxy)inosine | R-HSA-9735763 | 2.353392e-01 | 0.628 | 0 | 0 |
| Signaling by LRP5 mutants | R-HSA-5339717 | 2.353392e-01 | 0.628 | 0 | 0 |
| GRB7 events in ERBB2 signaling | R-HSA-1306955 | 2.353392e-01 | 0.628 | 0 | 0 |
| Defective LFNG causes SCDO3 | R-HSA-5083630 | 2.353392e-01 | 0.628 | 0 | 0 |
| Defective SLC1A3 causes episodic ataxia 6 (EA6) | R-HSA-5619062 | 2.687890e-01 | 0.571 | 0 | 0 |
| Activated NTRK2 signals through RAS | R-HSA-9026519 | 1.456280e-01 | 0.837 | 0 | 0 |
| p75NTR recruits signalling complexes | R-HSA-209543 | 1.611240e-01 | 0.793 | 0 | 0 |
| Signaling by NOTCH1 HD Domain Mutants in Cancer | R-HSA-2691230 | 1.611240e-01 | 0.793 | 0 | 0 |
| Constitutive Signaling by NOTCH1 HD Domain Mutants | R-HSA-2691232 | 1.611240e-01 | 0.793 | 0 | 0 |
| SLIT2:ROBO1 increases RHOA activity | R-HSA-8985586 | 3.007775e-01 | 0.522 | 0 | 0 |
| Inhibition of Signaling by Overexpressed EGFR | R-HSA-5638303 | 3.007775e-01 | 0.522 | 0 | 0 |
| Signaling by Overexpressed Wild-Type EGFR in Cancer | R-HSA-5638302 | 3.007775e-01 | 0.522 | 0 | 0 |
| Signaling by RNF43 mutants | R-HSA-5340588 | 3.007775e-01 | 0.522 | 0 | 0 |
| Adenylate cyclase activating pathway | R-HSA-170660 | 1.769000e-01 | 0.752 | 0 | 0 |
| Defective binding of RB1 mutants to E2F1,(E2F2, E2F3) | R-HSA-9661069 | 1.769000e-01 | 0.752 | 0 | 0 |
| ERBB2 Activates PTK6 Signaling | R-HSA-8847993 | 1.929018e-01 | 0.715 | 0 | 0 |
| Erythropoietin activates STAT5 | R-HSA-9027283 | 3.313684e-01 | 0.480 | 0 | 0 |
| RAS signaling downstream of NF1 loss-of-function variants | R-HSA-6802953 | 3.313684e-01 | 0.480 | 0 | 0 |
| Erythropoietin activates RAS | R-HSA-9027284 | 2.090797e-01 | 0.680 | 0 | 0 |
| Adenylate cyclase inhibitory pathway | R-HSA-170670 | 2.090797e-01 | 0.680 | 0 | 0 |
| SHC1 events in EGFR signaling | R-HSA-180336 | 2.090797e-01 | 0.680 | 0 | 0 |
| ERBB2 Regulates Cell Motility | R-HSA-6785631 | 2.090797e-01 | 0.680 | 0 | 0 |
| Displacement of DNA glycosylase by APEX1 | R-HSA-110357 | 3.606227e-01 | 0.443 | 0 | 0 |
| RUNX3 regulates WNT signaling | R-HSA-8951430 | 3.606227e-01 | 0.443 | 0 | 0 |
| CHL1 interactions | R-HSA-447041 | 3.606227e-01 | 0.443 | 0 | 0 |
| Binding of TCF/LEF:CTNNB1 to target gene promoters | R-HSA-4411364 | 3.606227e-01 | 0.443 | 0 | 0 |
| PP2A-mediated dephosphorylation of key metabolic factors | R-HSA-163767 | 3.606227e-01 | 0.443 | 0 | 0 |
| Pre-NOTCH Processing in the Endoplasmic Reticulum | R-HSA-1912399 | 3.606227e-01 | 0.443 | 0 | 0 |
| Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits | R-HSA-997272 | 1.630055e-01 | 0.788 | 0 | 0 |
| Activation of G protein gated Potassium channels | R-HSA-1296041 | 1.630055e-01 | 0.788 | 0 | 0 |
| G protein gated Potassium channels | R-HSA-1296059 | 1.630055e-01 | 0.788 | 0 | 0 |
| GRB2 events in ERBB2 signaling | R-HSA-1963640 | 2.417838e-01 | 0.617 | 0 | 0 |
| EPHA-mediated growth cone collapse | R-HSA-3928663 | 1.848950e-01 | 0.733 | 0 | 0 |
| PI3K events in ERBB2 signaling | R-HSA-1963642 | 2.582289e-01 | 0.588 | 0 | 0 |
| ROBO receptors bind AKAP5 | R-HSA-9010642 | 3.885988e-01 | 0.410 | 0 | 0 |
| phospho-PLA2 pathway | R-HSA-111995 | 3.885988e-01 | 0.410 | 0 | 0 |
| EGFR interacts with phospholipase C-gamma | R-HSA-212718 | 3.885988e-01 | 0.410 | 0 | 0 |
| RNA Polymerase III Transcription Termination | R-HSA-73980 | 2.746875e-01 | 0.561 | 0 | 0 |
| Late endosomal microautophagy | R-HSA-9615710 | 2.074971e-01 | 0.683 | 0 | 0 |
| Impaired BRCA2 binding to RAD51 | R-HSA-9709570 | 2.074971e-01 | 0.683 | 0 | 0 |
| Impaired BRCA2 binding to PALB2 | R-HSA-9709603 | 2.911270e-01 | 0.536 | 0 | 0 |
| Signaling by RAF1 mutants | R-HSA-9656223 | 1.786184e-01 | 0.748 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to PALB2 loss of function | R-HSA-9701193 | 3.075177e-01 | 0.512 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to BRCA1 loss of function | R-HSA-9701192 | 3.075177e-01 | 0.512 | 0 | 0 |
| Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA1 binding function | R-HSA-9704331 | 3.075177e-01 | 0.512 | 0 | 0 |
| Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA2/RAD51/RAD51C binding function | R-HSA-9704646 | 3.075177e-01 | 0.512 | 0 | 0 |
| Developmental Lineage of Multipotent Pancreatic Progenitor Cells | R-HSA-9937080 | 2.424352e-01 | 0.615 | 0 | 0 |
| SHC-mediated cascade:FGFR3 | R-HSA-5654704 | 3.238324e-01 | 0.490 | 0 | 0 |
| SHC-mediated cascade:FGFR4 | R-HSA-5654719 | 3.400465e-01 | 0.468 | 0 | 0 |
| Developmental Lineage of Mammary Stem Cells | R-HSA-9938206 | 3.561375e-01 | 0.448 | 0 | 0 |
| RET signaling | R-HSA-8853659 | 3.023624e-01 | 0.519 | 0 | 0 |
| Regulation of RAS by GAPs | R-HSA-5658442 | 2.623827e-01 | 0.581 | 0 | 0 |
| Signaling by BRAF and RAF1 fusions | R-HSA-6802952 | 2.305689e-01 | 0.637 | 0 | 0 |
| Signaling by high-kinase activity BRAF mutants | R-HSA-6802948 | 3.144707e-01 | 0.502 | 0 | 0 |
| SHC-mediated cascade:FGFR1 | R-HSA-5654688 | 3.878716e-01 | 0.411 | 0 | 0 |
| Developmental Lineage of Pancreatic Ductal Cells | R-HSA-9925563 | 2.635572e-01 | 0.579 | 0 | 0 |
| Resolution of D-loop Structures through Synthesis-Dependent Strand Annealing (SDSA) | R-HSA-5693554 | 4.034800e-01 | 0.394 | 0 | 0 |
| Degradation of GLI1 by the proteasome | R-HSA-5610780 | 3.749220e-01 | 0.426 | 0 | 0 |
| Major pathway of rRNA processing in the nucleolus and cytosol | R-HSA-6791226 | 3.401976e-01 | 0.468 | 0 | 0 |
| Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants | R-HSA-1236382 | 3.238324e-01 | 0.490 | 0 | 0 |
| Signaling by Ligand-Responsive EGFR Variants in Cancer | R-HSA-5637815 | 3.238324e-01 | 0.490 | 0 | 0 |
| Constitutive Signaling by EGFRvIII | R-HSA-5637810 | 2.582289e-01 | 0.588 | 0 | 0 |
| Signaling by EGFRvIII in Cancer | R-HSA-5637812 | 2.582289e-01 | 0.588 | 0 | 0 |
| Neutrophil degranulation | R-HSA-6798695 | 1.804459e-01 | 0.744 | 0 | 0 |
| Eukaryotic Translation Elongation | R-HSA-156842 | 1.761976e-01 | 0.754 | 0 | 0 |
| Anchoring of the basal body to the plasma membrane | R-HSA-5620912 | 2.842680e-01 | 0.546 | 0 | 0 |
| Processing of DNA double-strand break ends | R-HSA-5693607 | 3.671235e-01 | 0.435 | 0 | 0 |
| PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling | R-HSA-6811558 | 2.729548e-01 | 0.564 | 0 | 0 |
| G0 and Early G1 | R-HSA-1538133 | 2.424352e-01 | 0.615 | 0 | 0 |
| p75NTR signals via NF-kB | R-HSA-193639 | 2.090797e-01 | 0.680 | 0 | 0 |
| Axonal growth inhibition (RHOA activation) | R-HSA-193634 | 3.885988e-01 | 0.410 | 0 | 0 |
| MAP2K and MAPK activation | R-HSA-5674135 | 3.749220e-01 | 0.426 | 0 | 0 |
| RIPK1-mediated regulated necrosis | R-HSA-5213460 | 3.265888e-01 | 0.486 | 0 | 0 |
| Interleukin-15 signaling | R-HSA-8983432 | 1.611240e-01 | 0.793 | 0 | 0 |
| Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks | R-HSA-5693565 | 1.836654e-01 | 0.736 | 0 | 0 |
| Co-inhibition by CTLA4 | R-HSA-389513 | 3.075177e-01 | 0.512 | 0 | 0 |
| Regulation of IFNA/IFNB signaling | R-HSA-912694 | 3.561375e-01 | 0.448 | 0 | 0 |
| DNA Double-Strand Break Repair | R-HSA-5693532 | 3.578763e-01 | 0.446 | 0 | 0 |
| DNA Double Strand Break Response | R-HSA-5693606 | 2.469190e-01 | 0.607 | 0 | 0 |
| Regulation of necroptotic cell death | R-HSA-5675482 | 2.542917e-01 | 0.595 | 0 | 0 |
| Insulin receptor signalling cascade | R-HSA-74751 | 4.018777e-01 | 0.396 | 0 | 0 |
| Phosphorylation and nuclear translocation of the CRY:PER:kinase complex | R-HSA-9931530 | 1.611240e-01 | 0.793 | 0 | 0 |
| The CRY:PER:kinase complex represses transactivation by the BMAL:CLOCK (ARNTL:CLOCK) complex | R-HSA-9931521 | 2.417838e-01 | 0.617 | 0 | 0 |
| GABA receptor activation | R-HSA-977443 | 1.912287e-01 | 0.718 | 0 | 0 |
| Developmental Cell Lineages | R-HSA-9734767 | 2.048528e-01 | 0.689 | 0 | 0 |
| Long-term potentiation | R-HSA-9620244 | 1.630055e-01 | 0.788 | 0 | 0 |
| Signaling by CSF3 (G-CSF) | R-HSA-9674555 | 2.074971e-01 | 0.683 | 0 | 0 |
| Golgi Associated Vesicle Biogenesis | R-HSA-432722 | 1.408382e-01 | 0.851 | 0 | 0 |
| ADP signalling through P2Y purinoceptor 1 | R-HSA-418592 | 3.878716e-01 | 0.411 | 0 | 0 |
| Expression of BMAL (ARNTL), CLOCK, and NPAS2 | R-HSA-9931509 | 3.387045e-01 | 0.470 | 0 | 0 |
| Negative regulation of the PI3K/AKT network | R-HSA-199418 | 2.056281e-01 | 0.687 | 0 | 0 |
| Chaperone Mediated Autophagy | R-HSA-9613829 | 2.746875e-01 | 0.561 | 0 | 0 |
| TNFR1-mediated ceramide production | R-HSA-5626978 | 2.353392e-01 | 0.628 | 0 | 0 |
| Regulation of FOXO transcriptional activity by acetylation | R-HSA-9617629 | 1.611240e-01 | 0.793 | 0 | 0 |
| Insulin effects increased synthesis of Xylulose-5-Phosphate | R-HSA-163754 | 3.606227e-01 | 0.443 | 0 | 0 |
| Formyl peptide receptors bind formyl peptides and many other ligands | R-HSA-444473 | 3.885988e-01 | 0.410 | 0 | 0 |
| Aberrant regulation of mitotic cell cycle due to RB1 defects | R-HSA-9687139 | 2.190218e-01 | 0.660 | 0 | 0 |
| HDR through Single Strand Annealing (SSA) | R-HSA-5685938 | 2.542917e-01 | 0.595 | 0 | 0 |
| rRNA processing in the nucleus and cytosol | R-HSA-8868773 | 3.241032e-01 | 0.489 | 0 | 0 |
| HCMV Early Events | R-HSA-9609690 | 3.683541e-01 | 0.434 | 0 | 0 |
| Nuclear events mediated by NFE2L2 | R-HSA-9759194 | 1.556514e-01 | 0.808 | 0 | 0 |
| Regulation of CDH1 posttranslational processing and trafficking to plasma membrane | R-HSA-9768727 | 2.662273e-01 | 0.575 | 0 | 0 |
| PI5P Regulates TP53 Acetylation | R-HSA-6811555 | 1.769000e-01 | 0.752 | 0 | 0 |
| Lysosome Vesicle Biogenesis | R-HSA-432720 | 3.023624e-01 | 0.519 | 0 | 0 |
| Fcgamma receptor (FCGR) dependent phagocytosis | R-HSA-2029480 | 1.613201e-01 | 0.792 | 0 | 0 |
| SARS-CoV-1-mediated effects on programmed cell death | R-HSA-9692913 | 2.353392e-01 | 0.628 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in interleukin signaling | R-HSA-8939247 | 2.687890e-01 | 0.571 | 0 | 0 |
| Lysosphingolipid and LPA receptors | R-HSA-419408 | 2.090797e-01 | 0.680 | 0 | 0 |
| RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known | R-HSA-8939243 | 2.542917e-01 | 0.595 | 0 | 0 |
| Attenuation phase | R-HSA-3371568 | 3.508059e-01 | 0.455 | 0 | 0 |
| FCGR3A-mediated phagocytosis | R-HSA-9664422 | 4.042512e-01 | 0.393 | 0 | 0 |
| Leishmania phagocytosis | R-HSA-9664417 | 4.042512e-01 | 0.393 | 0 | 0 |
| Parasite infection | R-HSA-9664407 | 4.042512e-01 | 0.393 | 0 | 0 |
| Interferon Signaling | R-HSA-913531 | 2.723904e-01 | 0.565 | 0 | 0 |
| TAK1-dependent IKK and NF-kappa-B activation | R-HSA-445989 | 2.335359e-01 | 0.632 | 0 | 0 |
| Formation of paraxial mesoderm | R-HSA-9793380 | 1.989004e-01 | 0.701 | 0 | 0 |
| Regulation of actin dynamics for phagocytic cup formation | R-HSA-2029482 | 2.787496e-01 | 0.555 | 0 | 0 |
| trans-Golgi Network Vesicle Budding | R-HSA-199992 | 2.889625e-01 | 0.539 | 0 | 0 |
| Downregulation of ERBB2 signaling | R-HSA-8863795 | 2.190218e-01 | 0.660 | 0 | 0 |
| Regulation of signaling by CBL | R-HSA-912631 | 2.911270e-01 | 0.536 | 0 | 0 |
| Ovarian tumor domain proteases | R-HSA-5689896 | 3.144707e-01 | 0.502 | 0 | 0 |
| Inactivation of CSF3 (G-CSF) signaling | R-HSA-9705462 | 3.400465e-01 | 0.468 | 0 | 0 |
| Diseases of DNA Double-Strand Break Repair | R-HSA-9675136 | 2.782271e-01 | 0.556 | 0 | 0 |
| Regulation of NF-kappa B signaling | R-HSA-9758274 | 2.253878e-01 | 0.647 | 0 | 0 |
| Pyroptosis | R-HSA-5620971 | 1.961157e-01 | 0.707 | 0 | 0 |
| Interleukin-9 signaling | R-HSA-8985947 | 3.885988e-01 | 0.410 | 0 | 0 |
| CLEC7A (Dectin-1) signaling | R-HSA-5607764 | 3.461073e-01 | 0.461 | 0 | 0 |
| MyD88:MAL(TIRAP) cascade initiated on plasma membrane | R-HSA-166058 | 1.464449e-01 | 0.834 | 0 | 0 |
| Cellular response to heat stress | R-HSA-3371556 | 2.604471e-01 | 0.584 | 0 | 0 |
| Toll Like Receptor TLR6:TLR2 Cascade | R-HSA-168188 | 1.464449e-01 | 0.834 | 0 | 0 |
| Toll Like Receptor TLR1:TLR2 Cascade | R-HSA-168179 | 1.603584e-01 | 0.795 | 0 | 0 |
| mRNA Editing: A to I Conversion | R-HSA-75064 | 1.637861e-01 | 0.786 | 0 | 0 |
| C6 deamination of adenosine | R-HSA-75102 | 1.637861e-01 | 0.786 | 0 | 0 |
| Negative regulation of TCF-dependent signaling by DVL-interacting proteins | R-HSA-5368598 | 2.003615e-01 | 0.698 | 0 | 0 |
| Activation of BIM and translocation to mitochondria | R-HSA-111446 | 2.003615e-01 | 0.698 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in BCR signaling | R-HSA-8939245 | 2.687890e-01 | 0.571 | 0 | 0 |
| NF-kB is activated and signals survival | R-HSA-209560 | 1.456280e-01 | 0.837 | 0 | 0 |
| Signaling by AXIN mutants | R-HSA-4839735 | 1.456280e-01 | 0.837 | 0 | 0 |
| Signaling by AMER1 mutants | R-HSA-4839748 | 1.456280e-01 | 0.837 | 0 | 0 |
| Regulation of IFNG signaling | R-HSA-877312 | 1.611240e-01 | 0.793 | 0 | 0 |
| Ceramide signalling | R-HSA-193681 | 3.007775e-01 | 0.522 | 0 | 0 |
| Activation of caspases through apoptosome-mediated cleavage | R-HSA-111459 | 3.007775e-01 | 0.522 | 0 | 0 |
| Membrane binding and targetting of GAG proteins | R-HSA-174490 | 1.769000e-01 | 0.752 | 0 | 0 |
| Aberrant regulation of mitotic G1/S transition in cancer due to RB1 defects | R-HSA-9659787 | 1.769000e-01 | 0.752 | 0 | 0 |
| FGFR1b ligand binding and activation | R-HSA-190370 | 3.885988e-01 | 0.410 | 0 | 0 |
| Phase 0 - rapid depolarisation | R-HSA-5576892 | 1.961157e-01 | 0.707 | 0 | 0 |
| Signaling by cytosolic FGFR1 fusion mutants | R-HSA-1839117 | 2.746875e-01 | 0.561 | 0 | 0 |
| PKA activation in glucagon signalling | R-HSA-164378 | 2.746875e-01 | 0.561 | 0 | 0 |
| G2/M DNA damage checkpoint | R-HSA-69473 | 1.646582e-01 | 0.783 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to BRCA2 loss of function | R-HSA-9701190 | 2.782271e-01 | 0.556 | 0 | 0 |
| TRAF6 mediated NF-kB activation | R-HSA-933542 | 3.878716e-01 | 0.411 | 0 | 0 |
| Toll Like Receptor 2 (TLR2) Cascade | R-HSA-181438 | 1.603584e-01 | 0.795 | 0 | 0 |
| Acyl chain remodelling of PS | R-HSA-1482801 | 4.034800e-01 | 0.394 | 0 | 0 |
| G2/M Checkpoints | R-HSA-69481 | 3.049031e-01 | 0.516 | 0 | 0 |
| Opioid Signalling | R-HSA-111885 | 2.583828e-01 | 0.588 | 0 | 0 |
| Pre-NOTCH Expression and Processing | R-HSA-1912422 | 3.277490e-01 | 0.484 | 0 | 0 |
| Signaling by the B Cell Receptor (BCR) | R-HSA-983705 | 2.665414e-01 | 0.574 | 0 | 0 |
| CD209 (DC-SIGN) signaling | R-HSA-5621575 | 1.523725e-01 | 0.817 | 0 | 0 |
| Transcriptional Regulation by E2F6 | R-HSA-8953750 | 3.387045e-01 | 0.470 | 0 | 0 |
| Microbial modulation of RIPK1-mediated regulated necrosis | R-HSA-9686347 | 3.606227e-01 | 0.443 | 0 | 0 |
| Effects of PIP2 hydrolysis | R-HSA-114508 | 2.662273e-01 | 0.575 | 0 | 0 |
| Hedgehog 'on' state | R-HSA-5632684 | 2.804412e-01 | 0.552 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of myeloid cells | R-HSA-8939246 | 3.885988e-01 | 0.410 | 0 | 0 |
| Regulation of CDH11 Expression and Function | R-HSA-9759475 | 2.074971e-01 | 0.683 | 0 | 0 |
| HSF1 activation | R-HSA-3371511 | 3.023624e-01 | 0.519 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation | R-HSA-9843743 | 3.508059e-01 | 0.455 | 0 | 0 |
| Diseases associated with the TLR signaling cascade | R-HSA-5602358 | 3.508059e-01 | 0.455 | 0 | 0 |
| Diseases of Immune System | R-HSA-5260271 | 3.508059e-01 | 0.455 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation by EBF2 | R-HSA-9844594 | 3.508059e-01 | 0.455 | 0 | 0 |
| Protein-protein interactions at synapses | R-HSA-6794362 | 2.396673e-01 | 0.620 | 0 | 0 |
| Adrenoceptors | R-HSA-390696 | 3.885988e-01 | 0.410 | 0 | 0 |
| Regulation of TP53 Activity through Methylation | R-HSA-6804760 | 2.746875e-01 | 0.561 | 0 | 0 |
| Toll Like Receptor 4 (TLR4) Cascade | R-HSA-166016 | 2.138379e-01 | 0.670 | 0 | 0 |
| Activation of NOXA and translocation to mitochondria | R-HSA-111448 | 2.353392e-01 | 0.628 | 0 | 0 |
| Synthesis And Processing Of GAG, GAGPOL Polyproteins | R-HSA-174495 | 1.929018e-01 | 0.715 | 0 | 0 |
| Activation of PUMA and translocation to mitochondria | R-HSA-139915 | 3.606227e-01 | 0.443 | 0 | 0 |
| Activated NTRK3 signals through PI3K | R-HSA-9603381 | 3.606227e-01 | 0.443 | 0 | 0 |
| Downregulation of ERBB4 signaling | R-HSA-1253288 | 3.885988e-01 | 0.410 | 0 | 0 |
| Homologous DNA Pairing and Strand Exchange | R-HSA-5693579 | 3.265888e-01 | 0.486 | 0 | 0 |
| Regulation of Expression and Function of Type II Classical Cadherins | R-HSA-9764260 | 2.542917e-01 | 0.595 | 0 | 0 |
| Pyruvate metabolism | R-HSA-70268 | 2.617173e-01 | 0.582 | 0 | 0 |
| Interleukin-7 signaling | R-HSA-1266695 | 1.630055e-01 | 0.788 | 0 | 0 |
| Listeria monocytogenes entry into host cells | R-HSA-8876384 | 3.400465e-01 | 0.468 | 0 | 0 |
| TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation | R-HSA-975138 | 1.734908e-01 | 0.761 | 0 | 0 |
| Regulation of BACH1 activity | R-HSA-9708530 | 2.253878e-01 | 0.647 | 0 | 0 |
| Meiosis | R-HSA-1500620 | 2.396673e-01 | 0.620 | 0 | 0 |
| rRNA modification in the nucleus and cytosol | R-HSA-6790901 | 3.918992e-01 | 0.407 | 0 | 0 |
| Interleukin-1 signaling | R-HSA-9020702 | 3.854055e-01 | 0.414 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest | R-HSA-6804114 | 2.417838e-01 | 0.617 | 0 | 0 |
| PKMTs methylate histone lysines | R-HSA-3214841 | 1.699254e-01 | 0.770 | 0 | 0 |
| Organelle biogenesis and maintenance | R-HSA-1852241 | 1.928851e-01 | 0.715 | 0 | 0 |
| Negative regulation of MAPK pathway | R-HSA-5675221 | 1.786184e-01 | 0.748 | 0 | 0 |
| Regulation of TP53 Activity through Phosphorylation | R-HSA-6804756 | 1.374338e-01 | 0.862 | 0 | 0 |
| Diseases of Mismatch Repair (MMR) | R-HSA-5423599 | 2.003615e-01 | 0.698 | 0 | 0 |
| CASP5-mediated substrate cleavage | R-HSA-9960525 | 2.003615e-01 | 0.698 | 0 | 0 |
| p75NTR negatively regulates cell cycle via SC1 | R-HSA-193670 | 2.353392e-01 | 0.628 | 0 | 0 |
| TLR3-mediated TICAM1-dependent programmed cell death | R-HSA-9013957 | 2.353392e-01 | 0.628 | 0 | 0 |
| Resolution of AP sites via the single-nucleotide replacement pathway | R-HSA-110381 | 2.687890e-01 | 0.571 | 0 | 0 |
| SMAC(DIABLO)-mediated dissociation of IAP:caspase complexes | R-HSA-111464 | 2.687890e-01 | 0.571 | 0 | 0 |
| Signalling to p38 via RIT and RIN | R-HSA-187706 | 3.007775e-01 | 0.522 | 0 | 0 |
| Protein methylation | R-HSA-8876725 | 2.090797e-01 | 0.680 | 0 | 0 |
| LDL remodeling | R-HSA-8964041 | 3.606227e-01 | 0.443 | 0 | 0 |
| Synthesis of PIPs in the nucleus | R-HSA-8847453 | 3.606227e-01 | 0.443 | 0 | 0 |
| TRIF-mediated programmed cell death | R-HSA-2562578 | 3.606227e-01 | 0.443 | 0 | 0 |
| Astrocytic Glutamate-Glutamine Uptake And Metabolism | R-HSA-210455 | 3.885988e-01 | 0.410 | 0 | 0 |
| Neurotransmitter uptake and metabolism In glial cells | R-HSA-112313 | 3.885988e-01 | 0.410 | 0 | 0 |
| Depolymerization of the Nuclear Lamina | R-HSA-4419969 | 2.746875e-01 | 0.561 | 0 | 0 |
| Meiotic synapsis | R-HSA-1221632 | 2.918521e-01 | 0.535 | 0 | 0 |
| Downstream signaling events of B Cell Receptor (BCR) | R-HSA-1168372 | 2.719711e-01 | 0.565 | 0 | 0 |
| Negative regulation of NOTCH4 signaling | R-HSA-9604323 | 3.508059e-01 | 0.455 | 0 | 0 |
| Glucagon-like Peptide-1 (GLP1) regulates insulin secretion | R-HSA-381676 | 3.869159e-01 | 0.412 | 0 | 0 |
| Immune System | R-HSA-168256 | 1.972739e-01 | 0.705 | 0 | 0 |
| Pre-NOTCH Transcription and Translation | R-HSA-1912408 | 1.646742e-01 | 0.783 | 0 | 0 |
| Netrin-1 signaling | R-HSA-373752 | 2.055374e-01 | 0.687 | 0 | 0 |
| High laminar flow shear stress activates signaling by PIEZO1 and PECAM1:CDH5:KDR in endothelial cells | R-HSA-9856530 | 2.042947e-01 | 0.690 | 0 | 0 |
| Integration of energy metabolism | R-HSA-163685 | 1.527517e-01 | 0.816 | 0 | 0 |
| EPHB-mediated forward signaling | R-HSA-3928662 | 2.055374e-01 | 0.687 | 0 | 0 |
| MyD88 dependent cascade initiated on endosome | R-HSA-975155 | 1.788405e-01 | 0.748 | 0 | 0 |
| TRIF (TICAM1)-mediated TLR4 signaling | R-HSA-937061 | 3.065648e-01 | 0.513 | 0 | 0 |
| SMAC, XIAP-regulated apoptotic response | R-HSA-111469 | 3.007775e-01 | 0.522 | 0 | 0 |
| Intra-Golgi traffic | R-HSA-6811438 | 1.786184e-01 | 0.748 | 0 | 0 |
| Interleukin-4 and Interleukin-13 signaling | R-HSA-6785807 | 3.461056e-01 | 0.461 | 0 | 0 |
| Diseases of programmed cell death | R-HSA-9645723 | 2.691835e-01 | 0.570 | 0 | 0 |
| MyD88-independent TLR4 cascade | R-HSA-166166 | 3.065648e-01 | 0.513 | 0 | 0 |
| Toll Like Receptor 3 (TLR3) Cascade | R-HSA-168164 | 2.719348e-01 | 0.566 | 0 | 0 |
| Rap1 signalling | R-HSA-392517 | 2.911270e-01 | 0.536 | 0 | 0 |
| CREB1 phosphorylation through NMDA receptor-mediated activation of RAS signaling | R-HSA-442742 | 2.542917e-01 | 0.595 | 0 | 0 |
| Presynaptic phase of homologous DNA pairing and strand exchange | R-HSA-5693616 | 2.902768e-01 | 0.537 | 0 | 0 |
| Toll Like Receptor 7/8 (TLR7/8) Cascade | R-HSA-168181 | 2.009388e-01 | 0.697 | 0 | 0 |
| Innate Immune System | R-HSA-168249 | 2.845593e-01 | 0.546 | 0 | 0 |
| Toll Like Receptor 9 (TLR9) Cascade | R-HSA-168138 | 2.181981e-01 | 0.661 | 0 | 0 |
| Toll-like Receptor Cascades | R-HSA-168898 | 3.405789e-01 | 0.468 | 0 | 0 |
| TRAF3-dependent IRF activation pathway | R-HSA-918233 | 2.417838e-01 | 0.617 | 0 | 0 |
| Synthesis of PIPs at the Golgi membrane | R-HSA-1660514 | 1.738523e-01 | 0.760 | 0 | 0 |
| Cardiac conduction | R-HSA-5576891 | 2.163421e-01 | 0.665 | 0 | 0 |
| Developmental Biology | R-HSA-1266738 | 1.954139e-01 | 0.709 | 0 | 0 |
| Ca-dependent events | R-HSA-111996 | 1.874571e-01 | 0.727 | 0 | 0 |
| Transcriptional regulation of granulopoiesis | R-HSA-9616222 | 3.818966e-01 | 0.418 | 0 | 0 |
| Stimulation of the cell death response by PAK-2p34 | R-HSA-211736 | 1.637861e-01 | 0.786 | 0 | 0 |
| CASP4-mediated substrate cleavage | R-HSA-9960519 | 2.003615e-01 | 0.698 | 0 | 0 |
| FLT3 signaling through SRC family kinases | R-HSA-9706374 | 2.353392e-01 | 0.628 | 0 | 0 |
| SMAC (DIABLO) binds to IAPs | R-HSA-111463 | 2.687890e-01 | 0.571 | 0 | 0 |
| Phosphorylation and nuclear translocation of BMAL1 (ARNTL) and CLOCK | R-HSA-9931529 | 2.687890e-01 | 0.571 | 0 | 0 |
| RUNX2 regulates chondrocyte maturation | R-HSA-8941284 | 2.687890e-01 | 0.571 | 0 | 0 |
| Co-inhibition by BTLA | R-HSA-9927353 | 2.687890e-01 | 0.571 | 0 | 0 |
| Release of apoptotic factors from the mitochondria | R-HSA-111457 | 3.007775e-01 | 0.522 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression linked to lipogenesis | R-HSA-9029558 | 1.769000e-01 | 0.752 | 0 | 0 |
| Regulation of KIT signaling | R-HSA-1433559 | 1.929018e-01 | 0.715 | 0 | 0 |
| MAP3K8 (TPL2)-dependent MAPK1/3 activation | R-HSA-5684264 | 1.929018e-01 | 0.715 | 0 | 0 |
| TGFBR3 regulates TGF-beta signaling | R-HSA-9839389 | 3.606227e-01 | 0.443 | 0 | 0 |
| Phase 3 - rapid repolarisation | R-HSA-5576890 | 3.606227e-01 | 0.443 | 0 | 0 |
| PKA activation | R-HSA-163615 | 2.746875e-01 | 0.561 | 0 | 0 |
| Trafficking of AMPA receptors | R-HSA-399719 | 2.306733e-01 | 0.637 | 0 | 0 |
| Integrin signaling | R-HSA-354192 | 2.542917e-01 | 0.595 | 0 | 0 |
| Differentiation of Keratinocytes in Interfollicular Epidermis in Mammalian Skin | R-HSA-9725554 | 3.387045e-01 | 0.470 | 0 | 0 |
| VEGFR2 mediated cell proliferation | R-HSA-5218921 | 4.034800e-01 | 0.394 | 0 | 0 |
| TGFBR3 expression | R-HSA-9839394 | 4.034800e-01 | 0.394 | 0 | 0 |
| Signaling by NTRK1 (TRKA) | R-HSA-187037 | 3.113923e-01 | 0.507 | 0 | 0 |
| Response of endothelial cells to shear stress | R-HSA-9860931 | 1.478714e-01 | 0.830 | 0 | 0 |
| Synthesis of PA | R-HSA-1483166 | 3.317410e-01 | 0.479 | 0 | 0 |
| Signaling by Hippo | R-HSA-2028269 | 2.582289e-01 | 0.588 | 0 | 0 |
| DDX58/IFIH1-mediated induction of interferon-alpha/beta | R-HSA-168928 | 3.304794e-01 | 0.481 | 0 | 0 |
| Ub-specific processing proteases | R-HSA-5689880 | 3.577292e-01 | 0.446 | 0 | 0 |
| MAP kinase activation | R-HSA-450294 | 1.989004e-01 | 0.701 | 0 | 0 |
| Transcriptional and post-translational regulation of MITF-M expression and activity | R-HSA-9856649 | 2.804412e-01 | 0.552 | 0 | 0 |
| Regulation of MECP2 expression and activity | R-HSA-9022692 | 2.542917e-01 | 0.595 | 0 | 0 |
| DAG and IP3 signaling | R-HSA-1489509 | 2.147618e-01 | 0.668 | 0 | 0 |
| Signaling by NTRKs | R-HSA-166520 | 2.138379e-01 | 0.670 | 0 | 0 |
| Formation of the nephric duct | R-HSA-9830364 | 1.630055e-01 | 0.788 | 0 | 0 |
| Defective Intrinsic Pathway for Apoptosis | R-HSA-9734009 | 1.848950e-01 | 0.733 | 0 | 0 |
| Diseases of DNA repair | R-HSA-9675135 | 2.240975e-01 | 0.650 | 0 | 0 |
| VLDL assembly | R-HSA-8866423 | 3.313684e-01 | 0.480 | 0 | 0 |
| Nef and signal transduction | R-HSA-164944 | 3.313684e-01 | 0.480 | 0 | 0 |
| Syndecan interactions | R-HSA-3000170 | 1.419715e-01 | 0.848 | 0 | 0 |
| Nef Mediated CD4 Down-regulation | R-HSA-167590 | 3.606227e-01 | 0.443 | 0 | 0 |
| Synthesis of PG | R-HSA-1483148 | 2.417838e-01 | 0.617 | 0 | 0 |
| Regulation of TP53 Expression and Degradation | R-HSA-6806003 | 1.530107e-01 | 0.815 | 0 | 0 |
| VEGFR2 mediated vascular permeability | R-HSA-5218920 | 1.699254e-01 | 0.770 | 0 | 0 |
| Interleukin-17 signaling | R-HSA-448424 | 2.719711e-01 | 0.565 | 0 | 0 |
| Intracellular signaling by second messengers | R-HSA-9006925 | 1.986386e-01 | 0.702 | 0 | 0 |
| Cellular responses to mechanical stimuli | R-HSA-9855142 | 2.066296e-01 | 0.685 | 0 | 0 |
| PIP3 activates AKT signaling | R-HSA-1257604 | 3.380993e-01 | 0.471 | 0 | 0 |
| Generic Transcription Pathway | R-HSA-212436 | 3.402644e-01 | 0.468 | 0 | 0 |
| Intrinsic Pathway for Apoptosis | R-HSA-109606 | 1.616760e-01 | 0.791 | 0 | 0 |
| Stimuli-sensing channels | R-HSA-2672351 | 2.925977e-01 | 0.534 | 0 | 0 |
| Ephrin signaling | R-HSA-3928664 | 2.746875e-01 | 0.561 | 0 | 0 |
| Signal transduction by L1 | R-HSA-445144 | 3.075177e-01 | 0.512 | 0 | 0 |
| Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models | R-HSA-8862803 | 3.878716e-01 | 0.411 | 0 | 0 |
| Neurodegenerative Diseases | R-HSA-8863678 | 3.878716e-01 | 0.411 | 0 | 0 |
| PI Metabolism | R-HSA-1483255 | 1.381774e-01 | 0.860 | 0 | 0 |
| Calmodulin induced events | R-HSA-111933 | 3.023624e-01 | 0.519 | 0 | 0 |
| Regulation of cholesterol biosynthesis by SREBP (SREBF) | R-HSA-1655829 | 3.496169e-01 | 0.456 | 0 | 0 |
| Receptor-type tyrosine-protein phosphatases | R-HSA-388844 | 2.253878e-01 | 0.647 | 0 | 0 |
| Modulation of host responses by IFN-stimulated genes | R-HSA-9909505 | 2.582289e-01 | 0.588 | 0 | 0 |
| CaM pathway | R-HSA-111997 | 3.023624e-01 | 0.519 | 0 | 0 |
| SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription | R-HSA-2173796 | 3.144707e-01 | 0.502 | 0 | 0 |
| Signaling by FGFR1 | R-HSA-5654736 | 3.217278e-01 | 0.493 | 0 | 0 |
| Kidney development | R-HSA-9830369 | 2.469190e-01 | 0.607 | 0 | 0 |
| RUNX1 and FOXP3 control the development of regulatory T lymphocytes (Tregs) | R-HSA-8877330 | 1.769000e-01 | 0.752 | 0 | 0 |
| Signaling by FGFR4 | R-HSA-5654743 | 3.988540e-01 | 0.399 | 0 | 0 |
| Zinc efflux and compartmentalization by the SLC30 family | R-HSA-435368 | 2.687890e-01 | 0.571 | 0 | 0 |
| TYSND1 cleaves peroxisomal proteins | R-HSA-9033500 | 3.007775e-01 | 0.522 | 0 | 0 |
| PKA-mediated phosphorylation of CREB | R-HSA-111931 | 3.238324e-01 | 0.490 | 0 | 0 |
| TP53 regulates transcription of additional cell cycle genes whose exact role in the p53 pathway remain uncertain | R-HSA-6804115 | 3.561375e-01 | 0.448 | 0 | 0 |
| NOTCH3 Intracellular Domain Regulates Transcription | R-HSA-9013508 | 2.190218e-01 | 0.660 | 0 | 0 |
| Turbulent (oscillatory, disturbed) flow shear stress activates signaling by PIEZO1 and integrins in endothelial cells | R-HSA-9860927 | 2.902768e-01 | 0.537 | 0 | 0 |
| Synaptic adhesion-like molecules | R-HSA-8849932 | 2.746875e-01 | 0.561 | 0 | 0 |
| Assembly Of The HIV Virion | R-HSA-175474 | 3.400465e-01 | 0.468 | 0 | 0 |
| Glycogen breakdown (glycogenolysis) | R-HSA-70221 | 4.034800e-01 | 0.394 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in G1 Cell Cycle Arrest | R-HSA-6804116 | 2.253878e-01 | 0.647 | 0 | 0 |
| Nephron development | R-HSA-9831926 | 2.746875e-01 | 0.561 | 0 | 0 |
| Zygotic genome activation (ZGA) | R-HSA-9819196 | 3.238324e-01 | 0.490 | 0 | 0 |
| Glutamate binding, activation of AMPA receptors and synaptic plasticity | R-HSA-399721 | 2.542917e-01 | 0.595 | 0 | 0 |
| Constitutive Signaling by AKT1 E17K in Cancer | R-HSA-5674400 | 3.720853e-01 | 0.429 | 0 | 0 |
| CREB1 phosphorylation through the activation of CaMKII/CaMKK/CaMKIV cascasde | R-HSA-442729 | 3.885988e-01 | 0.410 | 0 | 0 |
| Transcriptional Regulation by MECP2 | R-HSA-8986944 | 1.646742e-01 | 0.783 | 0 | 0 |
| NPAS4 regulates expression of target genes | R-HSA-9768919 | 2.782271e-01 | 0.556 | 0 | 0 |
| Interleukin-23 signaling | R-HSA-9020933 | 3.885988e-01 | 0.410 | 0 | 0 |
| XBP1(S) activates chaperone genes | R-HSA-381038 | 2.543069e-01 | 0.595 | 0 | 0 |
| IRE1alpha activates chaperones | R-HSA-381070 | 2.995314e-01 | 0.524 | 0 | 0 |
| RAB GEFs exchange GTP for GDP on RABs | R-HSA-8876198 | 4.108604e-01 | 0.386 | 0 | 0 |
| Regulated proteolysis of p75NTR | R-HSA-193692 | 4.153524e-01 | 0.382 | 0 | 0 |
| Interleukin-21 signaling | R-HSA-9020958 | 4.153524e-01 | 0.382 | 0 | 0 |
| ALK mutants bind TKIs | R-HSA-9700645 | 4.153524e-01 | 0.382 | 0 | 0 |
| p75NTR regulates axonogenesis | R-HSA-193697 | 4.153524e-01 | 0.382 | 0 | 0 |
| MASTL Facilitates Mitotic Progression | R-HSA-2465910 | 4.153524e-01 | 0.382 | 0 | 0 |
| Inactivation of CDC42 and RAC1 | R-HSA-428543 | 4.153524e-01 | 0.382 | 0 | 0 |
| IRAK2 mediated activation of TAK1 complex | R-HSA-937042 | 4.153524e-01 | 0.382 | 0 | 0 |
| Activation of the AP-1 family of transcription factors | R-HSA-450341 | 4.153524e-01 | 0.382 | 0 | 0 |
| mRNA Editing | R-HSA-75072 | 4.153524e-01 | 0.382 | 0 | 0 |
| ARMS-mediated activation | R-HSA-170984 | 4.153524e-01 | 0.382 | 0 | 0 |
| MAPK1 (ERK2) activation | R-HSA-112411 | 4.153524e-01 | 0.382 | 0 | 0 |
| Regulation of signaling by NODAL | R-HSA-1433617 | 4.153524e-01 | 0.382 | 0 | 0 |
| Regulation of CDH11 gene transcription | R-HSA-9762293 | 4.153524e-01 | 0.382 | 0 | 0 |
| AMPK inhibits chREBP transcriptional activation activity | R-HSA-163680 | 4.153524e-01 | 0.382 | 0 | 0 |
| WNT mediated activation of DVL | R-HSA-201688 | 4.153524e-01 | 0.382 | 0 | 0 |
| GP1b-IX-V activation signalling | R-HSA-430116 | 4.153524e-01 | 0.382 | 0 | 0 |
| NOTCH4 Activation and Transmission of Signal to the Nucleus | R-HSA-9013700 | 4.153524e-01 | 0.382 | 0 | 0 |
| TCF dependent signaling in response to WNT | R-HSA-201681 | 4.168139e-01 | 0.380 | 0 | 0 |
| Signaling by EGFR in Cancer | R-HSA-1643713 | 4.188960e-01 | 0.378 | 0 | 0 |
| Myogenesis | R-HSA-525793 | 4.188960e-01 | 0.378 | 0 | 0 |
| Caspase activation via extrinsic apoptotic signalling pathway | R-HSA-5357769 | 4.188960e-01 | 0.378 | 0 | 0 |
| MECP2 regulates neuronal receptors and channels | R-HSA-9022699 | 4.188960e-01 | 0.378 | 0 | 0 |
| Regulation of PD-L1(CD274) transcription | R-HSA-9909649 | 4.217398e-01 | 0.375 | 0 | 0 |
| Somitogenesis | R-HSA-9824272 | 4.225269e-01 | 0.374 | 0 | 0 |
| Platelet Aggregation (Plug Formation) | R-HSA-76009 | 4.225269e-01 | 0.374 | 0 | 0 |
| Signaling by FGFR3 | R-HSA-5654741 | 4.225269e-01 | 0.374 | 0 | 0 |
| GPCR downstream signalling | R-HSA-388396 | 4.249695e-01 | 0.372 | 0 | 0 |
| Clathrin-mediated endocytosis | R-HSA-8856828 | 4.310069e-01 | 0.366 | 0 | 0 |
| HCMV Infection | R-HSA-9609646 | 4.323687e-01 | 0.364 | 0 | 0 |
| Platelet homeostasis | R-HSA-418346 | 4.325315e-01 | 0.364 | 0 | 0 |
| SARS-CoV-1-host interactions | R-HSA-9692914 | 4.325315e-01 | 0.364 | 0 | 0 |
| Processive synthesis on the C-strand of the telomere | R-HSA-174414 | 4.341064e-01 | 0.362 | 0 | 0 |
| SHC-mediated cascade:FGFR2 | R-HSA-5654699 | 4.341064e-01 | 0.362 | 0 | 0 |
| Cristae formation | R-HSA-8949613 | 4.341064e-01 | 0.362 | 0 | 0 |
| Signaling by NTRK2 (TRKB) | R-HSA-9006115 | 4.341064e-01 | 0.362 | 0 | 0 |
| Mitochondrial unfolded protein response (UPRmt) | R-HSA-9841251 | 4.341064e-01 | 0.362 | 0 | 0 |
| Regulation of pyruvate metabolism | R-HSA-9861718 | 4.342451e-01 | 0.362 | 0 | 0 |
| Signaling by TGFBR3 | R-HSA-9839373 | 4.342451e-01 | 0.362 | 0 | 0 |
| Erythropoietin activates Phospholipase C gamma (PLCG) | R-HSA-9027277 | 4.409369e-01 | 0.356 | 0 | 0 |
| TICAM1,TRAF6-dependent induction of TAK1 complex | R-HSA-9014325 | 4.409369e-01 | 0.356 | 0 | 0 |
| EGFR Transactivation by Gastrin | R-HSA-2179392 | 4.409369e-01 | 0.356 | 0 | 0 |
| Establishment of Sister Chromatid Cohesion | R-HSA-2468052 | 4.409369e-01 | 0.356 | 0 | 0 |
| Ion influx/efflux at host-pathogen interface | R-HSA-6803544 | 4.409369e-01 | 0.356 | 0 | 0 |
| Interleukin-27 signaling | R-HSA-9020956 | 4.409369e-01 | 0.356 | 0 | 0 |
| Defective RIPK1-mediated regulated necrosis | R-HSA-9693928 | 4.409369e-01 | 0.356 | 0 | 0 |
| Apoptosis induced DNA fragmentation | R-HSA-140342 | 4.409369e-01 | 0.356 | 0 | 0 |
| Maturation of spike protein | R-HSA-9683686 | 4.409369e-01 | 0.356 | 0 | 0 |
| MAPK3 (ERK1) activation | R-HSA-110056 | 4.409369e-01 | 0.356 | 0 | 0 |
| CaMK IV-mediated phosphorylation of CREB | R-HSA-111932 | 4.409369e-01 | 0.356 | 0 | 0 |
| Josephin domain DUBs | R-HSA-5689877 | 4.409369e-01 | 0.356 | 0 | 0 |
| Tandem pore domain potassium channels | R-HSA-1296346 | 4.409369e-01 | 0.356 | 0 | 0 |
| Receptor Mediated Mitophagy | R-HSA-8934903 | 4.409369e-01 | 0.356 | 0 | 0 |
| Adaptive Immune System | R-HSA-1280218 | 4.443193e-01 | 0.352 | 0 | 0 |
| Activation of kainate receptors upon glutamate binding | R-HSA-451326 | 4.490998e-01 | 0.348 | 0 | 0 |
| Mitotic G1 phase and G1/S transition | R-HSA-453279 | 4.509974e-01 | 0.346 | 0 | 0 |
| NGF-stimulated transcription | R-HSA-9031628 | 4.574070e-01 | 0.340 | 0 | 0 |
| Co-stimulation by CD28 | R-HSA-389356 | 4.574070e-01 | 0.340 | 0 | 0 |
| Signaling by Erythropoietin | R-HSA-9006335 | 4.638661e-01 | 0.334 | 0 | 0 |
| Endosomal Sorting Complex Required For Transport (ESCRT) | R-HSA-917729 | 4.638661e-01 | 0.334 | 0 | 0 |
| MAPK targets/ Nuclear events mediated by MAP kinases | R-HSA-450282 | 4.638661e-01 | 0.334 | 0 | 0 |
| Downstream signaling of activated FGFR3 | R-HSA-5654708 | 4.638661e-01 | 0.334 | 0 | 0 |
| RHOBTB3 ATPase cycle | R-HSA-9706019 | 4.654033e-01 | 0.332 | 0 | 0 |
| Presynaptic depolarization and calcium channel opening | R-HSA-112308 | 4.654033e-01 | 0.332 | 0 | 0 |
| Chylomicron assembly | R-HSA-8963888 | 4.654033e-01 | 0.332 | 0 | 0 |
| Synthesis of PIPs at the ER membrane | R-HSA-1483248 | 4.654033e-01 | 0.332 | 0 | 0 |
| PECAM1 interactions | R-HSA-210990 | 4.654033e-01 | 0.332 | 0 | 0 |
| Suppression of apoptosis | R-HSA-9635465 | 4.654033e-01 | 0.332 | 0 | 0 |
| CD163 mediating an anti-inflammatory response | R-HSA-9662834 | 4.654033e-01 | 0.332 | 0 | 0 |
| Degradation of CDH1 | R-HSA-9766229 | 4.688369e-01 | 0.329 | 0 | 0 |
| N-glycan trimming in the ER and Calnexin/Calreticulin cycle | R-HSA-532668 | 4.688369e-01 | 0.329 | 0 | 0 |
| APC/C-mediated degradation of cell cycle proteins | R-HSA-174143 | 4.705935e-01 | 0.327 | 0 | 0 |
| Regulation of mitotic cell cycle | R-HSA-453276 | 4.705935e-01 | 0.327 | 0 | 0 |
| Signaling by GPCR | R-HSA-372790 | 4.743965e-01 | 0.324 | 0 | 0 |
| C-type lectin receptors (CLRs) | R-HSA-5621481 | 4.766541e-01 | 0.322 | 0 | 0 |
| G alpha (s) signalling events | R-HSA-418555 | 4.766541e-01 | 0.322 | 0 | 0 |
| DAP12 signaling | R-HSA-2424491 | 4.783964e-01 | 0.320 | 0 | 0 |
| Activation of the pre-replicative complex | R-HSA-68962 | 4.783964e-01 | 0.320 | 0 | 0 |
| RORA,B,C and NR1D1 (REV-ERBA) regulate gene expression | R-HSA-9933387 | 4.783964e-01 | 0.320 | 0 | 0 |
| Activation of BH3-only proteins | R-HSA-114452 | 4.783964e-01 | 0.320 | 0 | 0 |
| Downstream signaling of activated FGFR4 | R-HSA-5654716 | 4.783964e-01 | 0.320 | 0 | 0 |
| Nuclear Events (kinase and transcription factor activation) | R-HSA-198725 | 4.801885e-01 | 0.319 | 0 | 0 |
| Antigen activates B Cell Receptor (BCR) leading to generation of second messengers | R-HSA-983695 | 4.881334e-01 | 0.311 | 0 | 0 |
| Phosphorylation of CLOCK, acetylation of BMAL1 (ARNTL) at target gene promoters | R-HSA-9931512 | 4.888003e-01 | 0.311 | 0 | 0 |
| Sensing of DNA Double Strand Breaks | R-HSA-5693548 | 4.888003e-01 | 0.311 | 0 | 0 |
| Negative regulation of TCF-dependent signaling by WNT ligand antagonists | R-HSA-3772470 | 4.888003e-01 | 0.311 | 0 | 0 |
| ERKs are inactivated | R-HSA-202670 | 4.888003e-01 | 0.311 | 0 | 0 |
| Inhibition of replication initiation of damaged DNA by RB1/E2F1 | R-HSA-113501 | 4.888003e-01 | 0.311 | 0 | 0 |
| Condensation of Prometaphase Chromosomes | R-HSA-2514853 | 4.888003e-01 | 0.311 | 0 | 0 |
| Mitotic Telophase/Cytokinesis | R-HSA-68884 | 4.888003e-01 | 0.311 | 0 | 0 |
| Activation of RAC1 | R-HSA-428540 | 4.888003e-01 | 0.311 | 0 | 0 |
| POLB-Dependent Long Patch Base Excision Repair | R-HSA-110362 | 4.888003e-01 | 0.311 | 0 | 0 |
| Cytochrome c-mediated apoptotic response | R-HSA-111461 | 4.888003e-01 | 0.311 | 0 | 0 |
| Regulation of CDH1 Expression and Function | R-HSA-9764265 | 4.889957e-01 | 0.311 | 0 | 0 |
| Regulation of Expression and Function of Type I Classical Cadherins | R-HSA-9764274 | 4.889957e-01 | 0.311 | 0 | 0 |
| Ca2+ pathway | R-HSA-4086398 | 4.897148e-01 | 0.310 | 0 | 0 |
| Activation of NF-kappaB in B cells | R-HSA-1169091 | 4.913635e-01 | 0.309 | 0 | 0 |
| Cargo concentration in the ER | R-HSA-5694530 | 4.926831e-01 | 0.307 | 0 | 0 |
| Budding and maturation of HIV virion | R-HSA-162588 | 4.926831e-01 | 0.307 | 0 | 0 |
| Negative regulators of DDX58/IFIH1 signaling | R-HSA-936440 | 4.926831e-01 | 0.307 | 0 | 0 |
| Regulation of Homotypic Cell-Cell Adhesion | R-HSA-9759476 | 4.933645e-01 | 0.307 | 0 | 0 |
| Adherens junctions interactions | R-HSA-418990 | 4.972732e-01 | 0.303 | 0 | 0 |
| SARS-CoV-1 Infection | R-HSA-9678108 | 5.012631e-01 | 0.300 | 0 | 0 |
| Neurexins and neuroligins | R-HSA-6794361 | 5.024491e-01 | 0.299 | 0 | 0 |
| E3 ubiquitin ligases ubiquitinate target proteins | R-HSA-8866654 | 5.024491e-01 | 0.299 | 0 | 0 |
| Transcriptional Regulation by NPAS4 | R-HSA-9634815 | 5.024491e-01 | 0.299 | 0 | 0 |
| Transcriptional Regulation by TP53 | R-HSA-3700989 | 5.063197e-01 | 0.296 | 0 | 0 |
| Erythropoietin activates Phosphoinositide-3-kinase (PI3K) | R-HSA-9027276 | 5.111748e-01 | 0.291 | 0 | 0 |
| GRB2 events in EGFR signaling | R-HSA-179812 | 5.111748e-01 | 0.291 | 0 | 0 |
| Interleukin-35 Signalling | R-HSA-8984722 | 5.111748e-01 | 0.291 | 0 | 0 |
| Role of second messengers in netrin-1 signaling | R-HSA-418890 | 5.111748e-01 | 0.291 | 0 | 0 |
| Z-decay: degradation of maternal mRNAs by zygotically expressed factors | R-HSA-9820865 | 5.111748e-01 | 0.291 | 0 | 0 |
| MET activates RAS signaling | R-HSA-8851805 | 5.111748e-01 | 0.291 | 0 | 0 |
| Downregulation of ERBB2:ERBB3 signaling | R-HSA-1358803 | 5.111748e-01 | 0.291 | 0 | 0 |
| NOTCH2 intracellular domain regulates transcription | R-HSA-2197563 | 5.111748e-01 | 0.291 | 0 | 0 |
| AKT phosphorylates targets in the cytosol | R-HSA-198323 | 5.111748e-01 | 0.291 | 0 | 0 |
| APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 | R-HSA-174178 | 5.134095e-01 | 0.290 | 0 | 0 |
| Interferon alpha/beta signaling | R-HSA-909733 | 5.168666e-01 | 0.287 | 0 | 0 |
| UCH proteinases | R-HSA-5689603 | 5.178434e-01 | 0.286 | 0 | 0 |
| Resolution of D-loop Structures through Holliday Junction Intermediates | R-HSA-5693568 | 5.205009e-01 | 0.284 | 0 | 0 |
| Regulation of TP53 Activity through Acetylation | R-HSA-6804758 | 5.205009e-01 | 0.284 | 0 | 0 |
| Activation of ATR in response to replication stress | R-HSA-176187 | 5.205009e-01 | 0.284 | 0 | 0 |
| FGFR1 mutant receptor activation | R-HSA-1839124 | 5.205009e-01 | 0.284 | 0 | 0 |
| Synthesis of IP3 and IP4 in the cytosol | R-HSA-1855204 | 5.205009e-01 | 0.284 | 0 | 0 |
| Cyclin A/B1/B2 associated events during G2/M transition | R-HSA-69273 | 5.205009e-01 | 0.284 | 0 | 0 |
| HDR through MMEJ (alt-NHEJ) | R-HSA-5685939 | 5.325712e-01 | 0.274 | 0 | 0 |
| PDH complex synthesizes acetyl-CoA from PYR | R-HSA-9861559 | 5.325712e-01 | 0.274 | 0 | 0 |
| IL-6-type cytokine receptor ligand interactions | R-HSA-6788467 | 5.325712e-01 | 0.274 | 0 | 0 |
| Interleukin-6 signaling | R-HSA-1059683 | 5.325712e-01 | 0.274 | 0 | 0 |
| Frs2-mediated activation | R-HSA-170968 | 5.325712e-01 | 0.274 | 0 | 0 |
| Diseases of nucleotide metabolism | R-HSA-9735804 | 5.325712e-01 | 0.274 | 0 | 0 |
| FGFR1c ligand binding and activation | R-HSA-190373 | 5.325712e-01 | 0.274 | 0 | 0 |
| Formation of axial mesoderm | R-HSA-9796292 | 5.325712e-01 | 0.274 | 0 | 0 |
| Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex | R-HSA-75035 | 5.325712e-01 | 0.274 | 0 | 0 |
| Maturation of nucleoprotein | R-HSA-9683610 | 5.325712e-01 | 0.274 | 0 | 0 |
| Respiratory Syncytial Virus Infection Pathway | R-HSA-9820952 | 5.337630e-01 | 0.273 | 0 | 0 |
| Resolution of D-Loop Structures | R-HSA-5693537 | 5.340219e-01 | 0.272 | 0 | 0 |
| Glucagon signaling in metabolic regulation | R-HSA-163359 | 5.340219e-01 | 0.272 | 0 | 0 |
| Acyl chain remodelling of PC | R-HSA-1482788 | 5.340219e-01 | 0.272 | 0 | 0 |
| DNA Damage Recognition in GG-NER | R-HSA-5696394 | 5.340219e-01 | 0.272 | 0 | 0 |
| Vitamin B5 (pantothenate) metabolism | R-HSA-199220 | 5.340219e-01 | 0.272 | 0 | 0 |
| Miscellaneous transport and binding events | R-HSA-5223345 | 5.340219e-01 | 0.272 | 0 | 0 |
| TP53 Regulates Transcription of DNA Repair Genes | R-HSA-6796648 | 5.361860e-01 | 0.271 | 0 | 0 |
| Signaling by FGFR | R-HSA-190236 | 5.375927e-01 | 0.270 | 0 | 0 |
| PI3K/AKT Signaling in Cancer | R-HSA-2219528 | 5.390605e-01 | 0.268 | 0 | 0 |
| Transcriptional regulation by RUNX1 | R-HSA-8878171 | 5.409341e-01 | 0.267 | 0 | 0 |
| Signaling by EGFR | R-HSA-177929 | 5.454961e-01 | 0.263 | 0 | 0 |
| Ion homeostasis | R-HSA-5578775 | 5.454961e-01 | 0.263 | 0 | 0 |
| Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer | R-HSA-2173793 | 5.454961e-01 | 0.263 | 0 | 0 |
| Phospholipid metabolism | R-HSA-1483257 | 5.455931e-01 | 0.263 | 0 | 0 |
| HATs acetylate histones | R-HSA-3214847 | 5.456239e-01 | 0.263 | 0 | 0 |
| SARS-CoV-1 modulates host translation machinery | R-HSA-9735869 | 5.472793e-01 | 0.262 | 0 | 0 |
| Signal amplification | R-HSA-392518 | 5.472793e-01 | 0.262 | 0 | 0 |
| Signaling by CSF1 (M-CSF) in myeloid cells | R-HSA-9680350 | 5.472793e-01 | 0.262 | 0 | 0 |
| Signaling by NOTCH2 | R-HSA-1980145 | 5.472793e-01 | 0.262 | 0 | 0 |
| Cell-cell junction organization | R-HSA-421270 | 5.527905e-01 | 0.257 | 0 | 0 |
| Prolactin receptor signaling | R-HSA-1170546 | 5.530324e-01 | 0.257 | 0 | 0 |
| cGMP effects | R-HSA-418457 | 5.530324e-01 | 0.257 | 0 | 0 |
| NRIF signals cell death from the nucleus | R-HSA-205043 | 5.530324e-01 | 0.257 | 0 | 0 |
| IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation | R-HSA-975163 | 5.530324e-01 | 0.257 | 0 | 0 |
| Hydrolysis of LPC | R-HSA-1483115 | 5.530324e-01 | 0.257 | 0 | 0 |
| CLEC7A (Dectin-1) induces NFAT activation | R-HSA-5607763 | 5.530324e-01 | 0.257 | 0 | 0 |
| Non-canonical inflammasome activation | R-HSA-9686114 | 5.530324e-01 | 0.257 | 0 | 0 |
| Signal regulatory protein family interactions | R-HSA-391160 | 5.530324e-01 | 0.257 | 0 | 0 |
| Acyl chain remodeling of CL | R-HSA-1482798 | 5.530324e-01 | 0.257 | 0 | 0 |
| Zinc transporters | R-HSA-435354 | 5.530324e-01 | 0.257 | 0 | 0 |
| Platelet activation, signaling and aggregation | R-HSA-76002 | 5.539331e-01 | 0.257 | 0 | 0 |
| Signaling by FGFR2 | R-HSA-5654738 | 5.541721e-01 | 0.256 | 0 | 0 |
| Nuclear Envelope Breakdown | R-HSA-2980766 | 5.559142e-01 | 0.255 | 0 | 0 |
| Acyl chain remodelling of PE | R-HSA-1482839 | 5.602701e-01 | 0.252 | 0 | 0 |
| Signalling to ERKs | R-HSA-187687 | 5.602701e-01 | 0.252 | 0 | 0 |
| Downstream signaling of activated FGFR2 | R-HSA-5654696 | 5.602701e-01 | 0.252 | 0 | 0 |
| Downstream signaling of activated FGFR1 | R-HSA-5654687 | 5.602701e-01 | 0.252 | 0 | 0 |
| Extra-nuclear estrogen signaling | R-HSA-9009391 | 5.614841e-01 | 0.251 | 0 | 0 |
| Formation of the beta-catenin:TCF transactivating complex | R-HSA-201722 | 5.661881e-01 | 0.247 | 0 | 0 |
| Butyrate Response Factor 1 (BRF1) binds and destabilizes mRNA | R-HSA-450385 | 5.725991e-01 | 0.242 | 0 | 0 |
| RNA Polymerase III Chain Elongation | R-HSA-73780 | 5.725991e-01 | 0.242 | 0 | 0 |
| Telomere C-strand synthesis initiation | R-HSA-174430 | 5.725991e-01 | 0.242 | 0 | 0 |
| TRAF6-mediated induction of TAK1 complex within TLR4 complex | R-HSA-937072 | 5.725991e-01 | 0.242 | 0 | 0 |
| DCC mediated attractive signaling | R-HSA-418885 | 5.725991e-01 | 0.242 | 0 | 0 |
| Synthesis of 12-eicosatetraenoic acid derivatives | R-HSA-2142712 | 5.725991e-01 | 0.242 | 0 | 0 |
| Sema3A PAK dependent Axon repulsion | R-HSA-399954 | 5.725991e-01 | 0.242 | 0 | 0 |
| Signaling by Activin | R-HSA-1502540 | 5.725991e-01 | 0.242 | 0 | 0 |
| Dopamine clearance from the synaptic cleft | R-HSA-379401 | 5.725991e-01 | 0.242 | 0 | 0 |
| Spry regulation of FGF signaling | R-HSA-1295596 | 5.725991e-01 | 0.242 | 0 | 0 |
| SARS-CoV-1 targets host intracellular signalling and regulatory pathways | R-HSA-9735871 | 5.725991e-01 | 0.242 | 0 | 0 |
| Biotin transport and metabolism | R-HSA-196780 | 5.725991e-01 | 0.242 | 0 | 0 |
| rRNA processing | R-HSA-72312 | 5.727881e-01 | 0.242 | 0 | 0 |
| G1/S-Specific Transcription | R-HSA-69205 | 5.729924e-01 | 0.242 | 0 | 0 |
| RNA Polymerase III Abortive And Retractive Initiation | R-HSA-749476 | 5.729924e-01 | 0.242 | 0 | 0 |
| RNA Polymerase III Transcription | R-HSA-74158 | 5.729924e-01 | 0.242 | 0 | 0 |
| GPVI-mediated activation cascade | R-HSA-114604 | 5.729924e-01 | 0.242 | 0 | 0 |
| SARS-CoV-2 activates/modulates innate and adaptive immune responses | R-HSA-9705671 | 5.738054e-01 | 0.241 | 0 | 0 |
| Ion channel transport | R-HSA-983712 | 5.842565e-01 | 0.233 | 0 | 0 |
| Deactivation of the beta-catenin transactivating complex | R-HSA-3769402 | 5.854446e-01 | 0.233 | 0 | 0 |
| TRAF6 mediated IRF7 activation | R-HSA-933541 | 5.854446e-01 | 0.233 | 0 | 0 |
| Regulation of PTEN gene transcription | R-HSA-8943724 | 5.862926e-01 | 0.232 | 0 | 0 |
| Leishmania infection | R-HSA-9658195 | 5.877422e-01 | 0.231 | 0 | 0 |
| Parasitic Infection Pathways | R-HSA-9824443 | 5.877422e-01 | 0.231 | 0 | 0 |
| Aberrant regulation of mitotic exit in cancer due to RB1 defects | R-HSA-9687136 | 5.913103e-01 | 0.228 | 0 | 0 |
| Fatty Acids bound to GPR40 (FFAR1) regulate insulin secretion | R-HSA-434316 | 5.913103e-01 | 0.228 | 0 | 0 |
| Class I peroxisomal membrane protein import | R-HSA-9603798 | 5.913103e-01 | 0.228 | 0 | 0 |
| Prolonged ERK activation events | R-HSA-169893 | 5.913103e-01 | 0.228 | 0 | 0 |
| Regulation of glycolysis by fructose 2,6-bisphosphate metabolism | R-HSA-9634600 | 5.913103e-01 | 0.228 | 0 | 0 |
| WNT5:FZD7-mediated leishmania damping | R-HSA-9673324 | 5.913103e-01 | 0.228 | 0 | 0 |
| Killing mechanisms | R-HSA-9664420 | 5.913103e-01 | 0.228 | 0 | 0 |
| Induction of Cell-Cell Fusion | R-HSA-9733458 | 5.913103e-01 | 0.228 | 0 | 0 |
| Negative regulation of FLT3 | R-HSA-9706369 | 5.913103e-01 | 0.228 | 0 | 0 |
| SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion | R-HSA-399955 | 5.913103e-01 | 0.228 | 0 | 0 |
| Activation of SMO | R-HSA-5635838 | 5.913103e-01 | 0.228 | 0 | 0 |
| Attachment and Entry | R-HSA-9678110 | 5.913103e-01 | 0.228 | 0 | 0 |
| Hemostasis | R-HSA-109582 | 5.913920e-01 | 0.228 | 0 | 0 |
| RSV-host interactions | R-HSA-9833110 | 5.923418e-01 | 0.227 | 0 | 0 |
| IRS-related events triggered by IGF1R | R-HSA-2428928 | 5.961187e-01 | 0.225 | 0 | 0 |
| Purine salvage | R-HSA-74217 | 5.976262e-01 | 0.224 | 0 | 0 |
| SLC-mediated transport of inorganic anions | R-HSA-9958790 | 5.976262e-01 | 0.224 | 0 | 0 |
| RNA Polymerase II Transcription | R-HSA-73857 | 5.981943e-01 | 0.223 | 0 | 0 |
| Asparagine N-linked glycosylation | R-HSA-446203 | 6.043529e-01 | 0.219 | 0 | 0 |
| Mitochondrial protein import | R-HSA-1268020 | 6.057914e-01 | 0.218 | 0 | 0 |
| Heme signaling | R-HSA-9707616 | 6.057914e-01 | 0.218 | 0 | 0 |
| SHC1 events in ERBB4 signaling | R-HSA-1250347 | 6.092035e-01 | 0.215 | 0 | 0 |
| mRNA decay by 5' to 3' exoribonuclease | R-HSA-430039 | 6.092035e-01 | 0.215 | 0 | 0 |
| Inactivation of APC/C via direct inhibition of the APC/C complex | R-HSA-141430 | 6.092035e-01 | 0.215 | 0 | 0 |
| Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components | R-HSA-141405 | 6.092035e-01 | 0.215 | 0 | 0 |
| Acetylcholine regulates insulin secretion | R-HSA-399997 | 6.092035e-01 | 0.215 | 0 | 0 |
| Galactose catabolism | R-HSA-70370 | 6.092035e-01 | 0.215 | 0 | 0 |
| Pentose phosphate pathway | R-HSA-71336 | 6.095369e-01 | 0.215 | 0 | 0 |
| Stabilization of p53 | R-HSA-69541 | 6.095369e-01 | 0.215 | 0 | 0 |
| Activation of gene expression by SREBF (SREBP) | R-HSA-2426168 | 6.153092e-01 | 0.211 | 0 | 0 |
| Inhibition of DNA recombination at telomere | R-HSA-9670095 | 6.211770e-01 | 0.207 | 0 | 0 |
| Regulation of RUNX3 expression and activity | R-HSA-8941858 | 6.211770e-01 | 0.207 | 0 | 0 |
| Glycogen metabolism | R-HSA-8982491 | 6.211770e-01 | 0.207 | 0 | 0 |
| Antigen processing-Cross presentation | R-HSA-1236975 | 6.219622e-01 | 0.206 | 0 | 0 |
| Removal of the Flap Intermediate from the C-strand | R-HSA-174437 | 6.263143e-01 | 0.203 | 0 | 0 |
| Mismatch repair (MMR) directed by MSH2:MSH6 (MutSalpha) | R-HSA-5358565 | 6.263143e-01 | 0.203 | 0 | 0 |
| Regulation of FZD by ubiquitination | R-HSA-4641263 | 6.263143e-01 | 0.203 | 0 | 0 |
| Synthesis of 15-eicosatetraenoic acid derivatives | R-HSA-2142770 | 6.263143e-01 | 0.203 | 0 | 0 |
| Elevation of cytosolic Ca2+ levels | R-HSA-139853 | 6.263143e-01 | 0.203 | 0 | 0 |
| Sulfide oxidation to sulfate | R-HSA-1614517 | 6.263143e-01 | 0.203 | 0 | 0 |
| DNA Repair | R-HSA-73894 | 6.298580e-01 | 0.201 | 0 | 0 |
| Peptide chain elongation | R-HSA-156902 | 6.301938e-01 | 0.201 | 0 | 0 |
| FLT3 Signaling | R-HSA-9607240 | 6.325475e-01 | 0.199 | 0 | 0 |
| Cellular response to hypoxia | R-HSA-1234174 | 6.338749e-01 | 0.198 | 0 | 0 |
| Reproduction | R-HSA-1474165 | 6.360185e-01 | 0.197 | 0 | 0 |
| PCNA-Dependent Long Patch Base Excision Repair | R-HSA-5651801 | 6.426769e-01 | 0.192 | 0 | 0 |
| GAB1 signalosome | R-HSA-180292 | 6.426769e-01 | 0.192 | 0 | 0 |
| Mismatch Repair | R-HSA-5358508 | 6.426769e-01 | 0.192 | 0 | 0 |
| FGFR1 ligand binding and activation | R-HSA-190242 | 6.426769e-01 | 0.192 | 0 | 0 |
| Vitamin D (calciferol) metabolism | R-HSA-196791 | 6.426769e-01 | 0.192 | 0 | 0 |
| Polo-like kinase mediated events | R-HSA-156711 | 6.426769e-01 | 0.192 | 0 | 0 |
| Tie2 Signaling | R-HSA-210993 | 6.426769e-01 | 0.192 | 0 | 0 |
| Telomere C-strand (Lagging Strand) Synthesis | R-HSA-174417 | 6.436497e-01 | 0.191 | 0 | 0 |
| Signaling by FGFR1 in disease | R-HSA-5655302 | 6.436497e-01 | 0.191 | 0 | 0 |
| Translation of Structural Proteins | R-HSA-9683701 | 6.436497e-01 | 0.191 | 0 | 0 |
| HDR through Homologous Recombination (HRR) | R-HSA-5685942 | 6.518084e-01 | 0.186 | 0 | 0 |
| Developmental Lineage of Mammary Gland Luminal Epithelial Cells | R-HSA-9927418 | 6.544851e-01 | 0.184 | 0 | 0 |
| Pre-NOTCH Processing in Golgi | R-HSA-1912420 | 6.583240e-01 | 0.182 | 0 | 0 |
| Germ layer formation at gastrulation | R-HSA-9754189 | 6.583240e-01 | 0.182 | 0 | 0 |
| Specification of the neural plate border | R-HSA-9834899 | 6.583240e-01 | 0.182 | 0 | 0 |
| Gastrin-CREB signalling pathway via PKC and MAPK | R-HSA-881907 | 6.583240e-01 | 0.182 | 0 | 0 |
| Translesion Synthesis by POLH | R-HSA-110320 | 6.583240e-01 | 0.182 | 0 | 0 |
| E2F mediated regulation of DNA replication | R-HSA-113510 | 6.583240e-01 | 0.182 | 0 | 0 |
| Synthesis of 5-eicosatetraenoic acids | R-HSA-2142688 | 6.583240e-01 | 0.182 | 0 | 0 |
| Maturation of nucleoprotein | R-HSA-9694631 | 6.583240e-01 | 0.182 | 0 | 0 |
| RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function | R-HSA-8936459 | 6.605366e-01 | 0.180 | 0 | 0 |
| HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA) | R-HSA-5693567 | 6.639000e-01 | 0.178 | 0 | 0 |
| Signaling by WNT | R-HSA-195721 | 6.648119e-01 | 0.177 | 0 | 0 |
| Defective pyroptosis | R-HSA-9710421 | 6.650560e-01 | 0.177 | 0 | 0 |
| Response of Mtb to phagocytosis | R-HSA-9637690 | 6.650560e-01 | 0.177 | 0 | 0 |
| Signaling by SCF-KIT | R-HSA-1433557 | 6.650560e-01 | 0.177 | 0 | 0 |
| Signaling by Insulin receptor | R-HSA-74752 | 6.686513e-01 | 0.175 | 0 | 0 |
| Formation of ATP by chemiosmotic coupling | R-HSA-163210 | 6.732869e-01 | 0.172 | 0 | 0 |
| VxPx cargo-targeting to cilium | R-HSA-5620916 | 6.732869e-01 | 0.172 | 0 | 0 |
| BBSome-mediated cargo-targeting to cilium | R-HSA-5620922 | 6.732869e-01 | 0.172 | 0 | 0 |
| Signaling by NODAL | R-HSA-1181150 | 6.732869e-01 | 0.172 | 0 | 0 |
| Acyl chain remodelling of PI | R-HSA-1482922 | 6.732869e-01 | 0.172 | 0 | 0 |
| Mitochondrial iron-sulfur cluster biogenesis | R-HSA-1362409 | 6.732869e-01 | 0.172 | 0 | 0 |
| Formation of definitive endoderm | R-HSA-9823730 | 6.732869e-01 | 0.172 | 0 | 0 |
| Nephrin family interactions | R-HSA-373753 | 6.732869e-01 | 0.172 | 0 | 0 |
| Glycogen synthesis | R-HSA-3322077 | 6.732869e-01 | 0.172 | 0 | 0 |
| DAP12 interactions | R-HSA-2172127 | 6.753646e-01 | 0.170 | 0 | 0 |
| COPII-mediated vesicle transport | R-HSA-204005 | 6.775152e-01 | 0.169 | 0 | 0 |
| Degradation of beta-catenin by the destruction complex | R-HSA-195253 | 6.775152e-01 | 0.169 | 0 | 0 |
| Cyclin E associated events during G1/S transition | R-HSA-69202 | 6.775152e-01 | 0.169 | 0 | 0 |
| Constitutive Signaling by Aberrant PI3K in Cancer | R-HSA-2219530 | 6.832431e-01 | 0.165 | 0 | 0 |
| Role of phospholipids in phagocytosis | R-HSA-2029485 | 6.836972e-01 | 0.165 | 0 | 0 |
| ADORA2B mediated anti-inflammatory cytokines production | R-HSA-9660821 | 6.854136e-01 | 0.164 | 0 | 0 |
| Vasopressin regulates renal water homeostasis via Aquaporins | R-HSA-432040 | 6.854136e-01 | 0.164 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in pigmentation | R-HSA-9824585 | 6.854136e-01 | 0.164 | 0 | 0 |
| G-protein activation | R-HSA-202040 | 6.875953e-01 | 0.163 | 0 | 0 |
| APC-Cdc20 mediated degradation of Nek2A | R-HSA-179409 | 6.875953e-01 | 0.163 | 0 | 0 |
| MyD88 deficiency (TLR2/4) | R-HSA-5602498 | 6.875953e-01 | 0.163 | 0 | 0 |
| Signalling to RAS | R-HSA-167044 | 6.875953e-01 | 0.163 | 0 | 0 |
| JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 | R-HSA-450321 | 6.875953e-01 | 0.163 | 0 | 0 |
| TNFR1-induced proapoptotic signaling | R-HSA-5357786 | 6.875953e-01 | 0.163 | 0 | 0 |
| ERK/MAPK targets | R-HSA-198753 | 6.875953e-01 | 0.163 | 0 | 0 |
| PD-L1(CD274) glycosylation and translocation to plasma membrane | R-HSA-9931295 | 6.875953e-01 | 0.163 | 0 | 0 |
| Basigin interactions | R-HSA-210991 | 6.875953e-01 | 0.163 | 0 | 0 |
| Acyl chain remodelling of PG | R-HSA-1482925 | 6.875953e-01 | 0.163 | 0 | 0 |
| Prevention of phagosomal-lysosomal fusion | R-HSA-9636383 | 6.875953e-01 | 0.163 | 0 | 0 |
| NOTCH2 Activation and Transmission of Signal to the Nucleus | R-HSA-2979096 | 6.875953e-01 | 0.163 | 0 | 0 |
| Regulation of T cell activation by CD28 family | R-HSA-388841 | 6.894325e-01 | 0.162 | 0 | 0 |
| Cyclin A:Cdk2-associated events at S phase entry | R-HSA-69656 | 6.938576e-01 | 0.159 | 0 | 0 |
| Purine catabolism | R-HSA-74259 | 6.938576e-01 | 0.159 | 0 | 0 |
| Mitochondrial biogenesis | R-HSA-1592230 | 6.964515e-01 | 0.157 | 0 | 0 |
| Rab regulation of trafficking | R-HSA-9007101 | 6.964515e-01 | 0.157 | 0 | 0 |
| Unfolded Protein Response (UPR) | R-HSA-381119 | 6.973369e-01 | 0.157 | 0 | 0 |
| Ribosome Quality Control (RQC) complex extracts and degrades nascent peptide | R-HSA-9954709 | 6.973781e-01 | 0.157 | 0 | 0 |
| Chromatin modifying enzymes | R-HSA-3247509 | 6.988323e-01 | 0.156 | 0 | 0 |
| IRAK4 deficiency (TLR2/4) | R-HSA-5603041 | 7.012779e-01 | 0.154 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 2 Promoter | R-HSA-76066 | 7.012779e-01 | 0.154 | 0 | 0 |
| Eicosanoids | R-HSA-211979 | 7.012779e-01 | 0.154 | 0 | 0 |
| activated TAK1 mediates p38 MAPK activation | R-HSA-450302 | 7.012779e-01 | 0.154 | 0 | 0 |
| Miscellaneous substrates | R-HSA-211958 | 7.012779e-01 | 0.154 | 0 | 0 |
| Glutathione synthesis and recycling | R-HSA-174403 | 7.012779e-01 | 0.154 | 0 | 0 |
| Attachment and Entry | R-HSA-9694614 | 7.012779e-01 | 0.154 | 0 | 0 |
| Ribavirin ADME | R-HSA-9755088 | 7.012779e-01 | 0.154 | 0 | 0 |
| Extracellular matrix organization | R-HSA-1474244 | 7.024303e-01 | 0.153 | 0 | 0 |
| Homology Directed Repair | R-HSA-5693538 | 7.026946e-01 | 0.153 | 0 | 0 |
| EPH-ephrin mediated repulsion of cells | R-HSA-3928665 | 7.047452e-01 | 0.152 | 0 | 0 |
| Signaling by ERBB4 | R-HSA-1236394 | 7.095672e-01 | 0.149 | 0 | 0 |
| Metal ion SLC transporters | R-HSA-425410 | 7.140342e-01 | 0.146 | 0 | 0 |
| FGFR2 alternative splicing | R-HSA-6803529 | 7.143621e-01 | 0.146 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 3 Promoter | R-HSA-76071 | 7.143621e-01 | 0.146 | 0 | 0 |
| Dopamine Neurotransmitter Release Cycle | R-HSA-212676 | 7.143621e-01 | 0.146 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 1 Promoter | R-HSA-76061 | 7.143621e-01 | 0.146 | 0 | 0 |
| RAF-independent MAPK1/3 activation | R-HSA-112409 | 7.143621e-01 | 0.146 | 0 | 0 |
| Mitotic Prophase | R-HSA-68875 | 7.149117e-01 | 0.146 | 0 | 0 |
| Protein ubiquitination | R-HSA-8852135 | 7.171865e-01 | 0.144 | 0 | 0 |
| Post-translational protein phosphorylation | R-HSA-8957275 | 7.177229e-01 | 0.144 | 0 | 0 |
| Regulation of insulin secretion | R-HSA-422356 | 7.177229e-01 | 0.144 | 0 | 0 |
| G alpha (i) signalling events | R-HSA-418594 | 7.216160e-01 | 0.142 | 0 | 0 |
| p53-Dependent G1 DNA Damage Response | R-HSA-69563 | 7.230769e-01 | 0.141 | 0 | 0 |
| p53-Dependent G1/S DNA damage checkpoint | R-HSA-69580 | 7.230769e-01 | 0.141 | 0 | 0 |
| Interleukin-20 family signaling | R-HSA-8854691 | 7.268739e-01 | 0.139 | 0 | 0 |
| Free fatty acids regulate insulin secretion | R-HSA-400451 | 7.268739e-01 | 0.139 | 0 | 0 |
| Fatty acids | R-HSA-211935 | 7.268739e-01 | 0.139 | 0 | 0 |
| Formation of the ureteric bud | R-HSA-9830674 | 7.268739e-01 | 0.139 | 0 | 0 |
| Estrogen-dependent nuclear events downstream of ESR-membrane signaling | R-HSA-9634638 | 7.268739e-01 | 0.139 | 0 | 0 |
| PI3K Cascade | R-HSA-109704 | 7.318769e-01 | 0.136 | 0 | 0 |
| NR1H2 and NR1H3-mediated signaling | R-HSA-9024446 | 7.319587e-01 | 0.136 | 0 | 0 |
| Formation of the cornified envelope | R-HSA-6809371 | 7.382685e-01 | 0.132 | 0 | 0 |
| Host Interactions of HIV factors | R-HSA-162909 | 7.382685e-01 | 0.132 | 0 | 0 |
| Interleukin-6 family signaling | R-HSA-6783589 | 7.388384e-01 | 0.131 | 0 | 0 |
| Thromboxane signalling through TP receptor | R-HSA-428930 | 7.388384e-01 | 0.131 | 0 | 0 |
| Deadenylation of mRNA | R-HSA-429947 | 7.388384e-01 | 0.131 | 0 | 0 |
| Plasma lipoprotein assembly | R-HSA-8963898 | 7.388384e-01 | 0.131 | 0 | 0 |
| Complex III assembly | R-HSA-9865881 | 7.388384e-01 | 0.131 | 0 | 0 |
| Meiotic recombination | R-HSA-912446 | 7.404382e-01 | 0.131 | 0 | 0 |
| Hedgehog ligand biogenesis | R-HSA-5358346 | 7.404382e-01 | 0.131 | 0 | 0 |
| SARS-CoV-1 activates/modulates innate immune responses | R-HSA-9692916 | 7.487647e-01 | 0.126 | 0 | 0 |
| MLL4 and MLL3 complexes regulate expression of PPARG target genes in adipogenesis and hepatic steatosis | R-HSA-9841922 | 7.494098e-01 | 0.125 | 0 | 0 |
| Epigenetic regulation of adipogenesis genes by MLL3 and MLL4 complexes | R-HSA-9851695 | 7.494098e-01 | 0.125 | 0 | 0 |
| Epigenetic regulation of gene expression by MLL3 and MLL4 complexes | R-HSA-9818564 | 7.494098e-01 | 0.125 | 0 | 0 |
| G1/S Transition | R-HSA-69206 | 7.494098e-01 | 0.125 | 0 | 0 |
| Regulation of PD-L1(CD274) expression | R-HSA-9909648 | 7.496587e-01 | 0.125 | 0 | 0 |
| Polymerase switching on the C-strand of the telomere | R-HSA-174411 | 7.502795e-01 | 0.125 | 0 | 0 |
| Tight junction interactions | R-HSA-420029 | 7.502795e-01 | 0.125 | 0 | 0 |
| HDMs demethylate histones | R-HSA-3214842 | 7.502795e-01 | 0.125 | 0 | 0 |
| Laminin interactions | R-HSA-3000157 | 7.502795e-01 | 0.125 | 0 | 0 |
| FCGR3A-mediated IL10 synthesis | R-HSA-9664323 | 7.548470e-01 | 0.122 | 0 | 0 |
| Response of EIF2AK4 (GCN2) to amino acid deficiency | R-HSA-9633012 | 7.553471e-01 | 0.122 | 0 | 0 |
| Regulation of PTEN stability and activity | R-HSA-8948751 | 7.568606e-01 | 0.121 | 0 | 0 |
| Transcriptional activation of mitochondrial biogenesis | R-HSA-2151201 | 7.596718e-01 | 0.119 | 0 | 0 |
| Phosphorylated BMAL1:CLOCK (ARNTL:CLOCK) activates expression of core clock genes | R-HSA-9931510 | 7.612200e-01 | 0.118 | 0 | 0 |
| Signaling by FLT3 fusion proteins | R-HSA-9703465 | 7.612200e-01 | 0.118 | 0 | 0 |
| Resolution of AP sites via the multiple-nucleotide patch replacement pathway | R-HSA-110373 | 7.612200e-01 | 0.118 | 0 | 0 |
| Metalloprotease DUBs | R-HSA-5689901 | 7.612200e-01 | 0.118 | 0 | 0 |
| Adrenaline,noradrenaline inhibits insulin secretion | R-HSA-400042 | 7.612200e-01 | 0.118 | 0 | 0 |
| Urea cycle | R-HSA-70635 | 7.612200e-01 | 0.118 | 0 | 0 |
| Glutamate Neurotransmitter Release Cycle | R-HSA-210500 | 7.612200e-01 | 0.118 | 0 | 0 |
| Suppression of phagosomal maturation | R-HSA-9637687 | 7.612200e-01 | 0.118 | 0 | 0 |
| Chromatin organization | R-HSA-4839726 | 7.622208e-01 | 0.118 | 0 | 0 |
| Co-inhibition by PD-1 | R-HSA-389948 | 7.622821e-01 | 0.118 | 0 | 0 |
| Developmental Cell Lineages of the Exocrine Pancreas | R-HSA-9820448 | 7.708904e-01 | 0.113 | 0 | 0 |
| Packaging Of Telomere Ends | R-HSA-171306 | 7.716819e-01 | 0.113 | 0 | 0 |
| Triglyceride biosynthesis | R-HSA-75109 | 7.716819e-01 | 0.113 | 0 | 0 |
| Insulin processing | R-HSA-264876 | 7.716819e-01 | 0.113 | 0 | 0 |
| CD28 dependent PI3K/Akt signaling | R-HSA-389357 | 7.716819e-01 | 0.113 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in Cytochrome C Release | R-HSA-6803204 | 7.716819e-01 | 0.113 | 0 | 0 |
| Maturation of hRSV A proteins | R-HSA-9828806 | 7.716819e-01 | 0.113 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176409 | 7.723775e-01 | 0.112 | 0 | 0 |
| G alpha (z) signalling events | R-HSA-418597 | 7.723775e-01 | 0.112 | 0 | 0 |
| Fc epsilon receptor (FCERI) signaling | R-HSA-2454202 | 7.749180e-01 | 0.111 | 0 | 0 |
| Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176814 | 7.798072e-01 | 0.108 | 0 | 0 |
| Epigenetic regulation by WDR5-containing histone modifying complexes | R-HSA-9917777 | 7.802199e-01 | 0.108 | 0 | 0 |
| Telomere Extension By Telomerase | R-HSA-171319 | 7.816860e-01 | 0.107 | 0 | 0 |
| Insulin receptor recycling | R-HSA-77387 | 7.816860e-01 | 0.107 | 0 | 0 |
| Negative regulation of FGFR3 signaling | R-HSA-5654732 | 7.816860e-01 | 0.107 | 0 | 0 |
| PPARA activates gene expression | R-HSA-1989781 | 7.847761e-01 | 0.105 | 0 | 0 |
| MAPK6/MAPK4 signaling | R-HSA-5687128 | 7.850213e-01 | 0.105 | 0 | 0 |
| IRS-mediated signalling | R-HSA-112399 | 7.870234e-01 | 0.104 | 0 | 0 |
| Circadian clock | R-HSA-9909396 | 7.904512e-01 | 0.102 | 0 | 0 |
| Degradation of the extracellular matrix | R-HSA-1474228 | 7.904512e-01 | 0.102 | 0 | 0 |
| Regulation of PD-L1(CD274) Post-translational modification | R-HSA-9909615 | 7.910020e-01 | 0.102 | 0 | 0 |
| Nitric oxide stimulates guanylate cyclase | R-HSA-392154 | 7.912523e-01 | 0.102 | 0 | 0 |
| Regulation of pyruvate dehydrogenase (PDH) complex | R-HSA-204174 | 7.912523e-01 | 0.102 | 0 | 0 |
| Negative regulation of FGFR4 signaling | R-HSA-5654733 | 7.912523e-01 | 0.102 | 0 | 0 |
| Platelet calcium homeostasis | R-HSA-418360 | 7.912523e-01 | 0.102 | 0 | 0 |
| DARPP-32 events | R-HSA-180024 | 7.912523e-01 | 0.102 | 0 | 0 |
| Regulation of lipid metabolism by PPARalpha | R-HSA-400206 | 7.936728e-01 | 0.100 | 0 | 0 |
| Gene expression (Transcription) | R-HSA-74160 | 8.003295e-01 | 0.097 | 0 | 0 |
| RNA Polymerase III Transcription Initiation | R-HSA-76046 | 8.004000e-01 | 0.097 | 0 | 0 |
| Energy dependent regulation of mTOR by LKB1-AMPK | R-HSA-380972 | 8.004000e-01 | 0.097 | 0 | 0 |
| Thrombin signalling through proteinase activated receptors (PARs) | R-HSA-456926 | 8.004000e-01 | 0.097 | 0 | 0 |
| Neurotransmitter clearance | R-HSA-112311 | 8.004000e-01 | 0.097 | 0 | 0 |
| Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation | R-HSA-1474151 | 8.004000e-01 | 0.097 | 0 | 0 |
| Extension of Telomeres | R-HSA-180786 | 8.008336e-01 | 0.096 | 0 | 0 |
| Peroxisomal protein import | R-HSA-9033241 | 8.008336e-01 | 0.096 | 0 | 0 |
| Deadenylation-dependent mRNA decay | R-HSA-429914 | 8.008336e-01 | 0.096 | 0 | 0 |
| Assembly of collagen fibrils and other multimeric structures | R-HSA-2022090 | 8.008336e-01 | 0.096 | 0 | 0 |
| Signaling by TGFB family members | R-HSA-9006936 | 8.064856e-01 | 0.093 | 0 | 0 |
| EGFR downregulation | R-HSA-182971 | 8.091474e-01 | 0.092 | 0 | 0 |
| Respiratory syncytial virus (RSV) attachment and entry | R-HSA-9820960 | 8.091474e-01 | 0.092 | 0 | 0 |
| Molecules associated with elastic fibres | R-HSA-2129379 | 8.091474e-01 | 0.092 | 0 | 0 |
| Downstream signal transduction | R-HSA-186763 | 8.091474e-01 | 0.092 | 0 | 0 |
| Peptide ligand-binding receptors | R-HSA-375276 | 8.096683e-01 | 0.092 | 0 | 0 |
| ER-Phagosome pathway | R-HSA-1236974 | 8.135548e-01 | 0.090 | 0 | 0 |
| Regulation of RUNX2 expression and activity | R-HSA-8939902 | 8.138435e-01 | 0.089 | 0 | 0 |
| Nucleotide salvage | R-HSA-8956321 | 8.138435e-01 | 0.089 | 0 | 0 |
| Aquaporin-mediated transport | R-HSA-445717 | 8.138435e-01 | 0.089 | 0 | 0 |
| Collagen degradation | R-HSA-1442490 | 8.138435e-01 | 0.089 | 0 | 0 |
| MITF-M-regulated melanocyte development | R-HSA-9730414 | 8.170587e-01 | 0.088 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected purine | R-HSA-110330 | 8.175119e-01 | 0.088 | 0 | 0 |
| Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs) | R-HSA-381426 | 8.188196e-01 | 0.087 | 0 | 0 |
| Downstream TCR signaling | R-HSA-202424 | 8.188605e-01 | 0.087 | 0 | 0 |
| DNA Damage/Telomere Stress Induced Senescence | R-HSA-2559586 | 8.200595e-01 | 0.086 | 0 | 0 |
| PELO:HBS1L and ABCE1 dissociate a ribosome on a non-stop mRNA | R-HSA-9954714 | 8.240372e-01 | 0.084 | 0 | 0 |
| Transport of the SLBP independent Mature mRNA | R-HSA-159227 | 8.255103e-01 | 0.083 | 0 | 0 |
| Negative regulation of FGFR1 signaling | R-HSA-5654726 | 8.255103e-01 | 0.083 | 0 | 0 |
| Cardiogenesis | R-HSA-9733709 | 8.255103e-01 | 0.083 | 0 | 0 |
| Diseases associated with glycosylation precursor biosynthesis | R-HSA-5609975 | 8.255103e-01 | 0.083 | 0 | 0 |
| PTEN Regulation | R-HSA-6807070 | 8.260579e-01 | 0.083 | 0 | 0 |
| G1/S DNA Damage Checkpoints | R-HSA-69615 | 8.260889e-01 | 0.083 | 0 | 0 |
| Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC) | R-HSA-975956 | 8.290871e-01 | 0.081 | 0 | 0 |
| Ion transport by P-type ATPases | R-HSA-936837 | 8.319359e-01 | 0.080 | 0 | 0 |
| Transport of the SLBP Dependant Mature mRNA | R-HSA-159230 | 8.331586e-01 | 0.079 | 0 | 0 |
| Heme degradation | R-HSA-189483 | 8.331586e-01 | 0.079 | 0 | 0 |
| Late SARS-CoV-2 Infection Events | R-HSA-9772573 | 8.340123e-01 | 0.079 | 0 | 0 |
| Nuclear import of Rev protein | R-HSA-180746 | 8.404721e-01 | 0.075 | 0 | 0 |
| Regulation of endogenous retroelements by the Human Silencing Hub (HUSH) complex | R-HSA-9843970 | 8.404721e-01 | 0.075 | 0 | 0 |
| Antigen Presentation: Folding, assembly and peptide loading of class I MHC | R-HSA-983170 | 8.404721e-01 | 0.075 | 0 | 0 |
| Negative regulation of FGFR2 signaling | R-HSA-5654727 | 8.404721e-01 | 0.075 | 0 | 0 |
| Calnexin/calreticulin cycle | R-HSA-901042 | 8.404721e-01 | 0.075 | 0 | 0 |
| Regulation of TLR by endogenous ligand | R-HSA-5686938 | 8.404721e-01 | 0.075 | 0 | 0 |
| Phosphate bond hydrolysis by NUDT proteins | R-HSA-2393930 | 8.404721e-01 | 0.075 | 0 | 0 |
| BMAL1:CLOCK,NPAS2 activates circadian expression | R-HSA-1368108 | 8.404721e-01 | 0.075 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected pyrimidine | R-HSA-110328 | 8.404721e-01 | 0.075 | 0 | 0 |
| tRNA modification in the nucleus and cytosol | R-HSA-6782315 | 8.431007e-01 | 0.074 | 0 | 0 |
| Collagen formation | R-HSA-1474290 | 8.434971e-01 | 0.074 | 0 | 0 |
| Formation of WDR5-containing histone-modifying complexes | R-HSA-9772755 | 8.474655e-01 | 0.072 | 0 | 0 |
| ZNF598 and the Ribosome-associated Quality Trigger (RQT) complex dissociate a ribosome stalled on a no-go mRNA | R-HSA-9954716 | 8.480611e-01 | 0.072 | 0 | 0 |
| SLC-mediated transport of amino acids | R-HSA-9958863 | 8.484270e-01 | 0.071 | 0 | 0 |
| Eukaryotic Translation Termination | R-HSA-72764 | 8.525089e-01 | 0.069 | 0 | 0 |
| Formation of a pool of free 40S subunits | R-HSA-72689 | 8.525089e-01 | 0.069 | 0 | 0 |
| Chromosome Maintenance | R-HSA-73886 | 8.531103e-01 | 0.069 | 0 | 0 |
| Collagen biosynthesis and modifying enzymes | R-HSA-1650814 | 8.535884e-01 | 0.069 | 0 | 0 |
| PRC2 methylates histones and DNA | R-HSA-212300 | 8.541526e-01 | 0.068 | 0 | 0 |
| AUF1 (hnRNP D0) binds and destabilizes mRNA | R-HSA-450408 | 8.541526e-01 | 0.068 | 0 | 0 |
| FLT3 signaling in disease | R-HSA-9682385 | 8.541526e-01 | 0.068 | 0 | 0 |
| Glycosphingolipid transport | R-HSA-9845576 | 8.541526e-01 | 0.068 | 0 | 0 |
| RUNX2 regulates bone development | R-HSA-8941326 | 8.541526e-01 | 0.068 | 0 | 0 |
| Role of LAT2/NTAL/LAB on calcium mobilization | R-HSA-2730905 | 8.568428e-01 | 0.067 | 0 | 0 |
| Leishmania parasite growth and survival | R-HSA-9664433 | 8.582253e-01 | 0.066 | 0 | 0 |
| Anti-inflammatory response favouring Leishmania parasite infection | R-HSA-9662851 | 8.582253e-01 | 0.066 | 0 | 0 |
| Ubiquinol biosynthesis | R-HSA-2142789 | 8.605470e-01 | 0.065 | 0 | 0 |
| Degradation of DVL | R-HSA-4641258 | 8.605470e-01 | 0.065 | 0 | 0 |
| Cleavage of the damaged purine | R-HSA-110331 | 8.605470e-01 | 0.065 | 0 | 0 |
| Beta-oxidation of very long chain fatty acids | R-HSA-390247 | 8.605470e-01 | 0.065 | 0 | 0 |
| Collagen chain trimerization | R-HSA-8948216 | 8.605470e-01 | 0.065 | 0 | 0 |
| Maternal to zygotic transition (MZT) | R-HSA-9816359 | 8.607705e-01 | 0.065 | 0 | 0 |
| Telomere Maintenance | R-HSA-157579 | 8.610649e-01 | 0.065 | 0 | 0 |
| Signaling by TGF-beta Receptor Complex | R-HSA-170834 | 8.610649e-01 | 0.065 | 0 | 0 |
| Regulation of endogenous retroelements by KRAB-ZFP proteins | R-HSA-9843940 | 8.634331e-01 | 0.064 | 0 | 0 |
| S Phase | R-HSA-69242 | 8.635003e-01 | 0.064 | 0 | 0 |
| Depurination | R-HSA-73927 | 8.666615e-01 | 0.062 | 0 | 0 |
| alpha-linolenic acid (ALA) metabolism | R-HSA-2046106 | 8.666615e-01 | 0.062 | 0 | 0 |
| Elastic fibre formation | R-HSA-1566948 | 8.666615e-01 | 0.062 | 0 | 0 |
| Gastrulation | R-HSA-9758941 | 8.668433e-01 | 0.062 | 0 | 0 |
| Signaling by ROBO receptors | R-HSA-376176 | 8.668943e-01 | 0.062 | 0 | 0 |
| Metabolism of cofactors | R-HSA-8978934 | 8.681246e-01 | 0.061 | 0 | 0 |
| Transport of Mature mRNA Derived from an Intronless Transcript | R-HSA-159231 | 8.725082e-01 | 0.059 | 0 | 0 |
| NS1 Mediated Effects on Host Pathways | R-HSA-168276 | 8.725082e-01 | 0.059 | 0 | 0 |
| Synthesis, secretion, and inactivation of Glucagon-like Peptide-1 (GLP-1) | R-HSA-381771 | 8.725082e-01 | 0.059 | 0 | 0 |
| RAS processing | R-HSA-9648002 | 8.725082e-01 | 0.059 | 0 | 0 |
| Respiratory syncytial virus (RSV) genome replication, transcription and translation | R-HSA-9820965 | 8.725082e-01 | 0.059 | 0 | 0 |
| Regulation of mRNA stability by proteins that bind AU-rich elements | R-HSA-450531 | 8.726678e-01 | 0.059 | 0 | 0 |
| Interconversion of nucleotide di- and triphosphates | R-HSA-499943 | 8.726678e-01 | 0.059 | 0 | 0 |
| Selenocysteine synthesis | R-HSA-2408557 | 8.768785e-01 | 0.057 | 0 | 0 |
| Switching of origins to a post-replicative state | R-HSA-69052 | 8.770665e-01 | 0.057 | 0 | 0 |
| Transport of Mature mRNAs Derived from Intronless Transcripts | R-HSA-159234 | 8.780988e-01 | 0.056 | 0 | 0 |
| Interactions of Rev with host cellular proteins | R-HSA-177243 | 8.780988e-01 | 0.056 | 0 | 0 |
| Maturation of TCA enzymes and regulation of TCA cycle | R-HSA-9854311 | 8.780988e-01 | 0.056 | 0 | 0 |
| Platelet degranulation | R-HSA-114608 | 8.784415e-01 | 0.056 | 0 | 0 |
| Protein localization | R-HSA-9609507 | 8.795331e-01 | 0.056 | 0 | 0 |
| Post-translational protein modification | R-HSA-597592 | 8.808483e-01 | 0.055 | 0 | 0 |
| Signaling by FGFR in disease | R-HSA-1226099 | 8.813247e-01 | 0.055 | 0 | 0 |
| ROS and RNS production in phagocytes | R-HSA-1222556 | 8.813247e-01 | 0.055 | 0 | 0 |
| Disease | R-HSA-1643685 | 8.822421e-01 | 0.054 | 0 | 0 |
| M-decay: degradation of maternal mRNAs by maternally stored factors | R-HSA-9820841 | 8.834446e-01 | 0.054 | 0 | 0 |
| NIK-->noncanonical NF-kB signaling | R-HSA-5676590 | 8.834446e-01 | 0.054 | 0 | 0 |
| Hh mutants are degraded by ERAD | R-HSA-5362768 | 8.834446e-01 | 0.054 | 0 | 0 |
| Resolution of Abasic Sites (AP sites) | R-HSA-73933 | 8.834446e-01 | 0.054 | 0 | 0 |
| Maturation of spike protein | R-HSA-9694548 | 8.834446e-01 | 0.054 | 0 | 0 |
| SPOP-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929491 | 8.834446e-01 | 0.054 | 0 | 0 |
| Purine ribonucleoside monophosphate biosynthesis | R-HSA-73817 | 8.834446e-01 | 0.054 | 0 | 0 |
| Translesion synthesis by Y family DNA polymerases bypasses lesions on DNA template | R-HSA-110313 | 8.834446e-01 | 0.054 | 0 | 0 |
| Viral mRNA Translation | R-HSA-192823 | 8.841704e-01 | 0.053 | 0 | 0 |
| ISG15 antiviral mechanism | R-HSA-1169408 | 8.854462e-01 | 0.053 | 0 | 0 |
| Cargo recognition for clathrin-mediated endocytosis | R-HSA-8856825 | 8.876701e-01 | 0.052 | 0 | 0 |
| ESR-mediated signaling | R-HSA-8939211 | 8.877156e-01 | 0.052 | 0 | 0 |
| SLC-mediated transport of neurotransmitters | R-HSA-442660 | 8.885564e-01 | 0.051 | 0 | 0 |
| Translation of Structural Proteins | R-HSA-9694635 | 8.932943e-01 | 0.049 | 0 | 0 |
| Cytosolic tRNA aminoacylation | R-HSA-379716 | 8.934442e-01 | 0.049 | 0 | 0 |
| MTOR signalling | R-HSA-165159 | 8.934442e-01 | 0.049 | 0 | 0 |
| Incretin synthesis, secretion, and inactivation | R-HSA-400508 | 8.934442e-01 | 0.049 | 0 | 0 |
| Cleavage of the damaged pyrimidine | R-HSA-110329 | 8.934442e-01 | 0.049 | 0 | 0 |
| Depyrimidination | R-HSA-73928 | 8.934442e-01 | 0.049 | 0 | 0 |
| Hh mutants abrogate ligand secretion | R-HSA-5387390 | 8.981179e-01 | 0.047 | 0 | 0 |
| SARS-CoV Infections | R-HSA-9679506 | 8.991923e-01 | 0.046 | 0 | 0 |
| Response to elevated platelet cytosolic Ca2+ | R-HSA-76005 | 8.998989e-01 | 0.046 | 0 | 0 |
| Developmental Lineage of Pancreatic Acinar Cells | R-HSA-9925561 | 9.006403e-01 | 0.045 | 0 | 0 |
| SRP-dependent cotranslational protein targeting to membrane | R-HSA-1799339 | 9.007414e-01 | 0.045 | 0 | 0 |
| Viral Infection Pathways | R-HSA-9824446 | 9.021538e-01 | 0.045 | 0 | 0 |
| SCF(Skp2)-mediated degradation of p27/p21 | R-HSA-187577 | 9.025869e-01 | 0.045 | 0 | 0 |
| Synthesis of Leukotrienes (LT) and Eoxins (EX) | R-HSA-2142691 | 9.025869e-01 | 0.045 | 0 | 0 |
| Amine ligand-binding receptors | R-HSA-375280 | 9.025869e-01 | 0.045 | 0 | 0 |
| GTP hydrolysis and joining of the 60S ribosomal subunit | R-HSA-72706 | 9.037876e-01 | 0.044 | 0 | 0 |
| L13a-mediated translational silencing of Ceruloplasmin expression | R-HSA-156827 | 9.037876e-01 | 0.044 | 0 | 0 |
| Nucleosome assembly | R-HSA-774815 | 9.068601e-01 | 0.042 | 0 | 0 |
| Deposition of new CENPA-containing nucleosomes at the centromere | R-HSA-606279 | 9.068601e-01 | 0.042 | 0 | 0 |
| Fanconi Anemia Pathway | R-HSA-6783310 | 9.068601e-01 | 0.042 | 0 | 0 |
| Dectin-1 mediated noncanonical NF-kB signaling | R-HSA-5607761 | 9.068601e-01 | 0.042 | 0 | 0 |
| Defective CFTR causes cystic fibrosis | R-HSA-5678895 | 9.068601e-01 | 0.042 | 0 | 0 |
| p53-Independent G1/S DNA Damage Checkpoint | R-HSA-69613 | 9.068601e-01 | 0.042 | 0 | 0 |
| Ubiquitin-Mediated Degradation of Phosphorylated Cdc25A | R-HSA-69601 | 9.068601e-01 | 0.042 | 0 | 0 |
| Degradation of cysteine and homocysteine | R-HSA-1614558 | 9.068601e-01 | 0.042 | 0 | 0 |
| TCR signaling | R-HSA-202403 | 9.096278e-01 | 0.041 | 0 | 0 |
| Beta-catenin independent WNT signaling | R-HSA-3858494 | 9.106003e-01 | 0.041 | 0 | 0 |
| mRNA Splicing - Minor Pathway | R-HSA-72165 | 9.109462e-01 | 0.041 | 0 | 0 |
| Neddylation | R-HSA-8951664 | 9.133111e-01 | 0.039 | 0 | 0 |
| Cytoprotection by HMOX1 | R-HSA-9707564 | 9.139382e-01 | 0.039 | 0 | 0 |
| mRNA Splicing - Major Pathway | R-HSA-72163 | 9.140394e-01 | 0.039 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Securin | R-HSA-174154 | 9.148532e-01 | 0.039 | 0 | 0 |
| Retrograde transport at the Trans-Golgi-Network | R-HSA-6811440 | 9.148532e-01 | 0.039 | 0 | 0 |
| Synthesis of PC | R-HSA-1483191 | 9.148532e-01 | 0.039 | 0 | 0 |
| alpha-linolenic (omega3) and linoleic (omega6) acid metabolism | R-HSA-2046104 | 9.148532e-01 | 0.039 | 0 | 0 |
| Nonsense-Mediated Decay (NMD) | R-HSA-927802 | 9.151448e-01 | 0.039 | 0 | 0 |
| Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC) | R-HSA-975957 | 9.151448e-01 | 0.039 | 0 | 0 |
| Ribosome-associated quality control | R-HSA-9948299 | 9.155599e-01 | 0.038 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of HSCs | R-HSA-8939236 | 9.169918e-01 | 0.038 | 0 | 0 |
| Global Genome Nucleotide Excision Repair (GG-NER) | R-HSA-5696399 | 9.169918e-01 | 0.038 | 0 | 0 |
| Plasma lipoprotein remodeling | R-HSA-8963899 | 9.185890e-01 | 0.037 | 0 | 0 |
| DNA Damage Bypass | R-HSA-73893 | 9.221612e-01 | 0.035 | 0 | 0 |
| HIV Infection | R-HSA-162906 | 9.247330e-01 | 0.034 | 0 | 0 |
| SARS-CoV-2-host interactions | R-HSA-9705683 | 9.265037e-01 | 0.033 | 0 | 0 |
| FCERI mediated Ca+2 mobilization | R-HSA-2871809 | 9.276209e-01 | 0.033 | 0 | 0 |
| Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha | R-HSA-1234176 | 9.288427e-01 | 0.032 | 0 | 0 |
| Eukaryotic Translation Initiation | R-HSA-72613 | 9.299048e-01 | 0.032 | 0 | 0 |
| Cap-dependent Translation Initiation | R-HSA-72737 | 9.299048e-01 | 0.032 | 0 | 0 |
| Class C/3 (Metabotropic glutamate/pheromone receptors) | R-HSA-420499 | 9.307896e-01 | 0.031 | 0 | 0 |
| FCERI mediated NF-kB activation | R-HSA-2871837 | 9.310390e-01 | 0.031 | 0 | 0 |
| Glycerophospholipid biosynthesis | R-HSA-1483206 | 9.314003e-01 | 0.031 | 0 | 0 |
| Cdc20:Phospho-APC/C mediated degradation of Cyclin A | R-HSA-174184 | 9.319655e-01 | 0.031 | 0 | 0 |
| mRNA 3'-end processing | R-HSA-72187 | 9.319655e-01 | 0.031 | 0 | 0 |
| AMPK-induced ERAD and lysosome mediated degradation of PD-L1(CD274) | R-HSA-9931269 | 9.319655e-01 | 0.031 | 0 | 0 |
| Orc1 removal from chromatin | R-HSA-68949 | 9.319655e-01 | 0.031 | 0 | 0 |
| mRNA Splicing | R-HSA-72172 | 9.348098e-01 | 0.029 | 0 | 0 |
| APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint | R-HSA-179419 | 9.349514e-01 | 0.029 | 0 | 0 |
| B-WICH complex positively regulates rRNA expression | R-HSA-5250924 | 9.349514e-01 | 0.029 | 0 | 0 |
| Nucleotide biosynthesis | R-HSA-8956320 | 9.349514e-01 | 0.029 | 0 | 0 |
| Base Excision Repair | R-HSA-73884 | 9.356771e-01 | 0.029 | 0 | 0 |
| Neurotransmitter release cycle | R-HSA-112310 | 9.356771e-01 | 0.029 | 0 | 0 |
| Transcriptional regulation by RUNX2 | R-HSA-8878166 | 9.363648e-01 | 0.029 | 0 | 0 |
| Base-Excision Repair, AP Site Formation | R-HSA-73929 | 9.378065e-01 | 0.028 | 0 | 0 |
| Metabolism of nucleotides | R-HSA-15869 | 9.394070e-01 | 0.027 | 0 | 0 |
| SARS-CoV-2 Infection | R-HSA-9694516 | 9.401907e-01 | 0.027 | 0 | 0 |
| Potential therapeutics for SARS | R-HSA-9679191 | 9.422147e-01 | 0.026 | 0 | 0 |
| MITF-M-dependent gene expression | R-HSA-9856651 | 9.422147e-01 | 0.026 | 0 | 0 |
| FCGR activation | R-HSA-2029481 | 9.444875e-01 | 0.025 | 0 | 0 |
| Dectin-2 family | R-HSA-5621480 | 9.456425e-01 | 0.024 | 0 | 0 |
| Mitochondrial protein degradation | R-HSA-9837999 | 9.465037e-01 | 0.024 | 0 | 0 |
| NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux | R-HSA-9029569 | 9.480289e-01 | 0.023 | 0 | 0 |
| Early SARS-CoV-2 Infection Events | R-HSA-9772572 | 9.480289e-01 | 0.023 | 0 | 0 |
| Class I MHC mediated antigen processing & presentation | R-HSA-983169 | 9.487756e-01 | 0.023 | 0 | 0 |
| Triglyceride metabolism | R-HSA-8979227 | 9.503106e-01 | 0.022 | 0 | 0 |
| Amino acid transport across the plasma membrane | R-HSA-352230 | 9.503106e-01 | 0.022 | 0 | 0 |
| RAB geranylgeranylation | R-HSA-8873719 | 9.524924e-01 | 0.021 | 0 | 0 |
| tRNA Aminoacylation | R-HSA-379724 | 9.524924e-01 | 0.021 | 0 | 0 |
| Glutathione conjugation | R-HSA-156590 | 9.524924e-01 | 0.021 | 0 | 0 |
| Signaling by Retinoic Acid | R-HSA-5362517 | 9.524924e-01 | 0.021 | 0 | 0 |
| Cellular response to starvation | R-HSA-9711097 | 9.545488e-01 | 0.020 | 0 | 0 |
| RNA Polymerase II Transcription Termination | R-HSA-73856 | 9.545784e-01 | 0.020 | 0 | 0 |
| Signaling by Nuclear Receptors | R-HSA-9006931 | 9.555212e-01 | 0.020 | 0 | 0 |
| Nucleotide catabolism | R-HSA-8956319 | 9.556275e-01 | 0.020 | 0 | 0 |
| Interferon gamma signaling | R-HSA-877300 | 9.559074e-01 | 0.020 | 0 | 0 |
| Regulation of APC/C activators between G1/S and early anaphase | R-HSA-176408 | 9.565730e-01 | 0.019 | 0 | 0 |
| tRNA processing in the nucleus | R-HSA-6784531 | 9.565730e-01 | 0.019 | 0 | 0 |
| Signaling by PDGF | R-HSA-186797 | 9.565730e-01 | 0.019 | 0 | 0 |
| Complex I biogenesis | R-HSA-6799198 | 9.584801e-01 | 0.018 | 0 | 0 |
| Glycolysis | R-HSA-70171 | 9.587825e-01 | 0.018 | 0 | 0 |
| Class A/1 (Rhodopsin-like receptors) | R-HSA-373076 | 9.592544e-01 | 0.018 | 0 | 0 |
| CD22 mediated BCR regulation | R-HSA-5690714 | 9.603036e-01 | 0.018 | 0 | 0 |
| Regulation of endogenous retroelements | R-HSA-9842860 | 9.617624e-01 | 0.017 | 0 | 0 |
| Regulation of HSF1-mediated heat shock response | R-HSA-3371453 | 9.617624e-01 | 0.017 | 0 | 0 |
| Selenoamino acid metabolism | R-HSA-2408522 | 9.621552e-01 | 0.017 | 0 | 0 |
| Nicotinate metabolism | R-HSA-196807 | 9.653080e-01 | 0.015 | 0 | 0 |
| Activation of HOX genes during differentiation | R-HSA-5619507 | 9.658479e-01 | 0.015 | 0 | 0 |
| Activation of anterior HOX genes in hindbrain development during early embryogenesis | R-HSA-5617472 | 9.658479e-01 | 0.015 | 0 | 0 |
| Nucleotide Excision Repair | R-HSA-5696398 | 9.671139e-01 | 0.015 | 0 | 0 |
| Estrogen-dependent gene expression | R-HSA-9018519 | 9.671761e-01 | 0.014 | 0 | 0 |
| Synthesis of DNA | R-HSA-69239 | 9.695119e-01 | 0.013 | 0 | 0 |
| Fatty acyl-CoA biosynthesis | R-HSA-75105 | 9.696823e-01 | 0.013 | 0 | 0 |
| Epigenetic regulation of gene expression | R-HSA-212165 | 9.698920e-01 | 0.013 | 0 | 0 |
| Positive epigenetic regulation of rRNA expression | R-HSA-5250913 | 9.710143e-01 | 0.013 | 0 | 0 |
| ECM proteoglycans | R-HSA-3000178 | 9.710143e-01 | 0.013 | 0 | 0 |
| Diseases associated with O-glycosylation of proteins | R-HSA-3906995 | 9.710143e-01 | 0.013 | 0 | 0 |
| Metabolism of porphyrins | R-HSA-189445 | 9.710143e-01 | 0.013 | 0 | 0 |
| DNA Replication Pre-Initiation | R-HSA-69002 | 9.717411e-01 | 0.012 | 0 | 0 |
| Keratinization | R-HSA-6805567 | 9.734295e-01 | 0.012 | 0 | 0 |
| Transport of Mature mRNA derived from an Intron-Containing Transcript | R-HSA-159236 | 9.735057e-01 | 0.012 | 0 | 0 |
| Transport of vitamins, nucleosides, and related molecules | R-HSA-425397 | 9.746700e-01 | 0.011 | 0 | 0 |
| FCERI mediated MAPK activation | R-HSA-2871796 | 9.747926e-01 | 0.011 | 0 | 0 |
| Inositol phosphate metabolism | R-HSA-1483249 | 9.747926e-01 | 0.011 | 0 | 0 |
| Citric acid cycle (TCA cycle) | R-HSA-71403 | 9.757832e-01 | 0.011 | 0 | 0 |
| TP53 Regulates Transcription of Cell Death Genes | R-HSA-5633008 | 9.757832e-01 | 0.011 | 0 | 0 |
| Influenza Infection | R-HSA-168255 | 9.770510e-01 | 0.010 | 0 | 0 |
| Interleukin-10 signaling | R-HSA-6783783 | 9.788381e-01 | 0.009 | 0 | 0 |
| ABC transporter disorders | R-HSA-5619084 | 9.788381e-01 | 0.009 | 0 | 0 |
| Integrin cell surface interactions | R-HSA-216083 | 9.788381e-01 | 0.009 | 0 | 0 |
| Metabolic disorders of biological oxidation enzymes | R-HSA-5579029 | 9.797683e-01 | 0.009 | 0 | 0 |
| Aerobic respiration and respiratory electron transport | R-HSA-1428517 | 9.806571e-01 | 0.008 | 0 | 0 |
| Signaling by MET | R-HSA-6806834 | 9.806577e-01 | 0.008 | 0 | 0 |
| Glucose metabolism | R-HSA-70326 | 9.807252e-01 | 0.008 | 0 | 0 |
| Peptide hormone metabolism | R-HSA-2980736 | 9.807252e-01 | 0.008 | 0 | 0 |
| Amyloid fiber formation | R-HSA-977225 | 9.815081e-01 | 0.008 | 0 | 0 |
| Regulation of expression of SLITs and ROBOs | R-HSA-9010553 | 9.816839e-01 | 0.008 | 0 | 0 |
| Arachidonate metabolism | R-HSA-2142753 | 9.816839e-01 | 0.008 | 0 | 0 |
| DNA Replication | R-HSA-69306 | 9.823110e-01 | 0.008 | 0 | 0 |
| Transport of Mature Transcript to Cytoplasm | R-HSA-72202 | 9.823211e-01 | 0.008 | 0 | 0 |
| Senescence-Associated Secretory Phenotype (SASP) | R-HSA-2559582 | 9.823211e-01 | 0.008 | 0 | 0 |
| TNFR2 non-canonical NF-kB pathway | R-HSA-5668541 | 9.830984e-01 | 0.007 | 0 | 0 |
| Infection with Mycobacterium tuberculosis | R-HSA-9635486 | 9.834819e-01 | 0.007 | 0 | 0 |
| Influenza Viral RNA Transcription and Replication | R-HSA-168273 | 9.835041e-01 | 0.007 | 0 | 0 |
| Peroxisomal lipid metabolism | R-HSA-390918 | 9.838416e-01 | 0.007 | 0 | 0 |
| HCMV Late Events | R-HSA-9610379 | 9.846200e-01 | 0.007 | 0 | 0 |
| Sensory perception of sweet, bitter, and umami (glutamate) taste | R-HSA-9717207 | 9.847127e-01 | 0.007 | 0 | 0 |
| Sulfur amino acid metabolism | R-HSA-1614635 | 9.858810e-01 | 0.006 | 0 | 0 |
| Infectious disease | R-HSA-5663205 | 9.877651e-01 | 0.005 | 0 | 0 |
| Class B/2 (Secretin family receptors) | R-HSA-373080 | 9.882060e-01 | 0.005 | 0 | 0 |
| SLC transporter disorders | R-HSA-5619102 | 9.891974e-01 | 0.005 | 0 | 0 |
| Sensory perception of taste | R-HSA-9717189 | 9.896458e-01 | 0.005 | 0 | 0 |
| Plasma lipoprotein assembly, remodeling, and clearance | R-HSA-174824 | 9.896952e-01 | 0.004 | 0 | 0 |
| Assembly of the pre-replicative complex | R-HSA-68867 | 9.901486e-01 | 0.004 | 0 | 0 |
| tRNA processing | R-HSA-72306 | 9.906338e-01 | 0.004 | 0 | 0 |
| Processing of Capped Intron-Containing Pre-mRNA | R-HSA-72203 | 9.920001e-01 | 0.003 | 0 | 0 |
| Antigen processing: Ubiquitination & Proteasome degradation | R-HSA-983168 | 9.926912e-01 | 0.003 | 0 | 0 |
| ABC-family proteins mediated transport | R-HSA-382556 | 9.931276e-01 | 0.003 | 0 | 0 |
| Late Phase of HIV Life Cycle | R-HSA-162599 | 9.937953e-01 | 0.003 | 0 | 0 |
| Antimicrobial peptides | R-HSA-6803157 | 9.959970e-01 | 0.002 | 0 | 0 |
| GPCR ligand binding | R-HSA-500792 | 9.965102e-01 | 0.002 | 0 | 0 |
| HIV Life Cycle | R-HSA-162587 | 9.965872e-01 | 0.001 | 0 | 0 |
| Cell surface interactions at the vascular wall | R-HSA-202733 | 9.967853e-01 | 0.001 | 0 | 0 |
| Metabolism of RNA | R-HSA-8953854 | 9.974588e-01 | 0.001 | 0 | 0 |
| Disorders of transmembrane transporters | R-HSA-5619115 | 9.977313e-01 | 0.001 | 0 | 0 |
| Metabolism of steroids | R-HSA-8957322 | 9.980210e-01 | 0.001 | 0 | 0 |
| Regulation of Complement cascade | R-HSA-977606 | 9.980540e-01 | 0.001 | 0 | 0 |
| Translation | R-HSA-72766 | 9.982645e-01 | 0.001 | 0 | 0 |
| SLC-mediated transmembrane transport | R-HSA-425407 | 9.983240e-01 | 0.001 | 0 | 0 |
| Transport of small molecules | R-HSA-382551 | 9.987319e-01 | 0.001 | 0 | 0 |
| Metabolism of proteins | R-HSA-392499 | 9.988019e-01 | 0.001 | 0 | 0 |
| Diseases of glycosylation | R-HSA-3781865 | 9.989002e-01 | 0.000 | 0 | 0 |
| Metabolism of water-soluble vitamins and cofactors | R-HSA-196849 | 9.990176e-01 | 0.000 | 0 | 0 |
| Complement cascade | R-HSA-166658 | 9.993413e-01 | 0.000 | 0 | 0 |
| Cytochrome P450 - arranged by substrate type | R-HSA-211897 | 9.997563e-01 | 0.000 | 0 | 0 |
| Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell | R-HSA-198933 | 9.998351e-01 | 0.000 | 0 | 0 |
| Metabolism of vitamins and cofactors | R-HSA-196854 | 9.998572e-01 | 0.000 | 0 | 0 |
| Respiratory electron transport | R-HSA-611105 | 9.998584e-01 | 0.000 | 0 | 0 |
| Fatty acid metabolism | R-HSA-8978868 | 9.999712e-01 | 0.000 | 0 | 0 |
| Metabolism of carbohydrates and carbohydrate derivatives | R-HSA-71387 | 9.999779e-01 | 0.000 | 0 | 0 |
| Drug ADME | R-HSA-9748784 | 9.999779e-01 | 0.000 | 0 | 0 |
| Bacterial Infection Pathways | R-HSA-9824439 | 9.999892e-01 | 0.000 | 0 | 0 |
| Phase II - Conjugation of compounds | R-HSA-156580 | 9.999915e-01 | 0.000 | 0 | 0 |
| Diseases of metabolism | R-HSA-5668914 | 9.999975e-01 | 0.000 | 0 | 0 |
| Phase I - Functionalization of compounds | R-HSA-211945 | 9.999986e-01 | 0.000 | 0 | 0 |
| Metabolism of amino acids and derivatives | R-HSA-71291 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of lipids | R-HSA-556833 | 1.000000e+00 | 0.000 | 0 | 0 |
| Biological oxidations | R-HSA-211859 | 1.000000e+00 | 0.000 | 0 | 0 |
| Sensory Perception | R-HSA-9709957 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism | R-HSA-1430728 | 1.000000e+00 | -0.000 | 0 | 0 |
Top15 pathways (red highlights are reference pathways)
Compared with reference pathways
Motif of predicted substrate sequence
Reactome pathways of predicted substrates
Download
| name | reactome_id | p | -log10p | ref_path | ref_path_lowest |
|---|---|---|---|---|---|
| Aggrephagy | R-HSA-9646399 | 1.110223e-16 | 15.955 | 0 | 0 |
| HSF1 activation | R-HSA-3371511 | 1.110223e-16 | 15.955 | 0 | 0 |
| Attenuation phase | R-HSA-3371568 | 1.110223e-16 | 15.955 | 0 | 0 |
| HSF1-dependent transactivation | R-HSA-3371571 | 1.110223e-16 | 15.955 | 0 | 0 |
| Cellular response to heat stress | R-HSA-3371556 | 1.110223e-16 | 15.955 | 0 | 0 |
| Regulation of HSF1-mediated heat shock response | R-HSA-3371453 | 1.110223e-16 | 15.955 | 0 | 0 |
| M Phase | R-HSA-68886 | 1.110223e-16 | 15.955 | 0 | 0 |
| Axon guidance | R-HSA-422475 | 1.110223e-16 | 15.955 | 0 | 0 |
| Nervous system development | R-HSA-9675108 | 1.110223e-16 | 15.955 | 0 | 0 |
| Cellular responses to stimuli | R-HSA-8953897 | 1.110223e-16 | 15.955 | 0 | 0 |
| Cellular responses to stress | R-HSA-2262752 | 1.110223e-16 | 15.955 | 0 | 0 |
| The role of GTSE1 in G2/M progression after G2 checkpoint | R-HSA-8852276 | 3.330669e-16 | 15.477 | 0 | 0 |
| HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand | R-HSA-3371497 | 1.887379e-15 | 14.724 | 0 | 0 |
| Antiviral mechanism by IFN-stimulated genes | R-HSA-1169410 | 2.442491e-15 | 14.612 | 0 | 0 |
| Translocation of SLC2A4 (GLUT4) to the plasma membrane | R-HSA-1445148 | 7.216450e-15 | 14.142 | 0 | 0 |
| Eukaryotic Translation Initiation | R-HSA-72613 | 1.465494e-14 | 13.834 | 0 | 0 |
| Cap-dependent Translation Initiation | R-HSA-72737 | 1.465494e-14 | 13.834 | 0 | 0 |
| Eukaryotic Translation Elongation | R-HSA-156842 | 1.709743e-14 | 13.767 | 0 | 0 |
| Metabolism of RNA | R-HSA-8953854 | 1.720846e-14 | 13.764 | 0 | 0 |
| Cell Cycle, Mitotic | R-HSA-69278 | 5.373479e-14 | 13.270 | 0 | 0 |
| Cell Cycle | R-HSA-1640170 | 1.022515e-13 | 12.990 | 0 | 0 |
| Mitotic Anaphase | R-HSA-68882 | 1.517675e-13 | 12.819 | 0 | 0 |
| Microtubule-dependent trafficking of connexons from Golgi to the plasma membrane | R-HSA-190840 | 1.521006e-13 | 12.818 | 0 | 0 |
| Mitotic Metaphase and Anaphase | R-HSA-2555396 | 1.717515e-13 | 12.765 | 0 | 0 |
| Transport of connexons to the plasma membrane | R-HSA-190872 | 2.743361e-13 | 12.562 | 0 | 0 |
| PKR-mediated signaling | R-HSA-9833482 | 3.377298e-13 | 12.471 | 0 | 0 |
| Cytokine Signaling in Immune system | R-HSA-1280215 | 3.850253e-13 | 12.415 | 0 | 0 |
| Assembly and cell surface presentation of NMDA receptors | R-HSA-9609736 | 5.195844e-13 | 12.284 | 0 | 0 |
| Formation of tubulin folding intermediates by CCT/TriC | R-HSA-389960 | 6.240564e-13 | 12.205 | 0 | 0 |
| GTP hydrolysis and joining of the 60S ribosomal subunit | R-HSA-72706 | 6.495915e-13 | 12.187 | 0 | 0 |
| Cooperation of Prefoldin and TriC/CCT in actin and tubulin folding | R-HSA-389958 | 9.222623e-13 | 12.035 | 0 | 0 |
| Ribosome-associated quality control | R-HSA-9948299 | 1.062261e-12 | 11.974 | 0 | 0 |
| Cell-Cell communication | R-HSA-1500931 | 1.265210e-12 | 11.898 | 0 | 0 |
| G2/M Transition | R-HSA-69275 | 1.606715e-12 | 11.794 | 0 | 0 |
| Mitotic G2-G2/M phases | R-HSA-453274 | 2.073564e-12 | 11.683 | 0 | 0 |
| Peptide chain elongation | R-HSA-156902 | 2.363887e-12 | 11.626 | 0 | 0 |
| Nuclear Envelope (NE) Reassembly | R-HSA-2995410 | 2.587153e-12 | 11.587 | 0 | 0 |
| SARS-CoV-1-host interactions | R-HSA-9692914 | 2.904565e-12 | 11.537 | 0 | 0 |
| Influenza Infection | R-HSA-168255 | 3.174350e-12 | 11.498 | 0 | 0 |
| Recycling pathway of L1 | R-HSA-437239 | 3.419043e-12 | 11.466 | 0 | 0 |
| Activation of AMPK downstream of NMDARs | R-HSA-9619483 | 3.584133e-12 | 11.446 | 0 | 0 |
| L13a-mediated translational silencing of Ceruloplasmin expression | R-HSA-156827 | 4.141687e-12 | 11.383 | 0 | 0 |
| Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC) | R-HSA-975956 | 5.254686e-12 | 11.279 | 0 | 0 |
| Separation of Sister Chromatids | R-HSA-2467813 | 9.494405e-12 | 11.023 | 0 | 0 |
| ZNF598 and the Ribosome-associated Quality Trigger (RQT) complex dissociate a ribosome stalled on a no-go mRNA | R-HSA-9954716 | 1.126643e-11 | 10.948 | 0 | 0 |
| Viral Infection Pathways | R-HSA-9824446 | 1.169831e-11 | 10.932 | 0 | 0 |
| Post-chaperonin tubulin folding pathway | R-HSA-389977 | 1.337075e-11 | 10.874 | 0 | 0 |
| Influenza Viral RNA Transcription and Replication | R-HSA-168273 | 1.427081e-11 | 10.846 | 0 | 0 |
| Recruitment of NuMA to mitotic centrosomes | R-HSA-380320 | 1.642952e-11 | 10.784 | 0 | 0 |
| Selective autophagy | R-HSA-9663891 | 1.642952e-11 | 10.784 | 0 | 0 |
| SRP-dependent cotranslational protein targeting to membrane | R-HSA-1799339 | 2.143508e-11 | 10.669 | 0 | 0 |
| Nonsense-Mediated Decay (NMD) | R-HSA-927802 | 4.888712e-11 | 10.311 | 0 | 0 |
| Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC) | R-HSA-975957 | 4.888712e-11 | 10.311 | 0 | 0 |
| Regulation of expression of SLITs and ROBOs | R-HSA-9010553 | 4.775969e-11 | 10.321 | 0 | 0 |
| Mitotic Prometaphase | R-HSA-68877 | 8.001311e-11 | 10.097 | 0 | 0 |
| Prefoldin mediated transfer of substrate to CCT/TriC | R-HSA-389957 | 8.096335e-11 | 10.092 | 0 | 0 |
| Formation of a pool of free 40S subunits | R-HSA-72689 | 8.626544e-11 | 10.064 | 0 | 0 |
| Translation | R-HSA-72766 | 1.040027e-10 | 9.983 | 0 | 0 |
| Interferon Signaling | R-HSA-913531 | 1.170639e-10 | 9.932 | 0 | 0 |
| Cell junction organization | R-HSA-446728 | 1.124616e-10 | 9.949 | 0 | 0 |
| Gap junction trafficking | R-HSA-190828 | 1.314031e-10 | 9.881 | 0 | 0 |
| PELO:HBS1L and ABCE1 dissociate a ribosome on a non-stop mRNA | R-HSA-9954714 | 1.875607e-10 | 9.727 | 0 | 0 |
| Apoptotic execution phase | R-HSA-75153 | 2.252807e-10 | 9.647 | 0 | 0 |
| Sealing of the nuclear envelope (NE) by ESCRT-III | R-HSA-9668328 | 2.660204e-10 | 9.575 | 0 | 0 |
| Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation | R-HSA-8950505 | 3.112275e-10 | 9.507 | 0 | 0 |
| Response of EIF2AK4 (GCN2) to amino acid deficiency | R-HSA-9633012 | 3.863221e-10 | 9.413 | 0 | 0 |
| Regulation of CDH1 Function | R-HSA-9764561 | 4.028212e-10 | 9.395 | 0 | 0 |
| Interleukin-12 signaling | R-HSA-9020591 | 4.126722e-10 | 9.384 | 0 | 0 |
| HCMV Early Events | R-HSA-9609690 | 4.786671e-10 | 9.320 | 0 | 0 |
| Major pathway of rRNA processing in the nucleolus and cytosol | R-HSA-6791226 | 4.985481e-10 | 9.302 | 0 | 0 |
| Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S | R-HSA-72662 | 5.055285e-10 | 9.296 | 0 | 0 |
| Gap junction trafficking and regulation | R-HSA-157858 | 4.855538e-10 | 9.314 | 0 | 0 |
| Gap junction assembly | R-HSA-190861 | 5.023458e-10 | 9.299 | 0 | 0 |
| Eukaryotic Translation Termination | R-HSA-72764 | 5.243571e-10 | 9.280 | 0 | 0 |
| Post NMDA receptor activation events | R-HSA-438064 | 5.801104e-10 | 9.236 | 0 | 0 |
| L1CAM interactions | R-HSA-373760 | 6.771805e-10 | 9.169 | 0 | 0 |
| rRNA processing in the nucleus and cytosol | R-HSA-8868773 | 8.542572e-10 | 9.068 | 0 | 0 |
| Signaling by ROBO receptors | R-HSA-376176 | 9.956114e-10 | 9.002 | 0 | 0 |
| Resolution of Sister Chromatid Cohesion | R-HSA-2500257 | 1.370316e-09 | 8.863 | 0 | 0 |
| Selenocysteine synthesis | R-HSA-2408557 | 1.370445e-09 | 8.863 | 0 | 0 |
| Translation initiation complex formation | R-HSA-72649 | 1.585705e-09 | 8.800 | 0 | 0 |
| Viral mRNA Translation | R-HSA-192823 | 1.862011e-09 | 8.730 | 0 | 0 |
| COPI-independent Golgi-to-ER retrograde traffic | R-HSA-6811436 | 1.983128e-09 | 8.703 | 0 | 0 |
| Ribosomal scanning and start codon recognition | R-HSA-72702 | 2.470184e-09 | 8.607 | 0 | 0 |
| Apoptosis | R-HSA-109581 | 3.463521e-09 | 8.460 | 0 | 0 |
| Interleukin-12 family signaling | R-HSA-447115 | 3.531603e-09 | 8.452 | 0 | 0 |
| SARS-CoV-1 modulates host translation machinery | R-HSA-9735869 | 4.966128e-09 | 8.304 | 0 | 0 |
| EML4 and NUDC in mitotic spindle formation | R-HSA-9648025 | 5.181181e-09 | 8.286 | 0 | 0 |
| Autophagy | R-HSA-9612973 | 7.678777e-09 | 8.115 | 0 | 0 |
| Developmental Lineage of Mammary Gland Myoepithelial Cells | R-HSA-9927432 | 8.263761e-09 | 8.083 | 0 | 0 |
| Activation of NMDA receptors and postsynaptic events | R-HSA-442755 | 8.696234e-09 | 8.061 | 0 | 0 |
| SARS-CoV-1 Infection | R-HSA-9678108 | 1.536950e-08 | 7.813 | 0 | 0 |
| Carboxyterminal post-translational modifications of tubulin | R-HSA-8955332 | 1.956202e-08 | 7.709 | 0 | 0 |
| Chaperonin-mediated protein folding | R-HSA-390466 | 2.040973e-08 | 7.690 | 0 | 0 |
| HCMV Infection | R-HSA-9609646 | 2.165644e-08 | 7.664 | 0 | 0 |
| Macroautophagy | R-HSA-1632852 | 2.412123e-08 | 7.618 | 0 | 0 |
| Cell-extracellular matrix interactions | R-HSA-446353 | 4.139774e-08 | 7.383 | 0 | 0 |
| Kinesins | R-HSA-983189 | 3.917539e-08 | 7.407 | 0 | 0 |
| SARS-CoV-2-host interactions | R-HSA-9705683 | 4.221821e-08 | 7.375 | 0 | 0 |
| Cargo trafficking to the periciliary membrane | R-HSA-5620920 | 4.418195e-08 | 7.355 | 0 | 0 |
| Protein folding | R-HSA-391251 | 5.003034e-08 | 7.301 | 0 | 0 |
| rRNA processing | R-HSA-72312 | 5.891644e-08 | 7.230 | 0 | 0 |
| Programmed Cell Death | R-HSA-5357801 | 7.446509e-08 | 7.128 | 0 | 0 |
| SARS-CoV-2 modulates host translation machinery | R-HSA-9754678 | 8.357889e-08 | 7.078 | 0 | 0 |
| Ribosome Quality Control (RQC) complex extracts and degrades nascent peptide | R-HSA-9954709 | 8.782242e-08 | 7.056 | 0 | 0 |
| Developmental Biology | R-HSA-1266738 | 1.085142e-07 | 6.965 | 0 | 0 |
| Formation of the ternary complex, and subsequently, the 43S complex | R-HSA-72695 | 1.174986e-07 | 6.930 | 0 | 0 |
| Cellular response to starvation | R-HSA-9711097 | 1.604024e-07 | 6.795 | 0 | 0 |
| Hedgehog 'off' state | R-HSA-5610787 | 1.712075e-07 | 6.766 | 0 | 0 |
| Regulation of CDH1 Expression and Function | R-HSA-9764265 | 1.915915e-07 | 6.718 | 0 | 0 |
| Regulation of Expression and Function of Type I Classical Cadherins | R-HSA-9764274 | 1.915915e-07 | 6.718 | 0 | 0 |
| Chaperone Mediated Autophagy | R-HSA-9613829 | 2.038930e-07 | 6.691 | 0 | 0 |
| Infectious disease | R-HSA-5663205 | 2.985220e-07 | 6.525 | 0 | 0 |
| Selenoamino acid metabolism | R-HSA-2408522 | 2.851937e-07 | 6.545 | 0 | 0 |
| Striated Muscle Contraction | R-HSA-390522 | 3.034568e-07 | 6.518 | 0 | 0 |
| Regulation of PLK1 Activity at G2/M Transition | R-HSA-2565942 | 3.322751e-07 | 6.479 | 0 | 0 |
| Apoptosis induced DNA fragmentation | R-HSA-140342 | 5.751238e-07 | 6.240 | 0 | 0 |
| Mitotic Prophase | R-HSA-68875 | 5.805914e-07 | 6.236 | 0 | 0 |
| Cell-cell junction organization | R-HSA-421270 | 8.244832e-07 | 6.084 | 0 | 0 |
| Cilium Assembly | R-HSA-5617833 | 8.432108e-07 | 6.074 | 0 | 0 |
| Host Interactions of HIV factors | R-HSA-162909 | 8.917483e-07 | 6.050 | 0 | 0 |
| Intraflagellar transport | R-HSA-5620924 | 1.190960e-06 | 5.924 | 0 | 0 |
| Signaling by Hedgehog | R-HSA-5358351 | 1.234587e-06 | 5.908 | 0 | 0 |
| Cellular Senescence | R-HSA-2559583 | 1.278237e-06 | 5.893 | 0 | 0 |
| Regulation of Homotypic Cell-Cell Adhesion | R-HSA-9759476 | 1.367794e-06 | 5.864 | 0 | 0 |
| Developmental Lineages of the Mammary Gland | R-HSA-9924644 | 1.663381e-06 | 5.779 | 0 | 0 |
| Regulation of mRNA stability by proteins that bind AU-rich elements | R-HSA-450531 | 1.663381e-06 | 5.779 | 0 | 0 |
| Signaling by Interleukins | R-HSA-449147 | 1.877408e-06 | 5.726 | 0 | 0 |
| COPI-mediated anterograde transport | R-HSA-6807878 | 2.295938e-06 | 5.639 | 0 | 0 |
| Diseases of signal transduction by growth factor receptors and second messengers | R-HSA-5663202 | 2.345558e-06 | 5.630 | 0 | 0 |
| Adherens junctions interactions | R-HSA-418990 | 2.393327e-06 | 5.621 | 0 | 0 |
| Response to elevated platelet cytosolic Ca2+ | R-HSA-76005 | 2.680568e-06 | 5.572 | 0 | 0 |
| Metalloprotease DUBs | R-HSA-5689901 | 3.007275e-06 | 5.522 | 0 | 0 |
| UCH proteinases | R-HSA-5689603 | 2.897175e-06 | 5.538 | 0 | 0 |
| AUF1 (hnRNP D0) binds and destabilizes mRNA | R-HSA-450408 | 4.527287e-06 | 5.344 | 0 | 0 |
| Muscle contraction | R-HSA-397014 | 4.882975e-06 | 5.311 | 0 | 0 |
| Platelet degranulation | R-HSA-114608 | 5.285480e-06 | 5.277 | 0 | 0 |
| Signaling by RAS mutants | R-HSA-6802949 | 5.288687e-06 | 5.277 | 0 | 0 |
| Signaling by moderate kinase activity BRAF mutants | R-HSA-6802946 | 5.288687e-06 | 5.277 | 0 | 0 |
| Signaling downstream of RAS mutants | R-HSA-9649948 | 5.288687e-06 | 5.277 | 0 | 0 |
| Paradoxical activation of RAF signaling by kinase inactive BRAF | R-HSA-6802955 | 5.288687e-06 | 5.277 | 0 | 0 |
| Nuclear Envelope Breakdown | R-HSA-2980766 | 5.349931e-06 | 5.272 | 0 | 0 |
| Signaling by Ligand-Responsive EGFR Variants in Cancer | R-HSA-5637815 | 5.583317e-06 | 5.253 | 0 | 0 |
| Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants | R-HSA-1236382 | 5.583317e-06 | 5.253 | 0 | 0 |
| FLT3 signaling by CBL mutants | R-HSA-9706377 | 6.341455e-06 | 5.198 | 0 | 0 |
| Transcriptional regulation by small RNAs | R-HSA-5578749 | 8.478864e-06 | 5.072 | 0 | 0 |
| Insulin-like Growth Factor-2 mRNA Binding Proteins (IGF2BPs/IMPs/VICKZs) bind RNA | R-HSA-428359 | 8.879627e-06 | 5.052 | 0 | 0 |
| Developmental Cell Lineages of the Integumentary System | R-HSA-9734779 | 9.460933e-06 | 5.024 | 0 | 0 |
| COPI-dependent Golgi-to-ER retrograde traffic | R-HSA-6811434 | 1.003084e-05 | 4.999 | 0 | 0 |
| Apoptotic cleavage of cellular proteins | R-HSA-111465 | 1.171432e-05 | 4.931 | 0 | 0 |
| Regulation of cytoskeletal remodeling and cell spreading by IPP complex components | R-HSA-446388 | 1.200832e-05 | 4.921 | 0 | 0 |
| MHC class II antigen presentation | R-HSA-2132295 | 1.254460e-05 | 4.902 | 0 | 0 |
| Signaling by RAF1 mutants | R-HSA-9656223 | 1.384672e-05 | 4.859 | 0 | 0 |
| Neurotransmitter receptors and postsynaptic signal transmission | R-HSA-112314 | 1.488867e-05 | 4.827 | 0 | 0 |
| Signaling by BRAF and RAF1 fusions | R-HSA-6802952 | 1.671092e-05 | 4.777 | 0 | 0 |
| Oxidative Stress Induced Senescence | R-HSA-2559580 | 1.875772e-05 | 4.727 | 0 | 0 |
| Signaling by EGFR in Cancer | R-HSA-1643713 | 2.443645e-05 | 4.612 | 0 | 0 |
| Mitochondrial unfolded protein response (UPRmt) | R-HSA-9841251 | 3.031035e-05 | 4.518 | 0 | 0 |
| Factors involved in megakaryocyte development and platelet production | R-HSA-983231 | 3.103027e-05 | 4.508 | 0 | 0 |
| Golgi-to-ER retrograde transport | R-HSA-8856688 | 3.271488e-05 | 4.485 | 0 | 0 |
| SARS-CoV-2 Infection | R-HSA-9694516 | 3.404126e-05 | 4.468 | 0 | 0 |
| Regulation of PTEN localization | R-HSA-8948747 | 3.457255e-05 | 4.461 | 0 | 0 |
| Immune System | R-HSA-168256 | 3.835258e-05 | 4.416 | 0 | 0 |
| Formation of Senescence-Associated Heterochromatin Foci (SAHF) | R-HSA-2559584 | 3.940614e-05 | 4.404 | 0 | 0 |
| Recruitment of mitotic centrosome proteins and complexes | R-HSA-380270 | 4.517180e-05 | 4.345 | 0 | 0 |
| Degradation of CDH1 | R-HSA-9766229 | 4.890196e-05 | 4.311 | 0 | 0 |
| PTK6 Regulates RTKs and Their Effectors AKT1 and DOK1 | R-HSA-8849469 | 5.408295e-05 | 4.267 | 0 | 0 |
| Downregulation of ERBB2 signaling | R-HSA-8863795 | 5.544418e-05 | 4.256 | 0 | 0 |
| DNA Damage/Telomere Stress Induced Senescence | R-HSA-2559586 | 5.545596e-05 | 4.256 | 0 | 0 |
| Centrosome maturation | R-HSA-380287 | 5.681907e-05 | 4.246 | 0 | 0 |
| ISG15 antiviral mechanism | R-HSA-1169408 | 5.681907e-05 | 4.246 | 0 | 0 |
| Transmission across Chemical Synapses | R-HSA-112315 | 5.764571e-05 | 4.239 | 0 | 0 |
| SARS-CoV Infections | R-HSA-9679506 | 6.015835e-05 | 4.221 | 0 | 0 |
| Gap-filling DNA repair synthesis and ligation in GG-NER | R-HSA-5696397 | 6.262711e-05 | 4.203 | 0 | 0 |
| Loss of proteins required for interphase microtubule organization from the centrosome | R-HSA-380284 | 6.281214e-05 | 4.202 | 0 | 0 |
| Loss of Nlp from mitotic centrosomes | R-HSA-380259 | 6.281214e-05 | 4.202 | 0 | 0 |
| Signaling by Non-Receptor Tyrosine Kinases | R-HSA-9006927 | 6.281214e-05 | 4.202 | 0 | 0 |
| Signaling by PTK6 | R-HSA-8848021 | 6.281214e-05 | 4.202 | 0 | 0 |
| Metabolism of proteins | R-HSA-392499 | 6.657322e-05 | 4.177 | 0 | 0 |
| TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) | R-HSA-2173791 | 7.236186e-05 | 4.140 | 0 | 0 |
| NOTCH3 Activation and Transmission of Signal to the Nucleus | R-HSA-9013507 | 7.837217e-05 | 4.106 | 0 | 0 |
| AURKA Activation by TPX2 | R-HSA-8854518 | 9.010889e-05 | 4.045 | 0 | 0 |
| Ub-specific processing proteases | R-HSA-5689880 | 8.248872e-05 | 4.084 | 0 | 0 |
| Smooth Muscle Contraction | R-HSA-445355 | 8.502902e-05 | 4.070 | 0 | 0 |
| Regulation of MECP2 expression and activity | R-HSA-9022692 | 9.593119e-05 | 4.018 | 0 | 0 |
| Processing of Capped Intron-Containing Pre-mRNA | R-HSA-72203 | 9.855977e-05 | 4.006 | 0 | 0 |
| HIV Infection | R-HSA-162906 | 1.061567e-04 | 3.974 | 0 | 0 |
| TGF-beta receptor signaling activates SMADs | R-HSA-2173789 | 1.105387e-04 | 3.956 | 0 | 0 |
| Josephin domain DUBs | R-HSA-5689877 | 1.176460e-04 | 3.929 | 0 | 0 |
| Recognition of DNA damage by PCNA-containing replication complex | R-HSA-110314 | 1.195651e-04 | 3.922 | 0 | 0 |
| Organelle biogenesis and maintenance | R-HSA-1852241 | 1.212278e-04 | 3.916 | 0 | 0 |
| Signaling by ALK fusions and activated point mutants | R-HSA-9725370 | 1.241925e-04 | 3.906 | 0 | 0 |
| Signaling by ALK in cancer | R-HSA-9700206 | 1.241925e-04 | 3.906 | 0 | 0 |
| Gene Silencing by RNA | R-HSA-211000 | 1.241925e-04 | 3.906 | 0 | 0 |
| Signaling by EGFR | R-HSA-177929 | 1.251353e-04 | 3.903 | 0 | 0 |
| Nuclear import of Rev protein | R-HSA-180746 | 1.346109e-04 | 3.871 | 0 | 0 |
| Neutrophil degranulation | R-HSA-6798695 | 1.376850e-04 | 3.861 | 0 | 0 |
| Downstream signaling events of B Cell Receptor (BCR) | R-HSA-1168372 | 1.417964e-04 | 3.848 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of HSCs | R-HSA-8939236 | 1.470472e-04 | 3.833 | 0 | 0 |
| Oncogenic MAPK signaling | R-HSA-6802957 | 1.622130e-04 | 3.790 | 0 | 0 |
| Membrane Trafficking | R-HSA-199991 | 1.739558e-04 | 3.760 | 0 | 0 |
| Regulation of TP53 Degradation | R-HSA-6804757 | 1.853304e-04 | 3.732 | 0 | 0 |
| Depolymerization of the Nuclear Lamina | R-HSA-4419969 | 2.021589e-04 | 3.694 | 0 | 0 |
| HIV Life Cycle | R-HSA-162587 | 2.371387e-04 | 3.625 | 0 | 0 |
| Ovarian tumor domain proteases | R-HSA-5689896 | 2.160350e-04 | 3.665 | 0 | 0 |
| Signaling by high-kinase activity BRAF mutants | R-HSA-6802948 | 2.160350e-04 | 3.665 | 0 | 0 |
| Cell Cycle Checkpoints | R-HSA-69620 | 2.142892e-04 | 3.669 | 0 | 0 |
| Glycolysis | R-HSA-70171 | 2.235658e-04 | 3.651 | 0 | 0 |
| Signaling by NOTCH4 | R-HSA-9013694 | 2.167908e-04 | 3.664 | 0 | 0 |
| Maturation of protein E | R-HSA-9683683 | 2.147577e-04 | 3.668 | 0 | 0 |
| Maturation of protein E | R-HSA-9694493 | 2.147577e-04 | 3.668 | 0 | 0 |
| p53-Dependent G1/S DNA damage checkpoint | R-HSA-69580 | 2.498211e-04 | 3.602 | 0 | 0 |
| p53-Dependent G1 DNA Damage Response | R-HSA-69563 | 2.498211e-04 | 3.602 | 0 | 0 |
| Regulation of signaling by CBL | R-HSA-912631 | 2.533373e-04 | 3.596 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Cyclin B | R-HSA-174048 | 2.533373e-04 | 3.596 | 0 | 0 |
| Translesion Synthesis by POLH | R-HSA-110320 | 2.533373e-04 | 3.596 | 0 | 0 |
| Regulation of APC/C activators between G1/S and early anaphase | R-HSA-176408 | 2.542706e-04 | 3.595 | 0 | 0 |
| Developmental Cell Lineages | R-HSA-9734767 | 2.745810e-04 | 3.561 | 0 | 0 |
| Semaphorin interactions | R-HSA-373755 | 2.840338e-04 | 3.547 | 0 | 0 |
| Regulation of TP53 Expression and Degradation | R-HSA-6806003 | 2.899948e-04 | 3.538 | 0 | 0 |
| Stabilization of p53 | R-HSA-69541 | 2.899948e-04 | 3.538 | 0 | 0 |
| Downregulation of ERBB2:ERBB3 signaling | R-HSA-1358803 | 3.045700e-04 | 3.516 | 0 | 0 |
| p75NTR recruits signalling complexes | R-HSA-209543 | 3.045700e-04 | 3.516 | 0 | 0 |
| Hedgehog ligand biogenesis | R-HSA-5358346 | 3.203226e-04 | 3.494 | 0 | 0 |
| Interactions of Rev with host cellular proteins | R-HSA-177243 | 3.340656e-04 | 3.476 | 0 | 0 |
| Negative regulation of NOTCH4 signaling | R-HSA-9604323 | 3.340656e-04 | 3.476 | 0 | 0 |
| Regulation of RUNX3 expression and activity | R-HSA-8941858 | 3.340656e-04 | 3.476 | 0 | 0 |
| Disease | R-HSA-1643685 | 3.360788e-04 | 3.474 | 0 | 0 |
| E3 ubiquitin ligases ubiquitinate target proteins | R-HSA-8866654 | 3.613021e-04 | 3.442 | 0 | 0 |
| Cdc20:Phospho-APC/C mediated degradation of Cyclin A | R-HSA-174184 | 3.613021e-04 | 3.442 | 0 | 0 |
| SARS-CoV-1 activates/modulates innate immune responses | R-HSA-9692916 | 3.613021e-04 | 3.442 | 0 | 0 |
| ER to Golgi Anterograde Transport | R-HSA-199977 | 3.646010e-04 | 3.438 | 0 | 0 |
| Hh mutants are degraded by ERAD | R-HSA-5362768 | 3.834476e-04 | 3.416 | 0 | 0 |
| SPOP-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929491 | 3.834476e-04 | 3.416 | 0 | 0 |
| Localization of the PINCH-ILK-PARVIN complex to focal adhesions | R-HSA-446343 | 4.278951e-04 | 3.369 | 0 | 0 |
| EGFR downregulation | R-HSA-182971 | 4.200859e-04 | 3.377 | 0 | 0 |
| Regulation of activated PAK-2p34 by proteasome mediated degradation | R-HSA-211733 | 4.200859e-04 | 3.377 | 0 | 0 |
| APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint | R-HSA-179419 | 4.065111e-04 | 3.391 | 0 | 0 |
| B-WICH complex positively regulates rRNA expression | R-HSA-5250924 | 4.065111e-04 | 3.391 | 0 | 0 |
| Deubiquitination | R-HSA-5688426 | 4.552114e-04 | 3.342 | 0 | 0 |
| CDK-mediated phosphorylation and removal of Cdc6 | R-HSA-69017 | 4.562775e-04 | 3.341 | 0 | 0 |
| MAP2K and MAPK activation | R-HSA-5674135 | 4.386096e-04 | 3.358 | 0 | 0 |
| Platelet activation, signaling and aggregation | R-HSA-76002 | 4.621807e-04 | 3.335 | 0 | 0 |
| Intra-Golgi and retrograde Golgi-to-ER traffic | R-HSA-6811442 | 4.208279e-04 | 3.376 | 0 | 0 |
| Assembly of the pre-replicative complex | R-HSA-68867 | 4.030793e-04 | 3.395 | 0 | 0 |
| DNA Replication Pre-Initiation | R-HSA-69002 | 4.999571e-04 | 3.301 | 0 | 0 |
| Developmental Lineage of Mammary Gland Luminal Epithelial Cells | R-HSA-9927418 | 5.000449e-04 | 3.301 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176409 | 5.109446e-04 | 3.292 | 0 | 0 |
| NRIF signals cell death from the nucleus | R-HSA-205043 | 5.179919e-04 | 3.286 | 0 | 0 |
| MAPK1/MAPK3 signaling | R-HSA-5684996 | 5.296166e-04 | 3.276 | 0 | 0 |
| DNA Replication | R-HSA-69306 | 5.329939e-04 | 3.273 | 0 | 0 |
| Developmental Lineage of Mammary Stem Cells | R-HSA-9938206 | 5.674031e-04 | 3.246 | 0 | 0 |
| Hh mutants abrogate ligand secretion | R-HSA-5387390 | 5.682715e-04 | 3.245 | 0 | 0 |
| Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176814 | 5.708722e-04 | 3.243 | 0 | 0 |
| SCF(Skp2)-mediated degradation of p27/p21 | R-HSA-187577 | 6.438324e-04 | 3.191 | 0 | 0 |
| APC/C-mediated degradation of cell cycle proteins | R-HSA-174143 | 6.441441e-04 | 3.191 | 0 | 0 |
| Regulation of mitotic cell cycle | R-HSA-453276 | 6.441441e-04 | 3.191 | 0 | 0 |
| Translesion synthesis by REV1 | R-HSA-110312 | 6.594500e-04 | 3.181 | 0 | 0 |
| Protein methylation | R-HSA-8876725 | 6.594500e-04 | 3.181 | 0 | 0 |
| InlB-mediated entry of Listeria monocytogenes into host cell | R-HSA-8875360 | 6.594500e-04 | 3.181 | 0 | 0 |
| Spry regulation of FGF signaling | R-HSA-1295596 | 6.594500e-04 | 3.181 | 0 | 0 |
| p75NTR signals via NF-kB | R-HSA-193639 | 6.594500e-04 | 3.181 | 0 | 0 |
| Vpu mediated degradation of CD4 | R-HSA-180534 | 6.623664e-04 | 3.179 | 0 | 0 |
| Regulation of TBK1, IKKε-mediated activation of IRF3, IRF7 upon TLR3 ligation | R-HSA-9828211 | 7.059917e-04 | 3.151 | 0 | 0 |
| Myoclonic epilepsy of Lafora | R-HSA-3785653 | 7.059917e-04 | 3.151 | 0 | 0 |
| Downregulation of ERBB4 signaling | R-HSA-1253288 | 7.059917e-04 | 3.151 | 0 | 0 |
| Modulation by Mtb of host immune system | R-HSA-9637628 | 7.059917e-04 | 3.151 | 0 | 0 |
| G2/M Checkpoints | R-HSA-69481 | 7.095054e-04 | 3.149 | 0 | 0 |
| Hemostasis | R-HSA-109582 | 7.130611e-04 | 3.147 | 0 | 0 |
| Defective CFTR causes cystic fibrosis | R-HSA-5678895 | 7.272955e-04 | 3.138 | 0 | 0 |
| Translesion synthesis by POLI | R-HSA-5656121 | 8.279968e-04 | 3.082 | 0 | 0 |
| Nuclear Pore Complex (NPC) Disassembly | R-HSA-3301854 | 8.775969e-04 | 3.057 | 0 | 0 |
| Autodegradation of Cdh1 by Cdh1:APC/C | R-HSA-174084 | 8.192530e-04 | 3.087 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Securin | R-HSA-174154 | 9.203219e-04 | 3.036 | 0 | 0 |
| Metabolism of non-coding RNA | R-HSA-194441 | 7.860580e-04 | 3.105 | 0 | 0 |
| snRNP Assembly | R-HSA-191859 | 7.860580e-04 | 3.105 | 0 | 0 |
| Transport of Mature mRNA derived from an Intron-Containing Transcript | R-HSA-159236 | 7.772999e-04 | 3.109 | 0 | 0 |
| Protein ubiquitination | R-HSA-8852135 | 9.323179e-04 | 3.030 | 0 | 0 |
| mRNA Splicing - Major Pathway | R-HSA-72163 | 7.934227e-04 | 3.100 | 0 | 0 |
| Signaling by ERBB2 | R-HSA-1227986 | 8.709494e-04 | 3.060 | 0 | 0 |
| FBXL7 down-regulates AURKA during mitotic entry and in early mitosis | R-HSA-8854050 | 8.775969e-04 | 3.057 | 0 | 0 |
| SCF-beta-TrCP mediated degradation of Emi1 | R-HSA-174113 | 8.775969e-04 | 3.057 | 0 | 0 |
| RAF/MAP kinase cascade | R-HSA-5673001 | 8.934157e-04 | 3.049 | 0 | 0 |
| Clathrin-mediated endocytosis | R-HSA-8856828 | 8.194188e-04 | 3.086 | 0 | 0 |
| Autodegradation of the E3 ubiquitin ligase COP1 | R-HSA-349425 | 7.640072e-04 | 3.117 | 0 | 0 |
| Ubiquitin-dependent degradation of Cyclin D | R-HSA-75815 | 7.640072e-04 | 3.117 | 0 | 0 |
| Regulation of Apoptosis | R-HSA-169911 | 8.775969e-04 | 3.057 | 0 | 0 |
| Export of Viral Ribonucleoproteins from Nucleus | R-HSA-168274 | 8.192530e-04 | 3.087 | 0 | 0 |
| Negative regulation of FLT3 | R-HSA-9706369 | 8.279968e-04 | 3.082 | 0 | 0 |
| Non-integrin membrane-ECM interactions | R-HSA-3000171 | 9.323179e-04 | 3.030 | 0 | 0 |
| IRAK2 mediated activation of TAK1 complex | R-HSA-937042 | 9.724410e-04 | 3.012 | 0 | 0 |
| Vif-mediated degradation of APOBEC3G | R-HSA-180585 | 1.004098e-03 | 2.998 | 0 | 0 |
| FLT3 signaling in disease | R-HSA-9682385 | 1.004098e-03 | 2.998 | 0 | 0 |
| Anchoring of the basal body to the plasma membrane | R-HSA-5620912 | 1.011526e-03 | 2.995 | 0 | 0 |
| Glucose metabolism | R-HSA-70326 | 1.023460e-03 | 2.990 | 0 | 0 |
| Translesion synthesis by POLK | R-HSA-5655862 | 1.026718e-03 | 2.989 | 0 | 0 |
| Vpr-mediated nuclear import of PICs | R-HSA-180910 | 1.144512e-03 | 2.941 | 0 | 0 |
| Degradation of DVL | R-HSA-4641258 | 1.144512e-03 | 2.941 | 0 | 0 |
| Degradation of AXIN | R-HSA-4641257 | 1.144512e-03 | 2.941 | 0 | 0 |
| GSK3B and BTRC:CUL1-mediated-degradation of NFE2L2 | R-HSA-9762114 | 1.144512e-03 | 2.941 | 0 | 0 |
| DNA Damage Bypass | R-HSA-73893 | 1.152382e-03 | 2.938 | 0 | 0 |
| G1/S DNA Damage Checkpoints | R-HSA-69615 | 1.171289e-03 | 2.931 | 0 | 0 |
| EPH-Ephrin signaling | R-HSA-2682334 | 1.279174e-03 | 2.893 | 0 | 0 |
| Regulation of RAS by GAPs | R-HSA-5658442 | 1.284727e-03 | 2.891 | 0 | 0 |
| Rev-mediated nuclear export of HIV RNA | R-HSA-165054 | 1.299874e-03 | 2.886 | 0 | 0 |
| TICAM1,TRAF6-dependent induction of TAK1 complex | R-HSA-9014325 | 1.302675e-03 | 2.885 | 0 | 0 |
| Pexophagy | R-HSA-9664873 | 1.302675e-03 | 2.885 | 0 | 0 |
| KEAP1-NFE2L2 pathway | R-HSA-9755511 | 1.315128e-03 | 2.881 | 0 | 0 |
| Nuclear events mediated by NFE2L2 | R-HSA-9759194 | 1.333831e-03 | 2.875 | 0 | 0 |
| mRNA Splicing | R-HSA-72172 | 1.380449e-03 | 2.860 | 0 | 0 |
| Activation of NF-kappaB in B cells | R-HSA-1169091 | 1.428890e-03 | 2.845 | 0 | 0 |
| GSK3B-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929356 | 1.471256e-03 | 2.832 | 0 | 0 |
| NS1 Mediated Effects on Host Pathways | R-HSA-168276 | 1.471256e-03 | 2.832 | 0 | 0 |
| Regulation of TP53 Activity through Methylation | R-HSA-6804760 | 1.527498e-03 | 2.816 | 0 | 0 |
| AMPK-induced ERAD and lysosome mediated degradation of PD-L1(CD274) | R-HSA-9931269 | 1.585604e-03 | 2.800 | 0 | 0 |
| Orc1 removal from chromatin | R-HSA-68949 | 1.585604e-03 | 2.800 | 0 | 0 |
| Interactions of Vpr with host cellular proteins | R-HSA-176033 | 1.659762e-03 | 2.780 | 0 | 0 |
| Transport of Mature Transcript to Cytoplasm | R-HSA-72202 | 1.686602e-03 | 2.773 | 0 | 0 |
| Senescence-Associated Secretory Phenotype (SASP) | R-HSA-2559582 | 1.686602e-03 | 2.773 | 0 | 0 |
| PTEN Regulation | R-HSA-6807070 | 1.698649e-03 | 2.770 | 0 | 0 |
| Alpha-protein kinase 1 signaling pathway | R-HSA-9645460 | 1.704175e-03 | 2.768 | 0 | 0 |
| InlA-mediated entry of Listeria monocytogenes into host cells | R-HSA-8876493 | 1.704175e-03 | 2.768 | 0 | 0 |
| APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 | R-HSA-174178 | 1.755626e-03 | 2.756 | 0 | 0 |
| Regulation of PTEN stability and activity | R-HSA-8948751 | 1.755626e-03 | 2.756 | 0 | 0 |
| Termination of translesion DNA synthesis | R-HSA-5656169 | 1.760332e-03 | 2.754 | 0 | 0 |
| Late endosomal microautophagy | R-HSA-9615710 | 1.760332e-03 | 2.754 | 0 | 0 |
| Translesion synthesis by Y family DNA polymerases bypasses lesions on DNA template | R-HSA-110313 | 1.866528e-03 | 2.729 | 0 | 0 |
| NIK-->noncanonical NF-kB signaling | R-HSA-5676590 | 1.866528e-03 | 2.729 | 0 | 0 |
| Loss of MECP2 binding ability to 5hmC-DNA | R-HSA-9022534 | 2.403318e-03 | 2.619 | 0 | 0 |
| APC-Cdc20 mediated degradation of Nek2A | R-HSA-179409 | 2.586876e-03 | 2.587 | 0 | 0 |
| Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC) | R-HSA-5619107 | 2.024025e-03 | 2.694 | 0 | 0 |
| IP3 and IP4 transport between cytosol and nucleus | R-HSA-1855196 | 2.316515e-03 | 2.635 | 0 | 0 |
| IP6 and IP7 transport between cytosol and nucleus | R-HSA-1855229 | 2.316515e-03 | 2.635 | 0 | 0 |
| Gap-filling DNA repair synthesis and ligation in TC-NER | R-HSA-6782210 | 2.353412e-03 | 2.628 | 0 | 0 |
| Late Phase of HIV Life Cycle | R-HSA-162599 | 2.133678e-03 | 2.671 | 0 | 0 |
| Positive epigenetic regulation of rRNA expression | R-HSA-5250913 | 2.395309e-03 | 2.621 | 0 | 0 |
| Negative regulators of DDX58/IFIH1 signaling | R-HSA-936440 | 2.316515e-03 | 2.635 | 0 | 0 |
| Regulation of TBK1, IKKε (IKBKE)-mediated activation of IRF3, IRF7 | R-HSA-9824878 | 2.184346e-03 | 2.661 | 0 | 0 |
| Degradation of CRY and PER proteins | R-HSA-9932298 | 2.092721e-03 | 2.679 | 0 | 0 |
| Negative regulation of MET activity | R-HSA-6807004 | 2.188138e-03 | 2.660 | 0 | 0 |
| NFE2L2 regulates pentose phosphate pathway genes | R-HSA-9818028 | 2.184346e-03 | 2.661 | 0 | 0 |
| Degradation of GLI1 by the proteasome | R-HSA-5610780 | 2.092721e-03 | 2.679 | 0 | 0 |
| Signaling by TGF-beta Receptor Complex | R-HSA-170834 | 1.989652e-03 | 2.701 | 0 | 0 |
| Evasion by RSV of host interferon responses | R-HSA-9833109 | 2.316515e-03 | 2.635 | 0 | 0 |
| ATF6 (ATF6-alpha) activates chaperone genes | R-HSA-381183 | 2.184346e-03 | 2.661 | 0 | 0 |
| Degradation of GLI2 by the proteasome | R-HSA-5610783 | 2.092721e-03 | 2.679 | 0 | 0 |
| GLI3 is processed to GLI3R by the proteasome | R-HSA-5610785 | 2.092721e-03 | 2.679 | 0 | 0 |
| Negative regulation of MAPK pathway | R-HSA-5675221 | 2.092721e-03 | 2.679 | 0 | 0 |
| NOTCH2 Activation and Transmission of Signal to the Nucleus | R-HSA-2979096 | 2.586876e-03 | 2.587 | 0 | 0 |
| Vesicle-mediated transport | R-HSA-5653656 | 2.192697e-03 | 2.659 | 0 | 0 |
| Prevention of phagosomal-lysosomal fusion | R-HSA-9636383 | 2.586876e-03 | 2.587 | 0 | 0 |
| TICAM1-dependent activation of IRF3/IRF7 | R-HSA-9013973 | 2.184346e-03 | 2.661 | 0 | 0 |
| NF-kB is activated and signals survival | R-HSA-209560 | 2.184346e-03 | 2.661 | 0 | 0 |
| Interleukin-3, Interleukin-5 and GM-CSF signaling | R-HSA-512988 | 2.339534e-03 | 2.631 | 0 | 0 |
| Formation of the dystrophin-glycoprotein complex (DGC) | R-HSA-9913351 | 2.316515e-03 | 2.635 | 0 | 0 |
| Transcriptional regulation by RUNX3 | R-HSA-8878159 | 1.989652e-03 | 2.701 | 0 | 0 |
| Nephrin family interactions | R-HSA-373753 | 2.188138e-03 | 2.660 | 0 | 0 |
| Response of Mtb to phagocytosis | R-HSA-9637690 | 2.608189e-03 | 2.584 | 0 | 0 |
| Constitutive Signaling by Overexpressed ERBB2 | R-HSA-9634285 | 2.750463e-03 | 2.561 | 0 | 0 |
| Signaling by NOTCH1 HD Domain Mutants in Cancer | R-HSA-2691230 | 2.750463e-03 | 2.561 | 0 | 0 |
| Constitutive Signaling by NOTCH1 HD Domain Mutants | R-HSA-2691232 | 2.750463e-03 | 2.561 | 0 | 0 |
| IRAK1 recruits IKK complex upon TLR7/8 or 9 stimulation | R-HSA-975144 | 2.750463e-03 | 2.561 | 0 | 0 |
| IRAK1 recruits IKK complex | R-HSA-937039 | 2.750463e-03 | 2.561 | 0 | 0 |
| VLDLR internalisation and degradation | R-HSA-8866427 | 2.750463e-03 | 2.561 | 0 | 0 |
| Switching of origins to a post-replicative state | R-HSA-69052 | 2.821525e-03 | 2.550 | 0 | 0 |
| Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors | R-HSA-8864260 | 2.899930e-03 | 2.538 | 0 | 0 |
| RMTs methylate histone arginines | R-HSA-3214858 | 2.899930e-03 | 2.538 | 0 | 0 |
| IPs transport between nucleus and cytosol | R-HSA-1855170 | 2.995634e-03 | 2.524 | 0 | 0 |
| Transport of the SLBP independent Mature mRNA | R-HSA-159227 | 2.995634e-03 | 2.524 | 0 | 0 |
| Ras activation upon Ca2+ influx through NMDA receptor | R-HSA-442982 | 3.035804e-03 | 2.518 | 0 | 0 |
| activated TAK1 mediates p38 MAPK activation | R-HSA-450302 | 3.035804e-03 | 2.518 | 0 | 0 |
| Listeria monocytogenes entry into host cells | R-HSA-8876384 | 3.035804e-03 | 2.518 | 0 | 0 |
| Initiation of Nuclear Envelope (NE) Reformation | R-HSA-2995383 | 3.035804e-03 | 2.518 | 0 | 0 |
| Assembly Of The HIV Virion | R-HSA-175474 | 3.035804e-03 | 2.518 | 0 | 0 |
| Inactivation of CSF3 (G-CSF) signaling | R-HSA-9705462 | 3.035804e-03 | 2.518 | 0 | 0 |
| Neuronal System | R-HSA-112316 | 3.182539e-03 | 2.497 | 0 | 0 |
| Nucleosome assembly | R-HSA-774815 | 3.216026e-03 | 2.493 | 0 | 0 |
| Deposition of new CENPA-containing nucleosomes at the centromere | R-HSA-606279 | 3.216026e-03 | 2.493 | 0 | 0 |
| NEP/NS2 Interacts with the Cellular Export Machinery | R-HSA-168333 | 3.216026e-03 | 2.493 | 0 | 0 |
| Asymmetric localization of PCP proteins | R-HSA-4608870 | 3.216026e-03 | 2.493 | 0 | 0 |
| Dectin-1 mediated noncanonical NF-kB signaling | R-HSA-5607761 | 3.216026e-03 | 2.493 | 0 | 0 |
| Ubiquitin-Mediated Degradation of Phosphorylated Cdc25A | R-HSA-69601 | 3.216026e-03 | 2.493 | 0 | 0 |
| p53-Independent G1/S DNA Damage Checkpoint | R-HSA-69613 | 3.216026e-03 | 2.493 | 0 | 0 |
| Transport of the SLBP Dependant Mature mRNA | R-HSA-159230 | 3.386207e-03 | 2.470 | 0 | 0 |
| Regulation of Glucokinase by Glucokinase Regulatory Protein | R-HSA-170822 | 3.386207e-03 | 2.470 | 0 | 0 |
| Membrane binding and targetting of GAG proteins | R-HSA-174490 | 3.409624e-03 | 2.467 | 0 | 0 |
| Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex | R-HSA-75035 | 3.409624e-03 | 2.467 | 0 | 0 |
| ATF6 (ATF6-alpha) activates chaperones | R-HSA-381033 | 3.409624e-03 | 2.467 | 0 | 0 |
| mTORC1-mediated signalling | R-HSA-166208 | 3.538368e-03 | 2.451 | 0 | 0 |
| Downregulation of TGF-beta receptor signaling | R-HSA-2173788 | 3.538368e-03 | 2.451 | 0 | 0 |
| Transcriptional Regulation by MECP2 | R-HSA-8986944 | 3.551700e-03 | 2.450 | 0 | 0 |
| Regulation of pyruvate metabolism | R-HSA-9861718 | 3.557763e-03 | 2.449 | 0 | 0 |
| MAPK family signaling cascades | R-HSA-5683057 | 3.690469e-03 | 2.433 | 0 | 0 |
| Chromosome Maintenance | R-HSA-73886 | 3.797477e-03 | 2.421 | 0 | 0 |
| Regulation of endogenous retroelements by the Human Silencing Hub (HUSH) complex | R-HSA-9843970 | 3.813457e-03 | 2.419 | 0 | 0 |
| Dual Incision in GG-NER | R-HSA-5696400 | 3.813457e-03 | 2.419 | 0 | 0 |
| Respiratory Syncytial Virus Infection Pathway | R-HSA-9820952 | 4.064953e-03 | 2.391 | 0 | 0 |
| Synthesis of DNA | R-HSA-69239 | 4.108193e-03 | 2.386 | 0 | 0 |
| PCP/CE pathway | R-HSA-4086400 | 4.151538e-03 | 2.382 | 0 | 0 |
| IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation | R-HSA-975163 | 4.168704e-03 | 2.380 | 0 | 0 |
| Synthesis And Processing Of GAG, GAGPOL Polyproteins | R-HSA-174495 | 4.168704e-03 | 2.380 | 0 | 0 |
| MAP3K8 (TPL2)-dependent MAPK1/3 activation | R-HSA-5684264 | 4.168704e-03 | 2.380 | 0 | 0 |
| TFAP2A acts as a transcriptional repressor during retinoic acid induced cell differentiation | R-HSA-8869496 | 4.275572e-03 | 2.369 | 0 | 0 |
| Turbulent (oscillatory, disturbed) flow shear stress activates signaling by PIEZO1 and integrins in endothelial cells | R-HSA-9860927 | 4.279405e-03 | 2.369 | 0 | 0 |
| Signal Transduction | R-HSA-162582 | 4.304131e-03 | 2.366 | 0 | 0 |
| rRNA modification in the nucleus and cytosol | R-HSA-6790901 | 4.368280e-03 | 2.360 | 0 | 0 |
| Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models | R-HSA-8862803 | 4.718141e-03 | 2.326 | 0 | 0 |
| Neurodegenerative Diseases | R-HSA-8863678 | 4.718141e-03 | 2.326 | 0 | 0 |
| Signaling by MET | R-HSA-6806834 | 4.803415e-03 | 2.318 | 0 | 0 |
| TRAF6-mediated induction of TAK1 complex within TLR4 complex | R-HSA-937072 | 5.034323e-03 | 2.298 | 0 | 0 |
| TICAM1, RIP1-mediated IKK complex recruitment | R-HSA-168927 | 5.034323e-03 | 2.298 | 0 | 0 |
| Manipulation of host energy metabolism | R-HSA-9636667 | 5.282264e-03 | 2.277 | 0 | 0 |
| Breakdown of the nuclear lamina | R-HSA-352238 | 5.282264e-03 | 2.277 | 0 | 0 |
| Synthesis of active ubiquitin: roles of E1 and E2 enzymes | R-HSA-8866652 | 6.975144e-03 | 2.156 | 0 | 0 |
| Transport of Mature mRNA Derived from an Intronless Transcript | R-HSA-159231 | 6.570833e-03 | 2.182 | 0 | 0 |
| Transport of Mature mRNAs Derived from Intronless Transcripts | R-HSA-159234 | 7.260757e-03 | 2.139 | 0 | 0 |
| RNA Polymerase I Promoter Escape | R-HSA-73772 | 6.220761e-03 | 2.206 | 0 | 0 |
| Meiotic synapsis | R-HSA-1221632 | 6.779273e-03 | 2.169 | 0 | 0 |
| Cyclin E associated events during G1/S transition | R-HSA-69202 | 7.504549e-03 | 2.125 | 0 | 0 |
| Defective Intrinsic Pathway for Apoptosis | R-HSA-9734009 | 6.975144e-03 | 2.156 | 0 | 0 |
| Regulation of PD-L1(CD274) Post-translational modification | R-HSA-9909615 | 7.243546e-03 | 2.140 | 0 | 0 |
| Regulation of innate immune responses to cytosolic DNA | R-HSA-3134975 | 7.110204e-03 | 2.148 | 0 | 0 |
| Deactivation of the beta-catenin transactivating complex | R-HSA-3769402 | 5.335521e-03 | 2.273 | 0 | 0 |
| Uptake and function of diphtheria toxin | R-HSA-5336415 | 5.714138e-03 | 2.243 | 0 | 0 |
| TNFR1-induced NF-kappa-B signaling pathway | R-HSA-5357956 | 6.975144e-03 | 2.156 | 0 | 0 |
| HATs acetylate histones | R-HSA-3214847 | 6.772117e-03 | 2.169 | 0 | 0 |
| Activated NOTCH1 Transmits Signal to the Nucleus | R-HSA-2122948 | 6.153396e-03 | 2.211 | 0 | 0 |
| Negative regulation of FGFR3 signaling | R-HSA-5654732 | 7.870620e-03 | 2.104 | 0 | 0 |
| Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha | R-HSA-1234176 | 5.697281e-03 | 2.244 | 0 | 0 |
| Activation of IRF3, IRF7 mediated by TBK1, IKKε (IKBKE) | R-HSA-936964 | 7.110204e-03 | 2.148 | 0 | 0 |
| Transport of Ribonucleoproteins into the Host Nucleus | R-HSA-168271 | 8.001540e-03 | 2.097 | 0 | 0 |
| TFAP2 (AP-2) family regulates transcription of growth factors and their receptors | R-HSA-8866910 | 7.110204e-03 | 2.148 | 0 | 0 |
| SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription | R-HSA-2173796 | 5.335521e-03 | 2.273 | 0 | 0 |
| TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling | R-HSA-975110 | 7.110204e-03 | 2.148 | 0 | 0 |
| SARS-CoV-2 activates/modulates innate and adaptive immune responses | R-HSA-9705671 | 5.535722e-03 | 2.257 | 0 | 0 |
| Regulation of NF-kappa B signaling | R-HSA-9758274 | 6.012816e-03 | 2.221 | 0 | 0 |
| Signaling by NOTCH | R-HSA-157118 | 6.393651e-03 | 2.194 | 0 | 0 |
| Suppression of phagosomal maturation | R-HSA-9637687 | 6.153396e-03 | 2.211 | 0 | 0 |
| Regulation of BACH1 activity | R-HSA-9708530 | 6.012816e-03 | 2.221 | 0 | 0 |
| Transport to the Golgi and subsequent modification | R-HSA-948021 | 6.581653e-03 | 2.182 | 0 | 0 |
| FLT3 Signaling | R-HSA-9607240 | 8.001540e-03 | 2.097 | 0 | 0 |
| HDACs deacetylate histones | R-HSA-3214815 | 8.006862e-03 | 2.097 | 0 | 0 |
| Signaling by NOTCH3 | R-HSA-9012852 | 8.006862e-03 | 2.097 | 0 | 0 |
| Constitutive Signaling by EGFRvIII | R-HSA-5637810 | 8.332172e-03 | 2.079 | 0 | 0 |
| Signaling by EGFRvIII in Cancer | R-HSA-5637812 | 8.332172e-03 | 2.079 | 0 | 0 |
| Regulation of FZD by ubiquitination | R-HSA-4641263 | 8.332172e-03 | 2.079 | 0 | 0 |
| Glycogen storage diseases | R-HSA-3229121 | 8.332172e-03 | 2.079 | 0 | 0 |
| Cyclin A:Cdk2-associated events at S phase entry | R-HSA-69656 | 8.652840e-03 | 2.063 | 0 | 0 |
| Diseases of programmed cell death | R-HSA-9645723 | 8.772571e-03 | 2.057 | 0 | 0 |
| Negative regulation of FGFR4 signaling | R-HSA-5654733 | 8.842964e-03 | 2.053 | 0 | 0 |
| Signaling by CSF3 (G-CSF) | R-HSA-9674555 | 8.842964e-03 | 2.053 | 0 | 0 |
| Cargo recognition for clathrin-mediated endocytosis | R-HSA-8856825 | 9.060626e-03 | 2.043 | 0 | 0 |
| Post-translational protein modification | R-HSA-597592 | 9.142651e-03 | 2.039 | 0 | 0 |
| Drug resistance in ERBB2 KD mutants | R-HSA-9665230 | 9.173901e-03 | 2.037 | 0 | 0 |
| Drug-mediated inhibition of ERBB2 signaling | R-HSA-9652282 | 9.173901e-03 | 2.037 | 0 | 0 |
| Resistance of ERBB2 KD mutants to afatinib | R-HSA-9665249 | 9.173901e-03 | 2.037 | 0 | 0 |
| Resistance of ERBB2 KD mutants to sapitinib | R-HSA-9665244 | 9.173901e-03 | 2.037 | 0 | 0 |
| TGFBR1 LBD Mutants in Cancer | R-HSA-3656535 | 9.173901e-03 | 2.037 | 0 | 0 |
| Resistance of ERBB2 KD mutants to tesevatinib | R-HSA-9665245 | 9.173901e-03 | 2.037 | 0 | 0 |
| Resistance of ERBB2 KD mutants to AEE788 | R-HSA-9665250 | 9.173901e-03 | 2.037 | 0 | 0 |
| Resistance of ERBB2 KD mutants to lapatinib | R-HSA-9665251 | 9.173901e-03 | 2.037 | 0 | 0 |
| Resistance of ERBB2 KD mutants to neratinib | R-HSA-9665246 | 9.173901e-03 | 2.037 | 0 | 0 |
| Resistance of ERBB2 KD mutants to osimertinib | R-HSA-9665247 | 9.173901e-03 | 2.037 | 0 | 0 |
| Drug resistance in ERBB2 TMD/JMD mutants | R-HSA-9665737 | 9.173901e-03 | 2.037 | 0 | 0 |
| Resistance of ERBB2 KD mutants to trastuzumab | R-HSA-9665233 | 9.173901e-03 | 2.037 | 0 | 0 |
| Cell death signalling via NRAGE, NRIF and NADE | R-HSA-204998 | 9.273963e-03 | 2.033 | 0 | 0 |
| DNA Double-Strand Break Repair | R-HSA-5693532 | 9.315135e-03 | 2.031 | 0 | 0 |
| ER-Phagosome pathway | R-HSA-1236974 | 9.333019e-03 | 2.030 | 0 | 0 |
| Caspase-mediated cleavage of cytoskeletal proteins | R-HSA-264870 | 9.374017e-03 | 2.028 | 0 | 0 |
| Regulation of PD-L1(CD274) expression | R-HSA-9909648 | 9.596738e-03 | 2.018 | 0 | 0 |
| Signaling by ERBB2 ECD mutants | R-HSA-9665348 | 9.684058e-03 | 2.014 | 0 | 0 |
| Signaling by ERBB2 in Cancer | R-HSA-1227990 | 9.895231e-03 | 2.005 | 0 | 0 |
| Signaling by ERBB4 | R-HSA-1236394 | 9.927726e-03 | 2.003 | 0 | 0 |
| Dual incision in TC-NER | R-HSA-6782135 | 1.014510e-02 | 1.994 | 0 | 0 |
| Signaling by FGFR4 | R-HSA-5654743 | 1.054879e-02 | 1.977 | 0 | 0 |
| Transcription-Coupled Nucleotide Excision Repair (TC-NER) | R-HSA-6781827 | 1.061512e-02 | 1.974 | 0 | 0 |
| Trafficking of AMPA receptors | R-HSA-399719 | 1.103038e-02 | 1.957 | 0 | 0 |
| Budding and maturation of HIV virion | R-HSA-162588 | 1.103038e-02 | 1.957 | 0 | 0 |
| IKK complex recruitment mediated by RIP1 | R-HSA-937041 | 1.117083e-02 | 1.952 | 0 | 0 |
| Unfolded Protein Response (UPR) | R-HSA-381119 | 1.119872e-02 | 1.951 | 0 | 0 |
| EPHB-mediated forward signaling | R-HSA-3928662 | 1.151261e-02 | 1.939 | 0 | 0 |
| Folding of actin by CCT/TriC | R-HSA-390450 | 1.161340e-02 | 1.935 | 0 | 0 |
| CaMK IV-mediated phosphorylation of CREB | R-HSA-111932 | 1.161340e-02 | 1.935 | 0 | 0 |
| Signaling by FGFR3 | R-HSA-5654741 | 1.253694e-02 | 1.902 | 0 | 0 |
| Viral Messenger RNA Synthesis | R-HSA-168325 | 1.267185e-02 | 1.897 | 0 | 0 |
| Regulation of RUNX2 expression and activity | R-HSA-8939902 | 1.267185e-02 | 1.897 | 0 | 0 |
| Protein hydroxylation | R-HSA-9629569 | 1.279709e-02 | 1.893 | 0 | 0 |
| Glycogen synthesis | R-HSA-3322077 | 1.279709e-02 | 1.893 | 0 | 0 |
| ABC transporter disorders | R-HSA-5619084 | 1.288890e-02 | 1.890 | 0 | 0 |
| TCR signaling | R-HSA-202403 | 1.320530e-02 | 1.879 | 0 | 0 |
| Regulation of necroptotic cell death | R-HSA-5675482 | 1.356063e-02 | 1.868 | 0 | 0 |
| Negative regulation of FGFR1 signaling | R-HSA-5654726 | 1.356063e-02 | 1.868 | 0 | 0 |
| Glutamate binding, activation of AMPA receptors and synaptic plasticity | R-HSA-399721 | 1.356063e-02 | 1.868 | 0 | 0 |
| CREB1 phosphorylation through NMDA receptor-mediated activation of RAS signaling | R-HSA-442742 | 1.356063e-02 | 1.868 | 0 | 0 |
| tRNA processing in the nucleus | R-HSA-6784531 | 1.360659e-02 | 1.866 | 0 | 0 |
| Regulation of TNFR1 signaling | R-HSA-5357905 | 1.362361e-02 | 1.866 | 0 | 0 |
| Loss of MECP2 binding ability to 5mC-DNA | R-HSA-9022538 | 1.400429e-02 | 1.854 | 0 | 0 |
| DDX58/IFIH1-mediated induction of interferon-alpha/beta | R-HSA-168928 | 1.404477e-02 | 1.852 | 0 | 0 |
| Early Phase of HIV Life Cycle | R-HSA-162594 | 1.456703e-02 | 1.837 | 0 | 0 |
| JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 | R-HSA-450321 | 1.456703e-02 | 1.837 | 0 | 0 |
| PD-L1(CD274) glycosylation and translocation to plasma membrane | R-HSA-9931295 | 1.456703e-02 | 1.837 | 0 | 0 |
| EPH-ephrin mediated repulsion of cells | R-HSA-3928665 | 1.477438e-02 | 1.830 | 0 | 0 |
| DNA Damage Recognition in GG-NER | R-HSA-5696394 | 1.496109e-02 | 1.825 | 0 | 0 |
| Amyloid fiber formation | R-HSA-977225 | 1.550044e-02 | 1.810 | 0 | 0 |
| RAF activation | R-HSA-5673000 | 1.645516e-02 | 1.784 | 0 | 0 |
| Signaling by CSF1 (M-CSF) in myeloid cells | R-HSA-9680350 | 1.645516e-02 | 1.784 | 0 | 0 |
| Negative regulation of FGFR2 signaling | R-HSA-5654727 | 1.645516e-02 | 1.784 | 0 | 0 |
| Signaling by NOTCH2 | R-HSA-1980145 | 1.645516e-02 | 1.784 | 0 | 0 |
| Unblocking of NMDA receptors, glutamate binding and activation | R-HSA-438066 | 1.648450e-02 | 1.783 | 0 | 0 |
| Negative regulation of NMDA receptor-mediated neuronal transmission | R-HSA-9617324 | 1.648450e-02 | 1.783 | 0 | 0 |
| Telomere Maintenance | R-HSA-157579 | 1.652796e-02 | 1.782 | 0 | 0 |
| Cellular response to hypoxia | R-HSA-1234174 | 1.670616e-02 | 1.777 | 0 | 0 |
| Integration of provirus | R-HSA-162592 | 1.694191e-02 | 1.771 | 0 | 0 |
| S Phase | R-HSA-69242 | 1.731849e-02 | 1.761 | 0 | 0 |
| Oncogene Induced Senescence | R-HSA-2559585 | 1.804520e-02 | 1.744 | 0 | 0 |
| p75 NTR receptor-mediated signalling | R-HSA-193704 | 1.835282e-02 | 1.736 | 0 | 0 |
| Global Genome Nucleotide Excision Repair (GG-NER) | R-HSA-5696399 | 1.847530e-02 | 1.733 | 0 | 0 |
| VEGFA-VEGFR2 Pathway | R-HSA-4420097 | 1.863381e-02 | 1.730 | 0 | 0 |
| Meiosis | R-HSA-1500620 | 1.955193e-02 | 1.709 | 0 | 0 |
| MAPK6/MAPK4 signaling | R-HSA-5687128 | 1.955193e-02 | 1.709 | 0 | 0 |
| MECP2 regulates transcription of genes involved in GABA signaling | R-HSA-9022927 | 1.970338e-02 | 1.705 | 0 | 0 |
| PLCG1 events in ERBB2 signaling | R-HSA-1251932 | 1.970338e-02 | 1.705 | 0 | 0 |
| MTF1 activates gene expression | R-HSA-5660489 | 1.970338e-02 | 1.705 | 0 | 0 |
| Sensory processing of sound by inner hair cells of the cochlea | R-HSA-9662360 | 2.027431e-02 | 1.693 | 0 | 0 |
| Syndecan interactions | R-HSA-3000170 | 2.077532e-02 | 1.682 | 0 | 0 |
| Protein localization | R-HSA-9609507 | 2.118921e-02 | 1.674 | 0 | 0 |
| Homology Directed Repair | R-HSA-5693538 | 2.140354e-02 | 1.670 | 0 | 0 |
| Estrogen-dependent gene expression | R-HSA-9018519 | 2.285384e-02 | 1.641 | 0 | 0 |
| Cytosolic sensors of pathogen-associated DNA | R-HSA-1834949 | 2.292882e-02 | 1.640 | 0 | 0 |
| Degradation of beta-catenin by the destruction complex | R-HSA-195253 | 2.292882e-02 | 1.640 | 0 | 0 |
| Pyruvate metabolism | R-HSA-70268 | 2.304915e-02 | 1.637 | 0 | 0 |
| Signaling by ERBB2 TMD/JMD mutants | R-HSA-9665686 | 2.315437e-02 | 1.635 | 0 | 0 |
| RIPK1-mediated regulated necrosis | R-HSA-5213460 | 2.341283e-02 | 1.631 | 0 | 0 |
| Golgi Cisternae Pericentriolar Stack Reorganization | R-HSA-162658 | 2.342508e-02 | 1.630 | 0 | 0 |
| NoRC negatively regulates rRNA expression | R-HSA-427413 | 2.434206e-02 | 1.614 | 0 | 0 |
| Hedgehog 'on' state | R-HSA-5632684 | 2.434206e-02 | 1.614 | 0 | 0 |
| RAS processing | R-HSA-9648002 | 2.540771e-02 | 1.595 | 0 | 0 |
| Pentose phosphate pathway | R-HSA-71336 | 2.540771e-02 | 1.595 | 0 | 0 |
| Long-term potentiation | R-HSA-9620244 | 2.569234e-02 | 1.590 | 0 | 0 |
| Nucleotide Excision Repair | R-HSA-5696398 | 2.589580e-02 | 1.587 | 0 | 0 |
| Loss of Function of TGFBR1 in Cancer | R-HSA-3656534 | 2.620489e-02 | 1.582 | 0 | 0 |
| Loss of phosphorylation of MECP2 at T308 | R-HSA-9022535 | 2.620489e-02 | 1.582 | 0 | 0 |
| Toxicity of botulinum toxin type G (botG) | R-HSA-5250989 | 2.620489e-02 | 1.582 | 0 | 0 |
| NFE2L2 regulating TCA cycle genes | R-HSA-9818025 | 2.620489e-02 | 1.582 | 0 | 0 |
| Maternal to zygotic transition (MZT) | R-HSA-9816359 | 2.666724e-02 | 1.574 | 0 | 0 |
| Downstream TCR signaling | R-HSA-202424 | 2.696481e-02 | 1.569 | 0 | 0 |
| Co-inhibition by PD-1 | R-HSA-389948 | 2.717066e-02 | 1.566 | 0 | 0 |
| Inhibition of DNA recombination at telomere | R-HSA-9670095 | 2.750833e-02 | 1.561 | 0 | 0 |
| Signaling by TGFB family members | R-HSA-9006936 | 2.763993e-02 | 1.558 | 0 | 0 |
| TNF signaling | R-HSA-75893 | 2.828323e-02 | 1.548 | 0 | 0 |
| Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer | R-HSA-2173793 | 2.828323e-02 | 1.548 | 0 | 0 |
| Signaling by FGFR1 | R-HSA-5654736 | 2.828323e-02 | 1.548 | 0 | 0 |
| Sensory processing of sound by outer hair cells of the cochlea | R-HSA-9662361 | 2.828323e-02 | 1.548 | 0 | 0 |
| Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3 | R-HSA-5625886 | 2.971618e-02 | 1.527 | 0 | 0 |
| M-decay: degradation of maternal mRNAs by maternally stored factors | R-HSA-9820841 | 2.971618e-02 | 1.527 | 0 | 0 |
| Antigen processing-Cross presentation | R-HSA-1236975 | 2.971877e-02 | 1.527 | 0 | 0 |
| IRE1alpha activates chaperones | R-HSA-381070 | 2.981818e-02 | 1.526 | 0 | 0 |
| Signaling by VEGF | R-HSA-194138 | 3.023735e-02 | 1.519 | 0 | 0 |
| G1/S Transition | R-HSA-69206 | 3.023735e-02 | 1.519 | 0 | 0 |
| Pentose phosphate pathway disease | R-HSA-6791465 | 3.344606e-02 | 1.476 | 0 | 0 |
| Noncanonical activation of NOTCH3 | R-HSA-9017802 | 3.344606e-02 | 1.476 | 0 | 0 |
| Loss of MECP2 binding ability to the NCoR/SMRT complex | R-HSA-9022537 | 3.344606e-02 | 1.476 | 0 | 0 |
| PTK6 promotes HIF1A stabilization | R-HSA-8857538 | 4.136754e-02 | 1.383 | 0 | 0 |
| MECP2 regulates transcription factors | R-HSA-9022707 | 4.991320e-02 | 1.302 | 0 | 0 |
| Type I hemidesmosome assembly | R-HSA-446107 | 5.902998e-02 | 1.229 | 0 | 0 |
| Formyl peptide receptors bind formyl peptides and many other ligands | R-HSA-444473 | 5.902998e-02 | 1.229 | 0 | 0 |
| Formation of annular gap junctions | R-HSA-196025 | 5.902998e-02 | 1.229 | 0 | 0 |
| GRB2:SOS provides linkage to MAPK signaling for Integrins | R-HSA-354194 | 3.532299e-02 | 1.452 | 0 | 0 |
| GRB2 events in ERBB2 signaling | R-HSA-1963640 | 3.986093e-02 | 1.399 | 0 | 0 |
| p130Cas linkage to MAPK signaling for integrins | R-HSA-372708 | 4.467886e-02 | 1.350 | 0 | 0 |
| EPHA-mediated growth cone collapse | R-HSA-3928663 | 3.125221e-02 | 1.505 | 0 | 0 |
| Packaging Of Telomere Ends | R-HSA-171306 | 3.125221e-02 | 1.505 | 0 | 0 |
| Signaling by ERBB2 KD Mutants | R-HSA-9664565 | 3.746563e-02 | 1.426 | 0 | 0 |
| DNA methylation | R-HSA-5334118 | 3.746563e-02 | 1.426 | 0 | 0 |
| Endosomal Sorting Complex Required For Transport (ESCRT) | R-HSA-917729 | 3.746563e-02 | 1.426 | 0 | 0 |
| Association of TriC/CCT with target proteins during biosynthesis | R-HSA-390471 | 5.587820e-02 | 1.253 | 0 | 0 |
| Formation of TC-NER Pre-Incision Complex | R-HSA-6781823 | 4.528081e-02 | 1.344 | 0 | 0 |
| Nonhomologous End-Joining (NHEJ) | R-HSA-5693571 | 5.137080e-02 | 1.289 | 0 | 0 |
| Regulation of PTEN gene transcription | R-HSA-8943724 | 3.627597e-02 | 1.440 | 0 | 0 |
| Developmental Lineage of Pancreatic Ductal Cells | R-HSA-9925563 | 5.914880e-02 | 1.228 | 0 | 0 |
| Amplification of signal from the kinetochores | R-HSA-141424 | 5.305588e-02 | 1.275 | 0 | 0 |
| Amplification of signal from unattached kinetochores via a MAD2 inhibitory signal | R-HSA-141444 | 5.305588e-02 | 1.275 | 0 | 0 |
| Regulation of endogenous retroelements | R-HSA-9842860 | 5.133428e-02 | 1.290 | 0 | 0 |
| SHC1 events in ERBB2 signaling | R-HSA-1250196 | 4.081920e-02 | 1.389 | 0 | 0 |
| GAB1 signalosome | R-HSA-180292 | 4.977193e-02 | 1.303 | 0 | 0 |
| Toxicity of botulinum toxin type B (botB) | R-HSA-5250958 | 5.902998e-02 | 1.229 | 0 | 0 |
| Condensation of Prophase Chromosomes | R-HSA-2299718 | 4.528081e-02 | 1.344 | 0 | 0 |
| Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks | R-HSA-5693565 | 3.415610e-02 | 1.467 | 0 | 0 |
| Serotonin Neurotransmitter Release Cycle | R-HSA-181429 | 4.977193e-02 | 1.303 | 0 | 0 |
| Peroxisomal protein import | R-HSA-9033241 | 3.415610e-02 | 1.467 | 0 | 0 |
| Mitotic Spindle Checkpoint | R-HSA-69618 | 4.720266e-02 | 1.326 | 0 | 0 |
| RNA Polymerase I Transcription | R-HSA-73864 | 3.593006e-02 | 1.445 | 0 | 0 |
| DNA Double Strand Break Response | R-HSA-5693606 | 5.346613e-02 | 1.272 | 0 | 0 |
| MTOR signalling | R-HSA-165159 | 3.445890e-02 | 1.463 | 0 | 0 |
| Aryl hydrocarbon receptor signalling | R-HSA-8937144 | 3.344606e-02 | 1.476 | 0 | 0 |
| RNA Polymerase I Promoter Clearance | R-HSA-73854 | 3.230758e-02 | 1.491 | 0 | 0 |
| Negative epigenetic regulation of rRNA expression | R-HSA-5250941 | 3.981123e-02 | 1.400 | 0 | 0 |
| Signaling by TGF-beta Receptor Complex in Cancer | R-HSA-3304351 | 4.136754e-02 | 1.383 | 0 | 0 |
| Sema4D induced cell migration and growth-cone collapse | R-HSA-416572 | 6.076072e-02 | 1.216 | 0 | 0 |
| PIP3 activates AKT signaling | R-HSA-1257604 | 6.127811e-02 | 1.213 | 0 | 0 |
| Sema3A PAK dependent Axon repulsion | R-HSA-399954 | 3.106909e-02 | 1.508 | 0 | 0 |
| RNA Polymerase I Promoter Opening | R-HSA-73728 | 3.125221e-02 | 1.505 | 0 | 0 |
| Meiotic recombination | R-HSA-912446 | 6.136049e-02 | 1.212 | 0 | 0 |
| Mechanical load activates signaling by PIEZO1 and integrins in osteocytes | R-HSA-9856532 | 5.513460e-02 | 1.259 | 0 | 0 |
| Intracellular signaling by second messengers | R-HSA-9006925 | 3.719644e-02 | 1.429 | 0 | 0 |
| DNA Repair | R-HSA-73894 | 5.560521e-02 | 1.255 | 0 | 0 |
| CHL1 interactions | R-HSA-447041 | 4.991320e-02 | 1.302 | 0 | 0 |
| Activation of BAD and translocation to mitochondria | R-HSA-111447 | 3.106909e-02 | 1.508 | 0 | 0 |
| Fanconi Anemia Pathway | R-HSA-6783310 | 4.240631e-02 | 1.373 | 0 | 0 |
| MAP kinase activation | R-HSA-450294 | 3.847845e-02 | 1.415 | 0 | 0 |
| ESR-mediated signaling | R-HSA-8939211 | 4.443999e-02 | 1.352 | 0 | 0 |
| Signaling by Hippo | R-HSA-2028269 | 4.467886e-02 | 1.350 | 0 | 0 |
| TAK1-dependent IKK and NF-kappa-B activation | R-HSA-445989 | 4.826888e-02 | 1.316 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of myeloid cells | R-HSA-8939246 | 5.902998e-02 | 1.229 | 0 | 0 |
| TCF dependent signaling in response to WNT | R-HSA-201681 | 3.101359e-02 | 1.508 | 0 | 0 |
| NOD1/2 Signaling Pathway | R-HSA-168638 | 6.005079e-02 | 1.221 | 0 | 0 |
| Reproduction | R-HSA-1474165 | 3.836613e-02 | 1.416 | 0 | 0 |
| Death Receptor Signaling | R-HSA-73887 | 4.639345e-02 | 1.334 | 0 | 0 |
| HCMV Late Events | R-HSA-9610379 | 5.122891e-02 | 1.290 | 0 | 0 |
| Signaling by FGFR2 | R-HSA-5654738 | 3.981123e-02 | 1.400 | 0 | 0 |
| Downregulation of SMAD2/3:SMAD4 transcriptional activity | R-HSA-2173795 | 4.802064e-02 | 1.319 | 0 | 0 |
| Transcriptional regulation by RUNX1 | R-HSA-8878171 | 3.247278e-02 | 1.488 | 0 | 0 |
| Gluconeogenesis | R-HSA-70263 | 5.137080e-02 | 1.289 | 0 | 0 |
| Processing of DNA double-strand break ends | R-HSA-5693607 | 4.185051e-02 | 1.378 | 0 | 0 |
| Sensory processing of sound | R-HSA-9659379 | 3.783796e-02 | 1.422 | 0 | 0 |
| ER Quality Control Compartment (ERQC) | R-HSA-901032 | 3.125221e-02 | 1.505 | 0 | 0 |
| N-glycan trimming in the ER and Calnexin/Calreticulin cycle | R-HSA-532668 | 5.458672e-02 | 1.263 | 0 | 0 |
| Interleukin-1 signaling | R-HSA-9020702 | 4.924034e-02 | 1.308 | 0 | 0 |
| Gamma carboxylation, hypusinylation, hydroxylation, and arylsulfatase activation | R-HSA-163841 | 5.550187e-02 | 1.256 | 0 | 0 |
| Negative Regulation of CDH1 Gene Transcription | R-HSA-9764725 | 3.627597e-02 | 1.440 | 0 | 0 |
| RUNX3 Regulates Immune Response and Cell Migration | R-HSA-8949275 | 4.991320e-02 | 1.302 | 0 | 0 |
| Apoptotic cleavage of cell adhesion proteins | R-HSA-351906 | 5.902998e-02 | 1.229 | 0 | 0 |
| SARS-CoV-2 targets host intracellular signalling and regulatory pathways | R-HSA-9755779 | 3.106909e-02 | 1.508 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected purine | R-HSA-110330 | 4.802064e-02 | 1.319 | 0 | 0 |
| Regulated Necrosis | R-HSA-5218859 | 5.626418e-02 | 1.250 | 0 | 0 |
| Signal transduction by L1 | R-HSA-445144 | 6.076072e-02 | 1.216 | 0 | 0 |
| Assembly of the ORC complex at the origin of replication | R-HSA-68616 | 5.186778e-02 | 1.285 | 0 | 0 |
| Adaptive Immune System | R-HSA-1280218 | 5.710783e-02 | 1.243 | 0 | 0 |
| Beta-catenin independent WNT signaling | R-HSA-3858494 | 4.961932e-02 | 1.304 | 0 | 0 |
| Transcriptional regulation by RUNX2 | R-HSA-8878166 | 5.083329e-02 | 1.294 | 0 | 0 |
| TNFR2 non-canonical NF-kB pathway | R-HSA-5668541 | 4.612938e-02 | 1.336 | 0 | 0 |
| Somitogenesis | R-HSA-9824272 | 4.240631e-02 | 1.373 | 0 | 0 |
| Signaling by the B Cell Receptor (BCR) | R-HSA-983705 | 5.291343e-02 | 1.276 | 0 | 0 |
| Calnexin/calreticulin cycle | R-HSA-901042 | 6.005079e-02 | 1.221 | 0 | 0 |
| ABC-family proteins mediated transport | R-HSA-382556 | 4.720266e-02 | 1.326 | 0 | 0 |
| SARS-CoV-1 targets host intracellular signalling and regulatory pathways | R-HSA-9735871 | 3.106909e-02 | 1.508 | 0 | 0 |
| NPAS4 regulates expression of target genes | R-HSA-9768919 | 6.005079e-02 | 1.221 | 0 | 0 |
| Cellular response to chemical stress | R-HSA-9711123 | 5.553368e-02 | 1.255 | 0 | 0 |
| Cyclin D associated events in G1 | R-HSA-69231 | 3.964491e-02 | 1.402 | 0 | 0 |
| G1 Phase | R-HSA-69236 | 3.964491e-02 | 1.402 | 0 | 0 |
| Regulation of TP53 Activity through Phosphorylation | R-HSA-6804756 | 5.550187e-02 | 1.256 | 0 | 0 |
| HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA) | R-HSA-5693567 | 3.851381e-02 | 1.414 | 0 | 0 |
| Metabolism of carbohydrates and carbohydrate derivatives | R-HSA-71387 | 5.759842e-02 | 1.240 | 0 | 0 |
| XBP1(S) activates chaperone genes | R-HSA-381038 | 5.550187e-02 | 1.256 | 0 | 0 |
| Disorders of transmembrane transporters | R-HSA-5619115 | 5.776894e-02 | 1.238 | 0 | 0 |
| PINK1-PRKN Mediated Mitophagy | R-HSA-5205685 | 3.427679e-02 | 1.465 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected pyrimidine | R-HSA-110328 | 6.005079e-02 | 1.221 | 0 | 0 |
| Mitophagy | R-HSA-5205647 | 6.005079e-02 | 1.221 | 0 | 0 |
| HDR through Homologous Recombination (HRR) | R-HSA-5685942 | 5.346613e-02 | 1.272 | 0 | 0 |
| Interleukin-17 signaling | R-HSA-448424 | 6.212014e-02 | 1.207 | 0 | 0 |
| Regulation of CDH1 Gene Transcription | R-HSA-9764560 | 6.212014e-02 | 1.207 | 0 | 0 |
| Uptake and actions of bacterial toxins | R-HSA-5339562 | 6.491793e-02 | 1.188 | 0 | 0 |
| Transcriptional and post-translational regulation of MITF-M expression and activity | R-HSA-9856649 | 6.517824e-02 | 1.186 | 0 | 0 |
| Base Excision Repair | R-HSA-73884 | 6.597912e-02 | 1.181 | 0 | 0 |
| Basigin interactions | R-HSA-210991 | 6.664355e-02 | 1.176 | 0 | 0 |
| RPIA deficiency: failed conversion of RU5P to R5P | R-HSA-6791461 | 6.858196e-02 | 1.164 | 0 | 0 |
| RPIA deficiency: failed conversion of R5P to RU5P | R-HSA-5659996 | 6.858196e-02 | 1.164 | 0 | 0 |
| Inhibition of PKR | R-HSA-169131 | 6.858196e-02 | 1.164 | 0 | 0 |
| Gap junction degradation | R-HSA-190873 | 6.866777e-02 | 1.163 | 0 | 0 |
| Hypusine synthesis from eIF5A-lysine | R-HSA-204626 | 6.866777e-02 | 1.163 | 0 | 0 |
| 5-Phosphoribose 1-diphosphate biosynthesis | R-HSA-73843 | 6.866777e-02 | 1.163 | 0 | 0 |
| Calcineurin activates NFAT | R-HSA-2025928 | 6.866777e-02 | 1.163 | 0 | 0 |
| NOTCH4 Activation and Transmission of Signal to the Nucleus | R-HSA-9013700 | 6.866777e-02 | 1.163 | 0 | 0 |
| Respiratory syncytial virus genome replication | R-HSA-9834752 | 6.866777e-02 | 1.163 | 0 | 0 |
| PRC2 methylates histones and DNA | R-HSA-212300 | 6.887666e-02 | 1.162 | 0 | 0 |
| Mitotic G1 phase and G1/S transition | R-HSA-453279 | 7.141472e-02 | 1.146 | 0 | 0 |
| Diseases of carbohydrate metabolism | R-HSA-5663084 | 7.155456e-02 | 1.145 | 0 | 0 |
| Signaling by PDGFR in disease | R-HSA-9671555 | 7.277590e-02 | 1.138 | 0 | 0 |
| Chromatin modifying enzymes | R-HSA-3247509 | 7.337937e-02 | 1.134 | 0 | 0 |
| SIRT1 negatively regulates rRNA expression | R-HSA-427359 | 7.352641e-02 | 1.134 | 0 | 0 |
| Cleavage of the damaged purine | R-HSA-110331 | 7.352641e-02 | 1.134 | 0 | 0 |
| G2/M DNA damage checkpoint | R-HSA-69473 | 7.487249e-02 | 1.126 | 0 | 0 |
| Depurination | R-HSA-73927 | 7.833126e-02 | 1.106 | 0 | 0 |
| Binding and entry of HIV virion | R-HSA-173107 | 7.877924e-02 | 1.104 | 0 | 0 |
| MECP2 regulates transcription of neuronal ligands | R-HSA-9022702 | 7.877924e-02 | 1.104 | 0 | 0 |
| 2-LTR circle formation | R-HSA-164843 | 7.877924e-02 | 1.104 | 0 | 0 |
| EGFR Transactivation by Gastrin | R-HSA-2179392 | 7.877924e-02 | 1.104 | 0 | 0 |
| Assembly and release of respiratory syncytial virus (RSV) virions | R-HSA-9820962 | 7.877924e-02 | 1.104 | 0 | 0 |
| Dopamine Neurotransmitter Release Cycle | R-HSA-212676 | 7.915015e-02 | 1.102 | 0 | 0 |
| Respiratory syncytial virus (RSV) genome replication, transcription and translation | R-HSA-9820965 | 8.328886e-02 | 1.079 | 0 | 0 |
| Plasma lipoprotein clearance | R-HSA-8964043 | 8.328886e-02 | 1.079 | 0 | 0 |
| Cellular responses to mechanical stimuli | R-HSA-9855142 | 8.379173e-02 | 1.077 | 0 | 0 |
| Circadian clock | R-HSA-9909396 | 8.522510e-02 | 1.069 | 0 | 0 |
| Interleukin-1 family signaling | R-HSA-446652 | 8.550588e-02 | 1.068 | 0 | 0 |
| Formation of Incision Complex in GG-NER | R-HSA-5696395 | 8.839666e-02 | 1.054 | 0 | 0 |
| ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression | R-HSA-427389 | 8.839666e-02 | 1.054 | 0 | 0 |
| Glycogen metabolism | R-HSA-8982491 | 8.839666e-02 | 1.054 | 0 | 0 |
| Regulation of localization of FOXO transcription factors | R-HSA-9614399 | 8.931972e-02 | 1.049 | 0 | 0 |
| CLEC7A (Dectin-1) signaling | R-HSA-5607764 | 9.027903e-02 | 1.044 | 0 | 0 |
| Deadenylation of mRNA | R-HSA-429947 | 9.259209e-02 | 1.033 | 0 | 0 |
| Norepinephrine Neurotransmitter Release Cycle | R-HSA-181430 | 9.259209e-02 | 1.033 | 0 | 0 |
| Chromatin modifications during the maternal to zygotic transition (MZT) | R-HSA-9821002 | 9.365188e-02 | 1.028 | 0 | 0 |
| MyD88 cascade initiated on plasma membrane | R-HSA-975871 | 9.704627e-02 | 1.013 | 0 | 0 |
| Toll Like Receptor 10 (TLR10) Cascade | R-HSA-168142 | 9.704627e-02 | 1.013 | 0 | 0 |
| Toll Like Receptor 5 (TLR5) Cascade | R-HSA-168176 | 9.704627e-02 | 1.013 | 0 | 0 |
| Signaling by FGFR | R-HSA-190236 | 9.704627e-02 | 1.013 | 0 | 0 |
| Regulation of endogenous retroelements by Piwi-interacting RNAs (piRNAs) | R-HSA-9845323 | 9.739101e-02 | 1.011 | 0 | 0 |
| Signaling by NOTCH1 in Cancer | R-HSA-2644603 | 9.739101e-02 | 1.011 | 0 | 0 |
| Constitutive Signaling by NOTCH1 PEST Domain Mutants | R-HSA-2644606 | 9.739101e-02 | 1.011 | 0 | 0 |
| Signaling by NOTCH1 PEST Domain Mutants in Cancer | R-HSA-2644602 | 9.739101e-02 | 1.011 | 0 | 0 |
| Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer | R-HSA-2894858 | 9.739101e-02 | 1.011 | 0 | 0 |
| Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants | R-HSA-2894862 | 9.739101e-02 | 1.011 | 0 | 0 |
| Translation of Structural Proteins | R-HSA-9683701 | 9.905160e-02 | 1.004 | 0 | 0 |
| Tight junction interactions | R-HSA-420029 | 9.964297e-02 | 1.002 | 0 | 0 |
| Sema4D in semaphorin signaling | R-HSA-400685 | 9.964297e-02 | 1.002 | 0 | 0 |
| Condensation of Prometaphase Chromosomes | R-HSA-2514853 | 1.002471e-01 | 0.999 | 0 | 0 |
| APOBEC3G mediated resistance to HIV-1 infection | R-HSA-180689 | 1.002471e-01 | 0.999 | 0 | 0 |
| Interactions of Tat with host cellular proteins | R-HSA-176034 | 1.010914e-01 | 0.995 | 0 | 0 |
| PTEN Loss of Function in Cancer | R-HSA-5674404 | 1.010914e-01 | 0.995 | 0 | 0 |
| TALDO1 deficiency: failed conversion of Fru(6)P, E4P to SH7P, GA3P | R-HSA-6791462 | 1.010914e-01 | 0.995 | 0 | 0 |
| TALDO1 deficiency: failed conversion of SH7P, GA3P to Fru(6)P, E4P | R-HSA-6791055 | 1.010914e-01 | 0.995 | 0 | 0 |
| Defective SLC4A1 causes hereditary spherocytosis type 4 (HSP4), distal renal tubular acidosis (dRTA) and dRTA with hemolytic anemia (dRTA-HA) | R-HSA-5619050 | 1.010914e-01 | 0.995 | 0 | 0 |
| Formation of paraxial mesoderm | R-HSA-9793380 | 1.019372e-01 | 0.992 | 0 | 0 |
| Chromatin organization | R-HSA-4839726 | 1.034794e-01 | 0.985 | 0 | 0 |
| Cleavage of the damaged pyrimidine | R-HSA-110329 | 1.045927e-01 | 0.980 | 0 | 0 |
| Depyrimidination | R-HSA-73928 | 1.045927e-01 | 0.980 | 0 | 0 |
| Transcriptional regulation of granulopoiesis | R-HSA-9616222 | 1.065874e-01 | 0.972 | 0 | 0 |
| Regulation of TP53 Activity | R-HSA-5633007 | 1.067431e-01 | 0.972 | 0 | 0 |
| Postmitotic nuclear pore complex (NPC) reformation | R-HSA-9615933 | 1.069022e-01 | 0.971 | 0 | 0 |
| Signaling by WNT | R-HSA-195721 | 1.070497e-01 | 0.970 | 0 | 0 |
| Defective pyroptosis | R-HSA-9710421 | 1.102719e-01 | 0.958 | 0 | 0 |
| Disorders of Nervous System Development | R-HSA-9697154 | 1.115216e-01 | 0.953 | 0 | 0 |
| Loss of function of MECP2 in Rett syndrome | R-HSA-9005891 | 1.115216e-01 | 0.953 | 0 | 0 |
| Pervasive developmental disorders | R-HSA-9005895 | 1.115216e-01 | 0.953 | 0 | 0 |
| Polymerase switching | R-HSA-69091 | 1.115216e-01 | 0.953 | 0 | 0 |
| Leading Strand Synthesis | R-HSA-69109 | 1.115216e-01 | 0.953 | 0 | 0 |
| Z-decay: degradation of maternal mRNAs by zygotically expressed factors | R-HSA-9820865 | 1.115216e-01 | 0.953 | 0 | 0 |
| Scavenging by Class F Receptors | R-HSA-3000484 | 1.115216e-01 | 0.953 | 0 | 0 |
| GRB2 events in EGFR signaling | R-HSA-179812 | 1.115216e-01 | 0.953 | 0 | 0 |
| RNA Polymerase I Transcription Termination | R-HSA-73863 | 1.143608e-01 | 0.942 | 0 | 0 |
| Interaction between L1 and Ankyrins | R-HSA-445095 | 1.143608e-01 | 0.942 | 0 | 0 |
| Insulin processing | R-HSA-264876 | 1.143608e-01 | 0.942 | 0 | 0 |
| Asparagine N-linked glycosylation | R-HSA-446203 | 1.144487e-01 | 0.941 | 0 | 0 |
| Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways | R-HSA-168643 | 1.161933e-01 | 0.935 | 0 | 0 |
| Response of endothelial cells to shear stress | R-HSA-9860931 | 1.189662e-01 | 0.925 | 0 | 0 |
| Regulation of T cell activation by CD28 family | R-HSA-388841 | 1.197643e-01 | 0.922 | 0 | 0 |
| Phase 0 - rapid depolarisation | R-HSA-5576892 | 1.220098e-01 | 0.914 | 0 | 0 |
| RSV-host interactions | R-HSA-9833110 | 1.228500e-01 | 0.911 | 0 | 0 |
| Platelet Adhesion to exposed collagen | R-HSA-75892 | 1.231058e-01 | 0.910 | 0 | 0 |
| Regulation of PD-L1(CD274) transcription | R-HSA-9909649 | 1.261950e-01 | 0.899 | 0 | 0 |
| Extracellular matrix organization | R-HSA-1474244 | 1.262303e-01 | 0.899 | 0 | 0 |
| Toll Like Receptor 3 (TLR3) Cascade | R-HSA-168164 | 1.267979e-01 | 0.897 | 0 | 0 |
| TGFBR2 Kinase Domain Mutants in Cancer | R-HSA-3645790 | 1.324681e-01 | 0.878 | 0 | 0 |
| Signaling by RAS GAP mutants | R-HSA-9753510 | 1.324681e-01 | 0.878 | 0 | 0 |
| Loss of Function of TGFBR2 in Cancer | R-HSA-3642278 | 1.324681e-01 | 0.878 | 0 | 0 |
| ATF6B (ATF6-beta) activates chaperones | R-HSA-8874177 | 1.324681e-01 | 0.878 | 0 | 0 |
| ERBB2 Activates PTK6 Signaling | R-HSA-8847993 | 1.349645e-01 | 0.870 | 0 | 0 |
| CRMPs in Sema3A signaling | R-HSA-399956 | 1.349645e-01 | 0.870 | 0 | 0 |
| Signal regulatory protein family interactions | R-HSA-391160 | 1.349645e-01 | 0.870 | 0 | 0 |
| Interleukin-4 and Interleukin-13 signaling | R-HSA-6785807 | 1.359148e-01 | 0.867 | 0 | 0 |
| GABA synthesis, release, reuptake and degradation | R-HSA-888590 | 1.378423e-01 | 0.861 | 0 | 0 |
| Activation of BH3-only proteins | R-HSA-114452 | 1.378423e-01 | 0.861 | 0 | 0 |
| TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation | R-HSA-975138 | 1.390191e-01 | 0.857 | 0 | 0 |
| Nuclear events stimulated by ALK signaling in cancer | R-HSA-9725371 | 1.406156e-01 | 0.852 | 0 | 0 |
| MyD88 dependent cascade initiated on endosome | R-HSA-975155 | 1.432160e-01 | 0.844 | 0 | 0 |
| NOTCH1 Intracellular Domain Regulates Transcription | R-HSA-2122947 | 1.470475e-01 | 0.833 | 0 | 0 |
| Erythropoietin activates RAS | R-HSA-9027284 | 1.470644e-01 | 0.832 | 0 | 0 |
| SHC1 events in EGFR signaling | R-HSA-180336 | 1.470644e-01 | 0.832 | 0 | 0 |
| ERBB2 Regulates Cell Motility | R-HSA-6785631 | 1.470644e-01 | 0.832 | 0 | 0 |
| DCC mediated attractive signaling | R-HSA-418885 | 1.470644e-01 | 0.832 | 0 | 0 |
| p38MAPK events | R-HSA-171007 | 1.470644e-01 | 0.832 | 0 | 0 |
| IRF3-mediated induction of type I IFN | R-HSA-3270619 | 1.470644e-01 | 0.832 | 0 | 0 |
| Regulation of endogenous retroelements by KRAB-ZFP proteins | R-HSA-9843940 | 1.473244e-01 | 0.832 | 0 | 0 |
| TRIF (TICAM1)-mediated TLR4 signaling | R-HSA-937061 | 1.474731e-01 | 0.831 | 0 | 0 |
| MyD88-independent TLR4 cascade | R-HSA-166166 | 1.474731e-01 | 0.831 | 0 | 0 |
| Transcriptional Regulation by TP53 | R-HSA-3700989 | 1.503179e-01 | 0.823 | 0 | 0 |
| Metabolism of amino acids and derivatives | R-HSA-71291 | 1.518895e-01 | 0.818 | 0 | 0 |
| Regulation of ornithine decarboxylase (ODC) | R-HSA-350562 | 1.543263e-01 | 0.812 | 0 | 0 |
| G0 and Early G1 | R-HSA-1538133 | 1.543263e-01 | 0.812 | 0 | 0 |
| Inositol phosphate metabolism | R-HSA-1483249 | 1.561642e-01 | 0.806 | 0 | 0 |
| KSRP (KHSRP) binds and destabilizes mRNA | R-HSA-450604 | 1.593745e-01 | 0.798 | 0 | 0 |
| Phosphorylation of the APC/C | R-HSA-176412 | 1.593745e-01 | 0.798 | 0 | 0 |
| Transcription of E2F targets under negative control by p107 (RBL1) and p130 (RBL2) in complex with HDAC1 | R-HSA-1362300 | 1.593745e-01 | 0.798 | 0 | 0 |
| Toll Like Receptor 7/8 (TLR7/8) Cascade | R-HSA-168181 | 1.605962e-01 | 0.794 | 0 | 0 |
| Signaling by cytosolic PDGFRA and PDGFRB fusion proteins | R-HSA-9673766 | 1.627514e-01 | 0.788 | 0 | 0 |
| MET interacts with TNS proteins | R-HSA-8875513 | 1.627514e-01 | 0.788 | 0 | 0 |
| Integrin signaling | R-HSA-354192 | 1.627895e-01 | 0.788 | 0 | 0 |
| Cyclin A/B1/B2 associated events during G2/M transition | R-HSA-69273 | 1.627895e-01 | 0.788 | 0 | 0 |
| mRNA 3'-end processing | R-HSA-72187 | 1.669975e-01 | 0.777 | 0 | 0 |
| Transcriptional Regulation by NPAS4 | R-HSA-9634815 | 1.669975e-01 | 0.777 | 0 | 0 |
| Disorders of Developmental Biology | R-HSA-9675151 | 1.718652e-01 | 0.765 | 0 | 0 |
| Response to metal ions | R-HSA-5660526 | 1.718652e-01 | 0.765 | 0 | 0 |
| Golgi Associated Vesicle Biogenesis | R-HSA-432722 | 1.738518e-01 | 0.760 | 0 | 0 |
| Toll Like Receptor 9 (TLR9) Cascade | R-HSA-168138 | 1.742265e-01 | 0.759 | 0 | 0 |
| TP53 Regulates Metabolic Genes | R-HSA-5628897 | 1.742265e-01 | 0.759 | 0 | 0 |
| Base-Excision Repair, AP Site Formation | R-HSA-73929 | 1.808011e-01 | 0.743 | 0 | 0 |
| Signaling by NOTCH1 | R-HSA-1980143 | 1.815756e-01 | 0.741 | 0 | 0 |
| PI3K events in ERBB2 signaling | R-HSA-1963642 | 1.845092e-01 | 0.734 | 0 | 0 |
| Modulation of host responses by IFN-stimulated genes | R-HSA-9909505 | 1.845092e-01 | 0.734 | 0 | 0 |
| Specification of primordial germ cells | R-HSA-9827857 | 1.845092e-01 | 0.734 | 0 | 0 |
| Signalling to ERKs | R-HSA-187687 | 1.889552e-01 | 0.724 | 0 | 0 |
| GRB7 events in ERBB2 signaling | R-HSA-1306955 | 1.919794e-01 | 0.717 | 0 | 0 |
| Phosphorylation of proteins involved in G1/S transition by active Cyclin E:Cdk2 complexes | R-HSA-69200 | 1.919794e-01 | 0.717 | 0 | 0 |
| TGFBR1 KD Mutants in Cancer | R-HSA-3656532 | 1.919794e-01 | 0.717 | 0 | 0 |
| TNFR1-mediated ceramide production | R-HSA-5626978 | 1.919794e-01 | 0.717 | 0 | 0 |
| NADE modulates death signalling | R-HSA-205025 | 1.919794e-01 | 0.717 | 0 | 0 |
| Toxicity of tetanus toxin (tetX) | R-HSA-5250982 | 1.919794e-01 | 0.717 | 0 | 0 |
| Gene expression (Transcription) | R-HSA-74160 | 1.922313e-01 | 0.716 | 0 | 0 |
| Signaling by Receptor Tyrosine Kinases | R-HSA-9006934 | 1.934582e-01 | 0.713 | 0 | 0 |
| Ion homeostasis | R-HSA-5578775 | 1.949678e-01 | 0.710 | 0 | 0 |
| PCNA-Dependent Long Patch Base Excision Repair | R-HSA-5651801 | 1.972806e-01 | 0.705 | 0 | 0 |
| RNA Polymerase III Transcription Termination | R-HSA-73980 | 1.972806e-01 | 0.705 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in extracellular matrix, focal adhesion and epithelial-to-mesenchymal transition | R-HSA-9926550 | 1.972806e-01 | 0.705 | 0 | 0 |
| RNA Polymerase III Abortive And Retractive Initiation | R-HSA-749476 | 1.979060e-01 | 0.704 | 0 | 0 |
| RNA Polymerase III Transcription | R-HSA-74158 | 1.979060e-01 | 0.704 | 0 | 0 |
| Calmodulin induced events | R-HSA-111933 | 1.979060e-01 | 0.704 | 0 | 0 |
| CaM pathway | R-HSA-111997 | 1.979060e-01 | 0.704 | 0 | 0 |
| MyD88:MAL(TIRAP) cascade initiated on plasma membrane | R-HSA-166058 | 1.979927e-01 | 0.703 | 0 | 0 |
| Toll Like Receptor TLR6:TLR2 Cascade | R-HSA-168188 | 1.979927e-01 | 0.703 | 0 | 0 |
| TP53 Regulates Transcription of Cell Cycle Genes | R-HSA-6791312 | 2.021765e-01 | 0.694 | 0 | 0 |
| Regulation of actin dynamics for phagocytic cup formation | R-HSA-2029482 | 2.037222e-01 | 0.691 | 0 | 0 |
| Infection with Mycobacterium tuberculosis | R-HSA-9635486 | 2.078396e-01 | 0.682 | 0 | 0 |
| Formation of the beta-catenin:TCF transactivating complex | R-HSA-201722 | 2.094631e-01 | 0.679 | 0 | 0 |
| Gastrin-CREB signalling pathway via PKC and MAPK | R-HSA-881907 | 2.101551e-01 | 0.677 | 0 | 0 |
| STING mediated induction of host immune responses | R-HSA-1834941 | 2.101551e-01 | 0.677 | 0 | 0 |
| MITF-M-regulated melanocyte development | R-HSA-9730414 | 2.111373e-01 | 0.675 | 0 | 0 |
| Toll Like Receptor TLR1:TLR2 Cascade | R-HSA-168179 | 2.128313e-01 | 0.672 | 0 | 0 |
| Toll Like Receptor 2 (TLR2) Cascade | R-HSA-181438 | 2.128313e-01 | 0.672 | 0 | 0 |
| MET promotes cell motility | R-HSA-8875878 | 2.160981e-01 | 0.665 | 0 | 0 |
| Extension of Telomeres | R-HSA-180786 | 2.168232e-01 | 0.664 | 0 | 0 |
| G2 Phase | R-HSA-68911 | 2.201888e-01 | 0.657 | 0 | 0 |
| Signaling by membrane-tethered fusions of PDGFRA or PDGFRB | R-HSA-9673768 | 2.201888e-01 | 0.657 | 0 | 0 |
| SMAD2/3 Phosphorylation Motif Mutants in Cancer | R-HSA-3304356 | 2.201888e-01 | 0.657 | 0 | 0 |
| Resolution of AP sites via the single-nucleotide replacement pathway | R-HSA-110381 | 2.201888e-01 | 0.657 | 0 | 0 |
| Suppression of autophagy | R-HSA-9636569 | 2.201888e-01 | 0.657 | 0 | 0 |
| Nectin/Necl trans heterodimerization | R-HSA-420597 | 2.201888e-01 | 0.657 | 0 | 0 |
| Phosphorylation and nuclear translocation of BMAL1 (ARNTL) and CLOCK | R-HSA-9931529 | 2.201888e-01 | 0.657 | 0 | 0 |
| FCERI mediated NF-kB activation | R-HSA-2871837 | 2.221319e-01 | 0.653 | 0 | 0 |
| Insertion of tail-anchored proteins into the endoplasmic reticulum membrane | R-HSA-9609523 | 2.231100e-01 | 0.651 | 0 | 0 |
| Formation of definitive endoderm | R-HSA-9823730 | 2.231100e-01 | 0.651 | 0 | 0 |
| RAB geranylgeranylation | R-HSA-8873719 | 2.242525e-01 | 0.649 | 0 | 0 |
| Cross-presentation of soluble exogenous antigens (endosomes) | R-HSA-1236978 | 2.253226e-01 | 0.647 | 0 | 0 |
| Differentiation of Keratinocytes in Interfollicular Epidermis in Mammalian Skin | R-HSA-9725554 | 2.253226e-01 | 0.647 | 0 | 0 |
| RNA Polymerase II Transcription Termination | R-HSA-73856 | 2.317467e-01 | 0.635 | 0 | 0 |
| Lagging Strand Synthesis | R-HSA-69186 | 2.361241e-01 | 0.627 | 0 | 0 |
| Acetylcholine Neurotransmitter Release Cycle | R-HSA-264642 | 2.361241e-01 | 0.627 | 0 | 0 |
| Signalling to RAS | R-HSA-167044 | 2.361241e-01 | 0.627 | 0 | 0 |
| NOTCH4 Intracellular Domain Regulates Transcription | R-HSA-9013695 | 2.361241e-01 | 0.627 | 0 | 0 |
| C-type lectin receptors (CLRs) | R-HSA-5621481 | 2.378930e-01 | 0.624 | 0 | 0 |
| Mitochondrial protein import | R-HSA-1268020 | 2.393014e-01 | 0.621 | 0 | 0 |
| Signaling by PDGF | R-HSA-186797 | 2.393014e-01 | 0.621 | 0 | 0 |
| Innate Immune System | R-HSA-168249 | 2.428979e-01 | 0.615 | 0 | 0 |
| Epigenetic regulation of gene expression | R-HSA-212165 | 2.430239e-01 | 0.614 | 0 | 0 |
| Resolution of Abasic Sites (AP sites) | R-HSA-73933 | 2.439869e-01 | 0.613 | 0 | 0 |
| Gastrulation | R-HSA-9758941 | 2.459604e-01 | 0.609 | 0 | 0 |
| Plus-strand DNA synthesis | R-HSA-164525 | 2.474149e-01 | 0.607 | 0 | 0 |
| CDH11 homotypic and heterotypic interactions | R-HSA-9833576 | 2.474149e-01 | 0.607 | 0 | 0 |
| PTK6 Regulates Cell Cycle | R-HSA-8849470 | 2.474149e-01 | 0.607 | 0 | 0 |
| Signaling by Overexpressed Wild-Type EGFR in Cancer | R-HSA-5638302 | 2.474149e-01 | 0.607 | 0 | 0 |
| Inhibition of Signaling by Overexpressed EGFR | R-HSA-5638303 | 2.474149e-01 | 0.607 | 0 | 0 |
| Phosphorylation of Emi1 | R-HSA-176417 | 2.474149e-01 | 0.607 | 0 | 0 |
| Loss of Function of SMAD2/3 in Cancer | R-HSA-3304349 | 2.474149e-01 | 0.607 | 0 | 0 |
| Regulation of CDH19 Expression and Function | R-HSA-9764302 | 2.474149e-01 | 0.607 | 0 | 0 |
| TYSND1 cleaves peroxisomal proteins | R-HSA-9033500 | 2.474149e-01 | 0.607 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 2 Promoter | R-HSA-76066 | 2.491776e-01 | 0.603 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in cell cycle and proliferation | R-HSA-9825892 | 2.491776e-01 | 0.603 | 0 | 0 |
| Ribavirin ADME | R-HSA-9755088 | 2.491776e-01 | 0.603 | 0 | 0 |
| Stimuli-sensing channels | R-HSA-2672351 | 2.566761e-01 | 0.591 | 0 | 0 |
| Developmental Cell Lineages of the Exocrine Pancreas | R-HSA-9820448 | 2.606451e-01 | 0.584 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 1 Promoter | R-HSA-76061 | 2.622518e-01 | 0.581 | 0 | 0 |
| Neurotoxicity of clostridium toxins | R-HSA-168799 | 2.622518e-01 | 0.581 | 0 | 0 |
| TP53 regulates transcription of additional cell cycle genes whose exact role in the p53 pathway remain uncertain | R-HSA-6804115 | 2.622518e-01 | 0.581 | 0 | 0 |
| RNA Polymerase I Transcription Initiation | R-HSA-73762 | 2.628855e-01 | 0.580 | 0 | 0 |
| Ca-dependent events | R-HSA-111996 | 2.628855e-01 | 0.580 | 0 | 0 |
| RUNX3 regulates YAP1-mediated transcription | R-HSA-8951671 | 2.736922e-01 | 0.563 | 0 | 0 |
| Autointegration results in viral DNA circles | R-HSA-177539 | 2.736922e-01 | 0.563 | 0 | 0 |
| G2/M DNA replication checkpoint | R-HSA-69478 | 2.736922e-01 | 0.563 | 0 | 0 |
| Uncoating of the HIV Virion | R-HSA-162585 | 2.736922e-01 | 0.563 | 0 | 0 |
| E2F-enabled inhibition of pre-replication complex formation | R-HSA-113507 | 2.736922e-01 | 0.563 | 0 | 0 |
| RAS signaling downstream of NF1 loss-of-function variants | R-HSA-6802953 | 2.736922e-01 | 0.563 | 0 | 0 |
| Integration of viral DNA into host genomic DNA | R-HSA-175567 | 2.736922e-01 | 0.563 | 0 | 0 |
| CREB phosphorylation | R-HSA-199920 | 2.736922e-01 | 0.563 | 0 | 0 |
| Activation of NIMA Kinases NEK9, NEK6, NEK7 | R-HSA-2980767 | 2.736922e-01 | 0.563 | 0 | 0 |
| VLDL assembly | R-HSA-8866423 | 2.736922e-01 | 0.563 | 0 | 0 |
| Nef and signal transduction | R-HSA-164944 | 2.736922e-01 | 0.563 | 0 | 0 |
| Toxicity of botulinum toxin type F (botF) | R-HSA-5250981 | 2.736922e-01 | 0.563 | 0 | 0 |
| Toxicity of botulinum toxin type D (botD) | R-HSA-5250955 | 2.736922e-01 | 0.563 | 0 | 0 |
| Regulation of PTEN mRNA translation | R-HSA-8943723 | 2.753294e-01 | 0.560 | 0 | 0 |
| Estrogen-dependent nuclear events downstream of ESR-membrane signaling | R-HSA-9634638 | 2.753294e-01 | 0.560 | 0 | 0 |
| G-protein mediated events | R-HSA-112040 | 2.778367e-01 | 0.556 | 0 | 0 |
| Proteasome assembly | R-HSA-9907900 | 2.819574e-01 | 0.550 | 0 | 0 |
| Netrin-1 signaling | R-HSA-373752 | 2.819574e-01 | 0.550 | 0 | 0 |
| Pre-NOTCH Transcription and Translation | R-HSA-1912408 | 2.841674e-01 | 0.546 | 0 | 0 |
| RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function | R-HSA-8936459 | 2.856670e-01 | 0.544 | 0 | 0 |
| TRAF6 mediated NF-kB activation | R-HSA-933542 | 2.883943e-01 | 0.540 | 0 | 0 |
| Platelet Aggregation (Plug Formation) | R-HSA-76009 | 2.915402e-01 | 0.535 | 0 | 0 |
| DAG and IP3 signaling | R-HSA-1489509 | 2.915402e-01 | 0.535 | 0 | 0 |
| Interferon gamma signaling | R-HSA-877300 | 2.958592e-01 | 0.529 | 0 | 0 |
| Plasma lipoprotein assembly, remodeling, and clearance | R-HSA-174824 | 2.977683e-01 | 0.526 | 0 | 0 |
| Cohesin Loading onto Chromatin | R-HSA-2470946 | 2.990535e-01 | 0.524 | 0 | 0 |
| Recycling of eIF2:GDP | R-HSA-72731 | 2.990535e-01 | 0.524 | 0 | 0 |
| Disinhibition of SNARE formation | R-HSA-114516 | 2.990535e-01 | 0.524 | 0 | 0 |
| Activated NTRK2 signals through CDK5 | R-HSA-9032845 | 2.990535e-01 | 0.524 | 0 | 0 |
| SOS-mediated signalling | R-HSA-112412 | 2.990535e-01 | 0.524 | 0 | 0 |
| Insulin effects increased synthesis of Xylulose-5-Phosphate | R-HSA-163754 | 2.990535e-01 | 0.524 | 0 | 0 |
| LDL remodeling | R-HSA-8964041 | 2.990535e-01 | 0.524 | 0 | 0 |
| TGFBR3 regulates TGF-beta signaling | R-HSA-9839389 | 2.990535e-01 | 0.524 | 0 | 0 |
| mRNA Splicing - Minor Pathway | R-HSA-72165 | 3.011449e-01 | 0.521 | 0 | 0 |
| Polymerase switching on the C-strand of the telomere | R-HSA-174411 | 3.014315e-01 | 0.521 | 0 | 0 |
| VEGFR2 mediated cell proliferation | R-HSA-5218921 | 3.014315e-01 | 0.521 | 0 | 0 |
| MicroRNA (miRNA) biogenesis | R-HSA-203927 | 3.014315e-01 | 0.521 | 0 | 0 |
| Laminin interactions | R-HSA-3000157 | 3.014315e-01 | 0.521 | 0 | 0 |
| PIWI-interacting RNA (piRNA) biogenesis | R-HSA-5601884 | 3.014315e-01 | 0.521 | 0 | 0 |
| Interferon alpha/beta signaling | R-HSA-909733 | 3.108899e-01 | 0.507 | 0 | 0 |
| MECP2 regulates neuronal receptors and channels | R-HSA-9022699 | 3.144270e-01 | 0.502 | 0 | 0 |
| MET activates PTK2 signaling | R-HSA-8874081 | 3.144270e-01 | 0.502 | 0 | 0 |
| Signaling by FLT3 fusion proteins | R-HSA-9703465 | 3.144270e-01 | 0.502 | 0 | 0 |
| Glutamate Neurotransmitter Release Cycle | R-HSA-210500 | 3.144270e-01 | 0.502 | 0 | 0 |
| Resolution of AP sites via the multiple-nucleotide patch replacement pathway | R-HSA-110373 | 3.144270e-01 | 0.502 | 0 | 0 |
| trans-Golgi Network Vesicle Budding | R-HSA-199992 | 3.172659e-01 | 0.499 | 0 | 0 |
| Interconversion of nucleotide di- and triphosphates | R-HSA-499943 | 3.172659e-01 | 0.499 | 0 | 0 |
| Ion channel transport | R-HSA-983712 | 3.222282e-01 | 0.492 | 0 | 0 |
| Reverse Transcription of HIV RNA | R-HSA-162589 | 3.235307e-01 | 0.490 | 0 | 0 |
| Minus-strand DNA synthesis | R-HSA-164516 | 3.235307e-01 | 0.490 | 0 | 0 |
| EGFR interacts with phospholipase C-gamma | R-HSA-212718 | 3.235307e-01 | 0.490 | 0 | 0 |
| MET receptor recycling | R-HSA-8875656 | 3.235307e-01 | 0.490 | 0 | 0 |
| Activation of RAS in B cells | R-HSA-1169092 | 3.235307e-01 | 0.490 | 0 | 0 |
| TGFBR3 PTM regulation | R-HSA-9839383 | 3.235307e-01 | 0.490 | 0 | 0 |
| CREB1 phosphorylation through the activation of CaMKII/CaMKK/CaMKIV cascasde | R-HSA-442729 | 3.235307e-01 | 0.490 | 0 | 0 |
| Interleukin-23 signaling | R-HSA-9020933 | 3.235307e-01 | 0.490 | 0 | 0 |
| Tat-mediated HIV elongation arrest and recovery | R-HSA-167243 | 3.273680e-01 | 0.485 | 0 | 0 |
| Pausing and recovery of Tat-mediated HIV elongation | R-HSA-167238 | 3.273680e-01 | 0.485 | 0 | 0 |
| Cristae formation | R-HSA-8949613 | 3.273680e-01 | 0.485 | 0 | 0 |
| Signaling by NTRK2 (TRKB) | R-HSA-9006115 | 3.273680e-01 | 0.485 | 0 | 0 |
| HIV elongation arrest and recovery | R-HSA-167287 | 3.402423e-01 | 0.468 | 0 | 0 |
| Pausing and recovery of HIV elongation | R-HSA-167290 | 3.402423e-01 | 0.468 | 0 | 0 |
| Telomere Extension By Telomerase | R-HSA-171319 | 3.402423e-01 | 0.468 | 0 | 0 |
| Iron uptake and transport | R-HSA-917937 | 3.411498e-01 | 0.467 | 0 | 0 |
| Post-translational protein phosphorylation | R-HSA-8957275 | 3.460536e-01 | 0.461 | 0 | 0 |
| Lipophagy | R-HSA-9613354 | 3.471546e-01 | 0.459 | 0 | 0 |
| ALK mutants bind TKIs | R-HSA-9700645 | 3.471546e-01 | 0.459 | 0 | 0 |
| APEX1-Independent Resolution of AP Sites via the Single Nucleotide Replacement Pathway | R-HSA-5649702 | 3.471546e-01 | 0.459 | 0 | 0 |
| Estrogen-stimulated signaling through PRKCZ | R-HSA-9634635 | 3.471546e-01 | 0.459 | 0 | 0 |
| GP1b-IX-V activation signalling | R-HSA-430116 | 3.471546e-01 | 0.459 | 0 | 0 |
| Activation of the AP-1 family of transcription factors | R-HSA-450341 | 3.471546e-01 | 0.459 | 0 | 0 |
| MASTL Facilitates Mitotic Progression | R-HSA-2465910 | 3.471546e-01 | 0.459 | 0 | 0 |
| Regulated proteolysis of p75NTR | R-HSA-193692 | 3.471546e-01 | 0.459 | 0 | 0 |
| Zinc influx into cells by the SLC39 gene family | R-HSA-442380 | 3.471546e-01 | 0.459 | 0 | 0 |
| Cellular response to mitochondrial stress | R-HSA-9840373 | 3.471546e-01 | 0.459 | 0 | 0 |
| HuR (ELAVL1) binds and stabilizes mRNA | R-HSA-450520 | 3.471546e-01 | 0.459 | 0 | 0 |
| Signaling by Erythropoietin | R-HSA-9006335 | 3.530388e-01 | 0.452 | 0 | 0 |
| MAPK targets/ Nuclear events mediated by MAP kinases | R-HSA-450282 | 3.530388e-01 | 0.452 | 0 | 0 |
| Neddylation | R-HSA-8951664 | 3.544793e-01 | 0.450 | 0 | 0 |
| Translation of Structural Proteins | R-HSA-9694635 | 3.571059e-01 | 0.447 | 0 | 0 |
| tRNA processing | R-HSA-72306 | 3.584336e-01 | 0.446 | 0 | 0 |
| Integrin cell surface interactions | R-HSA-216083 | 3.650837e-01 | 0.438 | 0 | 0 |
| RNA Polymerase III Transcription Initiation | R-HSA-76046 | 3.657474e-01 | 0.437 | 0 | 0 |
| Aberrant regulation of mitotic cell cycle due to RB1 defects | R-HSA-9687139 | 3.657474e-01 | 0.437 | 0 | 0 |
| Interleukin-37 signaling | R-HSA-9008059 | 3.657474e-01 | 0.437 | 0 | 0 |
| Extra-nuclear estrogen signaling | R-HSA-9009391 | 3.669255e-01 | 0.435 | 0 | 0 |
| MET activates RAP1 and RAC1 | R-HSA-8875555 | 3.699549e-01 | 0.432 | 0 | 0 |
| Establishment of Sister Chromatid Cohesion | R-HSA-2468052 | 3.699549e-01 | 0.432 | 0 | 0 |
| Regulation of CDH11 function | R-HSA-9762292 | 3.699549e-01 | 0.432 | 0 | 0 |
| MAPK3 (ERK1) activation | R-HSA-110056 | 3.699549e-01 | 0.432 | 0 | 0 |
| Toll Like Receptor 4 (TLR4) Cascade | R-HSA-166016 | 3.769966e-01 | 0.424 | 0 | 0 |
| Respiratory syncytial virus (RSV) attachment and entry | R-HSA-9820960 | 3.783586e-01 | 0.422 | 0 | 0 |
| Molecules associated with elastic fibres | R-HSA-2129379 | 3.783586e-01 | 0.422 | 0 | 0 |
| Downstream signal transduction | R-HSA-186763 | 3.783586e-01 | 0.422 | 0 | 0 |
| Fcgamma receptor (FCGR) dependent phagocytosis | R-HSA-2029480 | 3.796517e-01 | 0.421 | 0 | 0 |
| Signaling by Nuclear Receptors | R-HSA-9006931 | 3.872318e-01 | 0.412 | 0 | 0 |
| Opioid Signalling | R-HSA-111885 | 3.878139e-01 | 0.411 | 0 | 0 |
| Antigen processing: Ubiquitination & Proteasome degradation | R-HSA-983168 | 3.879208e-01 | 0.411 | 0 | 0 |
| Potential therapeutics for SARS | R-HSA-9679191 | 3.884617e-01 | 0.411 | 0 | 0 |
| DNA strand elongation | R-HSA-69190 | 3.908637e-01 | 0.408 | 0 | 0 |
| Diseases of mitotic cell cycle | R-HSA-9675126 | 3.908637e-01 | 0.408 | 0 | 0 |
| Developmental Lineage of Multipotent Pancreatic Progenitor Cells | R-HSA-9937080 | 3.908637e-01 | 0.408 | 0 | 0 |
| Fc epsilon receptor (FCERI) signaling | R-HSA-2454202 | 3.913940e-01 | 0.407 | 0 | 0 |
| NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10 | R-HSA-933543 | 3.919602e-01 | 0.407 | 0 | 0 |
| vRNP Assembly | R-HSA-192905 | 3.919602e-01 | 0.407 | 0 | 0 |
| Chylomicron assembly | R-HSA-8963888 | 3.919602e-01 | 0.407 | 0 | 0 |
| Activated NTRK3 signals through RAS | R-HSA-9034864 | 3.919602e-01 | 0.407 | 0 | 0 |
| Bicarbonate transporters | R-HSA-425381 | 3.919602e-01 | 0.407 | 0 | 0 |
| PECAM1 interactions | R-HSA-210990 | 3.919602e-01 | 0.407 | 0 | 0 |
| CD163 mediating an anti-inflammatory response | R-HSA-9662834 | 3.919602e-01 | 0.407 | 0 | 0 |
| Dissolution of Fibrin Clot | R-HSA-75205 | 3.919602e-01 | 0.407 | 0 | 0 |
| Activation of HOX genes during differentiation | R-HSA-5619507 | 3.947700e-01 | 0.404 | 0 | 0 |
| Activation of anterior HOX genes in hindbrain development during early embryogenesis | R-HSA-5617472 | 3.947700e-01 | 0.404 | 0 | 0 |
| Intrinsic Pathway for Apoptosis | R-HSA-109606 | 3.970307e-01 | 0.401 | 0 | 0 |
| Nuclear RNA decay | R-HSA-9930044 | 4.032547e-01 | 0.394 | 0 | 0 |
| Epigenetic regulation by WDR5-containing histone modifying complexes | R-HSA-9917777 | 4.114000e-01 | 0.386 | 0 | 0 |
| Synthesis of diphthamide-EEF2 | R-HSA-5358493 | 4.131983e-01 | 0.384 | 0 | 0 |
| Plasmalogen biosynthesis | R-HSA-75896 | 4.131983e-01 | 0.384 | 0 | 0 |
| Mitotic Telophase/Cytokinesis | R-HSA-68884 | 4.131983e-01 | 0.384 | 0 | 0 |
| Viral RNP Complexes in the Host Cell Nucleus | R-HSA-168330 | 4.131983e-01 | 0.384 | 0 | 0 |
| Activated NTRK2 signals through RAS | R-HSA-9026519 | 4.131983e-01 | 0.384 | 0 | 0 |
| Regulation of CDH1 posttranslational processing and trafficking to plasma membrane | R-HSA-9768727 | 4.155245e-01 | 0.381 | 0 | 0 |
| Deadenylation-dependent mRNA decay | R-HSA-429914 | 4.252462e-01 | 0.371 | 0 | 0 |
| Developmental Lineage of Mammary Gland Alveolar Cells | R-HSA-9927426 | 4.276663e-01 | 0.369 | 0 | 0 |
| Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding | R-HSA-6814122 | 4.276663e-01 | 0.369 | 0 | 0 |
| RAB GEFs exchange GTP for GDP on RABs | R-HSA-8876198 | 4.284808e-01 | 0.368 | 0 | 0 |
| Advanced glycosylation endproduct receptor signaling | R-HSA-879415 | 4.336958e-01 | 0.363 | 0 | 0 |
| Serotonin clearance from the synaptic cleft | R-HSA-380615 | 4.336958e-01 | 0.363 | 0 | 0 |
| MET activates RAS signaling | R-HSA-8851805 | 4.336958e-01 | 0.363 | 0 | 0 |
| Trafficking and processing of endosomal TLR | R-HSA-1679131 | 4.336958e-01 | 0.363 | 0 | 0 |
| Phosphorylation and nuclear translocation of the CRY:PER:kinase complex | R-HSA-9931530 | 4.336958e-01 | 0.363 | 0 | 0 |
| SHC-related events triggered by IGF1R | R-HSA-2428933 | 4.336958e-01 | 0.363 | 0 | 0 |
| Erythrocytes take up oxygen and release carbon dioxide | R-HSA-1247673 | 4.336958e-01 | 0.363 | 0 | 0 |
| Activated NTRK2 signals through FRS2 and FRS3 | R-HSA-9028731 | 4.336958e-01 | 0.363 | 0 | 0 |
| AKT phosphorylates targets in the cytosol | R-HSA-198323 | 4.336958e-01 | 0.363 | 0 | 0 |
| OAS antiviral response | R-HSA-8983711 | 4.336958e-01 | 0.363 | 0 | 0 |
| Metabolism of polyamines | R-HSA-351202 | 4.345517e-01 | 0.362 | 0 | 0 |
| RNA polymerase II transcribes snRNA genes | R-HSA-6807505 | 4.363085e-01 | 0.360 | 0 | 0 |
| Formation of WDR5-containing histone-modifying complexes | R-HSA-9772755 | 4.396741e-01 | 0.357 | 0 | 0 |
| PERK regulates gene expression | R-HSA-381042 | 4.396741e-01 | 0.357 | 0 | 0 |
| PLC beta mediated events | R-HSA-112043 | 4.438008e-01 | 0.353 | 0 | 0 |
| Lysosome Vesicle Biogenesis | R-HSA-432720 | 4.515425e-01 | 0.345 | 0 | 0 |
| G1/S-Specific Transcription | R-HSA-69205 | 4.515425e-01 | 0.345 | 0 | 0 |
| NCAM signaling for neurite out-growth | R-HSA-375165 | 4.529900e-01 | 0.344 | 0 | 0 |
| Defective binding of RB1 mutants to E2F1,(E2F2, E2F3) | R-HSA-9661069 | 4.534785e-01 | 0.343 | 0 | 0 |
| Formation of axial mesoderm | R-HSA-9796292 | 4.534785e-01 | 0.343 | 0 | 0 |
| Processing of SMDT1 | R-HSA-8949664 | 4.534785e-01 | 0.343 | 0 | 0 |
| Formation of the non-canonical BAF (ncBAF) complex | R-HSA-9933947 | 4.534785e-01 | 0.343 | 0 | 0 |
| Aberrant regulation of mitotic G1/S transition in cancer due to RB1 defects | R-HSA-9659787 | 4.534785e-01 | 0.343 | 0 | 0 |
| HDR through MMEJ (alt-NHEJ) | R-HSA-5685939 | 4.534785e-01 | 0.343 | 0 | 0 |
| Frs2-mediated activation | R-HSA-170968 | 4.534785e-01 | 0.343 | 0 | 0 |
| Interleukin-6 signaling | R-HSA-1059683 | 4.534785e-01 | 0.343 | 0 | 0 |
| Pre-NOTCH Expression and Processing | R-HSA-1912422 | 4.568304e-01 | 0.340 | 0 | 0 |
| Class I MHC mediated antigen processing & presentation | R-HSA-983169 | 4.671388e-01 | 0.331 | 0 | 0 |
| Neurotransmitter release cycle | R-HSA-112310 | 4.672904e-01 | 0.330 | 0 | 0 |
| Toll-like Receptor Cascades | R-HSA-168898 | 4.698604e-01 | 0.328 | 0 | 0 |
| Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs) | R-HSA-381426 | 4.704061e-01 | 0.328 | 0 | 0 |
| Ion transport by P-type ATPases | R-HSA-936837 | 4.711752e-01 | 0.327 | 0 | 0 |
| Removal of the Flap Intermediate | R-HSA-69166 | 4.725713e-01 | 0.326 | 0 | 0 |
| YAP1- and WWTR1 (TAZ)-stimulated gene expression | R-HSA-2032785 | 4.725713e-01 | 0.326 | 0 | 0 |
| Formation of the canonical BAF (cBAF) complex | R-HSA-9933937 | 4.725713e-01 | 0.326 | 0 | 0 |
| Formation of the polybromo-BAF (pBAF) complex | R-HSA-9933939 | 4.725713e-01 | 0.326 | 0 | 0 |
| Respiratory syncytial virus genome transcription | R-HSA-9828642 | 4.725713e-01 | 0.326 | 0 | 0 |
| Regulation of KIT signaling | R-HSA-1433559 | 4.725713e-01 | 0.326 | 0 | 0 |
| Zinc transporters | R-HSA-435354 | 4.725713e-01 | 0.326 | 0 | 0 |
| Signaling by FGFR4 in disease | R-HSA-5655291 | 4.725713e-01 | 0.326 | 0 | 0 |
| Elastic fibre formation | R-HSA-1566948 | 4.748421e-01 | 0.323 | 0 | 0 |
| SLC transporter disorders | R-HSA-5619102 | 4.852124e-01 | 0.314 | 0 | 0 |
| Formation of HIV-1 elongation complex containing HIV-1 Tat | R-HSA-167200 | 4.862649e-01 | 0.313 | 0 | 0 |
| Late SARS-CoV-2 Infection Events | R-HSA-9772573 | 4.901174e-01 | 0.310 | 0 | 0 |
| Adenylate cyclase inhibitory pathway | R-HSA-170670 | 4.909982e-01 | 0.309 | 0 | 0 |
| RNA Polymerase III Chain Elongation | R-HSA-73780 | 4.909982e-01 | 0.309 | 0 | 0 |
| Processive synthesis on the lagging strand | R-HSA-69183 | 4.909982e-01 | 0.309 | 0 | 0 |
| Tristetraprolin (TTP, ZFP36) binds and destabilizes mRNA | R-HSA-450513 | 4.909982e-01 | 0.309 | 0 | 0 |
| Formation of the embryonic stem cell BAF (esBAF) complex | R-HSA-9933946 | 4.909982e-01 | 0.309 | 0 | 0 |
| Butyrate Response Factor 1 (BRF1) binds and destabilizes mRNA | R-HSA-450385 | 4.909982e-01 | 0.309 | 0 | 0 |
| Signaling by PDGFRA transmembrane, juxtamembrane and kinase domain mutants | R-HSA-9673767 | 4.909982e-01 | 0.309 | 0 | 0 |
| Signaling by PDGFRA extracellular domain mutants | R-HSA-9673770 | 4.909982e-01 | 0.309 | 0 | 0 |
| Other semaphorin interactions | R-HSA-416700 | 4.909982e-01 | 0.309 | 0 | 0 |
| Rab regulation of trafficking | R-HSA-9007101 | 4.972214e-01 | 0.303 | 0 | 0 |
| HIV Transcription Elongation | R-HSA-167169 | 4.975316e-01 | 0.303 | 0 | 0 |
| Tat-mediated elongation of the HIV-1 transcript | R-HSA-167246 | 4.975316e-01 | 0.303 | 0 | 0 |
| Formation of HIV elongation complex in the absence of HIV Tat | R-HSA-167152 | 4.975316e-01 | 0.303 | 0 | 0 |
| Nuclear signaling by ERBB4 | R-HSA-1251985 | 4.975316e-01 | 0.303 | 0 | 0 |
| Collagen formation | R-HSA-1474290 | 5.051093e-01 | 0.297 | 0 | 0 |
| VEGFR2 mediated vascular permeability | R-HSA-5218920 | 5.086392e-01 | 0.294 | 0 | 0 |
| Purine ribonucleoside monophosphate biosynthesis | R-HSA-73817 | 5.086392e-01 | 0.294 | 0 | 0 |
| Aberrant regulation of mitotic exit in cancer due to RB1 defects | R-HSA-9687136 | 5.087824e-01 | 0.293 | 0 | 0 |
| Class I peroxisomal membrane protein import | R-HSA-9603798 | 5.087824e-01 | 0.293 | 0 | 0 |
| WNT5A-dependent internalization of FZD4 | R-HSA-5099900 | 5.087824e-01 | 0.293 | 0 | 0 |
| Receptor-type tyrosine-protein phosphatases | R-HSA-388844 | 5.087824e-01 | 0.293 | 0 | 0 |
| Prolonged ERK activation events | R-HSA-169893 | 5.087824e-01 | 0.293 | 0 | 0 |
| SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion | R-HSA-399955 | 5.087824e-01 | 0.293 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in G1 Cell Cycle Arrest | R-HSA-6804116 | 5.087824e-01 | 0.293 | 0 | 0 |
| Attachment and Entry | R-HSA-9678110 | 5.087824e-01 | 0.293 | 0 | 0 |
| Telomere C-strand (Lagging Strand) Synthesis | R-HSA-174417 | 5.195852e-01 | 0.284 | 0 | 0 |
| Antigen processing: Ub, ATP-independent proteasomal degradation | R-HSA-9912633 | 5.259464e-01 | 0.279 | 0 | 0 |
| TRAF3-dependent IRF activation pathway | R-HSA-918233 | 5.259464e-01 | 0.279 | 0 | 0 |
| Fibronectin matrix formation | R-HSA-1566977 | 5.259464e-01 | 0.279 | 0 | 0 |
| Inactivation of APC/C via direct inhibition of the APC/C complex | R-HSA-141430 | 5.259464e-01 | 0.279 | 0 | 0 |
| Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components | R-HSA-141405 | 5.259464e-01 | 0.279 | 0 | 0 |
| SHC1 events in ERBB4 signaling | R-HSA-1250347 | 5.259464e-01 | 0.279 | 0 | 0 |
| Synthesis, secretion, and inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP) | R-HSA-400511 | 5.259464e-01 | 0.279 | 0 | 0 |
| Acetylcholine regulates insulin secretion | R-HSA-399997 | 5.259464e-01 | 0.279 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest | R-HSA-6804114 | 5.259464e-01 | 0.279 | 0 | 0 |
| Cytosolic tRNA aminoacylation | R-HSA-379716 | 5.303671e-01 | 0.275 | 0 | 0 |
| Nuclear Events (kinase and transcription factor activation) | R-HSA-198725 | 5.409221e-01 | 0.267 | 0 | 0 |
| TBC/RABGAPs | R-HSA-8854214 | 5.409831e-01 | 0.267 | 0 | 0 |
| Signaling by SCF-KIT | R-HSA-1433557 | 5.409831e-01 | 0.267 | 0 | 0 |
| Removal of the Flap Intermediate from the C-strand | R-HSA-174437 | 5.425115e-01 | 0.266 | 0 | 0 |
| Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase | R-HSA-176407 | 5.425115e-01 | 0.266 | 0 | 0 |
| Mismatch repair (MMR) directed by MSH2:MSH3 (MutSbeta) | R-HSA-5358606 | 5.425115e-01 | 0.266 | 0 | 0 |
| Mismatch repair (MMR) directed by MSH2:MSH6 (MutSalpha) | R-HSA-5358565 | 5.425115e-01 | 0.266 | 0 | 0 |
| Epigenetic regulation of adipogenesis genes by MLL3 and MLL4 complexes | R-HSA-9851695 | 5.555037e-01 | 0.255 | 0 | 0 |
| MLL4 and MLL3 complexes regulate expression of PPARG target genes in adipogenesis and hepatic steatosis | R-HSA-9841922 | 5.555037e-01 | 0.255 | 0 | 0 |
| Epigenetic regulation of gene expression by MLL3 and MLL4 complexes | R-HSA-9818564 | 5.555037e-01 | 0.255 | 0 | 0 |
| Ephrin signaling | R-HSA-3928664 | 5.584988e-01 | 0.253 | 0 | 0 |
| Trafficking of GluR2-containing AMPA receptors | R-HSA-416993 | 5.584988e-01 | 0.253 | 0 | 0 |
| Tie2 Signaling | R-HSA-210993 | 5.584988e-01 | 0.253 | 0 | 0 |
| Mismatch Repair | R-HSA-5358508 | 5.584988e-01 | 0.253 | 0 | 0 |
| Signaling by TGFBR3 | R-HSA-9839373 | 5.718217e-01 | 0.243 | 0 | 0 |
| Abortive elongation of HIV-1 transcript in the absence of Tat | R-HSA-167242 | 5.739284e-01 | 0.241 | 0 | 0 |
| Signaling by FGFR2 IIIa TM | R-HSA-8851708 | 5.739284e-01 | 0.241 | 0 | 0 |
| Rap1 signalling | R-HSA-392517 | 5.739284e-01 | 0.241 | 0 | 0 |
| E2F mediated regulation of DNA replication | R-HSA-113510 | 5.739284e-01 | 0.241 | 0 | 0 |
| The NLRP3 inflammasome | R-HSA-844456 | 5.739284e-01 | 0.241 | 0 | 0 |
| O2/CO2 exchange in erythrocytes | R-HSA-1480926 | 5.739284e-01 | 0.241 | 0 | 0 |
| Erythrocytes take up carbon dioxide and release oxygen | R-HSA-1237044 | 5.739284e-01 | 0.241 | 0 | 0 |
| Strand-asynchronous mitochondrial DNA replication | R-HSA-9913635 | 5.739284e-01 | 0.241 | 0 | 0 |
| Other interleukin signaling | R-HSA-449836 | 5.739284e-01 | 0.241 | 0 | 0 |
| Signaling by NTRK1 (TRKA) | R-HSA-187037 | 5.741839e-01 | 0.241 | 0 | 0 |
| Retrograde transport at the Trans-Golgi-Network | R-HSA-6811440 | 5.817615e-01 | 0.235 | 0 | 0 |
| Formation of ATP by chemiosmotic coupling | R-HSA-163210 | 5.888196e-01 | 0.230 | 0 | 0 |
| Formation of neuronal progenitor and neuronal BAF (npBAF and nBAF) | R-HSA-9934037 | 5.888196e-01 | 0.230 | 0 | 0 |
| VxPx cargo-targeting to cilium | R-HSA-5620916 | 5.888196e-01 | 0.230 | 0 | 0 |
| Wax and plasmalogen biosynthesis | R-HSA-8848584 | 5.888196e-01 | 0.230 | 0 | 0 |
| BBSome-mediated cargo-targeting to cilium | R-HSA-5620922 | 5.888196e-01 | 0.230 | 0 | 0 |
| Creatine metabolism | R-HSA-71288 | 5.888196e-01 | 0.230 | 0 | 0 |
| TP53 Regulates Transcription of DNA Repair Genes | R-HSA-6796648 | 5.896034e-01 | 0.229 | 0 | 0 |
| GPER1 signaling | R-HSA-9634597 | 5.915304e-01 | 0.228 | 0 | 0 |
| NGF-stimulated transcription | R-HSA-9031628 | 5.915304e-01 | 0.228 | 0 | 0 |
| Chemokine receptors bind chemokines | R-HSA-380108 | 6.011284e-01 | 0.221 | 0 | 0 |
| MyD88 deficiency (TLR2/4) | R-HSA-5602498 | 6.031913e-01 | 0.220 | 0 | 0 |
| ADP signalling through P2Y purinoceptor 12 | R-HSA-392170 | 6.031913e-01 | 0.220 | 0 | 0 |
| SHC-mediated cascade:FGFR3 | R-HSA-5654704 | 6.031913e-01 | 0.220 | 0 | 0 |
| Synthesis, secretion, and deacylation of Ghrelin | R-HSA-422085 | 6.031913e-01 | 0.220 | 0 | 0 |
| Zygotic genome activation (ZGA) | R-HSA-9819196 | 6.031913e-01 | 0.220 | 0 | 0 |
| Azathioprine ADME | R-HSA-9748787 | 6.105553e-01 | 0.214 | 0 | 0 |
| Signaling by FGFR2 in disease | R-HSA-5655253 | 6.105553e-01 | 0.214 | 0 | 0 |
| IRAK4 deficiency (TLR2/4) | R-HSA-5603041 | 6.170615e-01 | 0.210 | 0 | 0 |
| Mitochondrial calcium ion transport | R-HSA-8949215 | 6.170615e-01 | 0.210 | 0 | 0 |
| SHC-mediated cascade:FGFR4 | R-HSA-5654719 | 6.170615e-01 | 0.210 | 0 | 0 |
| FRS-mediated FGFR3 signaling | R-HSA-5654706 | 6.170615e-01 | 0.210 | 0 | 0 |
| Serine metabolism | R-HSA-977347 | 6.170615e-01 | 0.210 | 0 | 0 |
| Androgen biosynthesis | R-HSA-193048 | 6.170615e-01 | 0.210 | 0 | 0 |
| Attachment and Entry | R-HSA-9694614 | 6.170615e-01 | 0.210 | 0 | 0 |
| Signaling by NTRK3 (TRKC) | R-HSA-9034015 | 6.170615e-01 | 0.210 | 0 | 0 |
| RNA Polymerase II Transcription | R-HSA-73857 | 6.224273e-01 | 0.206 | 0 | 0 |
| Formation of RNA Pol II elongation complex | R-HSA-112382 | 6.288972e-01 | 0.201 | 0 | 0 |
| Neurexins and neuroligins | R-HSA-6794361 | 6.288972e-01 | 0.201 | 0 | 0 |
| FGFR2 alternative splicing | R-HSA-6803529 | 6.304477e-01 | 0.200 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 3 Promoter | R-HSA-76071 | 6.304477e-01 | 0.200 | 0 | 0 |
| FRS-mediated FGFR4 signaling | R-HSA-5654712 | 6.304477e-01 | 0.200 | 0 | 0 |
| Signaling by phosphorylated juxtamembrane, extracellular and kinase domain KIT mutants | R-HSA-9670439 | 6.304477e-01 | 0.200 | 0 | 0 |
| RAF-independent MAPK1/3 activation | R-HSA-112409 | 6.304477e-01 | 0.200 | 0 | 0 |
| Signaling by KIT in disease | R-HSA-9669938 | 6.304477e-01 | 0.200 | 0 | 0 |
| RNA Polymerase II Transcription Elongation | R-HSA-75955 | 6.378132e-01 | 0.195 | 0 | 0 |
| Nucleotide biosynthesis | R-HSA-8956320 | 6.378132e-01 | 0.195 | 0 | 0 |
| Protein-protein interactions at synapses | R-HSA-6794362 | 6.420298e-01 | 0.192 | 0 | 0 |
| RNA Pol II CTD phosphorylation and interaction with CE during HIV infection | R-HSA-167160 | 6.433667e-01 | 0.192 | 0 | 0 |
| RNA Pol II CTD phosphorylation and interaction with CE | R-HSA-77075 | 6.433667e-01 | 0.192 | 0 | 0 |
| Formation of the ureteric bud | R-HSA-9830674 | 6.433667e-01 | 0.192 | 0 | 0 |
| Constitutive Signaling by AKT1 E17K in Cancer | R-HSA-5674400 | 6.433667e-01 | 0.192 | 0 | 0 |
| The role of Nef in HIV-1 replication and disease pathogenesis | R-HSA-164952 | 6.433667e-01 | 0.192 | 0 | 0 |
| G alpha (z) signalling events | R-HSA-418597 | 6.551392e-01 | 0.184 | 0 | 0 |
| Leishmania phagocytosis | R-HSA-9664417 | 6.555091e-01 | 0.183 | 0 | 0 |
| FCGR3A-mediated phagocytosis | R-HSA-9664422 | 6.555091e-01 | 0.183 | 0 | 0 |
| Parasite infection | R-HSA-9664407 | 6.555091e-01 | 0.183 | 0 | 0 |
| CD209 (DC-SIGN) signaling | R-HSA-5621575 | 6.558349e-01 | 0.183 | 0 | 0 |
| SHC-mediated cascade:FGFR1 | R-HSA-5654688 | 6.558349e-01 | 0.183 | 0 | 0 |
| Replacement of protamines by nucleosomes in the male pronucleus | R-HSA-9821993 | 6.558349e-01 | 0.183 | 0 | 0 |
| Plasma lipoprotein assembly | R-HSA-8963898 | 6.558349e-01 | 0.183 | 0 | 0 |
| Complex III assembly | R-HSA-9865881 | 6.558349e-01 | 0.183 | 0 | 0 |
| Signaling by FLT3 ITD and TKD mutants | R-HSA-9703648 | 6.558349e-01 | 0.183 | 0 | 0 |
| Interleukin-6 family signaling | R-HSA-6783589 | 6.558349e-01 | 0.183 | 0 | 0 |
| NRAGE signals death through JNK | R-HSA-193648 | 6.635511e-01 | 0.178 | 0 | 0 |
| SWI/SNF chromatin remodelers | R-HSA-9932451 | 6.678679e-01 | 0.175 | 0 | 0 |
| ATP-dependent chromatin remodelers | R-HSA-9932444 | 6.678679e-01 | 0.175 | 0 | 0 |
| Acyl chain remodelling of PS | R-HSA-1482801 | 6.678679e-01 | 0.175 | 0 | 0 |
| FRS-mediated FGFR1 signaling | R-HSA-5654693 | 6.678679e-01 | 0.175 | 0 | 0 |
| Hyaluronan degradation | R-HSA-2160916 | 6.678679e-01 | 0.175 | 0 | 0 |
| HDMs demethylate histones | R-HSA-3214842 | 6.678679e-01 | 0.175 | 0 | 0 |
| Generic Transcription Pathway | R-HSA-212436 | 6.774322e-01 | 0.169 | 0 | 0 |
| Adrenaline,noradrenaline inhibits insulin secretion | R-HSA-400042 | 6.794809e-01 | 0.168 | 0 | 0 |
| TRP channels | R-HSA-3295583 | 6.794809e-01 | 0.168 | 0 | 0 |
| Myogenesis | R-HSA-525793 | 6.794809e-01 | 0.168 | 0 | 0 |
| Sphingolipid catabolism | R-HSA-9845614 | 6.794809e-01 | 0.168 | 0 | 0 |
| Synthesis of PIPs at the Golgi membrane | R-HSA-1660514 | 6.794809e-01 | 0.168 | 0 | 0 |
| Peptide hormone metabolism | R-HSA-2980736 | 6.839844e-01 | 0.165 | 0 | 0 |
| Assembly of collagen fibrils and other multimeric structures | R-HSA-2022090 | 6.877970e-01 | 0.163 | 0 | 0 |
| PI3K/AKT Signaling in Cancer | R-HSA-2219528 | 6.896510e-01 | 0.161 | 0 | 0 |
| Processive synthesis on the C-strand of the telomere | R-HSA-174414 | 6.906886e-01 | 0.161 | 0 | 0 |
| Phosphorylation of CD3 and TCR zeta chains | R-HSA-202427 | 6.906886e-01 | 0.161 | 0 | 0 |
| SHC-mediated cascade:FGFR2 | R-HSA-5654699 | 6.906886e-01 | 0.161 | 0 | 0 |
| Maturation of hRSV A proteins | R-HSA-9828806 | 6.906886e-01 | 0.161 | 0 | 0 |
| Signaling by FGFR3 in disease | R-HSA-5655332 | 6.906886e-01 | 0.161 | 0 | 0 |
| tRNA Aminoacylation | R-HSA-379724 | 6.955538e-01 | 0.158 | 0 | 0 |
| Bacterial Infection Pathways | R-HSA-9824439 | 7.008772e-01 | 0.154 | 0 | 0 |
| Formation of the HIV-1 Early Elongation Complex | R-HSA-167158 | 7.015050e-01 | 0.154 | 0 | 0 |
| Formation of the Early Elongation Complex | R-HSA-113418 | 7.015050e-01 | 0.154 | 0 | 0 |
| RUNX2 regulates osteoblast differentiation | R-HSA-8940973 | 7.015050e-01 | 0.154 | 0 | 0 |
| FRS-mediated FGFR2 signaling | R-HSA-5654700 | 7.015050e-01 | 0.154 | 0 | 0 |
| Inflammasomes | R-HSA-622312 | 7.015050e-01 | 0.154 | 0 | 0 |
| ATF4 activates genes in response to endoplasmic reticulum stress | R-HSA-380994 | 7.015050e-01 | 0.154 | 0 | 0 |
| Pyroptosis | R-HSA-5620971 | 7.015050e-01 | 0.154 | 0 | 0 |
| Signaling by NTRKs | R-HSA-166520 | 7.022173e-01 | 0.154 | 0 | 0 |
| Synthesis of PIPs at the plasma membrane | R-HSA-1660499 | 7.105892e-01 | 0.148 | 0 | 0 |
| mRNA Capping | R-HSA-72086 | 7.119438e-01 | 0.148 | 0 | 0 |
| Regulation of gene expression in beta cells | R-HSA-210745 | 7.119438e-01 | 0.148 | 0 | 0 |
| Regulation of CDH11 Expression and Function | R-HSA-9759475 | 7.119438e-01 | 0.148 | 0 | 0 |
| Downstream signaling of activated FGFR3 | R-HSA-5654708 | 7.119438e-01 | 0.148 | 0 | 0 |
| DARPP-32 events | R-HSA-180024 | 7.119438e-01 | 0.148 | 0 | 0 |
| MITF-M-dependent gene expression | R-HSA-9856651 | 7.119771e-01 | 0.148 | 0 | 0 |
| Mitochondrial protein degradation | R-HSA-9837999 | 7.145183e-01 | 0.146 | 0 | 0 |
| Activation of the pre-replicative complex | R-HSA-68962 | 7.220182e-01 | 0.141 | 0 | 0 |
| Energy dependent regulation of mTOR by LKB1-AMPK | R-HSA-380972 | 7.220182e-01 | 0.141 | 0 | 0 |
| Downstream signaling of activated FGFR4 | R-HSA-5654716 | 7.220182e-01 | 0.141 | 0 | 0 |
| Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation | R-HSA-1474151 | 7.220182e-01 | 0.141 | 0 | 0 |
| Neurotransmitter clearance | R-HSA-112311 | 7.220182e-01 | 0.141 | 0 | 0 |
| DAP12 signaling | R-HSA-2424491 | 7.220182e-01 | 0.141 | 0 | 0 |
| Regulation of insulin secretion | R-HSA-422356 | 7.434994e-01 | 0.129 | 0 | 0 |
| Regulation of TP53 Activity through Acetylation | R-HSA-6804758 | 7.501794e-01 | 0.125 | 0 | 0 |
| Activation of ATR in response to replication stress | R-HSA-176187 | 7.501794e-01 | 0.125 | 0 | 0 |
| RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known | R-HSA-8939243 | 7.501794e-01 | 0.125 | 0 | 0 |
| Regulation of Expression and Function of Type II Classical Cadherins | R-HSA-9764260 | 7.501794e-01 | 0.125 | 0 | 0 |
| Synthesis of IP3 and IP4 in the cytosol | R-HSA-1855204 | 7.501794e-01 | 0.125 | 0 | 0 |
| Transcription of the HIV genome | R-HSA-167172 | 7.520002e-01 | 0.124 | 0 | 0 |
| Collagen biosynthesis and modifying enzymes | R-HSA-1650814 | 7.520002e-01 | 0.124 | 0 | 0 |
| Acyl chain remodelling of PC | R-HSA-1482788 | 7.589187e-01 | 0.120 | 0 | 0 |
| EGR2 and SOX10-mediated initiation of Schwann cell myelination | R-HSA-9619665 | 7.589187e-01 | 0.120 | 0 | 0 |
| Fatty acyl-CoA biosynthesis | R-HSA-75105 | 7.646249e-01 | 0.117 | 0 | 0 |
| PI Metabolism | R-HSA-1483255 | 7.649590e-01 | 0.116 | 0 | 0 |
| Cardiac conduction | R-HSA-5576891 | 7.660229e-01 | 0.116 | 0 | 0 |
| eNOS activation | R-HSA-203615 | 7.673527e-01 | 0.115 | 0 | 0 |
| Regulation of TLR by endogenous ligand | R-HSA-5686938 | 7.673527e-01 | 0.115 | 0 | 0 |
| Hyaluronan metabolism | R-HSA-2142845 | 7.673527e-01 | 0.115 | 0 | 0 |
| Antigen Presentation: Folding, assembly and peptide loading of class I MHC | R-HSA-983170 | 7.673527e-01 | 0.115 | 0 | 0 |
| Signal amplification | R-HSA-392518 | 7.673527e-01 | 0.115 | 0 | 0 |
| Glycosaminoglycan-protein linkage region biosynthesis | R-HSA-1971475 | 7.673527e-01 | 0.115 | 0 | 0 |
| Degradation of the extracellular matrix | R-HSA-1474228 | 7.705485e-01 | 0.113 | 0 | 0 |
| Metabolism of cofactors | R-HSA-8978934 | 7.707256e-01 | 0.113 | 0 | 0 |
| ECM proteoglycans | R-HSA-3000178 | 7.707256e-01 | 0.113 | 0 | 0 |
| Acyl chain remodelling of PE | R-HSA-1482839 | 7.754922e-01 | 0.110 | 0 | 0 |
| Downstream signaling of activated FGFR2 | R-HSA-5654696 | 7.754922e-01 | 0.110 | 0 | 0 |
| Downstream signaling of activated FGFR1 | R-HSA-5654687 | 7.754922e-01 | 0.110 | 0 | 0 |
| GPVI-mediated activation cascade | R-HSA-114604 | 7.833474e-01 | 0.106 | 0 | 0 |
| RUNX2 regulates bone development | R-HSA-8941326 | 7.833474e-01 | 0.106 | 0 | 0 |
| FGFR2 mutant receptor activation | R-HSA-1839126 | 7.833474e-01 | 0.106 | 0 | 0 |
| RNA Polymerase II Pre-transcription Events | R-HSA-674695 | 7.882073e-01 | 0.103 | 0 | 0 |
| Signaling by FGFR in disease | R-HSA-1226099 | 7.882073e-01 | 0.103 | 0 | 0 |
| TRAF6 mediated IRF7 activation | R-HSA-933541 | 7.909282e-01 | 0.102 | 0 | 0 |
| Ubiquinol biosynthesis | R-HSA-2142789 | 7.909282e-01 | 0.102 | 0 | 0 |
| Metabolism of folate and pterines | R-HSA-196757 | 7.909282e-01 | 0.102 | 0 | 0 |
| Integration of energy metabolism | R-HSA-163685 | 7.921530e-01 | 0.101 | 0 | 0 |
| Metabolism of nitric oxide: NOS3 activation and regulation | R-HSA-202131 | 7.982443e-01 | 0.098 | 0 | 0 |
| SLC-mediated transport of inorganic anions | R-HSA-9958790 | 7.982443e-01 | 0.098 | 0 | 0 |
| Transcriptional Regulation by E2F6 | R-HSA-8953750 | 8.053047e-01 | 0.094 | 0 | 0 |
| Synthesis, secretion, and inactivation of Glucagon-like Peptide-1 (GLP-1) | R-HSA-381771 | 8.053047e-01 | 0.094 | 0 | 0 |
| Expression of BMAL (ARNTL), CLOCK, and NPAS2 | R-HSA-9931509 | 8.053047e-01 | 0.094 | 0 | 0 |
| Cell surface interactions at the vascular wall | R-HSA-202733 | 8.069089e-01 | 0.093 | 0 | 0 |
| Interleukin-10 signaling | R-HSA-6783783 | 8.096849e-01 | 0.092 | 0 | 0 |
| G alpha (12/13) signalling events | R-HSA-416482 | 8.096849e-01 | 0.092 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation | R-HSA-9843743 | 8.121185e-01 | 0.090 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation by EBF2 | R-HSA-9844594 | 8.121185e-01 | 0.090 | 0 | 0 |
| RNA Polymerase II Transcription Pre-Initiation And Promoter Opening | R-HSA-73779 | 8.121185e-01 | 0.090 | 0 | 0 |
| Diseases of Immune System | R-HSA-5260271 | 8.121185e-01 | 0.090 | 0 | 0 |
| Diseases associated with the TLR signaling cascade | R-HSA-5602358 | 8.121185e-01 | 0.090 | 0 | 0 |
| Generation of second messenger molecules | R-HSA-202433 | 8.121185e-01 | 0.090 | 0 | 0 |
| Mitochondrial tRNA aminoacylation | R-HSA-379726 | 8.121185e-01 | 0.090 | 0 | 0 |
| PKMTs methylate histone lysines | R-HSA-3214841 | 8.186942e-01 | 0.087 | 0 | 0 |
| Transcriptional Regulation by VENTX | R-HSA-8853884 | 8.186942e-01 | 0.087 | 0 | 0 |
| High laminar flow shear stress activates signaling by PIEZO1 and PECAM1:CDH5:KDR in endothelial cells | R-HSA-9856530 | 8.196790e-01 | 0.086 | 0 | 0 |
| RNA Polymerase II HIV Promoter Escape | R-HSA-167162 | 8.250402e-01 | 0.084 | 0 | 0 |
| HIV Transcription Initiation | R-HSA-167161 | 8.250402e-01 | 0.084 | 0 | 0 |
| RNA Polymerase II Transcription Initiation | R-HSA-75953 | 8.250402e-01 | 0.084 | 0 | 0 |
| Scavenging by Class A Receptors | R-HSA-3000480 | 8.250402e-01 | 0.084 | 0 | 0 |
| SLC-mediated transport of neurotransmitters | R-HSA-442660 | 8.250402e-01 | 0.084 | 0 | 0 |
| Signaling by FGFR1 in disease | R-HSA-5655302 | 8.250402e-01 | 0.084 | 0 | 0 |
| Aerobic respiration and respiratory electron transport | R-HSA-1428517 | 8.252039e-01 | 0.083 | 0 | 0 |
| Activation of GABAB receptors | R-HSA-991365 | 8.311644e-01 | 0.080 | 0 | 0 |
| GABA B receptor activation | R-HSA-977444 | 8.311644e-01 | 0.080 | 0 | 0 |
| Incretin synthesis, secretion, and inactivation | R-HSA-400508 | 8.311644e-01 | 0.080 | 0 | 0 |
| RNA Polymerase II Promoter Escape | R-HSA-73776 | 8.370746e-01 | 0.077 | 0 | 0 |
| Synthesis of very long-chain fatty acyl-CoAs | R-HSA-75876 | 8.370746e-01 | 0.077 | 0 | 0 |
| Synthesis of Leukotrienes (LT) and Eoxins (EX) | R-HSA-2142691 | 8.427782e-01 | 0.074 | 0 | 0 |
| DAP12 interactions | R-HSA-2172127 | 8.427782e-01 | 0.074 | 0 | 0 |
| Mitochondrial biogenesis | R-HSA-1592230 | 8.440606e-01 | 0.074 | 0 | 0 |
| RNA Polymerase II Transcription Initiation And Promoter Clearance | R-HSA-76042 | 8.482826e-01 | 0.071 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in pigmentation | R-HSA-9824585 | 8.482826e-01 | 0.071 | 0 | 0 |
| ADORA2B mediated anti-inflammatory cytokines production | R-HSA-9660821 | 8.482826e-01 | 0.071 | 0 | 0 |
| Peptide ligand-binding receptors | R-HSA-375276 | 8.528955e-01 | 0.069 | 0 | 0 |
| Purinergic signaling in leishmaniasis infection | R-HSA-9660826 | 8.535945e-01 | 0.069 | 0 | 0 |
| Cell recruitment (pro-inflammatory response) | R-HSA-9664424 | 8.535945e-01 | 0.069 | 0 | 0 |
| Inactivation, recovery and regulation of the phototransduction cascade | R-HSA-2514859 | 8.535945e-01 | 0.069 | 0 | 0 |
| Metal ion SLC transporters | R-HSA-425410 | 8.636679e-01 | 0.064 | 0 | 0 |
| Plasma lipoprotein remodeling | R-HSA-8963899 | 8.636679e-01 | 0.064 | 0 | 0 |
| Formation of the cornified envelope | R-HSA-6809371 | 8.679553e-01 | 0.062 | 0 | 0 |
| Synthesis of Prostaglandins (PG) and Thromboxanes (TX) | R-HSA-2162123 | 8.730493e-01 | 0.059 | 0 | 0 |
| The phototransduction cascade | R-HSA-2514856 | 8.774955e-01 | 0.057 | 0 | 0 |
| Constitutive Signaling by Aberrant PI3K in Cancer | R-HSA-2219530 | 8.840696e-01 | 0.054 | 0 | 0 |
| Amino acids regulate mTORC1 | R-HSA-9639288 | 8.859269e-01 | 0.053 | 0 | 0 |
| Negative regulation of the PI3K/AKT network | R-HSA-199418 | 8.885644e-01 | 0.051 | 0 | 0 |
| Metabolism of nucleotides | R-HSA-15869 | 8.917703e-01 | 0.050 | 0 | 0 |
| Detoxification of Reactive Oxygen Species | R-HSA-3299685 | 8.975002e-01 | 0.047 | 0 | 0 |
| Dectin-2 family | R-HSA-5621480 | 9.010914e-01 | 0.045 | 0 | 0 |
| IRS-mediated signalling | R-HSA-112399 | 9.010914e-01 | 0.045 | 0 | 0 |
| FOXO-mediated transcription | R-HSA-9614085 | 9.021734e-01 | 0.045 | 0 | 0 |
| NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux | R-HSA-9029569 | 9.045569e-01 | 0.044 | 0 | 0 |
| Early SARS-CoV-2 Infection Events | R-HSA-9772572 | 9.045569e-01 | 0.044 | 0 | 0 |
| Regulation of beta-cell development | R-HSA-186712 | 9.079013e-01 | 0.042 | 0 | 0 |
| Parasitic Infection Pathways | R-HSA-9824443 | 9.098819e-01 | 0.041 | 0 | 0 |
| Leishmania infection | R-HSA-9658195 | 9.098819e-01 | 0.041 | 0 | 0 |
| GABA receptor activation | R-HSA-977443 | 9.111286e-01 | 0.040 | 0 | 0 |
| IRS-related events triggered by IGF1R | R-HSA-2428928 | 9.142430e-01 | 0.039 | 0 | 0 |
| Heme signaling | R-HSA-9707616 | 9.172485e-01 | 0.038 | 0 | 0 |
| Complex I biogenesis | R-HSA-6799198 | 9.201488e-01 | 0.036 | 0 | 0 |
| IGF1R signaling cascade | R-HSA-2428924 | 9.229477e-01 | 0.035 | 0 | 0 |
| Insulin receptor signalling cascade | R-HSA-74751 | 9.229477e-01 | 0.035 | 0 | 0 |
| Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R) | R-HSA-2404192 | 9.256486e-01 | 0.034 | 0 | 0 |
| tRNA modification in the nucleus and cytosol | R-HSA-6782315 | 9.282550e-01 | 0.032 | 0 | 0 |
| Kidney development | R-HSA-9830369 | 9.307702e-01 | 0.031 | 0 | 0 |
| Metabolism of steroid hormones | R-HSA-196071 | 9.307702e-01 | 0.031 | 0 | 0 |
| FCERI mediated MAPK activation | R-HSA-2871796 | 9.346585e-01 | 0.029 | 0 | 0 |
| Binding and Uptake of Ligands by Scavenger Receptors | R-HSA-2173782 | 9.375129e-01 | 0.028 | 0 | 0 |
| Ca2+ pathway | R-HSA-4086398 | 9.441166e-01 | 0.025 | 0 | 0 |
| PPARA activates gene expression | R-HSA-1989781 | 9.451055e-01 | 0.025 | 0 | 0 |
| Regulation of lipid metabolism by PPARalpha | R-HSA-400206 | 9.478956e-01 | 0.023 | 0 | 0 |
| NR1H2 and NR1H3-mediated signaling | R-HSA-9024446 | 9.515542e-01 | 0.022 | 0 | 0 |
| Regulation of cholesterol biosynthesis by SREBP (SREBF) | R-HSA-1655829 | 9.548937e-01 | 0.020 | 0 | 0 |
| PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling | R-HSA-6811558 | 9.554393e-01 | 0.020 | 0 | 0 |
| Transcriptional activation of mitochondrial biogenesis | R-HSA-2151201 | 9.580034e-01 | 0.019 | 0 | 0 |
| Adipogenesis | R-HSA-9843745 | 9.669548e-01 | 0.015 | 0 | 0 |
| G alpha (i) signalling events | R-HSA-418594 | 9.680054e-01 | 0.014 | 0 | 0 |
| Signaling by Insulin receptor | R-HSA-74752 | 9.736081e-01 | 0.012 | 0 | 0 |
| Transcriptional regulation of white adipocyte differentiation | R-HSA-381340 | 9.779285e-01 | 0.010 | 0 | 0 |
| Role of LAT2/NTAL/LAB on calcium mobilization | R-HSA-2730905 | 9.779285e-01 | 0.010 | 0 | 0 |
| Synthesis of bile acids and bile salts | R-HSA-192105 | 9.801738e-01 | 0.009 | 0 | 0 |
| Arachidonate metabolism | R-HSA-2142753 | 9.835955e-01 | 0.007 | 0 | 0 |
| Keratinization | R-HSA-6805567 | 9.869834e-01 | 0.006 | 0 | 0 |
| Bile acid and bile salt metabolism | R-HSA-194068 | 9.870945e-01 | 0.006 | 0 | 0 |
| FCERI mediated Ca+2 mobilization | R-HSA-2871809 | 9.899552e-01 | 0.004 | 0 | 0 |
| G alpha (q) signalling events | R-HSA-416476 | 9.907503e-01 | 0.004 | 0 | 0 |
| G alpha (s) signalling events | R-HSA-418555 | 9.911847e-01 | 0.004 | 0 | 0 |
| Leishmania parasite growth and survival | R-HSA-9664433 | 9.917200e-01 | 0.004 | 0 | 0 |
| Anti-inflammatory response favouring Leishmania parasite infection | R-HSA-9662851 | 9.917200e-01 | 0.004 | 0 | 0 |
| Glycosaminoglycan metabolism | R-HSA-1630316 | 9.955957e-01 | 0.002 | 0 | 0 |
| GPCR downstream signalling | R-HSA-388396 | 9.959395e-01 | 0.002 | 0 | 0 |
| Phospholipid metabolism | R-HSA-1483257 | 9.959934e-01 | 0.002 | 0 | 0 |
| Visual phototransduction | R-HSA-2187338 | 9.972365e-01 | 0.001 | 0 | 0 |
| Drug ADME | R-HSA-9748784 | 9.980838e-01 | 0.001 | 0 | 0 |
| Diseases of metabolism | R-HSA-5668914 | 9.986819e-01 | 0.001 | 0 | 0 |
| Class A/1 (Rhodopsin-like receptors) | R-HSA-373076 | 9.990640e-01 | 0.000 | 0 | 0 |
| Respiratory electron transport | R-HSA-611105 | 9.991246e-01 | 0.000 | 0 | 0 |
| Signaling by GPCR | R-HSA-372790 | 9.991979e-01 | 0.000 | 0 | 0 |
| Metabolism of steroids | R-HSA-8957322 | 9.996054e-01 | 0.000 | 0 | 0 |
| Sphingolipid metabolism | R-HSA-428157 | 9.996174e-01 | 0.000 | 0 | 0 |
| Glycerophospholipid biosynthesis | R-HSA-1483206 | 9.996440e-01 | 0.000 | 0 | 0 |
| Transport of small molecules | R-HSA-382551 | 9.996947e-01 | 0.000 | 0 | 0 |
| Phase I - Functionalization of compounds | R-HSA-211945 | 9.997302e-01 | 0.000 | 0 | 0 |
| Fatty acid metabolism | R-HSA-8978868 | 9.998435e-01 | 0.000 | 0 | 0 |
| Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell | R-HSA-198933 | 9.998655e-01 | 0.000 | 0 | 0 |
| Metabolism of water-soluble vitamins and cofactors | R-HSA-196849 | 9.998703e-01 | 0.000 | 0 | 0 |
| Metabolism of vitamins and cofactors | R-HSA-196854 | 9.998864e-01 | 0.000 | 0 | 0 |
| SLC-mediated transmembrane transport | R-HSA-425407 | 9.999613e-01 | 0.000 | 0 | 0 |
| GPCR ligand binding | R-HSA-500792 | 9.999967e-01 | 0.000 | 0 | 0 |
| Biological oxidations | R-HSA-211859 | 9.999999e-01 | 0.000 | 0 | 0 |
| Metabolism | R-HSA-1430728 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of lipids | R-HSA-556833 | 1.000000e+00 | 0.000 | 0 | 0 |
| Sensory Perception | R-HSA-9709957 | 1.000000e+00 | 0.000 | 0 | 0 |